Sentence,class,file
Nature 477:486 – 489. http://dx.doi.org/10.1038/nature10402 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1073/ pnas.1102716108 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
Mol Cell 46:595– 605. http://dx.doi.org/10.1016/ j.molcel.2012.03.018 .,OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1074/jbc.M111.270017 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1038/emboj.2011.41 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
Nat Rev Microbiol 9:467– 477. http://dx.doi.org/10.1038/ nrmicro2577 .,OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1128/mBio.00227 -10.,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
Front Cell Infect Microbiol 4:37. http://dx.doi.org/10.3389/fcimb.2014.00037 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
Bacte- riophage genes that inactivate the CRISPR/Cas bacterial immune system.Nature 493:429 – 432. http://dx.doi.org/10.1038/nature11723 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1128/mBio.00896-14 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
Clin Microbiol Infect 11:670 – 673. http://dx.doi.org/10.1111/ j.1469-0691.2005.01196.x .,OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1093/jac/dku546 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1111/j.1469-0691.2011.03570.x .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1093/nar/gkv094 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1371/journal.pone.0060575 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1128/JB.186.2.518-534.2004 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1038/nature15254 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1371/ journal.pone.0036995 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1002/ biot.200700035 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1128/ JCM.41.1.15-26.2003 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1111/ j.1365-2958.1993.tb00976.x .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
Microbiology 151: 653– 663. http://dx.doi.org/10.1099/mic.0.27437-0 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1016/j.tig.2010.05.008 .,OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
BMC Genomics 12:438. http://dx.doi.org/10.1186/1471-2164-12-438 .,OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1128/genomeA.00233-14 .,OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
Virus Res 189:43– 46. http://dx.doi.org/ 10.1016/j.virusres.2014.04.019 .,OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1016/j.jmb.2005.08.075 .,OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1371/journal.pone.0016963 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
Genomics of IncP-1 antibiotic resistance plasmids isolated from wastewater treatmentplants provides evidence for a widely accessible drug resistance gene pool.FEMS Microbiol Rev 31:449 – 477. http://dx.doi.org/10.1111/j.1574 -6976.2007.00074.x .,OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1128/AAC.00423-13 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1128/JB.00041-10 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1093/jac/dkp142 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/ 10.1038/nbt.2842 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1128/ IAI.70.8.3985-3993.2002 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/ 10.1128/MMBR.00015-09 .66.,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1073/ pnas.1500107112 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1038/nbt.3011 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1038/nbt.3043 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/ 10.1128/mBio.00928-13 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1371/journal.pgen.1003454 .,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1099/mic.0.060814-0 .Distribution of CRISPR-Cas Systems in P. aeruginosa November/December 2015 Volume 6 Issue 6 e01796-15®mbio.asm.org 13,Non-OADS,/arxiv_data1/oa_pdf/af/dd/mBio.01796-15.PMC4669384.pdf
http://dx.doi.org/10.1002/biot.200700168 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
Appl Microbiol Biotechnol 83:415– 423. http://dx.doi.org/10.1007/s00253-009 -2003-y .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1111/j.1574-6976.1995.tb00163.x .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1111/j.1574 -6976.1995.tb00212.x .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/ 10.1016/S0167-7799(97)01141-4 .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1111/j.1574-6968.1995.tb07344.x .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1016/j.jbiotec.2012.03.027 .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1016/j.jbiotec.2012.03.018 .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
BMC Syst Biol 7:120. http://dx.doi.org/10.1186/ 1752-0509-7-120 .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
BMC Genomics 14:849. http://dx.doi.org/ 10.1186/1471-2164-14-849 .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
Na- ture380:489. http://dx.doi.org/10.1038/380489a0 .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
J Bacteriol 183: 4823– 4838. http://dx.doi.org/10.1128/JB.183.16.4823-4838.2001 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1128/JB.187.20.7103 -7118.2005 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/ 10.1007/s00253-010-2741-x .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1186/ gb-2008-9-7-r114 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1007/s10295-005 -0050-7 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
Appl Environ Microbiol 73:4631– 4638. http://dx.doi.org/10.1128/AEM.00144-07 .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1099/ mic.0.037085-0 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1039/ C4MB00600C .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1021/pr9012078 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
Clin Proteomics 11:16. http://dx.doi.org/10.1186/1559-0275-11-16 .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
Proteome Sci 9:66.http://dx.doi.org/10.1186/1477-5956-9-66 .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1016/ j.ymeth.2013.03.013 .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1159/000320973 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1128/ JB.01380-10 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1128/JB.00088-11 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1186/s13068-015-0260-9 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1007/BF00499955 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
J Bacteriol 190:843– 850. http://dx.doi.org/10.1128/ JB.01417-07 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1016/ j.ymben.2008.07.005 .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
BiotechnolBiofuels 7:144. http://dx.doi.org/10.1186/s13068-014-0144-4 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
BMC Syst Biol 6:42. http://dx.doi.org/ 10.1186/1752-0509-6-42 .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1016/0003-9861(89)90489-X .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1007/BF00286322 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/ 10.1016/0003-2697(80)90286-9 .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
J Bacte- riol192:4452– 4461. http://dx.doi.org/10.1128/JB.00490-10 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1002/bit.22010 .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1002/bit.22009 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
Appl Microbiol Biotechnol 80:849 – 862. http://dx.doi.org/10.1007/s00253-008-1654-4 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1002/(SICI)1097-0290(20000105)67:1 /H110211::AID -BIT1/H110223.0.CO;2-G .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1002/ biot.200900142 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
BMC Genomics 15:154. http://dx.doi.org/ 10.1186/1471-2164-15-154 .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1128/AEM.05374-11 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1111/j.1574 -6968.2002.tb11450.x .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1046/j.1365-2958.2000.02071.x .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1128/ JB.184.7.1966-1973.2002 .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1128/JB.186.7.2006-2018.2004 .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
Biochem J 449: 79 – 89. http://dx.doi.org/ 10.1042/BJ20120871 .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/ 10.1099/13500872-145-8-1839 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/ 10.1016/S1046-5928(02)00032-3 .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1016/j.ymben.2014.08.002 .System-Scale Analysis of Clostridium acetobutylicum November/December 2015 Volume 6 Issue 6 e01808-15®mbio.asm.org 11,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
J Microbiol Methods 68:396 – 402. http://dx.doi.org/10.1016/j.mimet.2006.09.018 .,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1002/ bit.260280408 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
Metab Eng 18:1– 8. http://dx.doi.org/10.1016/j.ymben.2013.03.003 .Yoo et al.,OADS,/arxiv_data1/oa_pdf/9f/4f/mBio.01808-15.PMC4669385.pdf
http://dx.doi.org/10.1128/mBio.01780-15 .,Non-OADS,/arxiv_data1/oa_pdf/39/87/mBio.01838-15.PMC4669386.pdf
http://dx.doi.org/10.1128/ mBio.00622-15 .,Non-OADS,/arxiv_data1/oa_pdf/39/87/mBio.01838-15.PMC4669386.pdf
"http://dx.doi.org/10.1172/JCI82478 .4.Nasser W, Beres SB, Olsen RJ, Dean MA, Rice KA, Long SW, Kristinsson KG, Gottfredsson M, Vuopio J, Raisanen K, Caugant DA, Steinbakk M,Low DE, McGeer A, Darenberg J, Henriques-Normark B, Van BenedenCA, Hoffmann S, Musser JM .",OADS,/arxiv_data1/oa_pdf/39/87/mBio.01838-15.PMC4669386.pdf
http://dx.doi.org/10.1128/mBio.01378-15 .,Non-OADS,/arxiv_data1/oa_pdf/39/87/mBio.01838-15.PMC4669386.pdf
http://dx.doi.org/10.1093/ infdis/77.2.96 .,OADS,/arxiv_data1/oa_pdf/39/87/mBio.01838-15.PMC4669386.pdf
http://dx.doi.org/10.1007/s11604-008-0291-2 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
Nat Rev Immunol 3:801– 812. http://dx.doi.org/ 10.1038/nri1201 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
J Gen Virol 68:805– 811. http://dx.doi.org/10.1099/0022-1317-68 -3-805 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1136/mp.52.6.307 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1056/ NEJM198803243181203 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1002/rmv.456 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
Clin Can- cer Res 10:803– 821. http://dx.doi.org/10.1158/1078-0432.CCR-0670-3 .,OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1136/ jcp.2007.047977 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1007/978-3 -642-56515-1_9 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1016/S0002-9440(10)64940-1 .,OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1016/S0002-9440(10)64940-1 .,OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1128/ JVI.74.21.10142-10152.2000 .,OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/ 10.1016/0092-8674(87)90216-9 .,OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1016/ j.virol.2009.03.030 .,OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1038/nm830 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1007/978-0-387-46816-7_5 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1016/S1040-8428(02)00078-1 .21.,OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
J Virol86:6146 – 6158. http://dx.doi.org/10.1128/JVI.00013-12 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
Proc Natl Acad Sc iUSA 96:4546 – 4551. http://dx.doi.org/ 10.1073/pnas.96.8.4546 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/ 10.1038/sj.onc.1206556 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.2741/ 1394 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1002/ijc.2910530128 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1371/ journal.pone.0044810 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1128/JVI.76.24.12503-12512.2002 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
Arch Neurol 63:810 – 811. http://dx.doi.org/10.1001/ archneur.63.6.810 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
Arch Neu-rol63:839 – 844. http://dx.doi.org/10.1001/archneur.63.6.noc50328 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1177/1352458511408991 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.12659/AOT.883468 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/ 10.1136/practneurol-2011-000115 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1002/ (SICI)1097-4598(199911)22:11 /H110211607::AID-MUS21 /H110223.0.CO;2-J .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
Postgrad Med J 73:419 – 420. http://dx.doi.org/10.1136/pgmj.73.861.419 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1002/ana.10321 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1016/S0140-6736(79)90643-3 .,OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1001/ archneur.1980.00500510052009 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1586/ 14737175.8.3.331 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1097/00001648 -200003000-00023 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/ 10.1055/s-2007-1019126 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1001/jama.289.12.1533 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1084/jem.20071030 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1371/ journal.pone.0007214 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1007/BF00868517 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1084/jem.20071030 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
J Neurosci Res 35:585– 602. http://dx.doi.org/10.1002/jnr.490350603 .,OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1002/ jcb.25312 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
Virology 191:443– 447. http://dx.doi.org/10.1016/0042 -6822(92)90207-6 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1128/JVI.76.18.9407-9419.2002 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
Clinical characteristics of patients with Epstein-Barr virus in cerebrospinal ﬂuid.BMC Infect Dis 11:281. http://dx.doi.org/10.1186/1471-2334-11-281 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1128/mBio.02261-14 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1128/JVI.01019-12 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1128/JVI.02379-13 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1128/JVI.03575-12 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
Methods Mol Biol 1078: 1– 8. http://dx.doi.org/10.1007/978-1 -62703-640-5_1 .,OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1172/JCI43755 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
J Virol 85: 6148 – 6161. http://dx.doi.org/10.1128/JVI.02608-10 .,Non-OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1128/JVI.03568-13 .Jha et al.,OADS,/arxiv_data1/oa_pdf/af/29/mBio.01844-15.PMC4669387.pdf
http://dx.doi.org/10.1016/j.cell.2009.12.034 .,OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
http://dx.doi.org/10.1146/ annurev.pp.11.060160.001203 .,Non-OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
http://dx.doi.org/10.1111/mmi.12640 .,Non-OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
http://dx.doi.org/10.1016/j.cub.2013.08.011 .,OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
http://dx.doi.org/10.1016/j.tim.2010.10.004 .,OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
http://dx.doi.org/ 10.1111/jam.12343 .,Non-OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
J Appl Micro- biol 112:417– 429. http://dx.doi.org/10.1111/j.1365-2672.2011.05204.x .,OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
http://dx.doi.org/10.1128/ JB.01455-13 .,Non-OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
http://dx.doi.org/10.1128/JB.188.1.28 -36.2006 .,Non-OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
http://dx.doi.org/10.1128/JB.01555-14 .,Non-OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
http://dx.doi.org/10.1128/JB.02490-14 .,Non-OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
http://dx.doi.org/10.1128/ JB.01687-14 .,Non-OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
http://dx.doi.org/10.1128/JB.00405-12 .,Non-OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
"http://dx.doi.org/ 10.1128/JB.00326-10 .17.Yasuda Y, Tochikubo K .",OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
http://dx.doi.org/10.1111/j.1348-0421.1984.tb00671.x .,Non-OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
http://dx.doi.org/10.1128/AEM.03043-13 .,Non-OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
Mol Microbiol 92:813– 823. http://dx.doi.org/10.1111/ mmi.12591 .,OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
http://dx.doi.org/10.1128/JB.01546-14 .,Non-OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
TrendsMicrobiol 22:406 – 416. http://dx.doi.org/10.1016/j.tim.2014.04.003 .,OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
http://dx.doi.org/10.1038/ nrm1524 .,Non-OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
J Bacteriol 183: 4886 – 4893. http://dx.doi.org/10.1128/ JB.183.16.4886-4893.2001 .,Non-OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
http://dx.doi.org/10.1128/JB.02181-12 .,Non-OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
http://dx.doi.org/10.1016/S0378-1119(98)00172-3 .,OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
http://dx.doi.org/10.1128/JB.00345-10 .Wang et al.,OADS,/arxiv_data1/oa_pdf/cd/50/mBio.01859-15.PMC4669388.pdf
LT is from http://allseq.com/knowledgebank/sequencing-platforms/life-technologies-ion-torrent .,OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://dx.doi.org/10.1155/2012/251364 .,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
"Clin Infect Dis 60:881– 888. http://dx.doi.org/ 10.1093/cid/ciu940 .4.Wilson MR, Naccache SN, Samayoa E, Biagtan M, Bashir H, Yu G, Salamat SM, Somasekar S, Federman S, Miller S, Sokolic R, Garabedian E, Candotti F, Buckley RH, Reed KD, Meyer TL, Seroogy CM, GallowayR, Henderson SL, Gern JE, DeRisi JL, Chiu CY .",Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://dx.doi.org/10.1056/NEJMoa1401268 .,OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://dx.doi.org/10.1093/cid/ciu912 .,OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://dx.doi.org/10.1056/ NEJMoa1415627 .,OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://dx.doi.org/10.3201/ eid1606.091536 .,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
https://www.genomeweb.com/research-funding/cdc- earmarks-23m-ngs-bioinformatic-approaches-combat-infectious-disease .,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://dx.doi.org/10.1056/NEJMoa1106920 .,OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
N Engl J Med 364:33– 42. http://dx.doi.org/10.1056/NEJMoa1012928 .,OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://dx.doi.org/10.1017/ice.2015.73 .,OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://dx.doi.org/10.1126/scitranslmed.3004129 .,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://dx.doi.org/ 10.1007/s10096-012-1641-7 .,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://dx.doi.org/10.1093/jac/dkt180 .,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://dx.doi.org/10.1056/NEJMoa1011138 .,OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://dx.doi.org/10.1128/AAC.01454-12 .,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
J Virol 86:6231– 6237. http://dx.doi.org/10.1128/JVI.06541-11 .,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
Nature464:59 – 65. http://dx.doi.org/10.1038/nature08821 .,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://dx.doi.org/ 10.1038/tpj.2012.43 .,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
Nature 472:57– 63. http://dx.doi.org/10.1038/nature09922 .,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
Microbiome 1:27. http://dx.doi.org/10.1186/2049-2618-1-27 .,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://dx.doi.org/10.1038/ nbt.2280 .,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://dx.doi.org/10.1128/JCM.03117-13 .,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/ IVDRegulatoryAssistance/ucm123682.htm .,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://www.fda.gov/ucm/ groups/fdagov-public/@fdagov-meddev-gen/documents/document/ucm311176.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm386967.htm .,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://dx.doi.org/ 10.1056/NEJMp1314561 .,OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
Arch Pathol Lab Med 139:481– 493. http://dx.doi.org/10.5858/arpa.2014-0250-CP .,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://www.fda.gov/downloads/MedicalDevices/ NewsEvents/WorkshopsConferences/UCM393056.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
http://dx.doi.org/10.1038/gim.2013.92 .,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
Nat RevGenet 13:601– 612. http://dx.doi.org/10.1038/nrg3226 .Minireview 10®mbio.asm.org November/December 2015 Volume 6 Issue 6 e01888-15,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/mBio.01888-15.PMC4669390.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/8e/main.PMC4669408.pdf
Contents lists available at ScienceDirect Biochemical and Biophysical Research Communications journal homepage: www.elsevier.com /locate/ybbrc http://dx.doi.org/10.1016/j.bbrc.2015.10.169 0006-291X/ ©2015 The Francis Crick Insitute.,Non-OADS,/arxiv_data1/oa_pdf/c9/8e/main.PMC4669408.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).Biochemical and Biophysical Research Communications 468 (2015) 39 e45,Non-OADS,/arxiv_data1/oa_pdf/c9/8e/main.PMC4669408.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/cd/main.PMC4669411.pdf
"Moreover, the use of NAD and/or NADP by certain dehydrogenases had been associated with important http://dx.doi.org/10.1016/j.fob.2015.11.002 2211-5463/ /C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/51/cd/main.PMC4669411.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: G6P, glucose-6-phosphate; G6PDH, glucose-6-phosphate dehy- drogenase; PputG6PDH-1, glucose-6-phosphate dehydrogenase encoded by thegene zwf-1 from Pseudomonas putida KT2440; GND, 6-phospho-gluconate dehy- drogenase; EDP, Entner–Doudoroff pathway ⇑Corresponding author at: Avenida Professor Lineu Prestes, 1374, Cidade Universitária, CEP 05508-900 São Paulo, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/51/cd/main.PMC4669411.pdf
"Supplemen-tary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2015.11.002 .",OADS,/arxiv_data1/oa_pdf/51/cd/main.PMC4669411.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/dd/main.PMC4669415.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 675–682 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.02.013 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/dd/main.PMC4669415.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/dd/main.PMC4669415.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 635–641 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.02.003 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9f/29/main.PMC4669416.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/29/main.PMC4669416.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/29/main.PMC4669416.pdf
Available at URL < http://www.pharmacist.com/ principles-practice-pharmaceutical-care >.,Non-OADS,/arxiv_data1/oa_pdf/9f/29/main.PMC4669416.pdf
< http://www.ncsi.gov.om/NCSI_ website/book/SYB2012/2-population.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/9f/29/main.PMC4669416.pdf
http://dx.doi.org/10.1111/j.1759- 8893.2010.00034.x ISSN 1759-8885 .,Non-OADS,/arxiv_data1/oa_pdf/9f/29/main.PMC4669416.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/d7/main.PMC4669417.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 712–715 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.02.006 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1e/d7/main.PMC4669417.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/d7/main.PMC4669417.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC4669418.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 614–620 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.10.004 1319-0164 ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC4669418.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC4669418.pdf
<http://www.britannica.com/EBchecked/topic/256446/Al- Hasa >.618 T.M.,Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC4669418.pdf
http://dx.doi.org/10.1177/ 1049909112445464 .,Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC4669418.pdf
"13, 119. http://dx.doi.org/10.1186/ 1471-2369-13-119 .",Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC4669418.pdf
http://dx.doi.org/ 10.1056/NEJM199204093261501 .,Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC4669418.pdf
http://dx.doi.org/10.1111/j.1529- 8019.2005.00036.x .,Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC4669418.pdf
< http://apps.who.int/ medicinedocs/pdf/s4882e/s4882e.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC4669418.pdf
http://dx.doi.org/10.5301/jn.5000039 .,Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC4669418.pdf
"http://dx.doi.org/10.1016/ j.jsps.2012.09.004 .Khan, Tahir Mehmood, Al-Haider, Ibrahim, Sulaiman, Syed, Azhar, Syed, Hassali, Mohamed Azmi, 2013.",Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC4669418.pdf
http://dx.doi.org/10.1111/j.1365-2702.2011.03906.x .,Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC4669418.pdf
< http://www.nhs.uk/Conditions/ Dialysis/Pages/Side-effects.aspx >.,Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC4669418.pdf
< http://www.nlm.nih.gov/medlineplus/drug- info/meds/a605045.html >.,Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC4669418.pdf
http://dx.doi.org/10.1159/ 000349943 .,Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC4669418.pdf
http://dx.doi.org/10.1016/ j.jpainsymman.2012.03.001 .,OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC4669418.pdf
http://dx.doi.org/ 10.1371/journal.pone.0024061 .,Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC4669418.pdf
"Nephrology (Carlton) 17 (8), 710– 717.http://dx.doi.org/10.1111/j.1440-1797.2012.01655.x .",Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC4669418.pdf
http://dx.doi.org/10.1111/j.1528-1167.2010.,Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC4669418.pdf
http://dx.doi.org/10.1038/ng0197-62 .620 T.M.,Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC4669418.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 642–649 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.02.004 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/72/4a/main.PMC4669420.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/4a/main.PMC4669420.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/4a/main.PMC4669420.pdf
"< http://www.mhra.gov.uk/Safetyinformation/ Safetywarningsalertsandrecalls/ Safetywarningsandmessagesformedicines/CON065505 >, (retrieved 12.06.14).",Non-OADS,/arxiv_data1/oa_pdf/72/4a/main.PMC4669420.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/b3/main.PMC4669421.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 698–711 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.01.021 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/fd/b3/main.PMC4669421.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/b3/main.PMC4669421.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 667–674 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.02.021 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b9/76/main.PMC4669422.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/76/main.PMC4669422.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/76/main.PMC4669422.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 621–625 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.01.022 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/32/main.PMC4669423.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/32/main.PMC4669423.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/32/main.PMC4669423.pdf
< http://www.readabilityformulas.com/ﬂesch-grade-level- readability-formula.php > (Cited 10.09.14).,Non-OADS,/arxiv_data1/oa_pdf/78/32/main.PMC4669423.pdf
< http://www.readabilityfor- mulas.com/ﬂesch-reading-ease-readability-formula.php > (Cited 10.09.14).,Non-OADS,/arxiv_data1/oa_pdf/78/32/main.PMC4669423.pdf
<http://www.readabilityformulas.com/smog-readability-formula.,Non-OADS,/arxiv_data1/oa_pdf/78/32/main.PMC4669423.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 3.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/ac/main.PMC4669424.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 658–666 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.09.001 1319-0164 ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/46/ac/main.PMC4669424.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/ac/main.PMC4669424.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 626–634 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.02.016 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d0/d9/main.PMC4669425.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/d9/main.PMC4669425.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/d9/main.PMC4669425.pdf
National drug prices were obtained from the Saudi Food and Drug Authority (SFDA) HumanDrug List ( http://www.sfda.gov.sa ).,OADS,/arxiv_data1/oa_pdf/d0/d9/main.PMC4669425.pdf
Available from: < http://old.sfda.gov.sa/NR/rdonlyres/ 7C3A3046-81BA-41CD-B81B-F3D3AF1D28A6/0/Human_Drug_ List_Dec_2012_V1_Web.xls >.,OADS,/arxiv_data1/oa_pdf/d0/d9/main.PMC4669425.pdf
"17 (2), 164–172 (Available from: < http://onlinelibrary.wiley.com/ o/cochrane/cleed/articles/NHSEED-22000000877/frame.html >).",OADS,/arxiv_data1/oa_pdf/d0/d9/main.PMC4669425.pdf
"6 (3), 269–282 (Available from: < http://onlinelibrary.wiley.com/o/cochrane/ clcentral/articles/667/CN-00557667/frame.html >).",OADS,/arxiv_data1/oa_pdf/d0/d9/main.PMC4669425.pdf
"63 (5), 361–367 (Available from: < http://onlinelibrary.wiley.com/ o/cochrane/clcentral/articles/599/CN-00297599/frame.html >).",OADS,/arxiv_data1/oa_pdf/d0/d9/main.PMC4669425.pdf
"Diseases 6 (6), 294–302 (Available from:<http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/737/ CN-00346737/frame.html >).Cost-minimization analysis of imipenem/cilastatin versus meropenem 633",OADS,/arxiv_data1/oa_pdf/d0/d9/main.PMC4669425.pdf
"10 (4), 264–269 (Available from:<http://onlinelibrary.wiley.com/o/cochrane/cldare/articles/ DARE-12010006026/frame.html >).",OADS,/arxiv_data1/oa_pdf/d0/d9/main.PMC4669425.pdf
"26 (2), 118–122 (Available from: < http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/384/CN-00366384/frame.",OADS,/arxiv_data1/oa_pdf/d0/d9/main.PMC4669425.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/2f/main.PMC4669426.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 650–657 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.01.025 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/15/2f/main.PMC4669426.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/2f/main.PMC4669426.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/dd/main.PMC4669427.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 683–688 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.02.002 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/aa/dd/main.PMC4669427.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/dd/main.PMC4669427.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 689–697 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.01.023 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b6/17/main.PMC4669428.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/17/main.PMC4669428.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/17/main.PMC4669428.pdf
"http://dx.doi.org/10.1002/pca.2440 , June 18.",Non-OADS,/arxiv_data1/oa_pdf/b6/17/main.PMC4669428.pdf
"http://dx.doi.org/10.1055/s-0031-129548 , Epub 2012 February 16.",Non-OADS,/arxiv_data1/oa_pdf/b6/17/main.PMC4669428.pdf
"26 (10), 1282–1285.http://dx.doi.org/10.1002/bmc.269 , Epub 2012 February 16.",Non-OADS,/arxiv_data1/oa_pdf/b6/17/main.PMC4669428.pdf
http://dx.doi.org/10.1002/ jms.2004 .Comparison of different methods and their suitability 697,OADS,/arxiv_data1/oa_pdf/b6/17/main.PMC4669428.pdf
http://dx.doi.org/10.1016/j.jsps.2013.12.018,OADS,/arxiv_data1/oa_pdf/e5/91/main.PMC4669429.pdf
"DiabetesTher 3 (1), 13. http://dx.doi.org/10.1007/s13300-012-0013-8 .",Non-OADS,/arxiv_data1/oa_pdf/e5/91/main.PMC4669429.pdf
Diabetes Med.. http://dx.doi.org/10.1111/ dme.12267 .,Non-OADS,/arxiv_data1/oa_pdf/e5/91/main.PMC4669429.pdf
< http://www.who.int/mediacentre/ factsheets/fs312/en/ >.,Non-OADS,/arxiv_data1/oa_pdf/e5/91/main.PMC4669429.pdf
http://dx.doi.org/10.1016/j.jsps.2013.12.019,OADS,/arxiv_data1/oa_pdf/31/59/main.PMC4669430.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/33/main.PMC4669462.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 720–722 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.02.010 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/45/33/main.PMC4669462.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/33/main.PMC4669462.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/a3/main.PMC4669477.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 716–719 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.02.009 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/54/a3/main.PMC4669477.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/a3/main.PMC4669477.pdf
Available from: http://dailymed.nlm.nih.gov/ May 2010 (cited 22.05.14).,OADS,/arxiv_data1/oa_pdf/54/a3/main.PMC4669477.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Writer's crampTask speci ﬁcd y s t o n i a Functional magnetic resonance imagingReversal learningRewardProbabilistic response Basal ganglia StriatumDRD2/ANKK1-TaqIa polymorphism 1.,Non-OADS,/arxiv_data1/oa_pdf/2b/bb/main.PMC4669532.pdf
http://dx.doi.org/10.1016/j.nicl.2015.11.006 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/bb/main.PMC4669532.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/bb/main.PMC4669532.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Dopamine Putamen Motor cortexCerebellumBasal ganglia 1.,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1016/j.nicl.2015.11.005 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1002/hbm.22622 .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.01.017 .,OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1002/hbm.22701 .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
"NeuroImage 83, 103– 119. http://dx.doi.org/10.1016/j.neuroimage.",OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1007/s11065-010-9143-9 .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/ 10.1093/cercor/bhn041 .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
"9, 214. http://dx.doi.org/10.3389/ fnhum.2015.00214 .",Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.3389/fnsys.2010.00019 .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1523/JNEUROSCI.1868-09.2009 .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1093/brain/aws281 .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
"Brain 124, 558– 570. http://dx.doi.org/10.1093/ brain/124.3.558 .",Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1093/cercor/bhp178 .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1002/ana.22361 .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1093/ brain/awq012 .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0810-09.2009 .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1056/ NEJM198804073181402 .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1093/brain/awt192 .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
"21, 636 –644.http://dx.doi.org/10.1016/j.conb.2011.06.012 .",OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
"4, 143. http://dx.doi.org/10.3389/fnsys.2010.00143 .",Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1016/j.neuroscience.2010.12.060 .,OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1037/a0031226 .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1212/01.wnl.0000335973.66333.58 .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1111/j.1532-5415.2005.53221.x .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1093/cercor/bhp157 .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1016/j.nicl.2015.01.012 .,OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1002/mds.25255 .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/ 10.1016/j.neuroimage.2008.08.039 .,OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1161/STROKEAHA.114.006307 .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1093/brain/ awh569 .61 A.C. Simioni et al.,OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1093/brain/aws360 .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1002/hbm.20622 .,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
"460, 6 –10.http://dx.doi.org/10.1016/j.neulet.2009.05.046 .",OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.org/10.1002/hbm.22743 (n/a – n/a).,OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
"6, 15–28.http://dx.doi.org/10.1038/nrneurol.2009.198 .62 A.C. Simioni et al.",OADS,/arxiv_data1/oa_pdf/b8/c6/main.PMC4669533.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/ad/main.PMC4669534.pdf
"The population in the wild is also reported to be declining due to several human and environmental factors and therefore, declared as an endangered ﬁsh (http://www.iucnredlist.org /).",Non-OADS,/arxiv_data1/oa_pdf/5e/ad/main.PMC4669534.pdf
http://dx.doi.org/10.1016/j.mgene.2015.11.001 2214-5400/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/ad/main.PMC4669534.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/ad/main.PMC4669534.pdf
We also identi ﬁed simple sequence repeat (SSR) from the CDS of total transcriptome (merged CDS of all six tissues) using pearl script MISA ( http://pgrc.ipk-gatersleben.de/misa/ ).,OADS,/arxiv_data1/oa_pdf/5e/ad/main.PMC4669534.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/dd/main.PMC4669535.pdf
http://dx.doi.org/10.1016/j.mgene.2015.10.0052214-5400/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/dd/main.PMC4669535.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/dd/main.PMC4669535.pdf
http://dx.doi.org/10.1002/mds.26022 .,Non-OADS,/arxiv_data1/oa_pdf/4b/dd/main.PMC4669535.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/03/main.PMC4669579.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.09.001 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/64/03/main.PMC4669579.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/03/main.PMC4669579.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/,Non-OADS,/arxiv_data1/oa_pdf/64/03/main.PMC4669579.pdf
"Whole-exome capture, sequencing and data analysis The patient underwent WES through the Whole Genome Laboratory (https://www.bcm.edu/research/medical-genetics-labs/index.cfm?",Non-OADS,/arxiv_data1/oa_pdf/64/03/main.PMC4669579.pdf
Creative Commons Attribution Non-Commercial No Derivatives 3.0 License: https://creativecommons.org/licenses/by-nc-nd/3.0/us/ INTRODUCTION BRAF mutations are present in between 5% and 15% of colorectal cancer (CRC).,Non-OADS,/arxiv_data1/oa_pdf/7a/ae/zlj4032.PMC4669589.pdf
"Creative Commons Attribution Non-Commercial No Derivatives 3.0 License: https://creativecommons.org/licenses/by-nc-nd/3.0/us/ INTRODUCTION Basal cell carcinoma (BCC), the most common hu- man malignancy, is diagnosed in more than one million people in the United States annually, andincidence is increasing.",Non-OADS,/arxiv_data1/oa_pdf/68/35/zlj4058.PMC4669591.pdf
"In the clinical setting, this is most often one-on-one counseling in  primary care or referable ancillary services outside of the clinical setting (e.g., tobacco  quitlines) using specific state-of-the-art techniques such as motivation-based interviewing  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/62/1b/nihms737924.PMC4669683.pdf
http://dx.doi.org/10.1001/jama.291.10.1238 .,Non-OADS,/arxiv_data1/oa_pdf/62/1b/nihms737924.PMC4669683.pdf
http://dx.doi.org/ 10.1016/S0749-3797(02)00415-4 .,OADS,/arxiv_data1/oa_pdf/62/1b/nihms737924.PMC4669683.pdf
http://dx.doi.org/10.1016/S0749-3797(99)00123-3 .,OADS,/arxiv_data1/oa_pdf/62/1b/nihms737924.PMC4669683.pdf
http://dx.doi.org/10.1016/ j.amepre.2006.11.007 .,OADS,/arxiv_data1/oa_pdf/62/1b/nihms737924.PMC4669683.pdf
http://dx.doi.org/10.1016/S0749-3797(99)00119-1 .,OADS,/arxiv_data1/oa_pdf/62/1b/nihms737924.PMC4669683.pdf
http://dx.doi.org/10.1016/ S0749-3797(99)00122-1 .,OADS,/arxiv_data1/oa_pdf/62/1b/nihms737924.PMC4669683.pdf
2007; 147(2):117– 122. http://dx.doi.org/10.7326/0003-4819-147-2-200707170-00170 .,Non-OADS,/arxiv_data1/oa_pdf/62/1b/nihms737924.PMC4669683.pdf
http://dx.doi.org/10.7326/M13-2128 .,Non-OADS,/arxiv_data1/oa_pdf/62/1b/nihms737924.PMC4669683.pdf
http://dx.doi.org/10.1093/aje/kwm189 .,Non-OADS,/arxiv_data1/oa_pdf/62/1b/nihms737924.PMC4669683.pdf
http://dx.doi.org/10.7326/0003-4819-147-12-200712180-00007 .,Non-OADS,/arxiv_data1/oa_pdf/62/1b/nihms737924.PMC4669683.pdf
http://dx.doi.org/10.1001/jama.2009.1025 .,Non-OADS,/arxiv_data1/oa_pdf/62/1b/nihms737924.PMC4669683.pdf
http://dx.doi.org/10.1016/ j.amepre.2012.04.009 .,OADS,/arxiv_data1/oa_pdf/62/1b/nihms737924.PMC4669683.pdf
http://dx.doi.org/10.1016/j.amepre.2012.01.019 .,OADS,/arxiv_data1/oa_pdf/62/1b/nihms737924.PMC4669683.pdf
http://dx.doi.org/ 10.1016/S0140-6736(14)60259-2 .,OADS,/arxiv_data1/oa_pdf/62/1b/nihms737924.PMC4669683.pdf
"Available  from: http://www.goldcopd.org/uploads/users/files/GOLD_ Report_2011_Feb21.pdf , accessed on October 8, 2012.",OADS,/arxiv_data1/oa_pdf/5d/00/IJMR-142-245.PMC4669859.pdf
http://www.r-project.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/e4/IJMR-142-276.PMC4669862.pdf
"Available from: http://www.cdc.gov/streplab/ downloads/pcr-africa-clinical-specimens.pdf , accessed on  January 19, 2014.",Non-OADS,/arxiv_data1/oa_pdf/3c/16/IJMR-142-286.PMC4669863.pdf
"Available from: http://www.cdc.gov/nchs/data/   nhanes/growthcharts/html_charts/bmiagerev.htm , accessed on  October 28, 2013.",OADS,/arxiv_data1/oa_pdf/97/a8/IJMR-142-293.PMC4669864.pdf
"Available from: https://www.clinicalresearch.pitt.edu/ Content/docs/adherence_calculator.pdf , accessed on May 5,  2014.",Non-OADS,/arxiv_data1/oa_pdf/2f/b8/IJMR-142-301.PMC4669865.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/72/main.PMC4669895.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2015.08.003,OADS,/arxiv_data1/oa_pdf/16/72/main.PMC4669895.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/3c/main.PMC4669897.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.06.007 272,OADS,/arxiv_data1/oa_pdf/b4/3c/main.PMC4669897.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/ef/tcrm-11-1749.PMC4669915.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1749–1758Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1749Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S7908 0Spotlight on rituximab in the treatment of  antineutrophil cytoplasmic antibody-associated  vasculitis: current perspectives Philipp Moog Klaus Thuermel Abteilung für Nephrologie, Klinikum  rechts der isar, T echnische Universität  München, Munich, GermanyAbstract:  A 54-year-old patient presented to his general practitioner because of strong muscle  pain in both thighs.",Non-OADS,/arxiv_data1/oa_pdf/fe/ef/tcrm-11-1749.PMC4669915.pdf
"According to the revised Chapel Hill criteria, AAVs can be further divided into differ - ent entities, namely granulomatosis with polyangiitis (GPA), microscopic polyangiitis  (MPA), and eosinophilic GPA.1 A recent cluster analysis of European Vasculitis Study  Group studies suggests that with respect to clinical phenotypes, it might be reasonable  to distinguish even more disease subsets.2 Necrotizing small-vessel vasculitis and  granuloma formation (except in MPA) are the pathological hallmarks that can lead Correspondence: Philipp Moog Abteilung für Nephrologie, Klinikum  rechts der isar, Technische Universität  München, 22 ismaninger Strasse, Munich  81675, Germany Tel +49 89 4140 5892 email philipp.moog@mri.tum.d e Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Moog and Thuermel Running head recto: Rituximab for ANCA-associated vasculitis DOI: http://dx.doi.org/10.2147/TCRM.S79080",Non-OADS,/arxiv_data1/oa_pdf/fe/ef/tcrm-11-1749.PMC4669915.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/fe/ef/tcrm-11-1749.PMC4669915.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/ef/tcrm-11-1749.PMC4669915.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/78/8e/ppa-9-1715.PMC4669916.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1715–1720Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1715OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9431 0What do patients take into account when they  choose their dentist?,Non-OADS,/arxiv_data1/oa_pdf/78/8e/ppa-9-1715.PMC4669916.pdf
"Keywords:  patient preference, dental care, quality improvement, patient satisfaction Introduction The importance of characteristics influencing patients’  choice of a dentist Various research have shown that patients choose their dentist based on a variety of  factors.1,2 These factors can be divided into factors related to dentists only (ability Correspondence: Marius-Ionuţ  Ungureanu Department of Public health and  Management, Iuliu Haţieganu University  of Medicine and Pharmacy, 8 Victor Babeş  street, cluj-napoca 400008, romania Tel +40 264 597 256 email m.i.ungureanu@gmail.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Ungureanu and Mocean Running head recto: Patients’ preference for dentists’ characteristics DOI: http://dx.doi.org/10.2147/PPA.S94310",Non-OADS,/arxiv_data1/oa_pdf/78/8e/ppa-9-1715.PMC4669916.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/78/8e/ppa-9-1715.PMC4669916.pdf
Available from:  http://www.iso.org/iso/qmp_2012.pd f. Accessed February 2015.,Non-OADS,/arxiv_data1/oa_pdf/78/8e/ppa-9-1715.PMC4669916.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/90/opth-9-2235.PMC4669917.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 2235–2241Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2235Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9319 7association of retinal thickness and optic  disc-to-fovea angle to axial length of young  healthy eyes Takehiro Yamashita1 Taiji sakamoto1 hiroto T erasaki1 Minoru Tanaka1 Yuya Kii1 eisuke Uchino1 T oshio hisatomi2 Kumiko nakao1 1Department of Ophthalmology,   Kagoshima University graduate  school of Medical and Dental  sciences, Kagoshima, Japan;   2Department of Ophthalmology,   national hospital Organization  Kyushu Medical Center,   Fukuoka,  JapanAim:  To determine the relationship between the axial length (AL) and the retinal thickness in  the posterior pole and to the optic disc-to-fovea (ODF) angle of healthy eyes.",Non-OADS,/arxiv_data1/oa_pdf/1f/90/opth-9-2235.PMC4669917.pdf
ac.jp Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Y amashita et al Running head recto: Retinal thickness and optic disc-to-fovea angle DOI: http://dx.doi.org/10.2147/OPTH.S93197,Non-OADS,/arxiv_data1/oa_pdf/1f/90/opth-9-2235.PMC4669917.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/1f/90/opth-9-2235.PMC4669917.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/90/opth-9-2235.PMC4669917.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/8b/ott-8-3533.PMC4669918.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3533–3538OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3533Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9236 1The XRCC1  Arg194T rp polymorphism is significantly  associated with lung adenocarcinoma: a case-control  study in an eastern european caucasian group Andreea Cătană1 Monica Pop2 Bianca Domokos hincu2 ioan V Pop1 Felicia M Petris ¸or1 Mihai D Porojan3 radu a Popp1 1Department of Molecular sciences,   2Department of Pneumology,   3Department of internal Medicine,   Iuliu Haţieganu University of Medicine  and Pharmacy, cluj-n apoca, romaniaAbstract:  DNA repair plays an important role in maintaining the integrity of the genome by  repairing DNA damage induced by carcinogens.",Non-OADS,/arxiv_data1/oa_pdf/fe/8b/ott-8-3533.PMC4669918.pdf
"Previous reports have indicated that certain genetic poly - morphisms, particularly the XRCC1 -gene variants, were associated with a high risk  of malignancy, such as primary lung cancer,3,4 hepatocellular carcinoma,5 cervical  cancer,6 childhood acute lymphoblastic leukemia,7 and gastric cancer.8 A genome-wide association study of 1,154 ever-smoking non-small-cell lung cancer  patients, with genotyping of 317,498 tagging single-nucleotide polymorphisms and  1,137 ever-smoking controls in a Texas population of self-reported European descent, Correspondence: Andreea Cătană Department of Molecular sciences,  Iuliu Haţieganu University of Medicine  and Pharmacy, 6 louis Pasteur street,  cluj-napoca 400349, romania Tel +40 721 289 741 email catanaandreea@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: C ătană et al Running head recto: XRCC1  Arg194Trp in lung adenocarcinoma DOI: http://dx.doi.org/10.2147/OTT.S92361",Non-OADS,/arxiv_data1/oa_pdf/fe/8b/ott-8-3533.PMC4669918.pdf
"Available  from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.asp x. Accessed  November 17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/fe/8b/ott-8-3533.PMC4669918.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/fe/8b/ott-8-3533.PMC4669918.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/8b/ott-8-3533.PMC4669918.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b9/75/imcrj-8-301.PMC4669919.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 301–304International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  301Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S9533 4treatment with sodium hyaluronate eye drops   in a patient who had early-onset bleb leakage  after trabeculectomy with mitomycin C Hideto sagara1,2 tetsuju sekiryu2 Hiroki Noji2 Masashi ogasawara2 Kimihiro Imaizumi2 Keiko Yago3 1the Marui eye Clinic, Minamisoma,   2Department of ophthalmology,   school of Medicine, Fukushima  Medical University.",Non-OADS,/arxiv_data1/oa_pdf/b9/75/imcrj-8-301.PMC4669919.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/b9/75/imcrj-8-301.PMC4669919.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/75/imcrj-8-301.PMC4669919.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/32/6f/dddt-9-6259.PMC4669920.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 6259–6268Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6259Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8836 1enzymatic vitreolysis with recombinant tissue  plasminogen activator for vitreomacular traction Dorota Raczyńska1 Paweł Lipowski1 Katarzyna Zorena2 Andrzej Skorek3 Paulina glasner1 1Department of Ophthalmology,   Medical University of Gdańsk, Poland;   2Department of immunobiology  and environment Microbiology,   Medical University of Gdańsk, Poland;   3Department of Otolaryngology,   Medical University of Gdańsk, PolandAims:  The aim of our research was to gain data about the efficacy of intravitreal injections  of a recombinant tissue plasminogen activator (rTPA) in dissolving vitreoretinal tractions  (VRTs).",Non-OADS,/arxiv_data1/oa_pdf/32/6f/dddt-9-6259.PMC4669920.pdf
"It results from RPE (as well as Correspondence: Dorota Raczyńska Department of Ophthalmology, Medical  University of Gdańsk, Smoluchowskiego  17, 80-952 Gdańsk, Poland Tel +48 58 349 3580 email dorotaraczynska@gumed.edu.p l Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Raczy ńska et al Running head recto: Enzymatic vitreolysis with rTPA for VMT DOI: http://dx.doi.org/10.2147/DDDT.S88361 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/32/6f/dddt-9-6259.PMC4669920.pdf
Or use: http://youtu.be/Zso_QjT16j UVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/32/6f/dddt-9-6259.PMC4669920.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/32/6f/dddt-9-6259.PMC4669920.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/6f/dddt-9-6259.PMC4669920.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0e/de/opth-9-2229.PMC4669921.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 2229–2233Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2229Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S9185 8Comparison of the effect of W-shaped and linear  skin incisions on scar visibility in bilateral external  dacryocystorhinostomy Bulent Yazici Department of Ophthalmology,   Uludag University, Bursa, turkeyDear editor The article entitled “Comparison of the effect of W-shaped and linear skin incisions  on scar visibility in bilateral external dacryocystorhinostomy” by Ekinci et al1 was  published in Clinical Ophthalmology ; I reviewed this paper for another journal ( Journal  of Ophthalmology ) several months ago before it appeared in your journal.",Non-OADS,/arxiv_data1/oa_pdf/0e/de/opth-9-2229.PMC4669921.pdf
"Given that both the rejected manuscript and the published paper Correspondence: Bulent Yazici Department of Ophthalmology, Uludag  University, Bursa 16059, turkey email byazici@uludag.edu.t r Journal name: Clinical Ophthalmology Article Designation: Letter Y ear: 2015 Volume: 9 Running head verso: Y azici Running head recto: Comparison of the effect of W-shaped skin incisions on scar visibility DOI: http://dx.doi.org/10.2147/OPTH.S91858",Non-OADS,/arxiv_data1/oa_pdf/0e/de/opth-9-2229.PMC4669921.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/0e/de/opth-9-2229.PMC4669921.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/de/opth-9-2229.PMC4669921.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/c8/jpr-8-829.PMC4669922.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 829–844Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  829ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S9043 4association of genetic and psychological factors  with persistent pain after cosmetic thoracic  surgery Violeta Dimova1–3 Jörn lötsch3 Kathrin hühne4 andreas Winterpacht4 Michael heesen5 andreas Parthum1,2 Peter g Weber6 Roman carbon6 norbert griessinger2 Reinhard sittl2 stefan lautenbacher1 1Physiological Psychology, Otto- Friedrich University Bamberg,   2Pain center, Friedrich- alexander  University erlangen, 3institute of  clinical Pharmacology, goethe  University, Frankfurt am Main,   4Department of human genetics,   Friedrich- alexander University  erlangen, germany; 5Department of  anaesthesia, Kantonsspital Baden,   Baden, switzerland; 6Department of  Pediatric surgery, Friedrich- alexander  University erlangen, germany correspondence: Violeta Dimova   institute of clinical Pharmacology,  goethe University, Theodor stern Kai 7,  60590 Frankfurt am Main, germany   Tel +49 69 6301 87818   Fax +49 69 6301 7636   email d imova@med.uni-frankfurt.d eAbstract:  The genetic control of pain has been repeatedly demonstrated in human associa - tion studies.",Non-OADS,/arxiv_data1/oa_pdf/b0/c8/jpr-8-829.PMC4669922.pdf
"The gold standard in this field is the  Gene Ontology (GO; http://www.geneontology.org/ ),22 where  the major biological processes of the genes, respectively,  gene products, are described by a controlled vocabulary (GO  terms).23 An overview on GO as well as on concepts such  as “ontology” in computer science can be found in Thomas  et al.24 The functions of the 17 selected pain genes were ana - lyzed by means of an overrepresentation analysis (ORA)25  using the web-based GeneTrail tool ( http://genetrail.bioinf.",OADS,/arxiv_data1/oa_pdf/b0/c8/jpr-8-829.PMC4669922.pdf
"Among them, the  seven most significant terms ( Table  S1) pointed to biologi - cal processes of “response to chemical stimuli”, “response  to stress”, “immune system response”, “immune response”,  “cognition”, “inflammatory response”, and “sensory percep - tion” (detailed definitions of the GO terms available at the  AmiGo search tool for the GO at http://amigo.geneontology.",Non-OADS,/arxiv_data1/oa_pdf/b0/c8/jpr-8-829.PMC4669922.pdf
Notes: The graph resulted from an over representation analysis (ORa) on the present set of 17 genes with the geneTrial web-based analysis tool ( http://genetrail.bioinf.uni-sb.de /).1 ORA determines a significant set of terms for  given genes based on Fisher’s exact test statistics.2 Only terms that exceed a predefined P threshold (correction of α level included) are significantly annotated to the genes.,OADS,/arxiv_data1/oa_pdf/b0/c8/jpr-8-829.PMC4669922.pdf
"The terms (gene ontology [GO] terms) are derived  from a knowledge database, gene Ontology (gO; http://www.geneontology.org /), where the major biological processes of genes, respectively, gene products, are described by a controlled vocabulary (so-called gO terms).",OADS,/arxiv_data1/oa_pdf/b0/c8/jpr-8-829.PMC4669922.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/b0/c8/jpr-8-829.PMC4669922.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/c8/jpr-8-829.PMC4669922.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/47/64/lra-8-095.PMC4669927.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pLocal and Regional Anesthesia 2015:8 95–100Local and Regional Anesthesia Dove press submit your manuscript | www.dovepress.co m Dove press  95Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S4183 6T opical local anesthesia: focus on lidocaine– tetracaine combination Davide Giordano1 Maria Gabriella Raso2 Carmine Pernice1 vanni Agnoletti3 verter Barbieri1 1Otorhinolaryngology Unit,   Department of Surgery, Arcispedale  Santa Maria Nuova – iRCCS, Reggio  emilia,  2Anesthesiology, intensive  Care, and Pain Medicine Unit,   Department of Surgical Sciences ,  University Hospital of Parma, Parma,   3Anesthesiology and intensive Care  Unit, Department of Cardiology,   Thoracic and vascular Surgery, and  Critical Care Medicine,  Arcispedale  Santa Maria Nuova – iRCCS, Reggio  emilia, italy Correspondence: Davide Giordano   Otorhinolaryngology Unit, Department  of Surgery, Arcispedale Santa Maria   Nuova – iRCCS, viale Risorgimento  80,   42123 Reggio emilia, italy   Tel +39 05 2229 6273  Fax +39 05 2229 5839  email d avide.",Non-OADS,/arxiv_data1/oa_pdf/47/64/lra-8-095.PMC4669927.pdf
Available from:  http://www.galdermausa.com/pdf/10156700-0407%20PLIAGLIS% 20 Package %20Insert.pd f. 8.,Non-OADS,/arxiv_data1/oa_pdf/47/64/lra-8-095.PMC4669927.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/47/64/lra-8-095.PMC4669927.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/47/64/lra-8-095.PMC4669927.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/82/a8/tcrm-11-1743.PMC4669928.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1743–1748Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1743ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9317 2The role of nOs2a −954g/C and vascular  endothelial growth factor +936C/T polymorphisms  in type 2 diabetes mellitus and diabetic  nonproliferative retinopathy risk management Mihai Dumitru Porojan1 Andreea Cătană2 Radu a Popp2 Dan l Dumitrascu1 Cornelia Bala3 1Department of internal Medicine,   2Department of Molecular sciences,   3Department of Diabetes, nutrition  and Metabolic Diseases, iuliu  hatieganu, University of Pharmacy and  Medicine, Cluj napoca, RomaniaAbstract:  Type 2 diabetes mellitus (T2DM) remains one of the major health problems in  Europe.",Non-OADS,/arxiv_data1/oa_pdf/82/a8/tcrm-11-1743.PMC4669928.pdf
"Keywords:  type 2 diabetes mellitus, T2DM, retinopathy, +936C/T variant of VEGF  gene,  −954G/C of NOS2A  gene Introduction Type 2 diabetes mellitus (DM) is a major public health problem, being one of the most  common metabolic disorders.1,2 Even if the hyperglycemic status has a hereditary  component with dominant expression in the phenotype, diabetes is considered as a  multifactorial disease in which there is an imbalance associated with hereditary and  environmental factors.3,4 Over the last 2 decades, genome-wide association studies,  linkage analysis, candidate gene approach, and combined analysis of these candidate  loci led to the identification of several molecular markers associated with the patho - genesis of T2DM and its complications.5–7Correspondence: Andreea Cătană Department of Molecular sciences, iuliu  hatieganu, University of Pharmacy and  Medicine, 6 louis Pasteur, Cluj-napoca,  400349, Romania Tel +40 264 597 256 Fax +40 264 596 912 email catanaandreea@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Porojan et al Running head recto: NOS2A −954G/C and VEGF +936C/T polymorphisms in T2DM DOI: http://dx.doi.org/10.2147/TCRM.S93172",Non-OADS,/arxiv_data1/oa_pdf/82/a8/tcrm-11-1743.PMC4669928.pdf
Available from: http://apps.who.int/ healthinfo/statistics/mortality/whodpms /.,Non-OADS,/arxiv_data1/oa_pdf/82/a8/tcrm-11-1743.PMC4669928.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/82/a8/tcrm-11-1743.PMC4669928.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/a8/tcrm-11-1743.PMC4669928.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5c/a9/ott-8-3539.PMC4669929.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3539–3548OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3539Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9480 0Ultrasound-guided rna interference targeting  hiF-1 alpha improves the effects of transarterial  chemoembolization in rat liver tumors cheng-shi chen1,2,* Qing Zhao1,* sheng Qian1 hai-liang li2 chen-Yang guo2 Wei Zhang1 Zhi-Ping Yan1 rong liu1 Jian-hua Wang1 1Department of interventional  radiology, Zhongshan hospital, Fudan  University, shanghai, People’s republic  of china; 2Department of radiology,   henan cancer hospital, Zhengzhou  University, Zhengzhou, People’s  republic of china *These authors contributed equally  to this workAim:  To investigate whether ultrasound-guided RNA interference (RNAi) targeting hypoxia- inducible factor-1alpha (HIF-1 α) can enhance the efficacy of transarterial chemoembolization  (TACE) in treating hepatocellular carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/5c/a9/ott-8-3539.PMC4669929.pdf
"In the nucleus, HIF-1 induces the transcription of target  genes that are implicated in events such as metabolism, cell survival/apoptosis, pH correspondence: rong liu;   Jian-hua Wang Department of interventional radiology,  Zhongshan hospital, Fudan University,  180 Fenglin road, Xuhui District,  shanghai 200032, People’s republic  of china Tel/fax +86 21 6404 1990 ext 3088 email fdzslr@163.co m;   docwjh@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Chen et al Running head recto: Ultrasound-guided RNAi targeting HIF-1 α facilitated TACE in treating rat HCC DOI: http://dx.doi.org/10.2147/OTT.S94800",Non-OADS,/arxiv_data1/oa_pdf/5c/a9/ott-8-3539.PMC4669929.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5c/a9/ott-8-3539.PMC4669929.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/a9/ott-8-3539.PMC4669929.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/84/0e/dddt-9-6247.PMC4669930.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 6247–6258Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6247Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9643 5Timosaponin B-ii ameliorates diabetic  nephropathy via TXniP , mTOr, and nF- κB  signaling pathways in alloxan-induced mice Y ong-liang Yuan1,* chang-run guo1,* ling-ling cui1 shi-Xia ruan1 chun-Feng Zhang1 De Ji2 Zhong-lin Yang1 Fei li1 1state Key laboratory of natural  Medicines, china Pharmaceutical  University, 2college of Pharmacy,   nanjing University of chinese  Medicine, nanjing, People’s republic  of china *These authors contributed equally  to this workBackground:  Many synthesized drugs with clinical severe side effects have been used for  diabetic nephropathy (DN) treatment.",Non-OADS,/arxiv_data1/oa_pdf/84/0e/dddt-9-6247.PMC4669930.pdf
"Long-term hyperglycemia affects many tissues and organs of  the body, leading to various diabetic chronic complications, such as nephropathy,5  neuropathy,6 and retinopathy.7 Diabetic nephropathy (DN) is one of the most common  diabetic complications, developing in approximately 30% of diabetic patients, which correspondence: Zhong-lin Yang; Fei li state Key laboratory of natural  Medicines, china Pharmaceutical  University, 24 Tongjia lane, nanjing  210009, People’s republic of china Tel +86 25 8327 1425; +86 25 8327 1382 email yzl1950@126.co m;   lifeicpu@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Yuan et al Running head recto: Timosaponin B-II ameliorates diabetic nephropathy DOI: http://dx.doi.org/10.2147/DDDT.S96435",Non-OADS,/arxiv_data1/oa_pdf/84/0e/dddt-9-6247.PMC4669930.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/84/0e/dddt-9-6247.PMC4669930.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/0e/dddt-9-6247.PMC4669930.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c9/ac/ijn-10-7223.PMC4669931.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7223–7230International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7223OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9433 6Distribution of β-carotene-encapsulated polysorbate  80-coated poly(D, l-lactide-co-glycolide)  nanoparticles in rodent tissues following  intravenous administration Taiki Miyazawa1,2 Kiyotaka Nakagawa1,2 Takahiro harigae2 ryo Onuma2 Fumiko Kimura2 T omoyuki Fujii3 T eruo Miyazawa4,5 1Vascular Biology laboratory,   Jean Mayer U sDa (United states  Department of agriculture)- human  Nutrition research center on aging,   T ufts University, Boston, M a, Usa;   2Food and Biodynamic chemistry  laboratory, 3T erahertz Optical & Food  engineering laboratory, graduate  school of agricultural science, 4Food  and Biotechnology Innovation Project,   New Industry creation hatchery  center (NIche), 5Food and health  science research Unit, graduate  school of agricultural science, Tohoku  University, sendai, JapanPurpose:  Biodegradable nanoparticles (NPs) composed of poly(D, L-lactide-co-glycolide)  (PLGA) have attracted considerable attention as delivery systems of drugs and antioxidative  compounds, such as β-carotene (BC).",Non-OADS,/arxiv_data1/oa_pdf/c9/ac/ijn-10-7223.PMC4669931.pdf
"Keywords:  β-carotene, intravenous administration, nanoparticles, poly(D, L-lactide-co- glycolide) (PLGA), polysorbate 80 (PS80), tissue distribution Introduction Use of biodegradable polymer-based nanoparticles (NPs) for drug delivery purposes  can result in enhanced distribution of drugs to target organs.1 One of the most attrac - tive biodegradable polymers used for the preparation of NPs is poly(D, L-lactide-co- glycolide) (PLGA).2 PLGA undergoes hydrolysis in the body to produce the naturally  occurring monomers lactic acid and glycolic acid.3 Intravenous (IV) administration of PLGA-based NPs (PLGA-NPs) coated with  nonionic surfactants has been shown to result in accumulation in specific tissues.4  For example, IV administration of polysorbate 80 (PS80)-coated PLGA-NPs results in  significant uptake by the brain.5–7 However, to the best of our knowledge, few studies have  investigated the effect of PS80 coating on whole-body tissue distribution of NPs.correspondence: Kiyotaka Nakagawa Food and Biodynamic chemistry  laboratory, graduate school of  agricultural science, Tohoku University,  1-1 Tsutsumidori-amamiyamachi,  aobaku, sendai 981-8555, Japan Tel +81 22 717 8906 Fax +81 22 717 8905 email nkgw@m.tohoku.ac.j p Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Miyazawa et al Running head recto: Tissue distribution of polysorbate 80 coated β-carotene-PLGA nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S94336",Non-OADS,/arxiv_data1/oa_pdf/c9/ac/ijn-10-7223.PMC4669931.pdf
Disclosure Taiki Miyazawa was supported by Japan Society for the  Promotion of Science Postdoctoral Fellowships for Research  Abroad ( http://www.jsps.go.jp /).,Non-OADS,/arxiv_data1/oa_pdf/c9/ac/ijn-10-7223.PMC4669931.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c9/ac/ijn-10-7223.PMC4669931.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/ac/ijn-10-7223.PMC4669931.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3c/98/ott-8-3523.PMC4669932.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3523–3531OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3523Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9335 7relationship between high-mobility group box 1   overexpression in ovarian cancer tissue and  serum: a meta-analysis haipeng Wang1,2 Zengjun li2 Yanlai sun2 Zhongfa Xu2 Jianjun han2 Bao song3 Wentao song1,2 chen Qin1,2 lei Yin1,2 1Department of surgery, shandong  academy of Medical sciences,   University of Jinan, Jinan, shandong,   People’s republic of china;   2Department of general surgery,   shandong cancer hospital and  institute, shandong academy of  Medical sciences, University of Jinan,   Jinan, shandong, People’s republic  of china; 3cancer research center,   shandong Provincial Key laboratory  of Oncology, shandong cancer  hospital and institute, shandong  academy of Medical sciences,   University of Jinan, Jinan, shandong,   People’s republic of chinaObjective:  To implement a meta-analysis to investigate the relationship between high-mobility  group box 1 (HMGB1) overexpression in the tissue and serum of ovarian cancer patients, and  to evaluate its prognostic significance.",Non-OADS,/arxiv_data1/oa_pdf/3c/98/ott-8-3523.PMC4669932.pdf
"Indeed, 75% of patients present with advanced (stage III or IV) cancer, and  although more than 80% of these benefit from first-line therapy, tumor recurrences  occur in almost all patients in a median time of 15 months from diagnosis.2correspondence: Zengjun li Department of general surgery,  shandong cancer hospital and  institute, shandong academy of  Medical sciences, University of Jinan,  440 Jiyan road, Jinan 250117, shandong,  People’s republic of china Tel +86 531 6762 6245 email lizengjun6@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Wang et al Running head recto: HMGB1 overexpression in ovarian cancer tissue and serum DOI: http://dx.doi.org/10.2147/OTT.S93357",Non-OADS,/arxiv_data1/oa_pdf/3c/98/ott-8-3523.PMC4669932.pdf
"http://www.ohri.ca/programs/ clinical_epidemiology /oxford.ht m. Accessed February 10, 2010.",Non-OADS,/arxiv_data1/oa_pdf/3c/98/ott-8-3523.PMC4669932.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/3c/98/ott-8-3523.PMC4669932.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/98/ott-8-3523.PMC4669932.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f9/02/main.PMC4669941.pdf
http://dx.doi.org/10.1016/j.bbacli.2015.02.004 2214-6474/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/02/main.PMC4669941.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f9/02/main.PMC4669941.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/f9/02/main.PMC4669941.pdf
"Protein database search, characterization and quanti ﬁcation Peptides were identi ﬁed by peak lists converted from the nanoLCMS/MS spectra by bioinformatics searching against Homo sapiens taxonomy in the Swiss-Prot databases for exact matches using the Mascot search program ( http://www.matrixscience.com )[28,29] .",OADS,/arxiv_data1/oa_pdf/f9/02/main.PMC4669941.pdf
categorized based on their biological process and molecular function using the PANTHER classi ﬁcation system ( http://www.pantherdb.org ) as described in the previous studies [30–32].,OADS,/arxiv_data1/oa_pdf/f9/02/main.PMC4669941.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/a2/main.PMC4669942.pdf
http://dx.doi.org/10.1016/j.bbacli.2015.02.002 2214-6474/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/a2/main.PMC4669942.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/a2/main.PMC4669942.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/65/a2/main.PMC4669942.pdf
In silico analysis The MSRV- envsequence (AF331500) was aligned with the human genome assembly GRCh37.p5 using BLAST ( http://www.ensembl.org ).,OADS,/arxiv_data1/oa_pdf/65/a2/main.PMC4669942.pdf
"The query results were analyzed by pDRAW32 (developed by AcaClone, http://www.acaclone.com ) to identify putative open reading frames (ORFs) containing the speci ﬁc primers and probe reported for MSRV envRNA detection [24].",OADS,/arxiv_data1/oa_pdf/65/a2/main.PMC4669942.pdf
"In short, quantitative real time PCR of the cDNA used a probe (CGCTCTAACT GCTTCCTGCT) and primers (forward: TATTGGGGAGGTGGCTGAT; reverse: GCTACAAATCATTCTTCAAATGGA) designed using PRIMER3 v4.0 software ( http://frodo.wi.mit.edu/ ) for MSRV-like envderived from chromosome 20, and Glucuronidase-beta as housekeeping gene (HKG, GUS-B assay from Applied Biosystems).",OADS,/arxiv_data1/oa_pdf/65/a2/main.PMC4669942.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/f6/main.PMC4669977.pdf
http://dx.doi.org/10.1016/j.bbacli.2015.01.001 2214-6474/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/07/f6/main.PMC4669977.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/f6/main.PMC4669977.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/07/f6/main.PMC4669977.pdf
"(CellMol Gastroenterol Hepatol 2015;1:503 –515; http://dx.doi.org/ 10.1016/j.jcmgh.2015.06.008 ) Keywords: Colitis; In ﬂammation; MicroRNA; Substance P. Substance P (SP), an 11-amino-acid peptide member of the tachykinin family, is expressed in many organs including the intestine.1SP plays a critical role in colitis pathophysiology by interacting with its high-af ﬁnity neu- rokinin-1 receptor (NK-1R)2–4and activating signaling pathways related to nuclear factor- kB (NF- kB)5–7and c-Jun N-terminal kinase (JNK)8in different cell types, including colonocytes.5,8,9NK-1R expression is increased in the colon of inﬂammatory bowel disease (IBD) patients,10,11further suggesting an important role in IBD pathogenesis.",Non-OADS,/arxiv_data1/oa_pdf/44/4e/main.PMC4669978.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/4e/main.PMC4669978.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2015.06.008,OADS,/arxiv_data1/oa_pdf/44/4e/main.PMC4669978.pdf
"KID: Database for Capsule Endoscopy, http://is-innovation.eu/kid.",Non-OADS,/arxiv_data1/oa_pdf/72/3a/10.1177_2050640615601611.PMC4669990.pdf
"(http://clinicaltrials.gov/show/ NCT01421836) Results: There was the total of 30 patients with extrahepatic malignant biliary tract obstruction (19 male, 11 female).",Non-OADS,/arxiv_data1/oa_pdf/72/3a/10.1177_2050640615601611.PMC4669990.pdf
"Ahead of this study, we launched a website (http://colon-stent.com/)and pronounced the standard methods based on previous published data to standardize the maneuver of SEMS placement.",Non-OADS,/arxiv_data1/oa_pdf/0c/bc/10.1177_2050640615601623.PMC4669991.pdf
"The specificity and accuracy of 111In-hexavalent lactoside in estimating liver reserve and its threshold value for mortality in mice, Journal of Hepatology 2015. doi: http://dx.doi.org/10.1016/j.jhep.2015.02.052.",Non-OADS,/arxiv_data1/oa_pdf/0c/bc/10.1177_2050640615601623.PMC4669991.pdf
2008. http://www.who.int/ tb.,Non-OADS,/arxiv_data1/oa_pdf/0c/bc/10.1177_2050640615601623.PMC4669991.pdf
References 1. http://www.bsg.org.uk/images/stories/docs/clinical/guidelines/endoscopy/.,Non-OADS,/arxiv_data1/oa_pdf/0c/bc/10.1177_2050640615601623.PMC4669991.pdf
"Available from: http://globocan.iarc.fr, accessed 16/04/2015.",Non-OADS,/arxiv_data1/oa_pdf/0c/bc/10.1177_2050640615601623.PMC4669991.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b6/7b/jpr-8-851.PMC4670016.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 851–857Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  851PeRsPectivesopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/JPR.S8890 0Approach to the pharmacological management   of chronic pain in patients with an alcohol   use disorder Laura Murphy1,2 Karen WK Ng1 victoria cH su3 sarah Woodworth-Giroux4 todd s Levy1 Beth A sproule2,5 Andrea D Furlan1,6 1University Health Network, toronto,   ON, canada; 2Leslie Dan Faculty  of Pharmacy, University of toronto,   toronto, ON, canada; 3st Paul’s  Hospital, Lower Mainland Pharmacy  services, vancouver, Bc , canada;   4Windsor Regional Hospital, Windsor,   ON, canada; 5centre for Addiction  and Mental Health (c AMH), toronto,   ON, canada; 6institute for Work and  Health, toronto, ON, canada correspondence: Andrea D Furlan   toronto Rehabilitation institute,  University Health Network,  550 University Avenue, 7-141,  toronto, ON M5G 2A2, canada   tel +1 416 597 3422 ext 4607   Fax +1 416 597 7074   email afurlan@iwh.on.c aAbstract:  This paper provides an overview of research, guidelines, and clinical considerations  for the use of medications for chronic pain in the management of patients with an alcohol use  disorder.",Non-OADS,/arxiv_data1/oa_pdf/b6/7b/jpr-8-851.PMC4670016.pdf
"Available from: http://www.thomsonhc.co m. Accessed  March 9, 2012.",Non-OADS,/arxiv_data1/oa_pdf/b6/7b/jpr-8-851.PMC4670016.pdf
Available from: http://store.samhsa.,Non-OADS,/arxiv_data1/oa_pdf/b6/7b/jpr-8-851.PMC4670016.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/b6/7b/jpr-8-851.PMC4670016.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/7b/jpr-8-851.PMC4670016.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/06/ndt-11-2975.PMC4670017.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2975–2987Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2975Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S9112 6Risk of seizures in transcranial magnetic stimulation:  a clinical review to inform consent process focused  on bupropion Christine e Dobek1 Daniel M Blumberger2 Jonathan Downar3 Zafiris J Daskalakis2 Fidel vila-Rodriguez1 1Department of Psychiatry,   Faculty of Medicine, Non-invasive  Neurostimulation Therapies  (NiNeT) Laboratory, University of  British Columbia, vancouver, BC,   2Department of Psychiatry, Centre  for Addiction and Mental Health,   3Department of Psychiatry, University  Health Network, University of  T oronto, T oronto, ON, CanadaObjective:  When considering repetitive transcranial magnetic stimulation (rTMS) for major  depressive disorder, clinicians often face a lack of detailed information on potential interactions  between rTMS and pharmacotherapy.",Non-OADS,/arxiv_data1/oa_pdf/f9/06/ndt-11-2975.PMC4670017.pdf
"When discussing medications Correspondence: Fidel vila-Rodriguez Department of Psychiatry, Faculty of  Medicine, Non-invasive Neurostimulation  Therapies (NiNeT) Laboratory, UBC  Hospital, University of British Columbia,  Detwiller Pavilion, 2255 wesbrook Mall,  vancouver, BC v6T 2A1, Canada Tel +1 604 827 0175 email fidelvil@mail.ubc.c a Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Dobek et al Running head recto: rTMS and bupropion DOI: http://dx.doi.org/10.2147/NDT.S91126",Non-OADS,/arxiv_data1/oa_pdf/f9/06/ndt-11-2975.PMC4670017.pdf
Available from: http://www.psychiatrictimes.com/ depression/repetitive-transcranial-magnetic-stimulation-depression- changing-landscape.,Non-OADS,/arxiv_data1/oa_pdf/f9/06/ndt-11-2975.PMC4670017.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f9/06/ndt-11-2975.PMC4670017.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/06/ndt-11-2975.PMC4670017.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f4/90/dddt-9-6269.PMC4670018.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 6269–6274Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6269Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9396 4Xiaokeping mixture inhibits diabetic nephropathy  in streptozotocin-induced rats through blocking  TgF-β1/smad7 signaling chuanwei Xin Zhongni Xia cheng Jiang Mengmeng lin gonghua li Department of Pharmacy, Zhejiang  academy of Traditional chinese  Medicine, T ongde hospital of Zhejiang  Province, hangzhou, People’s republic  of chinaBackground:  Diabetic nephropathy (DN) is a major cause of chronic kidney failure and  characterized by excessive deposition of extracellular matrix.",Non-OADS,/arxiv_data1/oa_pdf/f4/90/dddt-9-6269.PMC4670018.pdf
"Thus, inhibiting the TGF- β1/Smad signaling pathway is helpful for  preventing renal tubulointerstitial fibrosis and preserving renal function.5correspondence: gonghua li Department of Pharmacy, Zhejiang  academy of Traditional chinese  Medicine, Tongde hospital of Zhejiang  Province, gucui road, 310020 hangzhou,  People’s republic of china Tel +86 571 899 722 40 email xyaoshi9@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Xin et al Running head recto: XKP inhibits DN in STZ rats through blocking TGF- β1/Smad7 DOI: http://dx.doi.org/10.2147/DDDT.S93964",Non-OADS,/arxiv_data1/oa_pdf/f4/90/dddt-9-6269.PMC4670018.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/f4/90/dddt-9-6269.PMC4670018.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/90/dddt-9-6269.PMC4670018.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/90/1e/copd-10-2593.PMC4670019.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 2593–2600International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2593OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8640 2The analyses of risk factors for COPD in the  li ethnic group in hainan, People’s republic  of China  Yipeng Ding1,* Junxu Xu2,* Jinjian Yao1 Yu Chen2 Ping he1 Yanhong Ouyang1 huan niu1 Zhongjie Tian1 Pei sun1 1Department of emergency, People’s  hospital of hainan Province,   2Department of respiratory, The Third  People’s hospital of haikou, haikou,   hainan, People’s republic of China *These authors contributed equally  to this workObjective:  To study the risk factors for chronic obstructive pulmonary disease (COPD) in Li  population in Hainan province, People’s Republic of China.",Non-OADS,/arxiv_data1/oa_pdf/90/1e/copd-10-2593.PMC4670019.pdf
"COPD has been reported as the fourth  leading cause of morbidity and mortality in the USA, with gross medical costs up to $24  billion in 1993.2 Although COPD was previously regarded as a disease of high-income Correspondence: Yipeng Ding Department of emergency, People’s  hospital of hainan Province, Mailbox  number 19 Xiuhua road, haikou, hainan  570311, People’s republic of China Tel +86 898 6622 2502 Fax +86 898 6622 2502 email yipengding69@yeah.ne t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Ding et al Running head recto: Epidemiology of COPD in the People’s Republic of China DOI: http://dx.doi.org/10.2147/COPD.S86402",Non-OADS,/arxiv_data1/oa_pdf/90/1e/copd-10-2593.PMC4670019.pdf
"Available  from: http://www.ersnet.org/images/firs-world-report.pd f. Accessed  November 25, 2014.18.",OADS,/arxiv_data1/oa_pdf/90/1e/copd-10-2593.PMC4670019.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/90/1e/copd-10-2593.PMC4670019.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/90/1e/copd-10-2593.PMC4670019.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7b/1a/jpr-8-845.PMC4670020.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 845–849Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  845Case RePo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/JPR.S9310 7Genitofemoral neuralgia: adding to the burden   of chronic vulvar pain Hans Verstraelen1 eline De Zutter1 Martine De Muynck2 1Department of obstetrics and  Gynaecology, Vulvovaginal Disease  Clinic, Ghent University Hospital,   Ghent, Belgium;  2Department of  Physical Medicine and Rehabilitation,   Ghent University Hospital, Ghent,   Belgium Correspondence: Hans Verstraelen   Department of obstetrics and  Gynaecology, Ghent University Hospital,  De Pintelaan  185, 9000 Ghent, Belgium   tel +32 9 240 3796  email hans.verstraelen@ugent.b eAbstract:  The vulva is a particularly common locus of chronic pain with neuropathic  characteristics that occurs in women of any age, though most women with neuropathic type  chronic vulvar pain will remain undiagnosed even following multiple physician visits.",Non-OADS,/arxiv_data1/oa_pdf/7b/1a/jpr-8-845.PMC4670020.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/7b/1a/jpr-8-845.PMC4670020.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/1a/jpr-8-845.PMC4670020.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/42/b0/copd-10-2571.PMC4670021.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 2571–2579International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2571OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9116 3The chronic obstructive pulmonary disease  assessment test improves the predictive value  of previous exacerbations for poor outcomes  in COPD Marc Miravitlles1 Patricia garcía-sidro2 alonso Fernández-n istal3 María Jesús Buendía4 María José espinosa de  los Monteros5 Cristina esquinas1 Jesús Molina6 1Pneumology Department, hospital  Universitari Vall d’hebron, Ciber  de enfermedades respiratorias,   Barcelona, 2Pneumology Unit,   hospital de la Plana, Villareal, 3Medical  Department, Takeda Farmacéutica  españa s.a., Madrid, 4Pneumology  Department, hospital Universitario  Infanta leonor, Madrid, 5Pneumology  Department, hospital Universitario  Virgen de la salud, T oledo, 6Centro de  salud “Francia”, Fuenlabrada, Madrid,   spainIntroduction:  Chronic obstructive pulmonary disease (COPD) exacerbations have a negative  impact on the quality of life of patients and the evolution of the disease.",Non-OADS,/arxiv_data1/oa_pdf/42/b0/copd-10-2571.PMC4670021.pdf
"Keywords:  COPD, CAT, CCQ, COPDSS, AQ20, exacerbations Introduction At present, chronic obstructive pulmonary disease (COPD) is the fourth leading cause  of death and estimates show that by 2030 COPD will become the third leading cause  of death.1,2 Moreover, a recent study about the global burden of disease (measured in  disability-adjusted life-years) places COPD in the second position.3 The chronic and progressive course of COPD is frequently aggravated by short  periods of increased cough, dyspnea, and the production of sputum that can become  purulent.1 These exacerbations have been shown to have a negative impact on health- related quality of life (HRQoL) and are the most frequent cause of medical visits, Correspondence: Marc Miravitlles Pneumology Department, hospital  Universitari Vall d’hebron,  Passeig Vall d’hebron, 119-129,  08035 Barcelona, spain Tel +34 93 274 6083 Fax +34 93 274 6083 email mmiravitlles@vhebron.ne t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Miravitlles et al Running head recto: Predictive value of CAT for poor outcomes in COPD  DOI: http://dx.doi.org/10.2147/COPD.S91163",Non-OADS,/arxiv_data1/oa_pdf/42/b0/copd-10-2571.PMC4670021.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/42/b0/copd-10-2571.PMC4670021.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b0/copd-10-2571.PMC4670021.pdf
Available from: http://www.ccq.nl /.,Non-OADS,/arxiv_data1/oa_pdf/42/b0/copd-10-2571.PMC4670021.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/06/1c/ndt-11-2967.PMC4670022.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2967–2973Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2967Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6084 9Profile of brivaracetam and its potential in the  treatment of epilepsy edoardo Ferlazzo1,2 emilio Russo3 Laura Mumoli1 Chiara Sueri2 Sara Gasparini1,2 Caterina Palleria3 Angelo Labate1 Antonio Gambardella1 Giovambattista De Sarro3 Umberto Aguglia1,2 1Department of Medical and Surgical  Sciences, Magna Græcia University,   Catanzaro, 2Regional epilepsy Centre,    Bianchi-Melacrino-Morelli Hospital,   Reggio Calabria, 3Institute of  Pharmacology, Magna Græcia  University, Catanzaro, italyAbstract:  Brivaracetam (BRV) (UCB 34714) is currently under review by the US Food and  Drug Administration and European Medicines Agency for approval as an add-on treatment for  adult patients with partial seizures.",Non-OADS,/arxiv_data1/oa_pdf/06/1c/ndt-11-2967.PMC4670022.pdf
"According Correspondence: edoardo Ferlazzo Regional epilepsy Centre, Bianchi- Melacrino-Morelli Hospital, via  Melacrino, 89100 Reggio Calabria, Italy Tel +39 0965 397 972 Fax +39 0965 397 973 email ferlazzo@unicz.i t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Ferlazzo et al Running head recto: Brivaracetam in epilepsy DOI: http://dx.doi.org/10.2147/NDT.S60849",Non-OADS,/arxiv_data1/oa_pdf/06/1c/ndt-11-2967.PMC4670022.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/06/1c/ndt-11-2967.PMC4670022.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/06/1c/ndt-11-2967.PMC4670022.pdf
"Expanded View for this article is available online: http://embor.embopress.org Acknowledgements We thank James Ellis, Jens Lykke-Andersen, Jason Moffat for reagents and PeterZandstra, Quaid Morris, Lynn Megeney, Emily Walker, Kamal Garcha, GarethPalidwor, Carol Perez-Iratxeta, and Andrey Shukalyuk for expert advice.",Non-OADS,/arxiv_data1/oa_pdf/cc/9d/EMBR-16-1334.PMC4670460.pdf
Available at: http://www.facit.org/Questionnaires.,Non-OADS,/arxiv_data1/oa_pdf/ac/5d/apt0039-0811.PMC4670472.pdf
Available at: http://work-learning.com/effect_sizes.htm.,Non-OADS,/arxiv_data1/oa_pdf/ac/5d/apt0039-0811.PMC4670472.pdf
"Children’s Oncology Group; 2013. http://www.survivorshipguidelines.org/pdf/LTFUGuidelines_40.pdf, accessed March 2015.",Non-OADS,/arxiv_data1/oa_pdf/c3/65/pbc0062-2197.PMC4670474.pdf
Travel time by car was measured using the web page “Visveg” (http://visveg.vegvesen.no/Visveg/mapviewer.jsf?,OADS,/arxiv_data1/oa_pdf/d2/5f/aogs0093-0647.PMC4670695.pdf
Available online at: http://www.fhi.no/eway/default.aspx?pid=239&trg=Content_6510 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d2/5f/aogs0093-0647.PMC4670695.pdf
Availableonline at: http://www.lovdata.no/all/hl-19750613-050.html.,Non-OADS,/arxiv_data1/oa_pdf/d2/5f/aogs0093-0647.PMC4670695.pdf
"8pp.Available online at: http://legeforeningen.no/Fagmed/Norsk-gynekologisk-forening/Veiledere/veileder-i-generell-gynekologi-2009/provosert-abort/ (accessed 2 November,2011).",OADS,/arxiv_data1/oa_pdf/d2/5f/aogs0093-0647.PMC4670695.pdf
"It is thereforerecommended to monitor patients continuously withan electrocardiogram for 6 h after the ﬁrst dose, and to extend the monitoring of patients who develop speciﬁc clinically relevant signs of heart arrhythmia(http://www.fda.gov/Drugs/DrugSafety/ucm303192.htm).",Non-OADS,/arxiv_data1/oa_pdf/23/e4/ene0023-0018.PMC4670697.pdf
(Available from: http://onlinelibrary.wiley.com/doi/10.1002/ 14651858.CD007331.pub2/abstract).,Non-OADS,/arxiv_data1/oa_pdf/50/48/tmi0020-0430.PMC4670701.pdf
(Avail- able from: http://onlinelibrary.wiley.com/doi/10.1002/ 14651858.CD009987.pub2/abstract).,Non-OADS,/arxiv_data1/oa_pdf/50/48/tmi0020-0430.PMC4670701.pdf
"’s [2001] dust source fraction data were provided by NOAA/GFDL, APCD, USA (http://www.gfdl.noaa.gov/atmospheric-physics-and-chemistry_data).",OADS,/arxiv_data1/oa_pdf/9f/6e/grl0042-1275.PMC4670712.pdf
"Barren/sparsely vegetated land data [ Fischer et al ., 2008] were provided by the HarmonizedWorld Soil Database IIASA, Laxenburg,Austria (http://webarchive.iiasa.ac.at/ Research/LUC/External-World-soil- database).",OADS,/arxiv_data1/oa_pdf/9f/6e/grl0042-1275.PMC4670712.pdf
"For performing new MAs, we used the COCHRANE REVIEWMANAGER version 5.2.7 computer software (The Cochra-ne Collaboration, http://ims.cochrane.org/revman/down-load).",OADS,/arxiv_data1/oa_pdf/c4/75/aogs0093-0571.PMC4670718.pdf
The results of the ongoing multicenter RCT in the UnitedStates (http://clinicaltrials.gov/ct2/show/NCT01131260)are some months away.,Non-OADS,/arxiv_data1/oa_pdf/c4/75/aogs0093-0571.PMC4670718.pdf
"Available online at: http://digitalcommons.uconn.edu/chip_docs/19 (accessed February 10, 2014).",Non-OADS,/arxiv_data1/oa_pdf/c4/75/aogs0093-0571.PMC4670718.pdf
"Version 5.1.0.Available online at: http://handbook.cochrane.org/front_page.htm (accessed February 10, 2014).",OADS,/arxiv_data1/oa_pdf/c4/75/aogs0093-0571.PMC4670718.pdf
Available online at: http://www.statsdirect.,Non-OADS,/arxiv_data1/oa_pdf/c4/75/aogs0093-0571.PMC4670718.pdf
5. https://clinicaltrials.gov/ct2/show/ NCT01355497 (accessed 11/07/2015).,Non-OADS,/arxiv_data1/oa_pdf/65/c7/jcsm0006-0272.PMC4670733.pdf
6. https://clinicaltrials.gov/ct2/show/ NCT01355484 (accessed 11/07/2015) 7.,Non-OADS,/arxiv_data1/oa_pdf/65/c7/jcsm0006-0272.PMC4670733.pdf
2005 [cited 7 August 2010].Available from: http://www.segenealogy.,OADS,/arxiv_data1/oa_pdf/bf/e0/jcsm0006-0317.PMC4670740.pdf
"577~584(2015) © 2015 Korean Society for Food Science of Animal RecourcesDOI http://dx.doi.org/10.5851/kosfa.2015.35.5.577 ISSN 1225-8563 eISSN 2234-246X 577Effect of Pre-rigor Salting Levels on Physicochemical and Textural Properties of Chicken Breast Muscles Hyun-Wook Kim, Ko-Eun Hwang, Dong-Heon Song, Yong-Jae Kim, Youn-Kyung Ham, Eui-Joo Yeo, Tae-Jun Jeong, Yun-Sang Choi1, and Cheon-Jei Kim* Department of Food science and Biotechnology of Animal Resources, Konkuk University, Seoul 05029, Korea 1Food Processing Research center, Korean Food Research Institute, Seongnam 13539, Korea Abstract This study was conducted to evaluate the effect of pre-rigor salting level (0-4% NaCl concentration) on physicochemical and tex tural properties of pre-rigor chicken breast muscles.",Non-OADS,/arxiv_data1/oa_pdf/dd/f7/kosfa-35-577.PMC4670885.pdf
"585~596(2015) © 2015 Korean Society for Food Science of Animal RecourcesDOI http://dx.doi.org/10.5851/kosfa.2015.35.5.585 ISSN 1225-8563 eISSN 2234-246X 585Influence of Citric Acid on th e Pink Color and Characteristics of Sous Vide Processed Chicken Breasts During Chill Storage Ji-Han Kim, Go-Eun Hong, Ki-Won Lim1, Woojoon Park, and Chi-Ho Lee* Department of Food Science & Biotechnology of Animal Resources, Konkuk University, Seoul 05029, Korea 1Laboratory of Exercise Nutrition, Department of Physical Education, Konkuk University, Seoul 05029, Korea Abstract Chicken breast dipped with citric acid (CA) was treated by sous vide processing and stored in a refrigerated state for 0, 3, 6,  9, and 14 d. A non-dipped control group (CON) and three groups dipped in different concentrations of citric acid concentration were analy zed (0.5%, 0.5CIT; 2.0%, 2CIT and 5.0%, 5CIT; w/v).",Non-OADS,/arxiv_data1/oa_pdf/f2/7d/kosfa-35-585.PMC4670886.pdf
"597~603(2015) © 2015 Korean Society for Food Science of Animal RecourcesDOI http://dx.doi.org/10.5851/kosfa.2015.35.5.597 ISSN 1225-8563 eISSN 2234-246X 597Effects of Drying Condition and Binding Agent on the Quality Characteristics of Ground Dried-Pork Meat Products Yun-Sang Choi, Su-Kyung Ku, Jong-Dae Park, Hee-Ju Kim1, Aera Jang2, and Young-Boong Kim* Food Processing Research Center, Korea Food Research Institute, Sungnam 13539, Korea 1Meat bank, Inchon 22650, Korea 2Department of Animal Products and Food Science, Kangwon National University, Chuncheon 24341, Korea Abstract The purpose of this study was to investigate the influence of processing conditions (temperature and time) and binding agent ty pes (glutinous rice flour, potato starch, bean flour, and acorn flour) on the physicochemical and sensory characteristics of ground  dried-pork meat product.",Non-OADS,/arxiv_data1/oa_pdf/d2/56/kosfa-35-597.PMC4670887.pdf
604~610(2015) © 2015 Korean Society for Food Science of Animal RecourcesDOI http://dx.doi.org/10.5851/kosfa.2015.35.5.604 ISSN 1225-8563 eISSN 2234-246X 604The Synergic Anti-inflammatory Impact of Gleditsia sinensis  Lam.,Non-OADS,/arxiv_data1/oa_pdf/0f/8c/kosfa-35-604.PMC4670888.pdf
The gel images were quantified using NIH Image J pro-gram (NIH http://rsb.info.nih.gov/ij/) and pAKT activitywas determined by the ratio of pAKT/total AKT.,OADS,/arxiv_data1/oa_pdf/0f/8c/kosfa-35-604.PMC4670888.pdf
"611~614(2015) © 2015 Korean Society for Food Science of Animal RecourcesDOI http://dx.doi.org/10.5851/kosfa.2015.35.5.611 ISSN 1225-8563 eISSN 2234-246X 611Application of an Antimicrobial Prot ein Film in Beef Patties Packaging Ji-Hyun Lee and Kyung Bin Song* Department of Food Science and Technology, Chungnam National University, Daejeon 34134, Korea Abstract This study was performed to apply a protein film containing a natural antimicrobial   compound to meat packaging and determine quality change of meat during storage.",Non-OADS,/arxiv_data1/oa_pdf/c1/a8/kosfa-35-611.PMC4670889.pdf
"615~621(2015) © 2015 Korean Society for Food Science of Animal RecourcesDOI http://dx.doi.org/10.5851/kosfa.2015.35.5.615 ISSN 1225-8563 eISSN 2234-246X 615Probiotic Characteristics of Lactobacillus plantarum  FH185 Isolated from Human Feces Sun-Young Park and Sang-Dong Lim* Korea Food Research Institute, Seongnam 13539, Korea Abstract Lactobacillus plantarum  FH185 was isolated from the feces of healthy adults.",Non-OADS,/arxiv_data1/oa_pdf/57/d8/kosfa-35-615.PMC4670890.pdf
"622~629(2015) © 2015 Korean Society for Food Science of Animal RecourcesDOI http://dx.doi.org/10.5851/kosfa.2015.35.5.622 ISSN 1225-8563 eISSN 2234-246X 622Effects of Replacing Sucrose wit h Various Sugar Alcohols on Quality Properties of Semi-dried Jerky Sung-Jin Jang, Hyun-Wook Kim, Ko-Eun Hwang, Dong-Heon Song, Yong-Jae Kim, Youn-Kyung Ham, Yun-Bin Lim, Tae-Jun Jeong, Si-Young Kim, and Cheon-Jei Kim* Department of Food Science and Biotechnology of Animal Resources, Konkuk University, Seoul 05029, Korea Abstract The objective of this study was to investigate the effects of replacing sucrose with sugar alcohols (sorbitol, glycerol and xyl itol) on the quality properties of semi-dried jerky.",Non-OADS,/arxiv_data1/oa_pdf/62/b5/kosfa-35-622.PMC4670891.pdf
"630~637(2015) © 2015 Korean Society for Food Science of Animal RecourcesDOI http://dx.doi.org/10.5851/kosfa.2015.35.5.630 ISSN 1225-8563 eISSN 2234-246X 630Effect of High Pressure Homogenization on the Physicochemical Properties of Natural Plant-based Model Emulsion Applicable for Dairy Products Sung Hee Park1, Sang-Gi Min2, Yeon-Ji Jo2*, and Ji-Yeon Chun3* 1Department of Marine Food Science and Technology, Gangneung-Wonju National University, Gangneung 25457, Korea 2Department of Bioindustrial Technologies, Konkuk University, Seoul 05029, Korea 3Department of Food Bioengineering, Jeju National University, Jeju 63243, Korea Abstract In the dairy industry, natural plant-based powders are widely used to develop flavor and functionality.",Non-OADS,/arxiv_data1/oa_pdf/2b/ed/kosfa-35-630.PMC4670892.pdf
"638~645(2015) © 2015 Korean Society for Food Science of Animal RecourcesDOI http://dx.doi.org/10.5851/kosfa.2015.35.5.638 ISSN 1225-8563 eISSN 2234-246X 638Quality Properties of Sausages Made with Replacement of Pork with Corn Starch, Chicken Breast and S urimi during Refrigerated Storage Hyun-Woo Seo, Geun-Ho Kang, Soo-Hyun Cho, Hoa Van Ba, and Pil-Nam Seong* National Institute of Animal Science, RDA, Wanju 55365, Korea Abstract This effect of replacing pork with corn starch, chicken breast and surimi on the chemical composition, physical, texture and se nsory properties of sausage were investigated during storage.",Non-OADS,/arxiv_data1/oa_pdf/65/57/kosfa-35-638.PMC4670893.pdf
"646~652(2015) © 2015 Korean Society for Food Science of Animal RecourcesDOI http://dx.doi.org/10.5851/kosfa.2015.35.5.646 ISSN 1225-8563 eISSN 2234-246X 646Evaluation of Meat Color and Phys iochemical Characteristics in Forequarter Muscles of Holstein Steers Sung Sil Moon1, Pil-Nam Seong, and Jin Young Jeong* Animal Products Utilization Division, National Institute of Animal Science, RDA, Wanju 55365, Korea 1Department of Animal Science and Biotechnology, Chonbuk National University, Chonju 54896, Korea Abstract The beef forequarter muscle comprises approximately 52% of carcass weight.",Non-OADS,/arxiv_data1/oa_pdf/94/b0/kosfa-35-646.PMC4670894.pdf
"653~659(2015) © 2015 Korean Society for Food Science of Animal RecourcesDOI http://dx.doi.org/10.5851/kosfa.2015.35.5.653 ISSN 1225-8563 eISSN 2234-246X 653Anti-obesity Effect of Fermented Whey Beverage using Lactic Acid Bacteria in Diet-induced Obese Rats Sung-Moon Hong, Eui-Chun Chung, and Cheol-Hyun Kim* Department of Animal Resource & Science, Dankook University, Cheonan 31116, Korea Abstract High-protein fermented whey beverage (FWB) was manufactured using whey protein concentrate (WPC) and Lactobacillus plan- tarum  DK211 isolated from kimchi.",Non-OADS,/arxiv_data1/oa_pdf/9c/66/kosfa-35-653.PMC4670895.pdf
"660~668(2015) © 2015 Korean Society for Food Science of Animal RecourcesDOI http://dx.doi.org/10.5851/kosfa.2015.35.5.660 ISSN 1225-8563 eISSN 2234-246X 660Effect of Dietary Processed Sulfur Supplementation on Texture Quality, Color and Mi neral Status of Dry-cured Ham Ji-Han Kim, Min-Gu Ju, Su-Jung Yeon, Go-Eun Hong, WooJoon Park, and Chi-Ho Lee* Department of Food Science and Biotechnology of Animal Resources, Konkuk University, Seoul 05029, Korea Abstract This study was performed to investigate the chemical composition, mineral status, oxidative stability, and texture attributes o f dry- cured ham from pigs fed processed sulfur (S, 1 g/kg feed), and from those fed a basal diet (CON), during the period from weanin g to slaughter (174 d).",Non-OADS,/arxiv_data1/oa_pdf/37/bb/kosfa-35-660.PMC4670896.pdf
http://dx.doi.drg/ 10.1071/AN14680 24.,Non-OADS,/arxiv_data1/oa_pdf/37/bb/kosfa-35-660.PMC4670896.pdf
"669~673(2015) © 2015 Korean Society for Food Science of Animal RecourcesDOI http://dx.doi.org/10.5851/kosfa.2015.35.5.669 ISSN 1225-8563 eISSN 2234-246X 669Occurrence and Antibiotic Susceptibility of Listeria Species in Turkey Meats Zeki Aras* and Mustafa Ard ç1 Department of Microbiology, Faculty of Veterinary Medicine, Aksaray University, Aksaray 68100, Turkey 1Department of Food Engineering, Faculty of Engineering, Aksaray University, Aksaray 68100, Turkey Abstract The aims of this study were to investigate the occurrence of Listeria  species in turkey meats and to check the antimicrobial suscepti- bility of the isolated strains.",Non-OADS,/arxiv_data1/oa_pdf/49/e9/kosfa-35-669.PMC4670897.pdf
674~682(2015) © 2015 Korean Society for Food Science of Animal RecourcesDOI http://dx.doi.org/10.5851/kosfa.2015.35.5.674 ISSN 1225-8563 eISSN 2234-246X 674Quantitative Microbia l Risk Assessment for Campylobacter spp.,Non-OADS,/arxiv_data1/oa_pdf/0f/01/kosfa-35-674.PMC4670898.pdf
Available from:http://nifds.go.kr/nifds/08_part/part01_c_b.jsp?mode=view&article_no=5687.,OADS,/arxiv_data1/oa_pdf/0f/01/kosfa-35-674.PMC4670898.pdf
Available from: http://www.mfds.go.kr/e-stat/index.do?nMenuCode=20.,OADS,/arxiv_data1/oa_pdf/0f/01/kosfa-35-674.PMC4670898.pdf
Available from: http://fsrio.nal.usda.,Non-OADS,/arxiv_data1/oa_pdf/0f/01/kosfa-35-674.PMC4670898.pdf
"683~691(2015) © 2015 Korean Society for Food Science of Animal RecourcesDOI http://dx.doi.org/10.5851/kosfa.2015.35.5.683 ISSN 1225-8563 eISSN 2234-246X 683Identification of Coccoidal Bacteria in Traditional Fermented Milk Products from Mongolia, and the Fermentation Properties of the Predominant Species, Streptococcus thermophilus Yan Ren, Wenjun Liu, and Heping Zhang* Key Laboratory of Dairy Biotechnology and Engineering, Education Ministry of P .",Non-OADS,/arxiv_data1/oa_pdf/16/d2/kosfa-35-683.PMC4670899.pdf
"692~702(2015) © 2015 Korean Society for Food Science of Animal RecourcesDOI http://dx.doi.org/10.5851/kosfa.2015.35.5.692 ISSN 1225-8563 eISSN 2234-246X 692Quantitative Proteogenomics and the Reconstruction of the Metabolic Pathway in Lactobacillus mucosae  LM1 Edward Alain B. Pajarillo†, Sang Hoon Kim†, Ji-Yoon Lee1, Valerie Diane V. Valeriano, and Dae-Kyung Kang* Department of Animal Resources Science, Dankook University, Cheonan 31116, Korea 1National Instrumentation Center for Environmental Management, Seoul National University, Seoul 08826, Korea Abstract Lactobacillus mucosae  is a natural resident of the gastrointestinal tract of humans and animals and a potential probiotic bacterium.",Non-OADS,/arxiv_data1/oa_pdf/ac/02/kosfa-35-692.PMC4670900.pdf
"Pro-teins were arranged from most to least abundant, and agraphical output was created using a scatter plot method.For pathway analysis, the complete genome sequence(.fasta) file was uploaded to the Kyoto Encyclopedia ofGenes and Genomes (KEGG, http://www.genome.jp/kegg/) Automatic Annotation Server (KAAS) for full annotation of functional genes by BLAST or GHOST comparisons,parallel to the manually curated KEGG GENES database.The bi-directional best-hit (BBH) method was used toassign orthologs.",OADS,/arxiv_data1/oa_pdf/ac/02/kosfa-35-692.PMC4670900.pdf
"703~706(2015) © 2015 Korean Society for Food Science of Animal RecourcesDOI http://dx.doi.org/10.5851/kosfa.2015.35.5.703 ISSN 1225-8563 eISSN 2234-246X 703Color Developing Capacity of Plasma-treated Water as a Source of Nitrite for Meat Curing Samooel Jung1, Hyun Joo Kim2, Sanghoo Park3, Hae In Yong, Jun Ho Choe4, Hee-Joon Jeon4, Wonho Choe3, and Cheorun Jo* Department of Agricultural Biotechnology, Center for Food and Bioconvergence, and Research Institute for Agriculture and Life Science, Seoul National University, Seoul 08826, Korea 1Department of Animal Science and Biotechnology, Chungnam National University, Daejeon 34134, Korea 2National Institute of Crop Science, RDA, Suwon 16616, Korea 3Department of Physics, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea 4Meat Processing Division, Lotte R&D Center, Seoul 07209, Korea Abstract The interaction of plasma with liquid generates nitrogen species including nitrite (NO− 2).",Non-OADS,/arxiv_data1/oa_pdf/b3/c4/kosfa-35-703.PMC4670901.pdf
"707~713(2015) © 2015 Korean Society for Food Science of Animal RecourcesDOI http://dx.doi.org/10.5851/kosfa.2015.35.5.707 ISSN 1225-8563 eISSN 2234-246X 707Whitening Effect of Watersoluble Royal Jelly from South Korea Sang Mi Han*, Jung Min Kim, In Phyo Hong, Soon Ok Woo, Se Gun Kim, Hye Ri Jang, Kwan Kyu Park1, and Sok Cheon Pak2 Department of Agricultural Biology, National Academy of Agricultural Science, Wanju 55365, Korea 1Catholic University of Daegu School of Medicine, Daegu 42472, Korea 2School of Biomedical Sciences, Charles Sturt University, Bathurst, NSW 2795, Australia Abstract Royal jelly has been widely used as a health supplement worldwide.",Non-OADS,/arxiv_data1/oa_pdf/2b/0e/kosfa-35-707.PMC4670902.pdf
"Recommendation and level of evidence of speciﬁc management options were classiﬁed according to predeﬁned scales, as outlinedinTables 1and 2(http://www.escardio.org/guidelines-surveys/esc- guidelines/about/Pages/rules-writing.aspx ).",OADS,/arxiv_data1/oa_pdf/0c/50/ehv162.PMC4670964.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/50/ehv162.PMC4670964.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/e4/ehv476.PMC4670965.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/15/ehv513.PMC4670966.pdf
"Increased mortality after dronedarone therapy for severe heart failure.N Engl J Med 2008; 358:2678–2687................................................................................................................................ ................................................Table 3 Upcoming trials relating to heart failure and atrial ﬁbrillation Trial Objective Status Further information CASTLE-AF Catheter ablation for AF and HFrEF Funded, recruiting https://clinicaltrials.gov/ct2/show/NCT00643188 RAFT AF Rate vs. rhythm control for AF and HFrEF Funded, recruiting https://clinicaltrials.gov/ct2/show/NCT01420393 GENETIC AF Genetically targeted AF therapy in HF Funded, recruiting https://clinicaltrials.gov/ct2/show/NCT01970501 IMPRESS-AF Spironolactone in AF with HFpEF Funded, recruiting http://www.isrctn.com/ISRCTN10259346 EAST Early rhythm control for AF Funded, recruiting https://clinicaltrials.gov/ct2/show/NCT01288352 CABANA Early rhythm control for AF Funded, recruiting https://clinicaltrials.gov/ct2/show/NCT00911508 CATCH ME AF genetics and tissue proﬁling Funded, recruiting http://www.catch-me.info DIGIT-HF Digitoxin vs. placebo in HFrEF Funded, recruiting https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-005326-38/DE RATE-AF Digoxin vs. b-blockers in AF Funded, not started https://clinicaltrials.gov/ct2/show/NCT02391337Heart failure & atrial ﬁbrillation 3257",Non-OADS,/arxiv_data1/oa_pdf/22/15/ehv513.PMC4670966.pdf
2014. http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/22/15/ehv513.PMC4670966.pdf
"Conference proceedings from the American College of CardiologyScientiﬁc Session March 16 2015, San Diego, 2015. http://www.abstractsonline.",Non-OADS,/arxiv_data1/oa_pdf/22/15/ehv513.PMC4670966.pdf
NationalInstitute for Health Research Project Portfolio 2014. http://www.nets.nihr.,Non-OADS,/arxiv_data1/oa_pdf/22/15/ehv513.PMC4670966.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ the paper on the Cell Research website.)",Non-OADS,/arxiv_data1/oa_pdf/fa/6b/cr2015139a.PMC4670995.pdf
V .T h i si sa no p e na c c e s sa r t i c l eu n d e rt h eC CB Y - N C - N Dl i c e n s e (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/fb/main.PMC4671084.pdf
"Upon proper pathogenic stimulation, LC undergo phenotypic and functional changes including the activation ofContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/pvrPapillomavirus Research http://dx.doi.org/10.1016/j.pvr.2015.05.001 2405-8521/ &2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ce/fb/main.PMC4671084.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: APC, antigen presenting cell; DC, dendritic cell; HPV, human papillomavirus; hrHPV, high-risk HPV; HPV16, HPV type 16; LC, Langerhans cell;MLR, mixed lymphocyte reaction; PAMP, pathogen associated molecular pattern; s-Poly-I:C, stabilized polyinosinic-polycytidilic acid; TLR3, toll-like receptor 3;cVLP, chimeric virus-like particle; VLP, virus-like particle nCorrespondence to: University of Southern California, 1450 Biggy Street, MC 9601, Los Angeles, CA 90033, USA.",Non-OADS,/arxiv_data1/oa_pdf/ce/fb/main.PMC4671084.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.pvr.2015.05.001 .,OADS,/arxiv_data1/oa_pdf/ce/fb/main.PMC4671084.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Overpressure blast injury and basilar artery HZ Toklu et al 1956 Journal of Cerebral Blood Flow & Metabolism (2015), 1950 –1956 © 2015 ISCBFM",Non-OADS,/arxiv_data1/oa_pdf/2a/20/jcbfm2015151a.PMC4671114.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International   © 2015 Surgical Neurology International | Published by Wolters Kluwer - MedknowS611Abstract Background:  Assessment of bone quality can guide spinal surgery.",Non-OADS,/arxiv_data1/oa_pdf/e4/39/SNI-6-611.PMC4671137.pdf
"http://surgicalneurologyint.com/Posterolateral-lumbar-fusion:-Relationship-between- computed-tomography-Hounsfield-units-and-symptomatic-pseudoarthrosis/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/e4/39/SNI-6-611.PMC4671137.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International   © 2015 Surgical Neurology International | Published by Wolters Kluwer - MedknowS619Abstract Background:  Superior cluneal nerve entrapment neuropathy (SCN‑EN) may  contribute to low back pain (LBP).",Non-OADS,/arxiv_data1/oa_pdf/cf/91/SNI-6-619.PMC4671138.pdf
"http://surgicalneurologyint.com/Treatment-of-low-back-pain-in-patients-with- vertebral-compression-fractures-and-superior-cluneal-nerve-entrapment- neuropathies/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/cf/91/SNI-6-619.PMC4671138.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International   © 2015 Surgical Neurology International | Published by Wolters Kluwer - MedknowS615En bloc  resection of a C2–C3 upper cervical chordoma:   Technical note Alexander G. Weil, Mohammed Shehadeh, Tareck Ayad1, Olivier Abboud1, Daniel Shedid Division of Neurosurgery, Hôpital Notre‑Dame du CHUM, University of Montreal, 1Division of Otolaryngology – Head and Neck Surgery, Hôpital Notre‑Dame du  CHUM, University of Montreal, Montreal, Québec, Canada E‑mail:  Alexander G. Weil ‑ alexandergweil@gmail.com; Mohammed Shehadeh ‑ mohshe1111@hotmail.com; Tareck Ayad ‑ tareck.ayad@umontreal.ca;   Olivier Abboud ‑ olivier.abboud@umontreal.ca; *Daniel Shedid ‑ danielshedid@gmail.com   *Corresponding author Received: 22 June 15   Accepted: 01 September 15  Published: 25 November 15 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.170450  Quick Response Code: Abstract Background:  Recently, en bloc  spondylectomy for upper cervical chordomas  has been reported.",Non-OADS,/arxiv_data1/oa_pdf/81/2e/SNI-6-615.PMC4671139.pdf
"http://surgicalneurologyint.com/ En-bloc -resection-of-a-C2–C3-upper-cervical- chordoma:-T echnical-note/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/81/2e/SNI-6-615.PMC4671139.pdf
"© 2015 Surgical Neurology International | Published by Wolters Kluwer - MedknowSurgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S608Arachnoiditis ossificans and syringomyelia: A  unique  presentation Charles F .",Non-OADS,/arxiv_data1/oa_pdf/ee/c0/SNI-6-608.PMC4671140.pdf
"http://surgicalneurologyint.com/Arachnoiditis-ossificans-and-syringomyelia:-A- unique-presentation/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/ee/c0/SNI-6-608.PMC4671140.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International   © 2015 Surgical Neurology International | Published by Wolters Kluwer - MedknowS591Abstract Background:  Instrumented lumbar spine surgery is associated with an increased  risk of adjacent segment disease (ASD).",Non-OADS,/arxiv_data1/oa_pdf/90/33/SNI-6-591.PMC4671141.pdf
"http://surgicalneurologyint.com/Adjacent-level-disease-following-lumbar-spine- surgery:-A-review/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/90/33/SNI-6-591.PMC4671141.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International   © 2015 Surgical Neurology International | Published by Wolters Kluwer - MedknowS600Abstract Background:  Open cervical laminoforaminotomy (CLF) provides safe and effective  decompression/excision of lateral/foraminal disc herniations/spurs contributing to  nerve root compression.",Non-OADS,/arxiv_data1/oa_pdf/3d/d3/SNI-6-600.PMC4671142.pdf
"http://surgicalneurologyint.com/Open-laminoforaminotomy:-A-lost-art?/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/3d/d3/SNI-6-600.PMC4671142.pdf
"International Journal of Preventive Medicine 2015, 6:111 http://www.ijpvmjournal.net/content/6/1/111Al mobility and its transmission to the groundwater as  well as its bioavailability through the food chain.",Non-OADS,/arxiv_data1/oa_pdf/c6/a3/IJPVM-6-111.PMC4671161.pdf
"International Journal of Preventive Medicine 2015, 6:111 http://www.ijpvmjournal.net/content/6/1/111different seasons was also illustrated by  Geographical  Information System (GIS) software version 10.",Non-OADS,/arxiv_data1/oa_pdf/c6/a3/IJPVM-6-111.PMC4671161.pdf
"International Journal of Preventive Medicine 2015, 6:111 http://www.ijpvmjournal.net/content/6/1/111DISCUSSION Results from this descriptive study support the idea of an  existing correlation between Al and Si in drinking water.",Non-OADS,/arxiv_data1/oa_pdf/c6/a3/IJPVM-6-111.PMC4671161.pdf
"International Journal of Preventive Medicine 2015, 6:111 http://www.ijpvmjournal.net/content/6/1/111the concentration of Si was decreased.",Non-OADS,/arxiv_data1/oa_pdf/c6/a3/IJPVM-6-111.PMC4671161.pdf
"International Journal of Preventive Medicine 2015, 6:111 http://www.ijpvmjournal.net/content/6/1/111plant effluent.",Non-OADS,/arxiv_data1/oa_pdf/c6/a3/IJPVM-6-111.PMC4671161.pdf
Available from: http://www.hc‑sc.gc.ca/waterquality.,Non-OADS,/arxiv_data1/oa_pdf/c6/a3/IJPVM-6-111.PMC4671161.pdf
"International Journal of Preventive Medicine 2015, 6:111 http://www.ijpvmjournal.net/content/6/1/11120.",Non-OADS,/arxiv_data1/oa_pdf/c6/a3/IJPVM-6-111.PMC4671161.pdf
"International Journal of Preventive Medicine 2015, 6:110 http://www.ijpvmjournal.net/content/6/1/110with minimal invasiveness and can be used for  regenerative therapy.",Non-OADS,/arxiv_data1/oa_pdf/e6/c7/IJPVM-6-110.PMC4671162.pdf
"International Journal of Preventive Medicine 2015, 6:110 http://www.ijpvmjournal.net/content/6/1/110it.",Non-OADS,/arxiv_data1/oa_pdf/e6/c7/IJPVM-6-110.PMC4671162.pdf
"International Journal of Preventive Medicine 2015, 6:110 http://www.ijpvmjournal.net/content/6/1/110BMP‑2 and BMP‑7 stimulate human PDL fibroblasts to  differentiate into osteoblastic phenotypes by increasing  the production of ALP , resulting in an accelerated bone  regeneration.",Non-OADS,/arxiv_data1/oa_pdf/e6/c7/IJPVM-6-110.PMC4671162.pdf
"International Journal of Preventive Medicine 2015, 6:110 http://www.ijpvmjournal.net/content/6/1/110limitations it has rarely found its way into clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/e6/c7/IJPVM-6-110.PMC4671162.pdf
"International Journal of Preventive Medicine 2015, 6:104 http://www.ijpvmjournal.net/content/6/1/104One of the most important limitations of oxaliplatin  use is peripheral neuropathy that occurs in 85–95% of  all patients.",Non-OADS,/arxiv_data1/oa_pdf/13/a4/IJPVM-6-104.PMC4671163.pdf
"International Journal of Preventive Medicine 2015, 6:104 http://www.ijpvmjournal.net/content/6/1/104Intervention and variable assessment Enrolled patients were randomized into two groups,  within 4 days of the beginning of the oxaliplatin  treatment, through random allocation sequence (block  size 25).",Non-OADS,/arxiv_data1/oa_pdf/13/a4/IJPVM-6-104.PMC4671163.pdf
"International Journal of Preventive Medicine 2015, 6:104 http://www.ijpvmjournal.net/content/6/1/104oxaliplatin‑induced neuropathies in patients with  colorectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/13/a4/IJPVM-6-104.PMC4671163.pdf
"International Journal of Preventive Medicine 2015, 6:104 http://www.ijpvmjournal.net/content/6/1/10421.",Non-OADS,/arxiv_data1/oa_pdf/13/a4/IJPVM-6-104.PMC4671163.pdf
"International Journal of Preventive Medicine 2015, 6:109 http://www.ijpvmjournal.net/content/6/1/109while USA women fell at the midpoint, the lowest levels  of PPD were reported for European and Australian  women, on the contrary, the highest depressive symptom  scores were seen for women from Asia as well as South  America.",Non-OADS,/arxiv_data1/oa_pdf/70/4d/IJPVM-6-109.PMC4671165.pdf
"International Journal of Preventive Medicine 2015, 6:109 http://www.ijpvmjournal.net/content/6/1/109control group and random assignment.",Non-OADS,/arxiv_data1/oa_pdf/70/4d/IJPVM-6-109.PMC4671165.pdf
"International Journal of Preventive Medicine 2015, 6:109 http://www.ijpvmjournal.net/content/6/1/109the problem, revising automatic thoughts, behavioral  approach tasks, and exposure to worry cues.",Non-OADS,/arxiv_data1/oa_pdf/70/4d/IJPVM-6-109.PMC4671165.pdf
"International Journal of Preventive Medicine 2015, 6:109 http://www.ijpvmjournal.net/content/6/1/109and Coats,[58] studied the effectiveness of CBT on  the reduction of depression symptoms and found no  significant change in self‑esteem although there was a  positive significant change in depression.",Non-OADS,/arxiv_data1/oa_pdf/70/4d/IJPVM-6-109.PMC4671165.pdf
"International Journal of Preventive Medicine 2015, 6:109 http://www.ijpvmjournal.net/content/6/1/109Received:  31 Aug 14 Accepted:  12 Jul 15   Published:  04 Nov 15 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/70/4d/IJPVM-6-109.PMC4671165.pdf
"International Journal of Preventive Medicine 2015, 6:109 http://www.ijpvmjournal.net/content/6/1/10949.",Non-OADS,/arxiv_data1/oa_pdf/70/4d/IJPVM-6-109.PMC4671165.pdf
"International Journal of Preventive Medicine 2015, 6:106 http://www.ijpvmjournal.net/content/6/1/106dental care.",Non-OADS,/arxiv_data1/oa_pdf/e1/1f/IJPVM-6-106.PMC4671166.pdf
"International Journal of Preventive Medicine 2015, 6:106 http://www.ijpvmjournal.net/content/6/1/106health care service utilization and resources inventory,  to identify the needs in the priority area for improving  and strengthening the primary pediatric care at the  polyclinics.",Non-OADS,/arxiv_data1/oa_pdf/e1/1f/IJPVM-6-106.PMC4671166.pdf
"International Journal of Preventive Medicine 2015, 6:106 http://www.ijpvmjournal.net/content/6/1/106desired home visits for newborns.",Non-OADS,/arxiv_data1/oa_pdf/e1/1f/IJPVM-6-106.PMC4671166.pdf
"International Journal of Preventive Medicine 2015, 6:106 http://www.ijpvmjournal.net/content/6/1/106they paid the whole cost upfront and then the insurance  reimbursed 80% of the approved cost.",Non-OADS,/arxiv_data1/oa_pdf/e1/1f/IJPVM-6-106.PMC4671166.pdf
"International Journal of Preventive Medicine 2015, 6:106 http://www.ijpvmjournal.net/content/6/1/106suggest that additional specialization by pediatricians  translates into a unique practice style that may ultimately  result in more efficient or effective care under certain  circumstances.",Non-OADS,/arxiv_data1/oa_pdf/e1/1f/IJPVM-6-106.PMC4671166.pdf
"International Journal of Preventive Medicine 2015, 6:106 http://www.ijpvmjournal.net/content/6/1/106and private sector.",Non-OADS,/arxiv_data1/oa_pdf/e1/1f/IJPVM-6-106.PMC4671166.pdf
Available from: http://www.new.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/IJPVM-6-106.PMC4671166.pdf
Available from: http://www.who.int/countries/brb/en/.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/IJPVM-6-106.PMC4671166.pdf
Available from: http://www.hdrstats.undp.org/images/explanations/ BRB.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/IJPVM-6-106.PMC4671166.pdf
Available from: http://www.new.paho.org/.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/IJPVM-6-106.PMC4671166.pdf
Available	from:	http://www.paho.org/saludenlasamericas/index.php?id=23 	 &option=com_content and Itemid=0 and lang=en.,OADS,/arxiv_data1/oa_pdf/e1/1f/IJPVM-6-106.PMC4671166.pdf
Available from: http://www.bphc.hrsa.gov/about/ requirements/index.html.,OADS,/arxiv_data1/oa_pdf/e1/1f/IJPVM-6-106.PMC4671166.pdf
"International Journal of Preventive Medicine 2015, 6:106 http://www.ijpvmjournal.net/content/6/1/10634.",Non-OADS,/arxiv_data1/oa_pdf/e1/1f/IJPVM-6-106.PMC4671166.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/ NBK11784/.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/IJPVM-6-106.PMC4671166.pdf
"International Journal of Preventive Medicine 2015, 6:105 http://www.ijpvmjournal.net/content/6/1/105political commitment, integration of evidence‑based  malaria research into health systems, intersectional  collaboration, coordination with relevant sectors  community participation, and mobilization of adequate  national and international human and financial resources  have been acknowledged.",Non-OADS,/arxiv_data1/oa_pdf/04/ca/IJPVM-6-105.PMC4671174.pdf
"International Journal of Preventive Medicine 2015, 6:105 http://www.ijpvmjournal.net/content/6/1/105was sought from all participants before the start of all  interviews (semi‑structured), including permission to use  anonymous quotes.",Non-OADS,/arxiv_data1/oa_pdf/04/ca/IJPVM-6-105.PMC4671174.pdf
"International Journal of Preventive Medicine 2015, 6:105 http://www.ijpvmjournal.net/content/6/1/105Some participants discussed that their current practice  are unlikely to be effective to improve public health and  requires fostering partnership for elimination malaria.",Non-OADS,/arxiv_data1/oa_pdf/04/ca/IJPVM-6-105.PMC4671174.pdf
"International Journal of Preventive Medicine 2015, 6:105 http://www.ijpvmjournal.net/content/6/1/105Participants mentioned the net usage rate was low  and the main reasons were discomfort and low disease  incidence, while the mass distribution of free LLINs was  performed to encourage the inhabitants use bed nets.",Non-OADS,/arxiv_data1/oa_pdf/04/ca/IJPVM-6-105.PMC4671174.pdf
"International Journal of Preventive Medicine 2015, 6:105 http://www.ijpvmjournal.net/content/6/1/105The participants also mentioned on the problem of  population movement especially immigrants from east  neighboring countries.",Non-OADS,/arxiv_data1/oa_pdf/04/ca/IJPVM-6-105.PMC4671174.pdf
Available from: http://www.who.int/malaria/areas/ global_technical_strategy/en/.,Non-OADS,/arxiv_data1/oa_pdf/04/ca/IJPVM-6-105.PMC4671174.pdf
"International Journal of Preventive Medicine 2015, 6:105 http://www.ijpvmjournal.net/content/6/1/105et al.",Non-OADS,/arxiv_data1/oa_pdf/04/ca/IJPVM-6-105.PMC4671174.pdf
"International Journal of Preventive Medicine 2015, 6:108 http://www.ijpvmjournal.net/content/6/1/108environmental toxins like cigarette smoke, may contain  large amounts of free radicals or stimulate the body’s  cells to produce more free radicals.",Non-OADS,/arxiv_data1/oa_pdf/38/60/IJPVM-6-108.PMC4671175.pdf
"International Journal of Preventive Medicine 2015, 6:108 http://www.ijpvmjournal.net/content/6/1/108The next trial was conducted in US, began in 2001 and  was stopped in 2008.",Non-OADS,/arxiv_data1/oa_pdf/38/60/IJPVM-6-108.PMC4671175.pdf
"International Journal of Preventive Medicine 2015, 6:108 http://www.ijpvmjournal.net/content/6/1/10822.",Non-OADS,/arxiv_data1/oa_pdf/38/60/IJPVM-6-108.PMC4671175.pdf
"International Journal of Preventive Medicine 2015, 6:108 http://www.ijpvmjournal.net/content/6/1/108role of recombinant human erythropoietin in kidney and lung injury  following renal bilateral ischemia‑reperfusion in Rat Model.",Non-OADS,/arxiv_data1/oa_pdf/38/60/IJPVM-6-108.PMC4671175.pdf
"International Journal of Preventive Medicine 2015, 6:103 http://www.ijpvmjournal.net/content/6/1/***achieve sufficient fluid intake.",Non-OADS,/arxiv_data1/oa_pdf/73/da/IJPVM-6-103.PMC4671176.pdf
"International Journal of Preventive Medicine 2015, 6:103 http://www.ijpvmjournal.net/content/6/1/***and cardiovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/73/da/IJPVM-6-103.PMC4671176.pdf
"International Journal of Preventive Medicine 2015, 6:103 http://www.ijpvmjournal.net/content/6/1/***Secondary study parameters/outcome of the study The other parameters are knowledge and awareness of  the risks of dehydration, quality‑of‑life, and experiences  with the interventions.",Non-OADS,/arxiv_data1/oa_pdf/73/da/IJPVM-6-103.PMC4671176.pdf
"International Journal of Preventive Medicine 2015, 6:103 http://www.ijpvmjournal.net/content/6/1/***Analyses Descriptive analyses •	Description of the study population on demographic  parameters (age, gender, living accommodations, type  of disease) •	Quantity of fluid intake, knowledge, and awareness  of the risks of dehydration, and quality‑of‑life before  and after the interventions.",Non-OADS,/arxiv_data1/oa_pdf/73/da/IJPVM-6-103.PMC4671176.pdf
"International Journal of Preventive Medicine 2015, 6:103 http://www.ijpvmjournal.net/content/6/1/***drinks alcohol, it is in any case evident that more than the  minimum recommended daily fluid intake will be required.",Non-OADS,/arxiv_data1/oa_pdf/73/da/IJPVM-6-103.PMC4671176.pdf
Available from: http://www.obli.info.,Non-OADS,/arxiv_data1/oa_pdf/73/da/IJPVM-6-103.PMC4671176.pdf
Available from: http://www.euroqol.org.,Non-OADS,/arxiv_data1/oa_pdf/73/da/IJPVM-6-103.PMC4671176.pdf
"International Journal of Preventive Medicine 2015, 6:102 http://www.ijpvmjournal.net/content/6/1/***and cancers.",Non-OADS,/arxiv_data1/oa_pdf/4b/27/IJPVM-6-102.PMC4671177.pdf
"International Journal of Preventive Medicine 2015, 6:102 http://www.ijpvmjournal.net/content/6/1/***RESULTS This study included a total sample of 5,810 adults  that was composed of 3,516 African Americans, 1,415  Caribbean Blacks, and 879 Non‑Hispanic Whites.",Non-OADS,/arxiv_data1/oa_pdf/4b/27/IJPVM-6-102.PMC4671177.pdf
"International Journal of Preventive Medicine 2015, 6:102 http://www.ijpvmjournal.net/content/6/1/***Table 2: Association between BMI level and perceived overweight with intention to control weight among non‑Hispanic  white men and women OR SE t P 95% CI Lower bound Upper bound White men Model I BMI 2.69 0.462 5.76 <0.001 1.865 3.878 Model II BMI 2.763 0.46 6.11 <0.001 1.938 3.94 Income 1.000 0.001 −0.41 0.691 1.000 1.000 Education 1.532 0.159 4.12 0.001 1.229 1.911 Age 1.01 0.008 1.22 0.242 0.992 1.028 Model III BMI 1.352 0.347 1.18 0.258 0.783 2.336 Income 1.000 0.001 0.09 0.933 1.000 1.000 Education 1.564 0.154 4.53 <0.001 1.267 1.93 Age 1.004 0.009 0.44 0.669 0.985 1.023 Perceived overweight 3.138 1.036 3.46 0.003 1.552 6.343 White women Model I BMI 1.722 0.169 5.53 <0.001 1.397 2.124 Model II BMI 1.809 0.178 6.03 <0.001 1.467 2.231 Income 1.000 0.001 2.01 0.063 1.000 1.000 Education 1.177 0.179 1.07 0.302 0.851 1.627 Age 0.987 0.005 −2.67 0.017 0.976 0.997 Model III BMI 0.68 0.113 −2.32 0.035 0.478 0.969 Income 1.000 0.001 0.93 0.368 1.000 1.000 Education 1.205 0.204 1.1 0.288 0.84 1.727 Age 0.979 0.008 −2.61 0.02 0.962 0.996 Perceived overweight 4.188 1.036 5.79 <0.001 2.472 7.097 CI=Confidence interval, BMI=Body mass index, OR=Odds ratio, SE=Standard error Table 3: Association between BMI level and perceived overweight with intention to control weight among African  American men and women OR SE t P 95% CI Lower bound Upper bound African American men Model I BMI 3.425 0.447 9.44 <0.001 2.627 4.464 Model II BMI 3.453 0.458 9.35 <0.001 2.638 4.521 Income 1.000 0.001 0.65 0.522 1.000 1.000 Education 1.351 0.086 4.74 <0.001 1.187 1.537 Age 1.000 0.006 0.05 0.964 0.989 1.012 Model III BMI 1.806 0.315 3.39 0.002 1.268 2.574 Income 1.000 0.001 0.43 0.669 1.000 1.000 Education 1.282 0.093 3.43 0.002 1.106 1.485 Perceived overweight 3.667 0.549 8.68 <0.001 2.706 4.971 Contd...",Non-OADS,/arxiv_data1/oa_pdf/4b/27/IJPVM-6-102.PMC4671177.pdf
"International Journal of Preventive Medicine 2015, 6:102 http://www.ijpvmjournal.net/content/6/1/***Table 4: Association between BMI level and perceived overweight with intention to control weight among Caribbean  Black men and women OR SE t P 95% CI Lower bound Upper bound Caribbean Black men Model I BMI 6.789 1.358 9.58 <0.001 4.488 10.268 Model II BMI 6.958 1.33 10.15 <0.001 4.685 10.333 Income 1.000 0.001 2.12 0.045 1.000 1.000 Education 1.029 0.301 0.1 0.923 0.562 1.885 Age 0.988 0.011 −1.17 0.253 0.966 1.01 Model III BMI 2.231 0.654 2.74 0.012 1.216 4.092 Income 1.000 0.001 1.72 0.099 1.000 1.000 Education 0.971 0.268 −0.11 0.916 0.548 1.72 Age 0.997 0.011 −0.3 0.769 0.974 1.02 Perceived overweight 12.438 3.689 8.5 <0.001 6.734 22.973 Caribbean Black women Model I BMI 1.659 0.218 3.85 0.001 1.264 2.179 Model II BMI 1.682 0.124 7.06 <0.001 1.444 1.959 Income 1.000 0.001 −1.1 0.281 1.000 1.000 Education 1.209 0.157 1.46 0.157 0.925 1.581 Age 0.981 0.006 −3.11 0.005 0.968 0.994 Model III BMI 0.993 0.235 −0.03 0.976 0.608 1.621 Income 1.000 0.001 −1.65 0.113 1.000 1.000 Education 1.207 0.144 1.58 0.128 0.943 1.543 Age 0.979 0.008 −2.47 0.022 0.962 0.997 Perceived overweight 3.283 1.017 3.84 0.001 1.73 6.232 CI=Confidence interval, BMI=Body mass index, OR=Odds ratio, SE=Standard errorTable 3: Contd.. OR SE t P 95% CI Lower bound Upper bound African American women Model I BMI 2.000 0.123 11.3 <0.001 1.766 2.266 Model II BMI 2.150 0.141 11.66 <0.001 1.882 2.457 Income 1.000 0.001 1.74 0.092 1.000 1.000 Education 1.268 0.094 3.21 0.003 1.091 1.474 Age 0.987 0.004 −3.54 0.001 0.98 0.995 Model III BMI 1.053 0.097 0.57 0.573 0.874 1.269 Income 1.000 0.001 0.46 0.648 1.000 1.000 Education 1.156 0.091 1.84 0.075 0.985 1.357 Age 0.985 0.003 −4.52 <0.001 0.978 0.992 Perceived overweight 3.714 0.31 15.72 <0.001 3.135 4.401 CI=Confidence interval, BMI=Body mass index, OR=Odds ratio, SE=Standard error",Non-OADS,/arxiv_data1/oa_pdf/4b/27/IJPVM-6-102.PMC4671177.pdf
"International Journal of Preventive Medicine 2015, 6:102 http://www.ijpvmjournal.net/content/6/1/***Black women, perceived overweight fully mediated the  association between actual BMI and intention to control  weight [Table 4].",Non-OADS,/arxiv_data1/oa_pdf/4b/27/IJPVM-6-102.PMC4671177.pdf
"International Journal of Preventive Medicine 2015, 6:102 http://www.ijpvmjournal.net/content/6/1/***investigated as well.",Non-OADS,/arxiv_data1/oa_pdf/4b/27/IJPVM-6-102.PMC4671177.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK44206/.,Non-OADS,/arxiv_data1/oa_pdf/4b/27/IJPVM-6-102.PMC4671177.pdf
Available from: http://www.cdc.gov.,OADS,/arxiv_data1/oa_pdf/4b/27/IJPVM-6-102.PMC4671177.pdf
Available from: http://www.eatright.org/Public/Media/PublicMedia_10333.,Non-OADS,/arxiv_data1/oa_pdf/4b/27/IJPVM-6-102.PMC4671177.pdf
"International Journal of Preventive Medicine 2015, 6:102 http://www.ijpvmjournal.net/content/6/1/***24.",Non-OADS,/arxiv_data1/oa_pdf/4b/27/IJPVM-6-102.PMC4671177.pdf
"International Journal of Preventive Medicine 2015, 6:102 http://www.ijpvmjournal.net/content/6/1/***Source of Support:  Nil, Conflict of Interest:  None declared.75.",Non-OADS,/arxiv_data1/oa_pdf/4b/27/IJPVM-6-102.PMC4671177.pdf
"International Journal of Preventive Medicine 2015, 6:107 http://www.ijpvmjournal.net/content/6/1/107reports of co‑morbidities and mortality, has led to  considerable interest in estimating and evaluating  obesity possible health effects’.",Non-OADS,/arxiv_data1/oa_pdf/12/8e/IJPVM-6-107.PMC4671178.pdf
"International Journal of Preventive Medicine 2015, 6:107 http://www.ijpvmjournal.net/content/6/1/107•	 The	 effect	size	of	excess	BMI	for	outcomes’	 specific	 mortality was included by RR.",Non-OADS,/arxiv_data1/oa_pdf/12/8e/IJPVM-6-107.PMC4671178.pdf
"International Journal of Preventive Medicine 2015, 6:107 http://www.ijpvmjournal.net/content/6/1/107death, IHD, stroke, HTN, and DM compared between  different age groups at national and provincial levels.",Non-OADS,/arxiv_data1/oa_pdf/12/8e/IJPVM-6-107.PMC4671178.pdf
"International Journal of Preventive Medicine 2015, 6:107 http://www.ijpvmjournal.net/content/6/1/107There is a considerable variety among studies regarding the  methods and results for PAF calculation and the selection of  appropriate counterfactuals.",Non-OADS,/arxiv_data1/oa_pdf/12/8e/IJPVM-6-107.PMC4671178.pdf
"International Journal of Preventive Medicine 2015, 6:107 http://www.ijpvmjournal.net/content/6/1/107Our analysis extends the relevant evidence on national  and sub‑national CRA analyses.",Non-OADS,/arxiv_data1/oa_pdf/12/8e/IJPVM-6-107.PMC4671178.pdf
"International Journal of Preventive Medicine 2015, 6:107 http://www.ijpvmjournal.net/content/6/1/107 Figure 4:  The national PAFs of excess body mass index attributed outcomes, by sex, by age groups, in 2005 and 2011 Considering all of strengths and limitations, under the  National Plan of Comprehensive NASBOD project,[28]  using most updated modern methodologies and  regarding more wide age ranges from 25 up to more than  80 years old,[27,29,30] we are going to estimate trends and  burden of BMI, obesity, and overweight, at the national  and sub‑national levels, for adult Iranian population  from 1990 to 2014.",Non-OADS,/arxiv_data1/oa_pdf/12/8e/IJPVM-6-107.PMC4671178.pdf
"International Journal of Preventive Medicine 2015, 6:107 http://www.ijpvmjournal.net/content/6/1/107 Table 1: The national and provincial population attributable fractions of excess BMI on IHD, stroke, HTN, and DM in Iranian males by age groups in 2011 The population attributable fractions of excess BMI Province IHD Stroke HTN DM 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 National 0.38 0.42 0.47 0.45 0.38 0.34 0.31 0.30 0.36 0.39 0.43 0.43 0.41 0.36 0.32 0.32 0.46 0.49 0.51 0.51 0.53 0.48 0.47 0.46 0.51 0.55 0.60 0.59 0.65 0.59 0.52 0.50 Alborz 0.43 0.53 0.47 0.67 0.40 0.40 0.40 0.49 0.44 0.64 0.39 0.40 0.49 0.55 0.52 0.63 0.57 0.57 0.56 0.67 0.61 0.80 0.63 0.63 Ardabil 0.39 0.73 0.31 0.35 0.27 0.37 0.69 0.29 0.38 0.27 0.46 0.65 0.36 0.47 0.41 0.52 0.86 0.40 0.61 0.46 Azerbaijan- East0.35 0.39 0.46 0.57 0.43 0.35 0.32 0.29 0.33 0.36 0.43 0.53 0.46 0.39 0.32 0.29 0.47 0.46 0.50 0.56 0.53 0.46 0.46 0.44 0.48 0.51 0.60 0.71 0.71 0.61 0.52 0.49 Azerbaijan- West0.24 0.33 0.47 0.62 0.36 0.38 0.32 0.22 0.32 0.45 0.58 0.39 0.37 0.32 0.34 0.43 0.53 0.61 0.47 0.54 0.48 0.33 0.45 0.61 0.76 0.61 0.60 0.54 Bushehr 0.50 0.44 0.49 0.43 0.51 0.22 0.31 0.47 0.41 0.46 0.39 0.55 0.24 0.31 0.53 0.48 0.52 0.48 0.57 0.34 0.45 0.64 0.57 0.62 0.55 0.79 0.41 0.51 ChaharMahal  and Bakhtiari0.35 0.09 0.55 0.40 0.36 0.32 0.09 0.52 0.40 0.36 0.43 0.14 0.57 0.57 0.52 0.47 0.13 0.69 0.64 0.58 Fars 0.19 0.43 0.29 0.49 0.14 0.29 0.25 0.29 0.17 0.40 0.26 0.45 0.16 0.32 0.25 0.29 0.28 0.50 0.37 0.53 0.25 0.43 0.38 0.44 0.26 0.56 0.39 0.62 0.28 0.54 0.43 0.49 Gilan 0.40 0.45 0.47 0.32 0.30 0.34 0.30 0.37 0.42 0.45 0.30 0.34 0.34 0.30 0.50 0.49 0.54 0.37 0.45 0.51 0.45 0.53 0.58 0.61 0.42 0.55 0.57 0.50 Golestan 0.51 0.41 0.60 0.38 0.46 0.49 0.44 0.40 0.48 0.38 0.57 0.36 0.50 0.52 0.44 0.40 0.54 0.47 0.59 0.46 0.56 0.56 0.62 0.58 0.64 0.54 0.74 0.51 0.73 0.77 0.68 0.64 Hamadan 0.49 0.40 0.25 0.19 00.32 0.45 0.36 0.28 0.19 0.33 0.53 0.43 0.40 0.29 0.48 0.63 0.50 0.47 0.34 0.54 Hormozgan 0.43 0.21 0.45 0.38 0.26 0.25 0.40 0.19 0.41 0.41 0.26 0.25 0.50 0.29 0.51 0.50 0.41 0.38 0.56 0.28 0.58 0.65 0.45 0.44 Ilam 0.28 0.46 0.29 0.18 0.25 0.43 0.29 0.18 0.36 0.52 0.42 0.28 0.37 0.59 0.47 0.32 Isfahan 0.23 0.43 0.58 0.40 0.31 0.35 0.36 0.33 0.21 0.41 0.54 0.37 0.34 0.38 0.35 0.33 0.32 0.52 0.59 0.47 0.44 0.48 0.52 0.49 0.31 0.57 0.72 0.52 0.54 0.61 0.58 0.55 Kerman 0.30 0.27 0.17 0.08 0.28 0.21 0.28 0.24 0.16 0.10 0.28 0.21 0.40 0.36 0.25 0.17 0.43 0.32 0.41 0.36 0.23 0.18 0.47 0.36 Kermanshah 0.46 0.47 0.31 0.40 0.40 0.29 0.25 0.43 0.42 0.29 0.36 0.44 0.29 0.25 0.52 0.50 0.40 0.47 0.53 0.44 0.39 0.59 0.59 0.42 0.52 0.68 0.50 0.44 Khorasan_ North0.18 0.47 0.29 0.28 0.34 0.17 0.44 0.27 0.31 0.33 0.26 0.54 0.37 0.38 0.50 0.25 0.61 0.39 0.49 0.55 Khorasan_ Razavi0.31 0.43 0.28 0.53 0.38 0.39 0.31 0.33 0.29 0.40 0.25 0.50 0.41 0.42 0.31 0.33 0.41 0.49 0.38 0.55 0.51 0.53 0.46 0.49 0.42 0.56 0.37 0.67 0.65 0.66 0.52 0.55 Khorasan_ South0.39 0.35 0.59 0.32 0.14 0.36 0.33 0.55 0.32 0.14 0.45 0.43 0.60 0.47 0.24 0.51 0.47 0.73 0.53 0.27 Khuzestan 0.38 0.31 0.49 0.32 0.29 0.34 0.30 0.34 0.35 0.29 0.46 0.30 0.32 0.37 0.31 0.34 0.46 0.40 0.54 0.42 0.43 0.50 0.46 0.51 0.50 0.42 0.63 0.44 0.53 0.60 0.52 0.57 Kohgiluyeh  and Boyer- Ahmad0.36 0.34 0.74 0.50 0.30 0.30 0.33 0.31 0.69 0.53 0.33 0.30 0.43 0.44 0.65 0.58 0.44 0.46 0.48 0.45 0.86 0.78 0.54 0.51 Kurdistan 0.44 0.49 0.16 0.28 0.41 0.47 0.16 0.27 0.50 0.54 0.26 0.41 0.57 0.63 0.29 0.47 Lorestan 0.52 0.26 0.17 0.56 0.29 0.17 0.59 0.42 0.27 0.81 0.49 0.31 Markazi 0.49 0.53 0.46 0.47 0.33 0.42 0.29 0.34 0.45 0.51 0.44 0.44 0.37 0.46 0.29 0.34 0.45 0.55 0.51 0.48 0.47 0.55 0.45 0.49 0.63 0.66 0.60 0.60 0.59 0.70 0.50 0.55 Mazandaran 0.61 0.56 0.74 0.48 0.36 0.32 0.27 0.34 0.58 0.52 0.70 0.44 0.40 0.35 0.27 0.33 0.61 0.58 0.63 0.53 0.51 0.47 0.41 0.48 0.76 0.70 0.87 0.61 0.63 0.57 0.46 0.54 Qazvin 0.18 0.47 0.29 0.28 0.34 0.27 0.51 0.17 0.44 0.27 0.31 0.33 0.25 0.47 0.26 0.54 0.37 0.38 0.50 0.35 0.53 0.25 0.61 0.39 0.49 0.55 0.37 0.64 Qom 0.38 0.60 0.36 0.41 0.44 0.36 0.57 0.40 0.44 0.44 0.46 0.58 0.48 0.52 0.61 0.51 0.75 0.63 0.69 0.68 Semnan 0.55 0.52 0.31 0.49 0.42 0.40 0.34 0.53 0.48 0.28 0.46 0.46 0.39 0.35 0.55 0.56 0.38 0.54 0.55 0.56 0.51 0.68 0.65 0.40 0.63 0.70 0.63 0.57 Sistan and  Baluchistan0.32 0.27 0.23 0.07 0.10 0.20 0.30 0.25 0.22 0.07 0.10 0.20 0.40 0.35 0.29 0.12 0.16 0.32 0.43 0.37 0.31 0.10 0.18 0.36 Tehran 0.45 0.47 0.53 0.49 0.35 0.40 0.37 0.35 0.42 0.44 0.49 0.45 0.38 0.44 0.36 0.35 0.52 0.51 0.55 0.53 0.47 0.52 0.53 0.51 0.58 0.61 0.67 0.63 0.61 0.68 0.60 0.58 Yazd 0.38 0.30 0.48 0.48 0.38 0.22 0.32 0.31 0.35 0.28 0.46 0.45 0.42 0.24 0.32 0.31 0.44 0.38 0.53 0.52 0.51 0.35 0.48 0.47 0.50 0.40 0.62 0.61 0.65 0.42 0.53 0.52 Zanjan 0.17 0.22 0.46 0.33 0.20 0.16 0.21 0.43 0.33 0.19 0.23 0.32 0.51 0.49 0.31 0.23 0.30 0.60 0.54 0.35 BMI=Body mass index, IHD=Ischemic heart disease, HTN=Hypertension, DM=Diabetes mellitus",Non-OADS,/arxiv_data1/oa_pdf/12/8e/IJPVM-6-107.PMC4671178.pdf
"International Journal of Preventive Medicine 2015, 6:107 http://www.ijpvmjournal.net/content/6/1/107 Table 2: The national and provincial population attributable fractions of excess BMI on IHD, stroke, HTN, and DM in Iranian females by age groups in 2011 The population attributable fractions of excess BMI Provinces IHD Stroke HTN DM 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 National 0.40 0.46 0.56 0.58 0.47 0.50 0.41 0.42 0.37 0.43 0.54 0.54 0.51 0.54 0.41 0.41 0.46 0.53 0.58 0.60 0.56 0.57 0.59 0.59 0.52 0.56 0.71 0.72 0.75 0.78 0.65 0.65 Alborz 0.25 0.43 0.45 0.48 0.48 0.44 0.48 0.22 0.41 0.41 0.52 0.52 0.43 0.48 0.34 0.49 0.51 0.56 0.57 0.60 0.65 0.34 0.57 0.58 0.77 0.75 0.67 0.72 Ardabil 0.47 0.43 0.62 0.73 0.44 0.64 0.39 0.35 0.44 0.41 0.58 0.68 0.48 0.68 0.39 0.35 0.52 0.49 0.63 0.66 0.57 0.63 0.56 0.51 0.60 0.56 0.76 0.85 0.73 0.90 0.62 0.57 Azerbaijan-East 0.34 0.60 0.61 0.63 0.56 0.51 0.43 0.44 0.32 0.57 0.57 0.60 0.60 0.55 0.43 0.43 0.42 0.60 0.61 0.62 0.61 0.60 0.61 0.62 0.46 0.74 0.75 0.77 0.84 0.80 0.68 0.68 Azerbaijan-West 0.36 0.54 0.54 0.70 0.42 0.48 0.47 0.46 0.33 0.50 0.50 0.66 0.45 0.52 0.46 0.46 0.44 0.57 0.55 0.64 0.52 0.59 0.63 0.63 0.48 0.68 0.67 0.84 0.69 0.77 0.71 0.70 Bushehr 0.38 0.48 0.64 0.34 0.50 0.49 0.37 0.42 0.36 0.45 0.60 0.32 0.54 0.53 0.36 0.42 0.44 0.54 0.64 0.42 0.59 0.58 0.53 0.58 0.51 0.62 0.78 0.46 0.78 0.78 0.59 0.65 ChaharMahal  and Bakhtiari0.54 0.49 0.62 0.42 0.63 0.50 0.32 0.51 0.45 0.59 0.46 0.67 0.50 0.32 0.56 0.57 0.61 0.54 0.62 0.67 0.48 0.68 0.63 0.76 0.69 0.88 0.74 0.54 Fars 0.40 0.37 0.35 0.37 0.36 0.48 0.35 0.35 0.38 0.34 0.32 0.34 0.39 0.52 0.34 0.35 0.50 0.45 0.43 0.45 0.48 0.59 0.51 0.52 0.53 0.49 0.47 0.49 0.63 0.77 0.57 0.58 Gilan 0.15 0.37 0.60 0.65 0.46 0.49 0.41 0.33 0.14 0.35 0.57 0.62 0.50 0.53 0.41 0.33 0.23 0.45 0.60 0.63 0.53 0.60 0.57 0.48 0.21 0.49 0.75 0.80 0.74 0.77 0.64 0.53 Golestan 0.49 0.56 0.72 0.52 0.50 0.61 0.47 0.44 0.46 0.52 0.67 0.49 0.54 0.65 0.47 0.43 0.54 0.60 0.65 0.57 0.60 0.62 0.64 0.60 0.62 0.70 0.84 0.66 0.79 0.86 0.71 0.68 Hamadan 0.46 0.27 0.64 0.57 0.30 0.49 0.43 0.52 0.43 0.25 0.60 0.53 0.34 0.53 0.43 0.51 0.53 0.37 0.59 0.58 0.42 0.57 0.60 0.70 0.59 0.37 0.78 0.71 0.54 0.77 0.67 0.77 Hormozgan 0.35 0.50 0.41 0.49 0.44 0.41 0.40 0.28 0.32 0.47 0.39 0.46 0.48 0.43 0.39 0.28 0.43 0.54 0.48 0.54 0.55 0.50 0.57 0.42 0.45 0.64 0.54 0.62 0.73 0.66 0.63 0.47 Ilam 0.21 0.37 0.42 0.46 0.42 0.32 0.30 0.35 0.20 0.34 0.39 0.43 0.45 0.35 0.30 0.35 0.30 0.46 0.50 0.52 0.54 0.46 0.45 0.51 0.29 0.49 0.55 0.59 0.68 0.57 0.50 0.58 Isfahan 0.28 0.37 0.52 0.48 0.48 0.48 0.45 0.46 0.27 0.34 0.49 0.45 0.53 0.52 0.44 0.46 0.39 0.45 0.55 0.52 0.56 0.57 0.62 0.64 0.39 0.49 0.67 0.61 0.77 0.77 0.69 0.70 Kerman 0.50 0.57 0.46 0.44 0.36 0.35 0.27 0.38 0.47 0.54 0.43 0.41 0.39 0.39 0.26 0.37 0.53 0.58 0.53 0.51 0.50 0.49 0.41 0.54 0.64 0.71 0.59 0.58 0.62 0.62 0.46 0.60 Kermanshah 0.40 0.37 0.60 0.61 0.33 0.50 0.37 0.46 0.37 0.35 0.57 0.58 0.36 0.53 0.38 0.46 0.48 0.45 0.59 0.60 0.46 0.56 0.55 0.64 0.54 0.49 0.75 0.75 0.59 0.78 0.61 0.70 Khorasan-North 0.27 0.51 0.46 0.50 0.30 0.25 0.47 0.42 0.54 0.30 0.35 0.53 0.53 0.59 0.45 0.37 0.64 0.59 0.79 0.51 Khorasan-Razavi 0.27 0.51 0.47 0.56 0.42 0.44 0.45 0.40 0.25 0.48 0.45 0.53 0.46 0.48 0.44 0.40 0.36 0.53 0.53 0.60 0.56 0.54 0.63 0.57 0.37 0.65 0.62 0.71 0.70 0.72 0.68 0.63 Khorasan-South 0.44 0.40 0.45 0.28 0.32 0.29 0.40 0.38 0.41 0.30 0.32 0.29 0.51 0.45 0.50 0.42 0.48 0.44 0.56 0.52 0.58 0.51 0.54 0.49 Khuzestan 0.41 0.42 0.63 0.50 0.49 0.44 0.43 0.46 0.38 0.39 0.60 0.46 0.53 0.48 0.42 0.46 0.48 0.48 0.61 0.53 0.59 0.54 0.61 0.63 0.54 0.56 0.78 0.64 0.78 0.73 0.67 0.70 Kohgiluyeh and  Boyer-Ahmad0.39 0.49 0.67 0.41 0.46 0.36 0.46 0.62 0.40 0.45 0.48 0.54 0.64 0.58 0.63 0.52 0.63 0.81 0.64 0.70 Kurdistan 0.40 0.33 0.50 0.59 0.55 0.55 0.44 0.32 0.37 0.31 0.47 0.55 0.59 0.59 0.44 0.31 0.37 0.31 0.47 0.55 0.59 0.59 0.44 0.31 0.53 0.44 0.64 0.73 0.83 0.83 0.68 0.53 Lorestan 0.25 0.62 0.59 0.61 0.53 0.50 0.48 0.40 0.23 0.57 0.56 0.58 0.57 0.54 0.48 0.39 0.33 0.59 0.62 0.60 0.61 0.58 0.65 0.56 0.34 0.76 0.73 0.76 0.81 0.79 0.72 0.63 Markazi 0.41 0.29 0.77 0.72 0.59 0.62 0.50 0.64 0.39 0.27 0.73 0.68 0.64 0.66 0.50 0.64 0.48 0.35 0.68 0.63 0.63 0.64 0.67 0.79 0.54 0.38 0.89 0.85 0.86 0.88 0.74 0.87 Mazandaran 0.42 0.58 0.58 0.67 0.54 0.47 0.50 0.50 0.39 0.54 0.54 0.63 0.58 0.51 0.50 0.50 0.48 0.57 0.57 0.62 0.60 0.55 0.68 0.67 0.55 0.72 0.72 0.81 0.82 0.76 0.75 0.75 Qazvin 0.46 0.50 0.30 0.42 0.54 0.30 0.53 0.59 0.45 0.59 0.79 0.51 Qom 0.38 0.69 0.62 0.53 0.56 0.55 0.46 0.35 0.65 0.58 0.57 0.60 0.55 0.46 0.46 0.66 0.59 0.60 0.62 0.72 0.65 0.50 0.83 0.75 0.81 0.84 0.80 0.71 Semnan 0.50 0.56 0.54 0.44 0.49 0.52 0.52 0.36 0.47 0.52 0.51 0.41 0.53 0.56 0.51 0.36 0.53 0.57 0.57 0.51 0.57 0.60 0.69 0.53 0.63 0.70 0.68 0.57 0.77 0.79 0.76 0.59 Sistan and  Baluchistan0.37 0.26 0.46 0.36 0.29 0.33 0.19 0.21 0.34 0.23 0.43 0.34 0.31 0.36 0.19 0.21 0.46 0.34 0.51 0.45 0.40 0.46 0.30 0.32 0.49 0.35 0.58 0.48 0.51 0.58 0.34 0.36 Tehran 0.42 0.52 0.61 0.64 0.52 0.48 0.47 0.48 0.39 0.48 0.58 0.60 0.56 0.53 0.47 0.47 0.50 0.55 0.62 0.64 0.59 0.58 0.64 0.66 0.56 0.66 0.76 0.78 0.80 0.77 0.72 0.72 Yazd 0.52 0.46 0.48 0.62 0.61 0.53 0.36 0.38 0.49 0.43 0.45 0.58 0.64 0.57 0.36 0.38 0.55 0.50 0.52 0.64 0.62 0.58 0.52 0.54 0.66 0.60 0.61 0.76 0.86 0.81 0.59 0.61 Zanjan 0.46 0.28 0.69 0.77 0.51 0.48 0.38 0.43 0.26 0.65 0.74 0.54 0.48 0.38 0.52 0.39 0.64 0.66 0.58 0.65 0.54 0.60 0.38 0.82 0.89 0.77 0.72 0.61 BMI=Body mass index, IHD=Ischemic heart disease, HTN=Hypertension, DM=Diabetes mellitus",Non-OADS,/arxiv_data1/oa_pdf/12/8e/IJPVM-6-107.PMC4671178.pdf
"International Journal of Preventive Medicine 2015, 6:107 http://www.ijpvmjournal.net/content/6/1/107REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/12/8e/IJPVM-6-107.PMC4671178.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/49/TOORTHJ-9-525.PMC4671224.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/c6/TOORTHJ-9-530.PMC4671225.pdf
"Available from http://rad.usuhs.edu/medpix/master.php3?mode=cas e_viewer&pt_id=5334&quiz [Accessed: November 23, 2014].",OADS,/arxiv_data1/oa_pdf/a3/3e/TOORTHJ-9-520.PMC4671226.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/3e/TOORTHJ-9-520.PMC4671226.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/89/TOORTHJ-9-536.PMC4671227.pdf
"bio- Rxiv doi: http://dx.doi.org/10.1101/005439 51.Riley K ,Yario T ,Steitz J.",OADS,/arxiv_data1/oa_pdf/bc/82/bies0037-0379.PMC4671252.pdf
http://clinicaltrials.gov/show/NCT0 1394562 EFFECT-HF [NCT0 1394562] (6 January 20 14).,Non-OADS,/arxiv_data1/oa_pdf/8e/3a/ejhf0017-0248.PMC4671256.pdf
"Abbreviations: cGAMP : cyclic GMP—AMP ·FL-DC : Flt3L-derived DC ·GM- DC: GM-CSF-derived dendritic cell ·IFNAR : IFNα/βreceptor ·pDC :p l a s - macytoid DC ·STING : Stimulator of IFN genes Full correspondence: Prof. Ken J. Ishii, Laboratory of Vaccine Science, WPI Immunology Frontier Research Center (iFReC), Osaka University, Osaka 565-0871, Japan Fax:+81-6-6879-4812 e-mail: kenishii@biken.osaka-u.ac.jp See accompanying article: http://dx.doi.org/10.1002/eji.201445133 Received: 14/8/2014 Revised: 3/11/2014 Accepted: 17/12/2014 Accepted article online: 22/12/2014 C/circlecopyrt2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2d/b7/eji0045-1159.PMC4671267.pdf
"Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, the  Rockefeller University, New York, NY, USA This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ *Correspondence:  Anne Durandy, INSERM U768, Hôpital Necker Enfants-Malades, 149, rue de Sevres, 75015 Paris, France,  anne.durandy@inserm.fr; tel : +33 1 44 49 50 89; fax : +33 1 42 73 06 40, sn262@cam.ac.uk.",Non-OADS,/arxiv_data1/oa_pdf/0b/d1/emss-66263.PMC4671279.pdf
"Results A complete line-listing of data is summarized in Supplemental Digital Content Survey Data,  available at http://links.lww.com/JPHMP/A72 .",OADS,/arxiv_data1/oa_pdf/30/52/nihms739517.PMC4671281.pdf
"These numbers contrast with the  legal authority for IIS reported in 2000: 24 (47%) IIS-specific, 9 (18%) immunization- information, and 3 (6%) general public health authority11 (see Supplemental Digital Content  Figure 1A, available at http://links.lww.com/JPHMP/A69 ), or the only 9 (18%) states with  any IIS authorization reported in 1995.3 Type of authority to operate an IIS for adults Of the 51 IIS programs that were authorized to operate an IIS for adults, 27 (52.9%) had  laws that specifically authorized operation of IIS, 8 (15.7%) had laws that authorized sharing  of immunization information, but did not specifically authorize the operation of IIS, 3 Martin et al.",Non-OADS,/arxiv_data1/oa_pdf/30/52/nihms739517.PMC4671281.pdf
"By  contrast, in 200011 only 12 states had mandated reporting (see Supplemental Digital Content  Figure 2A, available at http://links.lww.com/JPHMP/A70 ).",Non-OADS,/arxiv_data1/oa_pdf/30/52/nihms739517.PMC4671281.pdf
"As shown in  Supplemental Digital Content Figure 3A, available at http://links.lww.com/JPHMP/A71 ,  there has been a notable reduction in jurisdictions requiring explicit consent since 2000.",Non-OADS,/arxiv_data1/oa_pdf/30/52/nihms739517.PMC4671281.pdf
"[Accessed June 12, 2013] http://www.healthit.gov/providers-professionals/health-information- exchange/nationwide-hie-strategy .",Non-OADS,/arxiv_data1/oa_pdf/30/52/nihms739517.PMC4671281.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/96/3c/main.PMC4671298.pdf
E-mail address: rdixon@ualberta.ca http://dx.doi.org/10.1016/j.dadm.2015.08.002 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/96/3c/main.PMC4671298.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/3c/main.PMC4671298.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2015.08.002 .,OADS,/arxiv_data1/oa_pdf/96/3c/main.PMC4671298.pdf
Alzheimers Dement 2015. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/96/3c/main.PMC4671298.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/42/30/main.PMC4671300.pdf
http://dx.doi.org/10.1016/j.hrcr.2015.07.011,OADS,/arxiv_data1/oa_pdf/42/30/main.PMC4671300.pdf
Appendix Supplementary data Supplementary data associated with this article can be foundin the online version at http://dx.doi.org/10.1016/j.hrcr.2015.,OADS,/arxiv_data1/oa_pdf/42/30/main.PMC4671300.pdf
Bafilomycin A1 and methyl- β-cyclodextrin but not  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/b2/emss-66214.PMC4671317.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.tox.2015.09.008 .Europe PMC Funders Group Author Manuscript Toxicology .",Non-OADS,/arxiv_data1/oa_pdf/97/b2/emss-66214.PMC4671317.pdf
"Available online at: http://www.scb.se (accessed November 17, 2013).",Non-OADS,/arxiv_data1/oa_pdf/bd/37/aogs0094-0253.PMC4671320.pdf
"Available online at: http://www.lakemedelsverket.se(accessed April, 2014).",Non-OADS,/arxiv_data1/oa_pdf/bd/37/aogs0094-0253.PMC4671320.pdf
Open AccessH Venugopal and others A case of severe ectopic ACTH syndromeID: 15-0099; December 2015 DOI: 10.1530/EDM-15-0099 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2015 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd,Non-OADS,/arxiv_data1/oa_pdf/4c/f5/edmcr-2015-150099.PMC4671324.pdf
H Venugopal and others A case of severe ectopic ACTH syndromeID: 15-0099; December 2015 DOI: 10.1530/EDM-15-0099 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/4c/f5/edmcr-2015-150099.PMC4671324.pdf
Pre-treatmentWith maximal medical treatmentFollowing adrenal ablation Normal range After 2 weeks After 1 year After 18 months Serum cortisol 1480 (0655 h) 985 (0755 h) 341 (0600 h) 20 (0730 h) 150 (0800 h) 200–700 nmol/l 24-h urinary-free cortisol 3440 1040 111 120 220 !150 nmol/24 h H Venugopal and others A case of severe ectopic ACTH syndromeID: 15-0099; December 2015 DOI: 10.1530/EDM-15-0099 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/4c/f5/edmcr-2015-150099.PMC4671324.pdf
"In summary, evaluation and management of ectopic ACTH syndrome can be very challenging and our case emphasizes the importance of aggressive management of H Venugopal and others A case of severe ectopic ACTH syndromeID: 15-0099; December 2015 DOI: 10.1530/EDM-15-0099 http://www.edmcasereports.com 4",Non-OADS,/arxiv_data1/oa_pdf/4c/f5/edmcr-2015-150099.PMC4671324.pdf
(doi:10.1007/s00464-011-2020-7 ) Received in ﬁnal form 9 October 2015 Accepted 11 November 2015 H Venugopal and others A case of severe ectopic ACTH syndromeID: 15-0099; December 2015 DOI: 10.1530/EDM-15-0099 http://www.edmcasereports.com 5,Non-OADS,/arxiv_data1/oa_pdf/4c/f5/edmcr-2015-150099.PMC4671324.pdf
[Availableathttp://www.itu.int/rec/R-REC-P/en.],Non-OADS,/arxiv_data1/oa_pdf/f5/12/jgrd0120-5316.PMC4671453.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/15/iev143.PMC4671458.pdf
"The rice cultivar ‘Yukihikari’, which is chilling sen-sitive in the seedling stage and grown in Hokkaido, was used for the production of transgenic rice (Rice cultivar database: http://ineweb.narcc.affrc.go.jp).",Non-OADS,/arxiv_data1/oa_pdf/7f/bb/65_363.PMC4671696.pdf
"In contrast, expression of  Os07g0687900 (wsi76) and Os03g0316200 (OsGolS1) was induced by ABA application (Rice Expression Profile data - base: http:// http://ricexpro.dna.affrc.go.jp), and their rice-GolS homologue was expressed especially in anthers of rice.",Non-OADS,/arxiv_data1/oa_pdf/7f/bb/65_363.PMC4671696.pdf
Proportions of cracked kernels data and correlation co- efficients were analyzed using statistical software R 3.0.2 (http://www.R-project.org.),OADS,/arxiv_data1/oa_pdf/07/64/65_381.PMC4671698.pdf
URL: http://www.maff.go.jp/hokuriku/food/rice/kkome.html.,Non-OADS,/arxiv_data1/oa_pdf/07/64/65_381.PMC4671698.pdf
"To date, more than 80 genes for blast resistance (BR) have been recorded, of which 60 have been mapped genetically (Gramene database: http://www.gramene.org/).",OADS,/arxiv_data1/oa_pdf/e0/91/65_388.PMC4671699.pdf
The detection of QTLs was conducted by composite interval mapping with QTL Cartographer 2.5 (http://statgen.nesu.edu/qtlcart/WQTLcart.htem).,OADS,/arxiv_data1/oa_pdf/e0/91/65_388.PMC4671699.pdf
"The upper  high-density RFLP framework map was quoted from the Rice Genome  Research Program (RGP, http://rgp.dna.affrc.go.jp/E/publicdata/geneticmap2000/index.html).",OADS,/arxiv_data1/oa_pdf/e9/75/65_420.PMC4671703.pdf
"The upper high-density RFLP framework map was quoted from the Rice Genome  Research Program (RGP, http://rgp.dna.affrc.go.jp/E/publicdata/geneticmap2000/index.html).",OADS,/arxiv_data1/oa_pdf/e9/75/65_420.PMC4671703.pdf
"With an annual produc-tion of 740,500 metric tons of cocoa beans, it constitutes about 16% of world cocoa bean production (FAOSTAT 2012, production data available at http://faostat3.fao.org/faostat-   gateway/go/to/browse/Q/*/E).",Non-OADS,/arxiv_data1/oa_pdf/30/31/65_438.PMC4671705.pdf
94–111: http://pdf.usaid.gov/pdf_docs/ PDACH214.pdf.,Non-OADS,/arxiv_data1/oa_pdf/30/31/65_438.PMC4671705.pdf
"Genetic improvement of cacao,  FAO Ecoport version: http://ecoport.org/ep?SearchType=earticle   View&earticleId=197&page=-2, Chapter 3.",Non-OADS,/arxiv_data1/oa_pdf/30/31/65_438.PMC4671705.pdf
FAO statistics division: http://faostat3.fao.org/home/index.html.,Non-OADS,/arxiv_data1/oa_pdf/30/31/65_438.PMC4671705.pdf
"(2009) Molecular evolution, phylogenetics and epidemi - ology: FigTree v1.3.1 2006–2009: http://tree.bio.ed.ac.uk/software/ figtree/.",OADS,/arxiv_data1/oa_pdf/30/31/65_438.PMC4671705.pdf
"In: Cocoa market  update, March 2012: http://worldcocoafoundation.org/wp-content/ uploads/Cocoa-Market-Update-as-of-3.20.2012.pdf.",Non-OADS,/arxiv_data1/oa_pdf/30/31/65_438.PMC4671705.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ea/c5/copd-10-2619.PMC4671756.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 2619–2626International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2619OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9437 7The short Physical Performance Battery is a  discriminative tool for identifying patients with  COPD at risk of disability roberto Bernabeu-Mora1,2 Françesc Medina-Mirapeix2 eduardo llamazares-herrán3 gloria garcía-guillamón2 luz María giménez-giménez2 Juan Miguel sánchez-n ieto1,4 1Division of Pneumology, hospital  Morales Meseguer, 2Department  of Physical Therapy, University of  Murcia, Murcia, 3Department of  Physical Therapy, alcala University,   alcala de henares, 4Department of  Intern Medical, University of Murcia,   Murcia, spainBackground:  Limited mobility is a risk factor for developing chronic obstructive pulmonary  disease (COPD)-related disabilities.",Non-OADS,/arxiv_data1/oa_pdf/ea/c5/copd-10-2619.PMC4671756.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ea/c5/copd-10-2619.PMC4671756.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/c5/copd-10-2619.PMC4671756.pdf
Available from:  http://www.grc.nia.nih.gov/branches/leps/sppb /.,Non-OADS,/arxiv_data1/oa_pdf/ea/c5/copd-10-2619.PMC4671756.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/ea/c5/copd-10-2619.PMC4671756.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6b/52/copd-10-2601.PMC4671757.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 2601–2608International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2601RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S7963 5Switching treatments in COPD: implications  for costs and treatment adherence Fulvio Braido1 Federico Lavorini2 Francesco Blasi3 Ilaria Baiardini1,* Giorgio walter Canonica1,* 1Respiratory and Allergy Diseases  Clinic, Department of Internal  Medicine, University of Genoa,   IRCCS AOU San Martino-IST, Genoa,   2Department of experimental and  Clinical Medicine, Careggi University  Hospital, Florence, 3Department of  Pathophysiology and Transplantation,   Università degli Studi di Milano,   IRCCS Fondazione Ca’ Granda,   Ospedale Maggiore Policlinico, Milan,   Italy *These authors contributed equally  to this workAbstract:  Inhaled therapy is key to the management of chronic obstructive pulmonary disease  (COPD).",Non-OADS,/arxiv_data1/oa_pdf/6b/52/copd-10-2601.PMC4671757.pdf
"Furthermore, delivery of drugs by an inhaler requires the doctor to explain specific Correspondence: Fulvio Braido Respiratory and Allergy Diseases Clinic,  Department of Internal Medicine,  University of Genoa, IRCCS AOU  San Martino-IST, Largo R Benzi 10,  16132 Genoa, Italy Tel +39 010 555 3524 Fax +39 010 555 3524 email fulvio.braido@unige.i t Journal name: International Journal of COPD Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Braido et al Running head recto: Switching treatments in COPD DOI: http://dx.doi.org/10.2147/COPD.S79635",Non-OADS,/arxiv_data1/oa_pdf/6b/52/copd-10-2601.PMC4671757.pdf
Available from: http://www.goldcopd.org.,OADS,/arxiv_data1/oa_pdf/6b/52/copd-10-2601.PMC4671757.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/6b/52/copd-10-2601.PMC4671757.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/52/copd-10-2601.PMC4671757.pdf
"Available at: http://www.fda.gov/down - loads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ ucm070242.pd f. Accessed August 3, 2015.",Non-OADS,/arxiv_data1/oa_pdf/6b/52/copd-10-2601.PMC4671757.pdf
Available from: https://farmaci.agenziafarmaco.gov.it /.,Non-OADS,/arxiv_data1/oa_pdf/6b/52/copd-10-2601.PMC4671757.pdf
Available from: http://www.ginasthma.or g  22.,Non-OADS,/arxiv_data1/oa_pdf/6b/52/copd-10-2601.PMC4671757.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/93/imcrj-8-313.PMC4671758.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 313–316International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  313Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S9340 5subperiosteal hematoma from peribulbar block  during cataract surgery leading to optic nerve  compression in a patient with parahemophilia sudarshan Khokhar1 Bhagabat Nayak1 Bharat patil1 Milind Devidas Changole1 Gautam sinha1 Reetika sharma1 Lipika Nayak2 1Dr R p Centre for ophthalmic  sciences, all India Institute of  Medical sciences, New Delhi, India;   2Department of p ediatrics, Loknayak  Hospital, Maulana azad Medical  College, Delhi, India Correspondence: Bhagabat Nayak   Room No-484, Dr Rp Centre for  ophthalmic sciences, all India Institute  of Medical sciences, ansari Nagar,  New Delhi 110049, India   tel +91 11 2659 3133   Fax +91 11 2658 8131   email bhagabat80@gmail.co mAbstract:  A 17-year-old male presented with gradual painless diminution of vision since  childhood.",Non-OADS,/arxiv_data1/oa_pdf/e8/93/imcrj-8-313.PMC4671758.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/e8/93/imcrj-8-313.PMC4671758.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/93/imcrj-8-313.PMC4671758.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8f/15/vhrm-11-601.PMC4671759.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 601–611Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  601ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S7757 1Personalized medicine and stroke prevention:  where are we?,Non-OADS,/arxiv_data1/oa_pdf/8f/15/vhrm-11-601.PMC4671759.pdf
Available from: https://www.nhmrc.gov.au/guidelines- publications/ext10.,Non-OADS,/arxiv_data1/oa_pdf/8f/15/vhrm-11-601.PMC4671759.pdf
"Available from: http://www.safetyandquality.gov.au/wp-content/ uploads/2012/03/PCC_Paper_August.pd f. Accessed October 16,  2015.",Non-OADS,/arxiv_data1/oa_pdf/8f/15/vhrm-11-601.PMC4671759.pdf
"Available from: https://www.nhmrc.gov.au/_files_nhmrc/publications/ attachments /cp126.pd f. Accessed October 16, 2015.",Non-OADS,/arxiv_data1/oa_pdf/8f/15/vhrm-11-601.PMC4671759.pdf
"Available from: http://www.health.gov.au/internet/main/ publishing .nsf/content/mbsprimarycare-chronicdiseasemanagemen t.  Accessed October 14, 2015.",Non-OADS,/arxiv_data1/oa_pdf/8f/15/vhrm-11-601.PMC4671759.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/8f/15/vhrm-11-601.PMC4671759.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8f/15/vhrm-11-601.PMC4671759.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d7/75/amep-6-635.PMC4671760.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 635–639Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  635PErsPEctivEsopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/AMEP .S8947 9Us veterans and their unique issues: enhancing  health care professional awareness Maria Olenick1 Monica Flowers1 valerie J Diaz1,2 1Nicole Wertheim college of  Nursing and Health science, Florida  international University, Miami, FL,   UsA; 2Operational Health support  Unit Jacksonville, United states Navy  Nurse corps, Jacksonville, FL, UsA correspondence: Maria Olenick   Nicole Wertheim college of Nursing   and Health sciences, Florida international  University, 11200 8th street,   AHc3 – 329, Miami, FL 33199, UsA   tel +1 305 348 7757   Fax +1 305 348 7765   Email molenick@fiu.ed uAbstract:  United States veterans are a multifaceted population with a distinct culture that  includes, but is not limited to, values, customs, ethos, selfless duty, codes of conduct, implicit  patterns of communication, and obedience to command.",Non-OADS,/arxiv_data1/oa_pdf/d7/75/amep-6-635.PMC4671760.pdf
"The American Association of Colleges of Nursing15  offers a “Joining Forces: Enhancing Veterans’ Care Tool  Kit” ( http://www.aacn.nche.edu/downloads/joining-forces- tool-kit/educational-resource s) with a variety of educational  resources on many veteran issues, references to articles on  particular veteran issues, case studies, a veteran assessment  tool, curricular examples including slides and syllabi for  veteran-specific courses.",Non-OADS,/arxiv_data1/oa_pdf/d7/75/amep-6-635.PMC4671760.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/d7/75/amep-6-635.PMC4671760.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/75/amep-6-635.PMC4671760.pdf
Available from: http://www2.nami.org/Content/navigationMenu/  Mental_Illnesses/Depression/Depression_Veterans_Factsheet_2009.,Non-OADS,/arxiv_data1/oa_pdf/d7/75/amep-6-635.PMC4671760.pdf
Available from: http://www.psychiatry.org/patients-families/ptsd/what-is- ptsd.,Non-OADS,/arxiv_data1/oa_pdf/d7/75/amep-6-635.PMC4671760.pdf
Available from http://www.polytrauma.va.gov/understanding-tbi /.,Non-OADS,/arxiv_data1/oa_pdf/d7/75/amep-6-635.PMC4671760.pdf
"Available from http://www.hsrd.research.va.gov/ publications/internal/depression_primer.pd f. Accessed August 20,  2015.",Non-OADS,/arxiv_data1/oa_pdf/d7/75/amep-6-635.PMC4671760.pdf
"Available from http://www.va.gov/opa/docs/ suicide-data-report-2012-final.pd f. Accessed August 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d7/75/amep-6-635.PMC4671760.pdf
"Available from https://www.fas.org/sgp/crs/ natsec/RS22452.pd f. Accessed August 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d7/75/amep-6-635.PMC4671760.pdf
Available from http://nchv.org/index.php/news/media/ background_and_statistics /.,OADS,/arxiv_data1/oa_pdf/d7/75/amep-6-635.PMC4671760.pdf
Available from:  http://www.va.gov/vetdata/docs/QuickFacts/Population_ quickfacts.,OADS,/arxiv_data1/oa_pdf/d7/75/amep-6-635.PMC4671760.pdf
"Available  from http://www.aacn.nche.edu/downloads/joining-forces-tool-kit/ educational-resource s. Accessed August 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d7/75/amep-6-635.PMC4671760.pdf
"Available from: http://www.va.gov/ vetdata/Utilization.as p. Accessed August 20, 2015.",OADS,/arxiv_data1/oa_pdf/d7/75/amep-6-635.PMC4671760.pdf
Available from: http://www.publichealth.va.gov/epidemiology/ reports/oefoifond/health-care-utilization /.,Non-OADS,/arxiv_data1/oa_pdf/d7/75/amep-6-635.PMC4671760.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b7/a0/ijn-10-7265.PMC4671761.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7265–7274International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7265OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9519 4Physical characterization and in vivo  pharmacokinetic study of self-assembling  amphotericin B-loaded lecithin-based mixed  polymeric micelles Ying-chen chen* chia-Yu su* hua-Jun Jhan hsiu-O ho Ming-Thau sheu school of Pharmacy, college of  Pharmacy, Taipei Medical University,   Taipei, Taiwan *These authors contributed equally  to this workAbstract:  To alleviate the inherent problems of amphotericin B (AmB), such as poor water  solubility and nephrotoxicity, a novel self-assembling mixed polymeric micelle delivery system  based on lecithin and combined with amphiphilic polymers, Pluronic®, Kolliphor®, d-alpha  tocopheryl polyethylene glycol succinate, and 1,2-distearoyl- sn-glycero-3-phosphoethanolamine- N-methoxy(poly(ethylene glycol)-2000 (DSPE-PEG2K) was developed.",Non-OADS,/arxiv_data1/oa_pdf/b7/a0/ijn-10-7265.PMC4671761.pdf
"However, infusion toxicity and nephrotoxicity,  likely related to the relative aggregation state of AmB, still frequently cause trouble - some complications.3,8–10 Lipid-based formulations have been shown to encapsulate  and disaggregate AmB, shifting AmB distribution away from the kidneys, and a slow correspondence: Ming-Thau sheu;  hsiu-O ho school of Pharmacy, college of Pharmacy,  Taipei Medical University, 250 Wu-hsing  street, Taipei 110, Taiwan Tel +886 2 2736 1661 ext 6112 Fax +886 2 2736 1661 ext 6112 email mingsheu@tmu.edu.t w;   hsiuoho@tmu.edu.t e Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Chen et al Running head recto: Self-assembling AmB-loaded lecithin-based mixed polymeric micelles DOI: http://dx.doi.org/10.2147/IJN.S95194",Non-OADS,/arxiv_data1/oa_pdf/b7/a0/ijn-10-7265.PMC4671761.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b7/a0/ijn-10-7265.PMC4671761.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/a0/ijn-10-7265.PMC4671761.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/68/93/copd-10-2609.PMC4671762.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 2609–2618International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2609OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9014 8COPD exacerbation frequency and its association  with health care resource utilization and costs amol D Dhamane1 Chad Moretz2 Yunping Zhou2 Kate Burslem1 Kim saverno2 gagan Jain1 andrew renda3 shuchita Kaila1 1Boehringer Ingelheim Pharmaceuticals  Inc., Ridgefield, CT, USA; 2Comprehensive  Health Insights Inc., Louisville, KY, USA;  3Humana Inc., Louisville, KY, USABackground:  Chronic obstructive pulmonary disease (COPD) exacerbations account for a  substantial proportion of COPD-related costs.",Non-OADS,/arxiv_data1/oa_pdf/68/93/copd-10-2609.PMC4671762.pdf
"Chronic lower respiratory disease, which  primarily includes COPD, is the third leading cause of death in the US.3  One of the important manifestations of COPD is exacerbation – worsening of the  typical COPD symptoms.4 The American Thoracic Society (ATS) and the European Correspondence: amol D Dhamane health economics and Outcomes  research, Boehringer Ingelheim  Pharmaceuticals Inc., 900 ridgebury  Road, Ridgefield, CT 06877, USA Tel +1 203 791 6677 email amol.dhamane@boehringer- ingelheim.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Dhamane et al Running head recto: Exacerbation frequency, resource utilization, and costs DOI: http://dx.doi.org/10.2147/COPD.S90148",Non-OADS,/arxiv_data1/oa_pdf/68/93/copd-10-2609.PMC4671762.pdf
"Available from: http://www.thoracic.org/clinical/copd-guidelines/ resources/copddoc.pd f. Accessed February 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/68/93/copd-10-2609.PMC4671762.pdf
"Availablefrom: http://www.cdc.gov/nchs/data/ nvsr/nvsr61/nvsr61_06.pd f. Accessed February 5, 2015.",OADS,/arxiv_data1/oa_pdf/68/93/copd-10-2609.PMC4671762.pdf
"Available from:  http://www.thoracic.org/clinical/copd-guidelines/for-patients/what-is- an-exacerbation.ph p. Accessed February 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/68/93/copd-10-2609.PMC4671762.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/68/93/copd-10-2609.PMC4671762.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/68/93/copd-10-2609.PMC4671762.pdf
Available from: http://bidocs.boehringer-ingelheim.,Non-OADS,/arxiv_data1/oa_pdf/68/93/copd-10-2609.PMC4671762.pdf
Available from: https://www.gsksource.com/ gskprm/htdocs/documents/ADVAIR-DISKUS-PI-MG.PD F,Non-OADS,/arxiv_data1/oa_pdf/68/93/copd-10-2609.PMC4671762.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/af/a8/jmdh-8-519.PMC4671763.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 519–526Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  519ExpErt OpiniO nopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/JMDH.S9641 5Establishing a framework for building  multidisciplinary programs Cheryl Meguid1 Carrie E ryan2 Barish H Edil1 richard D Schulick1 Csaba Gajdos1 Megan Boniface1 tracey E Schefter3 W thomas purcell4 Martin McCarter1 1Department of Surgery, Division of  Gi, tumor, and Endocrine Surgery,   Section of Surgical Oncology,   University of Colorado Hospital,   Aurora, CO,  2Morsani College of  Medicine, University of South Florida,   tampa, FL,  3Department of radiation  Oncology, University of Colorado  Denver, Denver, CO,  4Department  of Medicine, Division of Medical  Oncology, University of Colorado  Hospital, Aurora, CO, USA Correspondence: Cheryl Meguid   Department of Surgery, Division of Gi,  tumor, and Endocrine Surgery, Section of  Surgical Oncology, University of Colorado  Hospital, 12631 E 17th Avenue Mail Stop  C313 Aurora, CO  80045, USA   Email cheryl.meguid@ucdenver.ed uAbstract:  While most providers support the concept of a multidisciplinary approach to patient  care, challenges exist to the implementation of successful multidisciplinary clinical programs.",Non-OADS,/arxiv_data1/oa_pdf/af/a8/jmdh-8-519.PMC4671763.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/af/a8/jmdh-8-519.PMC4671763.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/a8/jmdh-8-519.PMC4671763.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/15/09/dddt-9-6275.PMC4671764.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 6275–6283Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6275Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8797 3sulodexide therapy for the treatment of diabetic  nephropathy, a meta-analysis and literature review rui li1 Jing Xing1 Xaojing Mu2 hui Wang1 lei Zhang3 Yu Zhao1 Yu Zhang1 1emergency Department, First  affiliated hospital of Dalian Medical  University, 2Dalian hospital of  Traditional chinese Medicine, Dalian,   People’s republic of china; 3intensive  care Unit, Tianjin First central  hospital, People’s republic of chinaAbstract:  Sulodexide is a heterogeneous group of sulfated glycosaminoglycans (GAGs) that  is mainly composed of low-molecular-weight heparin.",Non-OADS,/arxiv_data1/oa_pdf/15/09/dddt-9-6275.PMC4671764.pdf
"In addition to oxidative stress and hemodynamic changes,  glycosaminoglycans (GAGs) are another factor contributing to the onset of glomerular  abnormalities in diabetic patients.1 The thickening of glomerular basement membrane  (GBM) and the depletion of GAGs cause decreased electrostatic charge barrier in the  pathophysiology of DN.5 A novel therapeutic approach for DN is the reestablishment of  heparin sulfate synthesis by GAG drugs.6 GAG replacement therapy for DN began 20  years ago, and sulodexide is the most extensively studied of the GAGs used to reduce  albuminuria in diabetic patients.7,8 Sulodexide is composed of low-molecular-weight correspondence: Yu Zhang Emergency Department, First Affiliated  hospital of Dalian Medical University,  number 222, Zhongshan, Dalian 116011,  People’s republic of china Tel +86 411 8363 5963 email yuzhangmd@yeah.ne tJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Li et al Running head recto: Sulodexide therapy for the treatment of diabetic nephropathy DOI: http://dx.doi.org/10.2147/DDDT.S87973",Non-OADS,/arxiv_data1/oa_pdf/15/09/dddt-9-6275.PMC4671764.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/15/09/dddt-9-6275.PMC4671764.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/15/09/dddt-9-6275.PMC4671764.pdf
Available from: http://www.hkcochrane.cuhk.edu.,Non-OADS,/arxiv_data1/oa_pdf/15/09/dddt-9-6275.PMC4671764.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/35/cia-10-1909.PMC4671765.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1909–1924Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1909RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S9792 6Cell-based therapies of liver diseases: age-related  challenges Konstantin N Yarygin Alexei Y Lupatov Irina v Kholodenko Laboratory of Cell Biology, Institute  of Biomedical Chemistry, Moscow,   RussiaAbstract:  The scope of this review is to revise recent advances of the cell-based therapies of  liver diseases with an emphasis on cell donor’s and patient’s age.",Non-OADS,/arxiv_data1/oa_pdf/9c/35/cia-10-1909.PMC4671765.pdf
"Accordingly, not just chronological, but biological age clearly is  a very important factor to be considered when new methods of treatment of the people Correspondence: Konstantin Yarygin Laboratory of Cell Biology, Institute  of Biomedical Chemistry, Pogodinskaya  Street 10, 119121 Moscow, Russia Tel +7 499 246 6980 Fax +7 499 245 0857 email kyarygin@yandex.r u Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Y arygin et al Running head recto: Cell therapies for aging liver DOI: http://dx.doi.org/10.2147/CIA.S97926",Non-OADS,/arxiv_data1/oa_pdf/9c/35/cia-10-1909.PMC4671765.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/9c/35/cia-10-1909.PMC4671765.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/9c/35/cia-10-1909.PMC4671765.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e5/01/cia-10-1901.PMC4671766.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1901–1907Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1901OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S9597 4Assessment of the effects of glutamic acid  decarboxylase antibodies and trace elements   on cognitive performance in older adults Ahmad h Alghadir1 sami A gabr1,2 einas s Al-eisa1 1Department of rehabilitation  sciences, College of Applied Medical  sciences, King saud University, riyadh,   saudi Arabia; 2Department of Anatomy,   Faculty of Medicine, Mansoura  University, Mansoura, egyptBackground:  Homeostatic imbalance of trace elements such as iron (Fe), copper (Cu), and  zinc (Zn) demonstrated adverse effects on brain function among older adults.",Non-OADS,/arxiv_data1/oa_pdf/e5/01/cia-10-1901.PMC4671766.pdf
"Keywords:  LOTCA, trace elements, anti-GADAs, cognitive performance, older adults Introduction Certain cognitive domains and physical inactivity were significantly associated with  human aging.1,2 A number of cognitive processes, including attention, learning and  memory, and executive control, were changed among older ages.3,4 A decline in cogni - tive abilities was shown to produce more drastic problems for older adults to perform  their daily life activities.5 The severity and prevalence rate of cognitive decline depend mainly on various  biological, social, and physiological factors such as lifestyle,6 social network,7,8 and  various biomarkers,9 including oxidative stress and free radical damage.10,11 Among  these potential markers, trace elements such as iron (Fe), copper (Cu), and zinc (Zn) Correspondence: sami A gabr Department of rehabilitation sciences,  College of Applied Medical sciences,  King saud University, PO Box 10219,  riyadh 11433, saudi Arabia Tel +966 5 6206 0018 Fax +966 1469 8541 email nadalab2009@hotmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Alghadir et al Running head recto: Trace elements effects on cognitive performance in older adults DOI: http://dx.doi.org/10.2147/CIA.S95974",Non-OADS,/arxiv_data1/oa_pdf/e5/01/cia-10-1901.PMC4671766.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/e5/01/cia-10-1901.PMC4671766.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/e5/01/cia-10-1901.PMC4671766.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d3/88/ijn-10-7207.PMC4671767.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7207–7221International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7207OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8726 8green synthesis of silver nanoparticles  using cranberry powder aqueous extract:  characterization and antimicrobial properties asmaa a ashour1 Dina raafat2 hanan M el-gowelli3 amal h el-Kamel1 1Department of Pharmaceutics,   2Department of Pharmaceutical  Microbiology, 3Department of  Pharmacology and Toxicology, Faculty  of Pharmacy, alexandria University,   alexandria, egyptBackground:  The growing threat of microbial resistance against traditional antibiotics has  prompted the development of several antimicrobial nanoparticles (NPs), including silver NPs  (AgNPs).",Non-OADS,/arxiv_data1/oa_pdf/d3/88/ijn-10-7207.PMC4671767.pdf
"In  this context, several classes of antimicrobial nanoparticles (NPs) and nanosize carriers  for antibiotic delivery have proven their effectiveness for the treatment of infectious  diseases, including antibiotic-resistant ones, both in in vitro and in animal models.1 Among the various types of metallic NPs, silver NPs (AgNPs) have proven to be  the most effective against bacteria and viruses.1 In addition, microbes are unlikely to  develop resistance against silver, because the metal attacks a broad range of target correspondence: amal h el-Kamel Department of Pharmaceutics, Faculty of  Pharmacy, alexandria University,   1 Khartoum square, azarita, alexandria,  21521, egypt Tel +20 100 508 0510 Fax +20 3 487 3273 email amalelkamel@yahoo.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Ashour et al Running head recto: Green AgNPs synthesis with cranberry DOI: http://dx.doi.org/10.2147/IJN.S87268",Non-OADS,/arxiv_data1/oa_pdf/d3/88/ijn-10-7207.PMC4671767.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d3/88/ijn-10-7207.PMC4671767.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/88/ijn-10-7207.PMC4671767.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ff/e8/imcrj-8-305.PMC4671768.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 305–312International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  305Case seRIesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IMCRJ.S9279 4strong topical steroid, NsaID, and carbonic  anhydrase inhibitor cocktail for treatment   of cystoid macular edema Masumi G asahi Gabriela L Bobarnac  Dogaru spencer M Onishi Ron P Gallemore Retina Macula Institute, T orrance, C a,   Usa Correspondence: Ron P Gallemore   Retina Macula Institute, 4201 Torrance  Boulevard ste 220, Torrance, Ca 90503,  Usa  Tel +1 310 944 9393   Fax +1 310 944 3393   email rongallemoremd@gmail.co mPurpose:  To report the combination cocktail of strong steroid, non-steroidal anti-inflammatory  drug (NSAID), and carbonic anhydrase inhibitor drops for treatment of cystoid macular edema.",Non-OADS,/arxiv_data1/oa_pdf/ff/e8/imcrj-8-305.PMC4671768.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/ff/e8/imcrj-8-305.PMC4671768.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/e8/imcrj-8-305.PMC4671768.pdf
Available from:  http://www.reviewofophthalmology.com/content/d/retinal_insider/ i/1310/c/25220 /.,Non-OADS,/arxiv_data1/oa_pdf/ff/e8/imcrj-8-305.PMC4671768.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ed/3e/ijn-10-7253.PMC4671769.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7253–7264International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7253OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9548 3Novel green synthesis of gold nanoparticles  using Citrullus lanatus  rind and investigation of  proteasome inhibitory activity, antibacterial, and  antioxidant potential Jayanta Kumar Patra Kwang-hyun Baek school of Biotechnology, Yeungnam  University, gyeongsan, gyeongbuk,   republic of KoreaAbstract:  Biological synthesis of nanoparticles using nontoxic, eco-friendly approaches is  gaining importance owing to their fascinating biocompatibility and environmentally benign  nature.",Non-OADS,/arxiv_data1/oa_pdf/ed/3e/ijn-10-7253.PMC4671769.pdf
"Keywords:  antibacterial, antioxidant, gold nanoparticles, proteasome inhibitor, watermelon  peel, green synthesis, biosynthesis Introduction Some natural compounds have the ability to reduce metal ions into metal nanoparticles.1  However, the shape, size, and morphology of nanoparticles play important roles in  controlling their physical and chemical properties.2,3 These unique, interesting physical,  chemical, and biological properties of the nano-ranged materials have attracted the  present scientific world for their potential applications in different biomedical, elec - trical, and applied sciences.4 Chemical reduction methods are usually used for the  synthesis of high amounts of metal nanoparticles on an industrial scale, however, correspondence: Kwang-hyun Baek school of Biotechnology, Yeungnam  University, gyeongsan, gyeongbuk   712-749, republic of Korea Tel +82 53 810 3029 Fax +82 53 810 4769 email khbaek@ynu.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Patra and Baek Running head recto: Synthesis of gold nanoparticles using Citrullus lanatus rind DOI: http://dx.doi.org/10.2147/IJN.S95483",Non-OADS,/arxiv_data1/oa_pdf/ed/3e/ijn-10-7253.PMC4671769.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ed/3e/ijn-10-7253.PMC4671769.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/3e/ijn-10-7253.PMC4671769.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c3/8f/ijn-10-7241.PMC4671771.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7241–7252International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7241OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9230 7antimicrobial activity and cytocompatibility  of silver nanoparticles coated catheters via a  biomimetic surface functionalization strategy Ke Wu1 Yun Yang2,3 Yanmei Zhang2,3 Jiexi Deng1 changjian lin2,3 1Department of cardiology, The  affiliated Dongnan hospital of  Xiamen University, Zhangzhou,   2Department of Medical Materials,   Beijing Medical Implant engineering  research center, Beijing Naton  T echnology group, Beijing, 3state Key  laboratory of Physical chemistry  of solid surfaces, Department of  chemistry, college of chemistry  and chemical engineering, Xiamen  University, Xiamen, People’s republic  of chinaAbstract:  Catheter-related bloodstream infections are a significant problem in the clinic and  may result in a serious infection.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/ijn-10-7241.PMC4671771.pdf
"269, Zhanghuazhong road,  Zhangzhou 363000, People’s republic  of china Tel +86 596 297 5537 Fax +86 596 297 5534 email jxdeng175@163.co m  changjian lin state Key laboratory of Physical  chemistry of solid surfaces, college  of chemistry and chemical engineering,  Xiamen University, Xiamen 361005,  People’s republic of china Tel +86 592 218 9354 Fax +86 592 218 6657 email cjlin@xmu.edu.c nJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Wu et al Running head recto: Antimicrobial activity and cytocompatibility of silver nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S92307",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/ijn-10-7241.PMC4671771.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/ijn-10-7241.PMC4671771.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/8f/ijn-10-7241.PMC4671771.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4d/d2/dddt-9-6303.PMC4671772.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 6303–6317Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6303Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9373 2Ginkgo biloba  extract mitigates liver fibrosis and  apoptosis by regulating p38 MAPK, NF- κB/iκBα,  and Bcl-2/Bax signaling Yuanyuan Wang rong Wang Yujie Wang Ruqin Peng Yan Wu Y ongfang Yuan Department of Pharmacy, Shanghai  9th People’s Hospital, Shanghai Jiao  T ong University School of Medicine,   Shanghai, People’s Republic of ChinaBackground:  Liver fibrosis is the consequence of diverse liver injuries and can eventually  develop into liver cirrhosis.",Non-OADS,/arxiv_data1/oa_pdf/4d/d2/dddt-9-6303.PMC4671772.pdf
"Current  research have provided growing evidence, which show that the key source of the ECM  is the hepatic stellate cells (HSCs).2,3 HSCs, the focus of the fibrogenic response, go  through a transdifferentiation from quiescent vitamin A-storing cells to proliferative  myofibroblasts that secrete superfluous ECM, finally leading to liver fibrosis.4 Upon  the transformation of quiescent to active HSCs, nuclear factor-kappa B (NF- κB) is  induced, which leads to the production of various inflammatory factors including correspondence: Yongfang Yuan Department of Pharmacy, Shanghai  9th People’s Hospital, Shanghai Jiao  Tong University School of Medicine,  639 Zhi Zao Ju Road, Shanghai 200011,  People’s Republic of China Tel +86 136 2167 6746 Fax +86 21 5678 6907 email nmxyyf@126.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Wang et al Running head recto: Ginkgo biloba  extract mitigates liver fibrosis and apoptosis DOI: http://dx.doi.org/10.2147/DDDT.S93732",Non-OADS,/arxiv_data1/oa_pdf/4d/d2/dddt-9-6303.PMC4671772.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4d/d2/dddt-9-6303.PMC4671772.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/d2/dddt-9-6303.PMC4671772.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4e/53/tcrm-11-1789.PMC4671777.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1789–1794Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1789Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8720 8Medical devices for restless legs syndrome – clinical  utility of the Relaxis pad Ulrike H Mitchell Department of exercise Sciences,   Brigham Y oung University, Provo,   UT, USAAbstract:  Restless Legs Syndrome or Willis–Ekbom Disease, a neurosensory disorder, can be  treated with pharmaceuticals or conservatively.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/tcrm-11-1789.PMC4671777.pdf
"This review will focus on the Correspondence: Ulrike H Mitchell Department of exercise Sciences,  Brigham Young University, SFH # 268,  Provo, UT 84602, USA Tel +1 801 422 3344 email rike_mitchell@byu.ed u Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Mitchell Running head recto: Medical devices for RLS DOI: http://dx.doi.org/10.2147/TCRM.S87208",Non-OADS,/arxiv_data1/oa_pdf/4e/53/tcrm-11-1789.PMC4671777.pdf
Available from: http://www.americannursetoday.,Non-OADS,/arxiv_data1/oa_pdf/4e/53/tcrm-11-1789.PMC4671777.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/4e/53/tcrm-11-1789.PMC4671777.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/53/tcrm-11-1789.PMC4671777.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e5/09/ijwh-7-945.PMC4671778.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 945–948International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  945Case reportopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IJWH.S8333 6Intrauterine contraceptive device embedded in  the omentum – case report piotr Zolnierczyk Krzysztof Cendrowski Wlodzimierz sawicki Department of obstetrics,   Gynecology and oncology, 2nd  Faculty of Medicine, Medical  University of Warsaw, Warsaw, polandAbstract:  This report describes the case of a 29-year-old patient, female (nulliparous) who had  an intrauterine device (IUD) inserted in 2010 and who has had no gynecological control since then  (for 4 years).",Non-OADS,/arxiv_data1/oa_pdf/e5/09/ijwh-7-945.PMC4671778.pdf
"The hyperechoic structure (the insert containing barite and copper Correspondence: piotr Zolnierczyk Department of obstetrics, Gynecology  and oncology, 2nd Faculty of Medicine,  Medical University of Warsaw, Ul  Kondratowicza 8, 03-242 Warsaw,  poland tel +48 60 130 1773 Fax +48 22 326 5818 email pzolnier@wp.p l Journal name: International Journal of Women’s Health Article Designation: Case report Y ear: 2015 Volume: 7 Running head verso: Zolnierczyk et al Running head recto: Intrauterine contraceptive device in omentum  DOI: http://dx.doi.org/10.2147/IJWH.S83336",Non-OADS,/arxiv_data1/oa_pdf/e5/09/ijwh-7-945.PMC4671778.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/e5/09/ijwh-7-945.PMC4671778.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/09/ijwh-7-945.PMC4671778.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/41/a2/tcrm-11-1767.PMC4671779.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1767–1777Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1767Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S7905 3Profile of secukinumab in the treatment of  psoriasis: current perspectives Michael Roman vandana K Madkan Melvin w Chiu Division of Dermatology, David  Geffen School of Medicine at UCLA,   Los Angeles, CA, USAAbstract:  Secukinumab (Cosentyx™) is a human monoclonal IgG1k antibody that has been  developed to target and block the actions of IL-17A.",Non-OADS,/arxiv_data1/oa_pdf/41/a2/tcrm-11-1767.PMC4671779.pdf
"Although the Correspondence: Melvin w Chiu Division of Dermatology, David  Geffen School of Medicine at UCLA,  10833 Le Conte Avenue, Los Angeles,  CA 90095, USA Tel +1 310 825 6911 email mc hiu@mednet.ucla.ed u Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Roman et al Running head recto: Profile of secukinumab DOI: http://dx.doi.org/10.2147/TCRM.S79053",Non-OADS,/arxiv_data1/oa_pdf/41/a2/tcrm-11-1767.PMC4671779.pdf
"Available from: http://www.pharma.us.novartis.com/product/pi/pdf/ cosentyx.pd f. Accessed February 23, 2015.",Non-OADS,/arxiv_data1/oa_pdf/41/a2/tcrm-11-1767.PMC4671779.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/41/a2/tcrm-11-1767.PMC4671779.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/a2/tcrm-11-1767.PMC4671779.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/41/b1/ijn-10-7231.PMC4671780.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7231–7240International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7231OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8813 4combination of calcium sulfate and simvastatin- controlled release microspheres enhances bone  repair in critical-sized rat calvarial bone defects Yin-chih Fu1–4 Yan-hsiung Wang1,5 chung-hwan chen1,3,4 chih-Kuang Wang1,6 gwo-Jaw Wang1,3,4 Mei-ling ho1,3,7,8 1Orthopaedic research center,   2graduate Institute of Medicine,   3Department of Orthopaedics,   4Department of Orthopaedics,   college of Medicine, 5school of  Dentistry, college of Dental Medicine,   6Department of Medicinal and applied  chemistry, 7Department of Physiology,   college of Medicine, Kaohsiung  Medical University, Kaohsiung, Taiwan;   8Department of Marine Biotechnology  and resources, National sun Yat-sen  University, Kaohsiung, TaiwanAbstract:  Most allogenic bone graft substitutes have only osteoconductive properties.",Non-OADS,/arxiv_data1/oa_pdf/41/b1/ijn-10-7231.PMC4671780.pdf
"Therefore, encapsulating osteoinductive proteins or drugs correspondence: Mei-ling ho Department of Physiology, college of  Medicine, Kaohsiung Medical University,  100 shih-chuan 1st road, Kaohsiung 807,  Taiwan email homelin@cc.kmu.edu.t w Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Fu et al Running head recto: Calcium sulfate + SIM/PLGA enhances bone repair DOI: http://dx.doi.org/10.2147/IJN.S88134",Non-OADS,/arxiv_data1/oa_pdf/41/b1/ijn-10-7231.PMC4671780.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/41/b1/ijn-10-7231.PMC4671780.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/b1/ijn-10-7231.PMC4671780.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/53/copd-10-2581.PMC4671781.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 2581–2591International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2581OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8870 2Bacterial flora in the sputum and comorbidity  in patients with acute exacerbations of COPD ramon Boixeda1 Pere almagro2,3 Jesús Díez-Manglano4 Francisco Javier Cabrera5 Jesús recio6 Isabel Martin-Garrido7 Joan B soriano8 On behalf of the COPD  and Pluripathological  Patients Groups of the  Spanish Internal Medicine  Society 1Internal Medicine Department,   hospital de Mataró – CsDM,   Universitat autònoma de Barcelona,   Mataró, Barcelona, spain; 2Internal  Medicine Department, hospital Mútua  de T errassa, T errassa, 3Universitat de  Barcelona, Barcelona, spain; 4Internal  Medicine Department, Hospital Royo  Villanova, Zaragoza, Zaragoza, spain;   5Internal Medicine Department,   hospital general Universitario  gregorio Marañón, Universidad  Complutense, Madrid, spain; 6Internal  Medicine Department, hospital Vall  d’Hebrón, Barcelona, Barcelona,   spain; 7Internal Medicine Department,   hospital Quirón san Camilo,   Madrid, Madrid, spain; 8Instituto de  Investigación hospital Universitario  de la Princesa (II sP), Universidad  autónoma de Madrid, Cátedra U aM- lindel, Madrid, spainObjective:  To determine in patients admitted with an acute exacerbation of chronic obstructive  pulmonary disease (AE-COPD) the association between the isolation of potential pathogens in  a conventional sputum culture and comorbidities.",Non-OADS,/arxiv_data1/oa_pdf/24/53/copd-10-2581.PMC4671781.pdf
"Nevertheless, sputum purulence seems to be the main  factor associated with infection.8,9 The choice of antimicrobial agent depends on the suspected microorganism,  based on the clinical circumstances,10 the severity of the COPD,11 and the presence  of comorbidities (diabetes mellitus, liver cirrhosis, chronic kidney failure, or heart  disease), infections, or previous antibiotherapy.Correspondence: ramon Boixeda Internal Medicine Department,  hospital de Mataró – CsDM,  Universitat autònoma de Barcelona,  Carretera Cirera s/n, 08304 Mataró,  Barcelona, spain Tel +34 93 741 7700 email rboixeda@csdm.ca t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Boixeda et al Running head recto: Bacterial flora in sputum and comorbidities DOI: http://dx.doi.org/10.2147/COPD.S88702",Non-OADS,/arxiv_data1/oa_pdf/24/53/copd-10-2581.PMC4671781.pdf
Available  from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/24/53/copd-10-2581.PMC4671781.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/24/53/copd-10-2581.PMC4671781.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/53/copd-10-2581.PMC4671781.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c0/b9/prom-6-243.PMC4671799.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Related Outcome Measures 2015:6 243–253Patient Related Outcome Measures Dove press submit your manuscript | www.dovepress.co m Dove press  243Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PROM.S6863 1Functional dysphonia: strategies to improve patient  outcomes Mara Behlau Glaucya Madazio Gisele Oliveira voice Department, Centro de estudos  da voz – Cev , São Paulo, Brazil Correspondence: Mara Behlau   voice Department, Centro de estudos  da voz  – Cev, Rua Machado Bittencourt   361, São Paulo  04044-001, Brazil   Tel +55 11 5575 1710  Fax +55 11 5575 1710  email mbehlau@uol.com.b rAbstract:  Functional dysphonia (FD) refers to a voice problem in the absence of a physical  condition.",Non-OADS,/arxiv_data1/oa_pdf/c0/b9/prom-6-243.PMC4671799.pdf
"Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-related-outcome-measures-journa lPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically  relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/c0/b9/prom-6-243.PMC4671799.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/c0/b9/prom-6-243.PMC4671799.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/79/06/tcrm-11-1759.PMC4671800.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1759–1765Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1759Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S5828 9Bevacizumab for glioblastoma Y oshitaka Narita Department of Neurosurgery and  Neuro-Oncology, National Cancer  Center Hospital, T okyo, JapanAbstract:  Individuals with glioblastoma are often characterized by older age, advanced  neurologic manifestations at the primary stage, and unresectable tumors, and these factors  are associated with poor treatment outcomes.",Non-OADS,/arxiv_data1/oa_pdf/79/06/tcrm-11-1759.PMC4671800.pdf
"Therefore, PS in more than 50% of  patients is already low during the primary diagnostic stage.1 Glioblastoma promotes secretion of vascular endothelial growth factor (VEGF),  which induces vascularization and increases capillary permeability of the blood–brain  barrier, subsequently causing extracellular edema.4,5 Bevacizumab (BV) (Avastin®;  Hoffman-La Roche Ltd., Basel, Switzerland) is a humanized monoclonal antibody  targeting VEGF and was first approved in the US for glioblastoma in 2009.6 Block - ing the VEGF pathway restores the abnormal tumor vasculature to a more normal  state, reducing vascular permeability and the regional cerebral blood volume around Correspondence: Yoshitaka Narita Department of Neurosurgery and  Neuro-Oncology, National Cancer  Center Hospital, 5-1-1, Tsukiji, Chuo-ku,  Tokyo, 104-0045, Japan Tel +81 3 3542 2511 Fax +81 3 3542 2551 email yonarita@ncc.go.j p Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Narita Running head recto: Bevacizumab for GBM DOI: http://dx.doi.org/10.2147/TCRM.S58289",Non-OADS,/arxiv_data1/oa_pdf/79/06/tcrm-11-1759.PMC4671800.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/79/06/tcrm-11-1759.PMC4671800.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/79/06/tcrm-11-1759.PMC4671800.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5e/1e/ott-8-3575.PMC4671801.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3575–3583OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3575Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9514 9The relationship between UGT1A1  gene  polymorphism and irinotecan effect on extensive- stage small-cell lung cancer Xiao-guang Xiao shu Xia Man Zou Qi Mei lei Zhou shu-jing Wang Yuan chen Department of Oncology, Tongji  hospital, Tongji Medical college of  huazhong University of science and  Technology, Wuhan, People’s republic  of chinaAims:  To analyze the distribution of uridine diphosphate glucuronosyltransferase (UGT)1A1  gene polymorphisms in Chinese patients with extensive-stage small-cell lung cancer (E-SCLC),  and to evaluate correlations between the UGT1A1  gene polymorphisms and toxicity, and efficacy  of irinotecan (CPT-11) based regimen in the patients with E-SCLC.",Non-OADS,/arxiv_data1/oa_pdf/5e/1e/ott-8-3575.PMC4671801.pdf
"Furthermore, approximately two-thirds of SCLC cases clinically belong  to extensive-stage (E-SCLC) when initially diagnosed.1 Many combinations have been  evaluated in the patients with extensive-stage disease, with little consistent evidence correspondence: Yuan chen Department of Oncology, Tongji  hospital, Tongji Medical college of  huazhong University of science and  Technology, 1095 Jiefang road, Wuhan  430030, People’s republic of china Tel +86 27 8366 3407 email chenyuan008@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Xiao et al Running head recto: Relationship between UGT1A1  gene polymorphism and irinotecan effect DOI: http://dx.doi.org/10.2147/OTT.S95149",Non-OADS,/arxiv_data1/oa_pdf/5e/1e/ott-8-3575.PMC4671801.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5e/1e/ott-8-3575.PMC4671801.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/1e/ott-8-3575.PMC4671801.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/fb/ott-8-3549.PMC4671802.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3549–3559OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3549Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9251 8inhibition of TgF- β signaling with halofuginone  can enhance the antitumor effect of irradiation   in lewis lung cancer runlong lin* shuai Yi* linlin gong Weishuai liu Peng Wang ningbo liu lujun Zhao Ping Wang Department of radiation Oncology,   Tianjin Medical University cancer  institute and hospital, national clinical  research center of cancer, Key  laboratory of cancer Prevention and  Therapy, Tianjin, People’s republic of  china *These authors contributed equally   to this workPurpose:  It was reported that halofuginone has inhibitory effects on transforming growth  factor-beta (TGF- β) signaling pathway.",Non-OADS,/arxiv_data1/oa_pdf/d0/fb/ott-8-3549.PMC4671802.pdf
"A pilot correspondence: lujun Zhao Department of radiation Oncology, Tianjin  Medical University cancer institute and  hospital, huan-hu-xi road, he-xi District,  Tianjin 300060, People’s republic of china Tel +86 22 2334 0123 Fax +86 22 2334 1405 email zhaolujun@tjmuch.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Lin et al Running head recto: Halofuginone enhances the antitumor effect of irradiation DOI: http://dx.doi.org/10.2147/OTT.S92518 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/d0/fb/ott-8-3549.PMC4671802.pdf
Or use: http://youtu.be/UkQGE4KuFd QVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/d0/fb/ott-8-3549.PMC4671802.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d0/fb/ott-8-3549.PMC4671802.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/fb/ott-8-3549.PMC4671802.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ae/b9/ott-8-3613.PMC4671803.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3613–3619OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3613Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9197 1First-line chemotherapy in patients with metastatic  gastroenteropancreatic neuroendocrine carcinoma alberto Bongiovanni1 nada riva1 Marianna ricci1 chiara liverani1 Federico la Manna1 alessandro De Vita1 Flavia Foca2 laura Mercatali1 stefano severi3 Dino amadori4 T oni ibrahim1 1Osteoncology and rare Tumors  center, 2Unit of Biostatistics and  clinical Trials, 3nuclear Medicine Unit,   4Department of Medical Oncology,   istituto scientifico romagnolo per lo  studio e la cura dei Tumori ( irsT)  irccs, Meldola, Fc , italyBackground and aim:  To investigate the efficacy of platinum-based chemotherapy in patients  with metastatic gastroenteropancreatic neuroendocrine carcinoma (mGEP-NEC) and define  predictive and prognostic factors.",Non-OADS,/arxiv_data1/oa_pdf/ae/b9/ott-8-3613.PMC4671803.pdf
"Pancreatic NECs account for ,1%  of all pancreatic carcinomas, and ,2%–3% of all pancreatic NENs.6 Although soma - tostatin analogs, targeted therapies and peptide radio receptor therapy play an impor - tant role in the management of metastatic (m)GEP-NETs, chemotherapy is the main correspondence: alberto Bongiovanni Osteoncology and rare Tumors center,  Istituto Scientifico Romagnolo per lo  studio e la cura dei Tumori (irsT)  irccs, Via Piero Maroncelli, 40,   47014 Meldola, Fc, italy Tel +39 0543 739 100 Fax +39 0543 739 123 email alberto.bongiovanni@irst.emr.i t Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Bongiovanni et al Running head recto: First-line chemotherapy in GEP-NEC DOI: http://dx.doi.org/10.2147/OTT.S91971",Non-OADS,/arxiv_data1/oa_pdf/ae/b9/ott-8-3613.PMC4671803.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ae/b9/ott-8-3613.PMC4671803.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/b9/ott-8-3613.PMC4671803.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/54/14/ott-8-3603.PMC4671804.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3603–3612OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3603Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9550 0restoration of Brg1 inhibits proliferation and  metastasis of lung cancer by regulating tumor  suppressor mir-148b Zheng Zhou1 Yanhe su2 Xianen Fa3 1Department of respiratory Medicine,   2Department of Thoracic surgery,   3Department of Thoracic and  cardiovascular surgery, The second  affiliated hospital of Zhengzhou  University, Zhengzhou, henan,   People’s republic of chinaBackground:  Brahma-related gene 1  (BRG1 ) has been implicated in a variety of biological  processes, and it has been found to be mutated or silenced in numerous cancers, including  lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/54/14/ott-8-3603.PMC4671804.pdf
"Keywords:  Brahma-related gene 1  (BRG1 ), proliferation, metastasis, miR-148b, WNT/  β-catenin signaling pathway Introduction Mammalian switch/sucrose nonfermentable (SWI/SNF) chromatin remodeling com - plexes contain either BRG1 or BRM exclusively as the catalytic ATPase subunit that  control the alteration of DNA–nucleosome structure and thus modulate target gene  transcription.1,2 The loss of BRG1 subunit disrupts the complex and inactivates its  function, which is associated with a variety of malignancies, including ovarian, renal,  liver, and pediatric cancers.3,4 Brahma-related gene 1 (BRG1 ) was the fourth most fre - quently altered gene in non-small-cell lung cancer (NSCLC) cell lines and low BRG1  protein level have also been observed in clinical lung primary tumors.5–7 Restoration  of wild-type BRG1 expression activated massive transcription in lung cancer cells and correspondence: Xianen Fa Department of Thoracic and  cardiovascular surgery, The second  Affiliated Hospital of Zhengzhou   University, no 2 Jingba road,  Zhengzhou, henan 450014,  People’s republic of china Tel +86 371 6393 4118 email xianenfazzu@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Zhou et al Running head recto: BRG1 inhibits lung cancer by regulating miR-148b DOI: http://dx.doi.org/10.2147/OTT.S95500",Non-OADS,/arxiv_data1/oa_pdf/54/14/ott-8-3603.PMC4671804.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/54/14/ott-8-3603.PMC4671804.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/54/14/ott-8-3603.PMC4671804.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bb/cd/opth-9-2263.PMC4671806.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 2263–2270Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2263Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8889 1Brinzolamide 1%/timolol versus dorzolamide 2%/ timolol in the treatment of open-angle glaucoma  or ocular hypertension: prospective randomized  patient-preference study romeo altafini1 Maria-luise scherzer2 Douglas a hubatsch3 Paolo Frezzotti4 1glaucoma segment Unit, “ san  Bortolo” hospital, Vicenza, italy;   2Private Practice, regenstauf,   germany; 3alcon laboratories, inc.,   Fort Worth, TX, Usa; 4Ophthalmic  Unit, University of siena, siena, italyPurpose:  The objective of this study was to assess preference for fixed-combination  brinzolamide 1%/timolol 0.5% (BTFC) versus fixed-combination dorzolamide 2%/timolol 0.5%  (DTFC) in patients with open-angle glaucoma or ocular hypertension.",Non-OADS,/arxiv_data1/oa_pdf/bb/cd/opth-9-2263.PMC4671806.pdf
"Of the estimated 60 + million  people worldwide with glaucoma in the year 2010, open-angle glaucoma accounted  for nearly 75% of cases,1 and it has been estimated that open-angle glaucoma was  the cause of bilateral blindness in more than 4.4 million people.1 Reducing IOP to  prevent or delay disease progression is the standard of care for ocular hypertension  and glaucoma,2 and treatment with topical ocular hypotensive medication has been  shown to slow the progression of visual field defects.3 Many patients require two or Correspondence: Romeo Altafini 155, Corso Palladio, andrea, 36100  Vicenza, italy Tel +39 0444 5254 45 Fax +39 0444 3272 06 email raltafi@tin.i tJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Altafini et al Running head recto: Patient preference for Azarga versus Cosopt DOI: http://dx.doi.org/10.2147/OPTH.S88891",Non-OADS,/arxiv_data1/oa_pdf/bb/cd/opth-9-2263.PMC4671806.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/bb/cd/opth-9-2263.PMC4671806.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/cd/opth-9-2263.PMC4671806.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6c/78/opth-9-2271.PMC4671807.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 2271–2276Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2271Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S8844 4Does autoimmunity against thyroglobulin play a  role in the pathogenesis of Graves’ ophthalmopathy:  a review Thayalini Shanmuganathan1 Christian Girgis2 Hooshang Lahooti1 Bernard Champion1 Jack R wall1 1Department of Medicine, Nepean  Clinical School, Nepean Hospital,   The University of Sydney, Sydney,   2Department of Medicine, westmead  Millennium institute, The University  of Sydney, Sydney, NSw , AustraliaAbstract:  While most authors believe that autoimmunity against the TSH receptor expressed  in the orbital connective tissue cells is the main reaction that leads to the development of oph - thalmopathy in patients with Graves’ hyperthyroidism, an older hypothesis that deserves fresh  consideration is based on the notion that thyroglobulin (Tg) in the thyroid gland passes in a  retrograde fashion to the orbit where it is recognized by Tg autoantibodies, leading to inflam - mation.",Non-OADS,/arxiv_data1/oa_pdf/6c/78/opth-9-2271.PMC4671807.pdf
"Moreover on a recent case report we showed that eye signs and other  soft tissue manifestations of Graves’ disease worsened in the context of psychological  stress, with reduced levels of TSHr antibody, occurred following stress.10 Regardless of the nature of the inflammatory process in the orbital connective  tissue and fat and extra ocular muscles (EOM), the eye disorder is presumed to begin  in the thyroid since the great majority of patients with Graves’ ophthalmopathy  (GO) have active thyroid inflammation, ie, thyroiditis, at the time they develop eye  signs.1,11 Thus, a logical hypothesis for the orbital reaction is that thyroid antigens are  released in the context of a thyroiditis and travel (“home”) to the orbital tissues where  they bind to various cell types and are targeted by autoantibodies and/or sensitized Correspondence: Jack R wall Department of Medicine, Nepean Clinical  School, Nepean Hospital, The University  of Sydney, South Block, 5th Floor,  Penrith, Sydney, NSw 2751, Australia Tel +61 2 4734 2613 Fax +61 2 4734 2614 email jack.wall@sydney.edu.a u Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Shanmuganathan et al Running head recto: Autoimmunity against thyroglobulin DOI: http://dx.doi.org/10.2147/OPTH.S88444",Non-OADS,/arxiv_data1/oa_pdf/6c/78/opth-9-2271.PMC4671807.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/6c/78/opth-9-2271.PMC4671807.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/78/opth-9-2271.PMC4671807.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/99/7b/opth-9-2243.PMC4671808.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 2243–2250Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2243Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9254 8Current barriers to treatment for wet age-related  macular degeneration (wAMD): findings from the  waMD patient and caregiver survey Monica Varano1 nicole eter2 steve Winyard3 Kim U Wittrup-Jensen4 rafael navarro5 Julie heraghty6 On behalf of the w aMD  Patient and Caregiver  survey Committee  members 1Department of Ophthalmology,   Fondazione gB Bietti-irCCs, rome,   italy; 2Department of Ophthalmology,   University of Münster, Münster,   germany; 3Department of Policy  and Campaigns, royal national  institute of Blind People, london, UK;   4Bayer Pharma ag, Berlin, germany;   5instituto de Microcirugía Ocular,   Barcelona, spain; 6Macular Disease  Foundation australia, sydney, nsW,   australiaPurpose:  A cross-sectional survey to evaluate the current management of wet age-related  macular degeneration (wAMD) and to identify barriers to treatment from a patient and caregiver  perspective.",Non-OADS,/arxiv_data1/oa_pdf/99/7b/opth-9-2243.PMC4671808.pdf
"Anti-VEGF agents are known to target a  key underlying pathway in the development and progression of wAMD and have been  shown to be clinically effective in large-scale studies;5–8 however, surveys on long-term  treatment patterns indicate that these agents are underutilized in real-life clinical set - tings.9 In addition, few studies have examined the impact of anti-VEGF treatments from  a caregiver perspective, with evidence suggesting that the impact may be similar to that Correspondence: Monica Varano Department of Ophthalmology,  Fondazione gB Bietti-irCCs, rome, italy Tel +39 6 8535 6727 Fax +39 6 8424 2333 email m.varano@mclink.i t Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Varano et al Running head recto: wAMD patient and caregiver survey DOI: http://dx.doi.org/10.2147/OPTH.S92548",Non-OADS,/arxiv_data1/oa_pdf/99/7b/opth-9-2243.PMC4671808.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/99/7b/opth-9-2243.PMC4671808.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/99/7b/opth-9-2243.PMC4671808.pdf
"Available from:  http://www.icoph.org/dynamic/attachments/resources/globalcostofvi_ finalreport.pd f. Accessed October 6, 2014.",OADS,/arxiv_data1/oa_pdf/99/7b/opth-9-2243.PMC4671808.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/55/80/ott-8-3565.PMC4671809.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3565–3573OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3565Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9539 5inhibition of FOXO1 by small interfering rna  enhances proliferation and inhibits apoptosis of  papillary thyroid carcinoma cells via akt/FOXO1/ Bim pathway hong-ming song* Jia-lu song* Deng-feng li Kai-yao hua Bing-kun Zhao lin Fang Department of Breast and Thyroid  surgery, shanghai Tenth People’s  hospital, school of Medicine, T ongji  University, shanghai, People’s republic  of china *These authors contributed equally  to this workAbstract:  Forkhead box protein O1 (FOXO1) is a multifunctional transcription factor of the  forkhead family.",Non-OADS,/arxiv_data1/oa_pdf/55/80/ott-8-3565.PMC4671809.pdf
"The transcription factor forkhead box protein O1 (FOXO1), a founding member  of the FOXO family, participates in diverse functions involving cell proliferation, cell correspondence: lin Fang;   hong-ming song Department of Breast and Thyroid  surgery, shanghai Tenth People’s  hospital, school of Medicine, Tongji  University, 301 Yanchang road, Zhabei  area, shanghai 200072, People’s republic  of china email syjrkfanglin@126.co m;   4778958@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Song et al Running head recto: FOXO1 and papillary thyroid carcinoma DOI: http://dx.doi.org/10.2147/OTT.S95395",Non-OADS,/arxiv_data1/oa_pdf/55/80/ott-8-3565.PMC4671809.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/55/80/ott-8-3565.PMC4671809.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/55/80/ott-8-3565.PMC4671809.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ea/40/lra-8-101.PMC4671810.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pLocal and Regional Anesthesia 2015:8 101–104Local and Regional Anesthesia Dove press submit your manuscript | www.dovepress.co m Dove press  101CAse Repo Rtopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/LRA.S8639 0thoracic combined spinal epidural anesthesia  for laparoscopic cholecystectomy in a geriatric  patient with ischemic heart disease and renal  insufficiency Nandita Mehta sunana Gupta Atul sharma Mohd Reidwan Dar Department of Anesthesiology and  Intensive Care, Acharya shri Chander  College of Medical sciences and  Hospital, Jammu, Jammu and Kashmir,   India Correspondence: Mohd Reidwan Dar   Department of Anesthesiology and   Intensive Care, Acharya shri Chander  College of Medical sciences and   Hospital, Jammu, Jammu and Kashmir,   180017, India   email mohdreidwandar@rediffmail.co mAbstract:  Older people undergoing any surgery have a higher incidence of morbidity  and  mortality, resulting from a decline in physiological reserves, associated  comorbidities,   polypharmacy, cognitive dysfunction, and frailty.",Non-OADS,/arxiv_data1/oa_pdf/ea/40/lra-8-101.PMC4671810.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/ea/40/lra-8-101.PMC4671810.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/40/lra-8-101.PMC4671810.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a5/43/opth-9-2277.PMC4671811.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 2277–2283Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2277Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8749 9subthreshold micropulse yellow laser treatment  for nonresolving central serous chorioretinopathy ahmed hosni abd elhamid Department of Ophthalmology,   ain shams University, Cairo, egyptPurpose:  To report the efficacy and safety of micropulse 577 nm yellow laser in the treatment  of nonresolving central serous chorioretinopathy (CSC) cases.",Non-OADS,/arxiv_data1/oa_pdf/a5/43/opth-9-2277.PMC4671811.pdf
"For example, Correspondence: ahmed hosni  abd elhamid Department of Ophthalmology,  ain shams University, abbasia,  Cairo, egypt email hosni712000@yahoo.co mJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Abd Elhamid Running head recto: Subthreshold micropulse yellow laser for nonresolving CSC DOI: http://dx.doi.org/10.2147/OPTH.S87499",Non-OADS,/arxiv_data1/oa_pdf/a5/43/opth-9-2277.PMC4671811.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a5/43/opth-9-2277.PMC4671811.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/43/opth-9-2277.PMC4671811.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/91/opth-9-2257.PMC4671812.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 2257–2261Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2257Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9574 8Macular sensitivity after half-dose verteporfin  photodynamic therapy in central serous  chorioretinopathy Thuss sanguansak Prapapan Pitujaturont Y osanan Y ospaiboon suthasinee sinawat Tanapat ratanapakorn Chavakij Bhoomibunchoo Department of Ophthalmology,   Faculty of Medicine, KKU eye Center,   Khon Kaen University, Khon Kaen,   ThailandObjective:  To study the macular sensitivity after half-dose verteporfin photodynamic therapy in  patients with resolved central serous chorioretinopathy using the automated static perimeter.",Non-OADS,/arxiv_data1/oa_pdf/6f/91/opth-9-2257.PMC4671812.pdf
"In some CSCR Correspondence: Yosanan Yospaiboon Department of Ophthalmology, Faculty  of Medicine, KKU eye Center, Khon  Kaen University, 123 Mitraparb highway,  Khon Kaen 40002, Thailand Tel +66 43 348 383 email yosanan@kku.ac.t h Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Sanguansak et al Running head recto: Retinal sensitivity after half-dose photodynamic therapy DOI: http://dx.doi.org/10.2147/OPTH.S95748",Non-OADS,/arxiv_data1/oa_pdf/6f/91/opth-9-2257.PMC4671812.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/6f/91/opth-9-2257.PMC4671812.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/91/opth-9-2257.PMC4671812.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/03/d3/ott-8-3585.PMC4671813.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3585–3593OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3585Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9283 2inhibitive effects of 15-deoxy- Δ12,14-prostaglandin  J2 on hepatoma-cell proliferation through reactive  oxygen species-mediated apoptosis Kan chen,1 Weiqi Dai,1 Fan  Wang,1 Yujing Xia,1 Jingjing  li,1 sainan li,1 T ong liu,1  rong Zhang,2 Jianrong  Wang,2 Wenxia lu,2 Yuqing  Zhou,3 Qin Yin,3 Yuanyuan  Zheng,1 huerxidan  abudumijiti,1 rongxia  chen,1 Jie lu,1 Yingqun  Zhou,1 chuanyong guo1 1Department of gastroenterology,   shanghai T enth People’s hospital,   Tongji University school of  Medicine, shanghai, 2Department of  gastroenterology, shanghai Tenth  People’s hospital, Tongji University  school of Medicine, First clinical  Medical college of nanjing Medical  University, nanjing, 3Department of  gastroenterology, shanghai Tenth  People’s hospital, Tongji University  school of Medicine, First affiliated  hospital of soochow University,   suzhou, People’s republic of chinaObjective:  15-Deoxy- Δ12,14-prostaglandin J2 (15d-PGJ2) induces reactive oxygen species  (ROS)-mediated apoptosis in many malignant cells, which has not been studied in hepatoma  cells.",Non-OADS,/arxiv_data1/oa_pdf/03/d3/ott-8-3585.PMC4671813.pdf
"It was originally discovered as an endogenous lipid mediator and ligand  for the nuclear receptor PPAR γ, which regulates lipid and carbohydrate metabolism,  adipocyte differentiation, and inflammation.8,9 Early studies indicated that 15d-PGJ2  can inhibit cancer cell proliferation and induce apoptosis through a PPAR γ-dependent  pathway.10–12 However, recent evidence indicates that the induction of apoptosis and  inhibition of cancer cell proliferation by 15d-PGJ2 are attributable to generation of  reactive oxygen species (ROS) rather than activation of PPAR γ.13–15 15d-PGJ2 contains  an α,β-unsaturated carbonyl group that acts as an electrophilic center, and thus it can  react with and modify nucleophiles, such as glutathione and thioredoxin, resulting in correspondence: Yingqun Zhou;  chuanyong guo Department of gastroenterology,  shanghai Tenth People’s hospital, Tongji  University school of Medicine, 301  Yanchang Middle road, Zhabei, shanghai  200072, People’s republic of china Tel +86 21 6630 2535 Fax +86 21 6630 3983 email yqzh02@163.co m;  guochuanyong@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Chen et al Running head recto: 15d-PGJ2 in HCC associated with ROS DOI: http://dx.doi.org/10.2147/OTT.S92832",Non-OADS,/arxiv_data1/oa_pdf/03/d3/ott-8-3585.PMC4671813.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/03/d3/ott-8-3585.PMC4671813.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/d3/ott-8-3585.PMC4671813.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b5/b0/ott-8-3561.PMC4671814.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3561–3564OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3561Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9076 6a metastatic colon adenocarcinoma harboring  BRAF V600e has a durable major response to  dabrafenib/trametinib and chemotherapy Casey B Williams1,* Caitlin McMahon2,* siraj M ali2 Mark abramovitz1 Kirstin a Williams1 Jessica Klein1 Heidi McKean1 roman Yelensky2 Thomas J George Jr3 Julia a elvin2 salil soman4 Doron Lipson2 Juliann Chmielecki2 Deborah Morosini2 Vincent a Miller2 philip J stephens2 Jeffrey s ross2,5 Brian Leyland-Jones1 1avera Cancer Institute, sioux Falls,   sD, Usa; 2Foundation Medicine, Inc.,   Cambridge, M a, Usa; 3University  of Florida College of Medicine,   Gainesville, FL, Usa; 4Beth Israel  Deaconess Medical Center, Boston,   Ma, Usa; 5albany Medical College,   albany, NY, Usa *These authors contributed equally  to this workAbstract:  The subset of metastatic colorectal adenocarcinomas that harbor BRAF  V600E  mutations are aggressive tumors with significantly shortened survival and limited treatment  options.",Non-OADS,/arxiv_data1/oa_pdf/b5/b0/ott-8-3561.PMC4671814.pdf
"Restaging scans 6 months later showed new enlarged lymph nodes as well as new Correspondence: Brian Leyland-Jones Department of Molecular and  experimental Medicine, avera Medical  Group, 1000 e 23rd st, suite 200,  sioux Falls, sD 57105, Usa Tel +1 605 322 6900 Fax +1 605 322 6901 email bleylandj@aol.co m Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2015 Volume: 8 Running head verso: Williams et al Running head recto: BRAF  V600E CRC response DOI: http://dx.doi.org/10.2147/OTT.S90766",Non-OADS,/arxiv_data1/oa_pdf/b5/b0/ott-8-3561.PMC4671814.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b5/b0/ott-8-3561.PMC4671814.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/b0/ott-8-3561.PMC4671814.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/96/d7/opth-9-2251.PMC4671815.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 2251–2256Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2251Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9654 0real-world assessment of diquafosol in dry eye   patients with risk factors such as contact  lens, meibomian gland dysfunction, and  conjunctivochalasis: subgroup analysis from  a prospective observational study Masahiko Yamaguchi1 Takeshi nishijima2 Jun shimazaki3 etsuko Takamura4 norihiko Y okoi5 hitoshi Watanabe6 Yuichi Ohashi1 1Department of Ophthalmology,   ehime University school of  Medicine, ehime, 2Department  of safety Vigilance group, santen  Pharmaceutical Co., ltd., Osaka,   3Department of Ophthalmology,   Tokyo Dental College, ichikawa  general hospital, Chiba, 4Department  of Ophthalmology, school of  Medicine, Tokyo Women’s Medical  University, T okyo, 5Department of  Ophthalmology, Kyoto Prefectural  University of Medicine, Kyoto,   6Department of Ophthalmology,   Kansai rosai hospital, hyogo,  JapanPurpose:  To evaluate the efficacy and safety of diquafosol (DQS) ophthalmic solution in dry  eye (DE) patients wearing contact lenses (CLs) or with concomitant meibomian gland dysfunc - tion (MGD) or conjunctivochalasis in a real-world setting.",Non-OADS,/arxiv_data1/oa_pdf/96/d7/opth-9-2251.PMC4671815.pdf
"Recently, a more Correspondence: Takeshi nishijima santen Pharmaceutical Co., ltd., 4-20  Ofukacho Kita-ku, Osaka 530-8552, Japan Tel +81 6 4802 9330 Fax +81 6 6359 3843 email takeshi.nishijima@santen.co.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Y amaguchi et al Running head recto: Efficacy and safety of diquafosol in dry eye patients DOI: http://dx.doi.org/10.2147/OPTH.S96540",Non-OADS,/arxiv_data1/oa_pdf/96/d7/opth-9-2251.PMC4671815.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/96/d7/opth-9-2251.PMC4671815.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/96/d7/opth-9-2251.PMC4671815.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/85/32/opth-9-2285.PMC4671816.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 2285–2290Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2285Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9358 0Visual outcome and efficacy of conjunctival  autograft, harvested from the body of pterygium  in pterygium excision Vipul Bhandari Chandan latha rao sri ganesh sheetal Brar Department of Cornea, nethradhama  superspeciality eye hospital,   Bangalore, indiaPurpose:  To evaluate the efficacy of conjunctival autograft after the pterygium excision with  fibrin adhesive using conjunctiva over the pterygium.",Non-OADS,/arxiv_data1/oa_pdf/85/32/opth-9-2285.PMC4671816.pdf
"The pterygium surgery with  conjunctival autograft remains the gold standard with less incidence of recurrence  after its initial description in 1985.1 Recurrence rates consistently reported are in the  range of 5%–10%.2 The recent technique is to use tissue fibrin glue for anchoring the  graft to the bed.Correspondence: Vipul Bhandari Department of Cornea, nethradhama  superspeciality eye hospital, 256/14  Kanakapura Main road, 7th Block,  Jayangar, 560070, Bangalore, india email drvipulbhandari@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Bhandari et al Running head recto: Pterygium excision with self-conjunctival autograft – a novel technique DOI: http://dx.doi.org/10.2147/OPTH.S93580",Non-OADS,/arxiv_data1/oa_pdf/85/32/opth-9-2285.PMC4671816.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/85/32/opth-9-2285.PMC4671816.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/85/32/opth-9-2285.PMC4671816.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/84/e4/ott-8-3595.PMC4671817.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3595–3601OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3595Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9146 9Prognostic value of programmed cell death-ligand  1 expression in patients with non-small-cell lung  cancer: evidence from an updated meta-analysis anyuan Zhong1,* Yufei Xing1,* Xue Pan1,* Minhua shi1 huajun Xu2 1Department of respiratory Diseases,   the second affiliated hospital  of soochow University, suzhou,   2Department of Otolaryngology,   shanghai Jiao Tong University  affiliated sixth People’s hospital,   Otolaryngology institute of shanghai  Jiao T ong University, shanghai,   People’s  republic of china *These authors contributed equally  to this workBackground:  The association between the expression of programmed cell death-ligand 1  (PD-L1) and survival in patients with non-small-cell lung cancer (NSCLC) is controversial.",Non-OADS,/arxiv_data1/oa_pdf/84/e4/ott-8-3595.PMC4671817.pdf
"Y et, the   development of drugs aimed at these targets has been hampered by drug resistance  and a high mutation rate of the relevant genes.correspondence: Minhua shi Department of respiratory Diseases, the  Second Affiliated Hospital of Soochow  University, 1055 sanxiang road, suzhou  215004, People’s republic of china email shiminhua@163.co m  huajun Xu Department of Otolaryngology, shanghai  Jiao Tong University Affiliated Sixth  People’s hospital, Otolaryngology  institute of shanghai Jiao Tong University,  600 Yishan road, shanghai 200233,  People’s republic of china email sunnydayxu2010@sjtu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Zhong et al Running head recto: Prognostic role of programmed cell death-ligand 1 expression in NSCLC DOI: http://dx.doi.org/10.2147/OTT.S91469",Non-OADS,/arxiv_data1/oa_pdf/84/e4/ott-8-3595.PMC4671817.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/84/e4/ott-8-3595.PMC4671817.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/e4/ott-8-3595.PMC4671817.pdf
"While new, promising strategies such as FIRM and ganglionatedplexi ablation are on the, they are still associated with procedure-related risks including cardiac perfora- tion, valvular injury, esophageal-atrial ﬁstula formation, andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.05.001 1880-4276/ &2015 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/78/ee/main.PMC4672029.pdf
J Am Coll Cardiol 2013;61:1177 –82.http://dx.doi.org/ 10.1016/j.jacc.2012.11.060 .,Non-OADS,/arxiv_data1/oa_pdf/78/ee/main.PMC4672029.pdf
The pigs were housed in individual cages (1.25 m3) underContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.05.004 1880-4276/ &2015 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/6f/fe/main.PMC4672030.pdf
"The right atrium was very thin, with anContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.05.002 1880-4276/ &2015 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/a2/14/main.PMC4672031.pdf
"However, these strategies runContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.04.007 1880-4276/ &2015 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/57/8a/main.PMC4672032.pdf
2 (C) and (D)].Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.04.005 1880-4276/ &2015 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/a2/35/main.PMC4672034.pdf
J Arrhythmia 2014. http://dx.doi.org/10.1016/j.joa.2014.07.004 .,OADS,/arxiv_data1/oa_pdf/f7/82/main.PMC4672035.pdf
Wien KlinWochenschr 2014;126(9 –10):270 –7.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.04.009 1880-4276/ &2015 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/f7/82/main.PMC4672035.pdf
"As the standard ECG leads are not speciﬁcally designed to record atrial activity, the multichannel andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.05.003 1880-4276/ &2015 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/20/d6/main.PMC4672036.pdf
At 16 min of aContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.04.006 1880-4276/ &2015 Japanese Heart Rhythm Society.,OADS,/arxiv_data1/oa_pdf/54/8c/main.PMC4672037.pdf
"Moreover, noContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.04.004 1880-4276/ &2015 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/b0/88/main.PMC4672038.pdf
Available from: 〈http://www.pmda.go.jp/english/service/pdf/ mhlw/20110812-1-prazaxa_capsules.pdf 〉; 2011 [accessed 12.08.11].,Non-OADS,/arxiv_data1/oa_pdf/b0/88/main.PMC4672038.pdf
2 illustrates an example of RNRVAS in our patient in DDD mode that was triggered by lack of atrial capture (subthreshold output) with underlying high pacing thresholds.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.04.010 1880-4276/ &2015 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/03/69/main.PMC4672072.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/38/main.PMC4672073.pdf
"After admission to our center, herContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2015.06.001 2213-0489/ &2015 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/db/38/main.PMC4672073.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/38/main.PMC4672073.pdf
"These procedures would have the bene ﬁt of lead placement in an extended area, regardless of coronary vein location, with better threshold and avoidance of twitching.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.06.005 1880-4276/ &2015 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/7f/ad/main.PMC4672074.pdf
reported [11] that atrial ﬁbrosis as de ﬁned by delayed enhanced magnetic resonance imaging is associated with slower and organized electrical activityContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.07.001 1880-4276/ &2015 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/be/89/main.PMC4672075.pdf
Despite recent technologicalContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.06.001 1880-4276/ &2015 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/f4/0e/main.PMC4672076.pdf
"A total of 114,334 patients (59,243 men and 55,091 women) who had undergone ECG recordings between January 1983 and July 2010 were included in this database, with a total ofContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.06.008 1880-4276/ &2015 Japanese Heart Rhythm Society.",OADS,/arxiv_data1/oa_pdf/bc/8d/main.PMC4672077.pdf
Elective replacement of the device was performed in 2009 and again in March 2014; the leads were performing well and were regularlyContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.06.002 1880-4276/ &2015 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/97/b7/main.PMC4672078.pdf
"Supporting information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.joa.2015.06.002 .References [1]Nayak HM, Verdino RJ, Russo AM, et al.",OADS,/arxiv_data1/oa_pdf/97/b7/main.PMC4672078.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/91/main.PMC4672079.pdf
The duration of response using imatinib was approximately 4 months prior to disease progressionContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2015.07.002 2213-0489/ &2015 The Authors.,OADS,/arxiv_data1/oa_pdf/70/91/main.PMC4672079.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/91/main.PMC4672079.pdf
WeContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of ArrhythmiaContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.06.004 1880-4276/ &2015 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/81/d5/main.PMC4672080.pdf
J Cardiovasc Electro- physiol 2013 .http://dx.doi.org/10.1111/jce.12130 [E-pub ahead of print].,Non-OADS,/arxiv_data1/oa_pdf/81/d5/main.PMC4672080.pdf
Despite the remote location of the earliest activation sites in the RV and LV (theContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.06.003 1880-4276/ &2015 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/f4/e5/main.PMC4672081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/75/main.PMC4672090.pdf
"Case report A 38-year old woman presented at the Department of Hema- tology, Lund University hospital in January 2011 with microcyticContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2015.10.001 2213-0489/ &2015 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/5c/75/main.PMC4672090.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/75/main.PMC4672090.pdf
" Annals of Surgical Treatment and Research 287pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.6.287 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Validation of the Korean version of the thyroid cancer- specific quality of life questionnaire Youjin Jeong, Jaekyung Choi, Ah-Leum Ahn, Eun-Jung Oh, Hee-Kyung Oh, Dong-Yung Cho,   Hyuk-Jung Kweon, Kyoung Sik Park1 Departments of Family Medicine and 1Surgery, Research Institute of Medical Science, Konkuk University Medical Center, Konkuk  University School of Medicine, Seoul, Korea INTRODUCTION An increasing incidence of thyroid cancer has been reported  both in Korea and worldwide during the past decades [1,2].",Non-OADS,/arxiv_data1/oa_pdf/c4/2b/astr-89-287.PMC4672091.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/2b/astr-89-287.PMC4672091.pdf
"1 2 3 4   Youjin Jeong, et al: Validation of the Korean version of THYCA-QoL Ann Surg Treat Res 2015;89(6):287-294 http://dx.doi.org/10.4174/astr.2015.89.6.287",Non-OADS,/arxiv_data1/oa_pdf/c4/2b/astr-89-287.PMC4672091.pdf
" Annals of Surgical Treatment and Research 295pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.6.295 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Clinicopathological characteristics and treatment  outcomes of 38 cases of primary thyroid lymphoma:  a multicenter study Young Jun Chai1,2,*, Jun Hyun Hong3,*, Do Hoon Koo4, Hyeong Won Yu2,3, Joon-Hyop Lee2,5, Hyungju Kwon2,3,  Su-jin Kim2,3, June Young Choi2,5, Kyu Eun Lee2,3 1Department of Surgery, Seoul National University Boramae Medical Center, Seoul, 2Cancer Research Institute, Seoul National  University College of Medicine, Seoul, 3Department of Surgery, Seoul National University Hospital, Seoul National University  College of Medicine, Seoul, 4Department of Surgery, Inje University Haeundae Paik Hospital, Inje University College of Medicine,  Busan, 5Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seongnam, Korea INTRODUCTION Primary thyroid lymphoma (PTL) is defined as a lymphoma developing in the thyroid gland with or without involvement  of regional lymph nodes or other visceral tissues [1].",Non-OADS,/arxiv_data1/oa_pdf/c5/73/astr-89-295.PMC4672092.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/73/astr-89-295.PMC4672092.pdf
"300pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.6.300 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE The role of preoperative ultrasonography, computed  tomography, and sestamibi scintigraphy localization in secondary hyperparathyroidism Jae Bok Lee, Woo Young Kim, Yu-Mi Lee1 Department of Surgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, 1Department of  Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea INTRODUCTION Secondary hyperparathyroidism (sHPT) is an intractable  disease of patients with chronic kidney disease (CKD),  leading to substantial morbidity or mortality through severe osteodystrophy and vascular calcification [1,2].",Non-OADS,/arxiv_data1/oa_pdf/1f/8a/astr-89-300.PMC4672093.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/8a/astr-89-300.PMC4672093.pdf
"306pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.6.306 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Modified intracorporeal gastroduodenostomy in totally  laparoscopic distal gastrectomy for gastric cancer:  early experience Chang Eun Jang, Sang-Il Lee Department of Surgery, Chungnam National University Hospital, Daejeon, Korea INTRODUCTION Stomach cancer is one of the most common malignancies in  Korea.",Non-OADS,/arxiv_data1/oa_pdf/48/c3/astr-89-306.PMC4672094.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/c3/astr-89-306.PMC4672094.pdf
" Annals of Surgical Treatment and Research 313pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.6.313 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Transanal tube placement for prevention of anastomotic  leakage following low anterior resection for rectal cancer: a systematic review and meta-analysis Gi Won Ha, Hyun Jung Kim1, Min Ro Lee Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute of Chonbuk National  University Hospital, Jeonju, 1Institute for Evidence-Based Medicine, Department of Preventive Medicine, Korea University College  of Medicine, Seoul, Korea INTRODUCTION Improvements in surgical techniques and perioperative  management have increased the use of low anterior resection  (LAR) for the treatment of rectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/99/bc/astr-89-313.PMC4672095.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/bc/astr-89-313.PMC4672095.pdf
" Annals of Surgical Treatment and Research 319pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.6.319 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE National trends for the treatment of peripheral arterial  disease in Korea between 2004 and 2013 Youn Young Park, Jin Hyun Joh1, Sang-Ah Han1, Sang Hyun Kim, Sungsin Cho, Ho-Chul Park1, Hyung Joon Ahn2 Department of Surgery, Graduate School, Kyung Hee University, Seoul, 1Department of Surgery, Kyung Hee University Hospital at  Gangdong, Kyung Hee University School of Medicine, Seoul, 2Department of Surgery, Kyung Hee University Medical Center,  Kyung Hee University School of Medicine, Seoul, Korea INTRODUCTION Peripheral arterial disease (PAD), a common vascular problem,  carries an increased risk of cardiovascular morbidity and mor - t ality [1].",Non-OADS,/arxiv_data1/oa_pdf/e7/cb/astr-89-319.PMC4672096.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/cb/astr-89-319.PMC4672096.pdf
" Annals of Surgical Treatment and Research 325pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.6.325 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Analgesic efficacy of bilateral superficial and deep  cervical plexus block in patients with secondary hyperparathyroidism due to chronic renal failure Yinglan Su, Zhongjun Zhang, Qiuli Zhang, Yaoxian Zhang, Zhanli Liu Department of Anesthesiology, The Second Clinical Medical College of JiNan University, Shenzhen People's Hospital, Shenzhen,  China INTRODUCTION Secondary hyperparathyroidism (SHPT) indicates excessive  secretion of parathyroid hormone (PTH) by the parathyroid  glands in response to hypocalcemia and associated hypertrophy of the glands [1].",Non-OADS,/arxiv_data1/oa_pdf/ef/8e/astr-89-325.PMC4672097.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/8e/astr-89-325.PMC4672097.pdf
"330pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.6.330 Annals of Surgical Treatment and ResearchCASE REPORT Result of using a biologic collagen implant (Permacol) for  mesenteric defect repair after excision of a huge mesenteric lymphangioma in a child Soo-Hong Kim, Kyung-Chul Yoon1, Woohyung Lee1, Hyun-Young Kim1, Sung-Eun Jung1 Department of Pediatric Surgery, Pusan National University Yangsan Hospital, Yangsan, 1Department of Pediatric Surgery, Seoul  National University Children’s Hospital, Seoul, Korea INTRODUCTION Lymphangiomas are usually located in the head and neck  area as well as the abdominal wall, but rarely in the mesentery  [1].",Non-OADS,/arxiv_data1/oa_pdf/3c/fc/astr-89-330.PMC4672098.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/fc/astr-89-330.PMC4672098.pdf
"334pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.6.334 Annals of Surgical Treatment and ResearchCASE REPORT Neonatal vitelline vein aneurysm with thrombosis:  prompt treatment should be needed Soo-Hong Kim, Hyeong Won Yu1, Hyun-Young Kim1, Heui Seung Jo2 Department of Pediatric Surgery, Pusan National University Yangsan Hospital, Yangsan, 1Department of Pediatric Surgery, Seoul  National University Children's Hospital, Seoul, 2Department of Pediatrics, CHA Bundang Medical Center, CHA University,  Seongnam, Korea INTRODUCTION Vitelline veins are a pair of embryonic structures that de - v elop portal vein systems, including splenic vein, superior  mesenteric vein, and portal vein.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/astr-89-334.PMC4672099.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/astr-89-334.PMC4672099.pdf
2011;  Retreived from http://www.forbes.com/ sites/sportsmoney/2011/07/22/CrossFit  s-relationship-with-reebok-enhances-its- financial-and-commercial-credibility/   6.,Non-OADS,/arxiv_data1/oa_pdf/bc/c2/JBS-32-1174771.PMC4672163.pdf
from http://journal.CrossFit .,Non-OADS,/arxiv_data1/oa_pdf/bc/c2/JBS-32-1174771.PMC4672163.pdf
2010; Retrieved  from http://cgsc.cdmhost.com/cdm/ singleitem/collection/p124201coll2/ id/580/rec/113.,OADS,/arxiv_data1/oa_pdf/bc/c2/JBS-32-1174771.PMC4672163.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)AICD and cancer immunotherapy K Cao et al 5970 Oncogene (2015) 5960 –5970 © 2015 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/c8/b4/onc201546a.PMC4672172.pdf
Availability : The implementations are available at: https://sites.google.com/site/postechdm/research/ implementation/orgos.Contact : sael@cs.stonybrook.edu or hwanjoyu@postech.ac.kr Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/24/b2/btv409.PMC4672174.pdf
"3653 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/b2/btv409.PMC4672174.pdf
"For clinical features of the BRCA, histolo-gical type, estrogen status, progesterone status and margin status wereused (the descriptions of the clinical features are provided at https://tcga-data.nci.nih.gov/docs/dictionary/).",OADS,/arxiv_data1/oa_pdf/24/b2/btv409.PMC4672174.pdf
"Frequently,  it is desirable to determine photosynthetic behaviour despite  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which  permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.© The Author 2015.",Non-OADS,/arxiv_data1/oa_pdf/3b/b8/erv065.PMC4672191.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/c8/iev084.PMC4672207.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/b7/iev099.PMC4672208.pdf
"cubeba , which were all purchased from Aladdin reagent (Shanghai) co. Ltd. (http://www.al addin-e.com/), were assayed on 10th- instar T. molitor with method 2.5.",OADS,/arxiv_data1/oa_pdf/7f/97/iev093.PMC4672209.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/f6/iev100.PMC4672210.pdf
The theoretical iso-electric point ( pI) and molecular weight (Mw) were calculated with the Compute pI/Mw (http://web.expasy.org/compute_pi/) (Gasteiger et al.,OADS,/arxiv_data1/oa_pdf/47/f6/iev100.PMC4672210.pdf
The signal-peptides of SeCYP9A11 and SeCPR were predicted by the SignalP 4.0 server (http://www.cbs.dtu.dk/services/SignalP/) ( Petersen et al.,OADS,/arxiv_data1/oa_pdf/47/f6/iev100.PMC4672210.pdf
"The secondary structure, binding domains, and catalytic residues of SeCYP9A11 and SeCPR were predicted by PHYRE2 Protein Fold Recognition Server (http://www.sbg.bio.ic.ac.uk/phyre2/html/) ( Kelley and Sternberg 2009 ), and the conserved domains were searched on the NCBI website (http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi)(Marchler-Bauer et al.",OADS,/arxiv_data1/oa_pdf/47/f6/iev100.PMC4672210.pdf
The transmembrane domains were ana- lyzed by the TMHMM Server 2.0 (http://www.cbs.dtu.dk/services/ TMHMM-2.0/) ( Krogh et al.,OADS,/arxiv_data1/oa_pdf/47/f6/iev100.PMC4672210.pdf
/ Kyte & Doolittle with ProtScale (http://web.expasy.org/protscale/) (Gasteiger et al.,OADS,/arxiv_data1/oa_pdf/47/f6/iev100.PMC4672210.pdf
The phylogenetic tree was con-structed by MEGA 5.0 using the default settings and neighbor-joining method (http://www.megasoftware.net/) ( Tamura et al.,OADS,/arxiv_data1/oa_pdf/47/f6/iev100.PMC4672210.pdf
The corresponding PDB file of the highest ranking model comparing to the R. norvegicus CPR was modified and labeled using UCSF Chimera software (http://www.cgl.ucsf.edu/chimera/) ( Pettersen et al.,OADS,/arxiv_data1/oa_pdf/47/f6/iev100.PMC4672210.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/93/iev091.PMC4672211.pdf
"Barcode data were entered into the BOLD database ( Ratnasingham and Hebert 2007 , http://www.boldsystems.org/).",OADS,/arxiv_data1/oa_pdf/59/c3/iev098.PMC4672213.pdf
"Every genetically distinguishable taxon obtained a unique BarcodeIndex Number (BIN, Ratnasingham and Hebert 2013 ) within ‘BoldSystems’ (http://www.boldsystems.org/), enabling an allocation of trait information to species in advance of their formal taxonomic descrip-tion.",OADS,/arxiv_data1/oa_pdf/59/c3/iev098.PMC4672213.pdf
(http://www.caterpillars.org) (accessed 10 July 2015).,Non-OADS,/arxiv_data1/oa_pdf/59/c3/iev098.PMC4672213.pdf
(http://www.caterpillars.org) (accessed 10 July 2015).,Non-OADS,/arxiv_data1/oa_pdf/59/c3/iev098.PMC4672213.pdf
(http://othes.univie.ac.at/32993/) (accessed 14 July 2015).,Non-OADS,/arxiv_data1/oa_pdf/59/c3/iev098.PMC4672213.pdf
Sequences were analyzed by the DNAMAN software version 6.0 and the vector sequence removed using the Vector Search and Trimtool in Sequin on the Genbank website (http://www.ncbi.nlm.nih.gov/ tools/vecscreen) for alignment.,OADS,/arxiv_data1/oa_pdf/6f/5b/iev104.PMC4672216.pdf
http://www.cab-direct.org/abstracts/20113409552.html.,Non-OADS,/arxiv_data1/oa_pdf/6f/5b/iev104.PMC4672216.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/86/iev109.PMC4672219.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/50/iev097.PMC4672220.pdf
"(http://www.extension.iastate.edu/CropNews/(2010)/0513barnhart.htm).Carlson, J. D., M. E. Whalon, D. A. Landis, and S. H. Gage.",OADS,/arxiv_data1/oa_pdf/f6/50/iev097.PMC4672220.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/42/iev102.PMC4672221.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/f7/omv065.PMC4672230.pdf
URL: http://www.who.int/growthref/who2007_height_for_age/en .,OADS,/arxiv_data1/oa_pdf/7d/f7/omv065.PMC4672230.pdf
URL: http://www.who.int/growthref/who2007_height_for_age/en .,OADS,/arxiv_data1/oa_pdf/7d/f7/omv065.PMC4672230.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/bf/omv067.PMC4672235.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/c9/omv066.PMC4672237.pdf
Available from: http://www.who.int/tobacco/global_report/2011/en/.,Non-OADS,/arxiv_data1/oa_pdf/5a/af/IJMPO-36-176.PMC4672461.pdf
Available from: http://www.bloomberg.com/apps/news?pid=newsarchive&sid=ay63Vy1ALVI8.,Non-OADS,/arxiv_data1/oa_pdf/5a/af/IJMPO-36-176.PMC4672461.pdf
Available from:  http://www.oas.samhsa.gov/NSDUH/2k5nsduh/tabs/Sect2peTabs37to41.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5a/af/IJMPO-36-176.PMC4672461.pdf
Available from: http://www.ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5a/af/IJMPO-36-176.PMC4672461.pdf
Available from: http://www.mohfw.,Non-OADS,/arxiv_data1/oa_pdf/5a/af/IJMPO-36-176.PMC4672461.pdf
Available from:  http://www.searo.who.int/LinkFiles/Regional_Tobacco_ Surveillance_System_GATS_India.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5a/af/IJMPO-36-176.PMC4672461.pdf
Available from:  http://www.pdf.usaid.gov/pdf_docs/PNADK385.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5a/af/IJMPO-36-176.PMC4672461.pdf
Available from: http://www.apps.who.int/iris/bitstream/10665/37510/1/9241561475_eng.pdf?ua=1.,OADS,/arxiv_data1/oa_pdf/5a/af/IJMPO-36-176.PMC4672461.pdf
Available from: http://www.monographs.iarc.fr/ENG/Monographs/vol85/mono85.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5a/af/IJMPO-36-176.PMC4672461.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/ce/main.PMC4672469.pdf
http://dx.doi.org/10.1016/j.joca.2015.06.010 1063-4584/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/ce/main.PMC4672469.pdf
This is an open access article under the CC BY-NC-ND l icense (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Osteoarthritis and Cartilage 23 (2015) 2094 e2101,Non-OADS,/arxiv_data1/oa_pdf/8d/ce/main.PMC4672469.pdf
"Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: S. A. Enam,  MD  Aga Kahn University; Karachi,  Sindh, Pakistan © 2015 Surgical Neurology International | Published by Wolters Kluwer - MedknowS628Abstract Background:  Esthesioneuroblastoma is a locally aggressive cancer of the nasal  cavity.",Non-OADS,/arxiv_data1/oa_pdf/10/01/SNI-6-628.PMC4672577.pdf
"http://surgicalneurologyint.com/Cranial-and-spinal-leptomeningeal-dissemination-in- esthesioneuroblastoma:-T wo-reports-of-distant-central-nervous-system-metastasis- and-rationale-for-treatment/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/10/01/SNI-6-628.PMC4672577.pdf
"Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: S. A. Enam,  MD  Aga Kahn University; Karachi,  Sindh, Pakistan © 2015 Surgical Neurology International | Published by Wolters Kluwer - MedknowS640Abstract Background:  Cushing’s disease is a condition rarely encountered during  pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/6c/3a/SNI-6-640.PMC4672578.pdf
"http://surgicalneurologyint.com/Surgical-management-of-recurrent-Cushing’s- disease-in-pregnancy:-A-case-report/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/6c/3a/SNI-6-640.PMC4672578.pdf
"Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: S. A. Enam,  MD  Aga Kahn University; Karachi,  Sindh, Pakistan © 2015 Surgical Neurology International | Published by Wolters Kluwer - MedknowS633Abstract Background: Fourth ventricle mass lesion in neurosarcoidosis is very rare and  difficult to be diagnosed pathologically.",Non-OADS,/arxiv_data1/oa_pdf/34/2d/SNI-6-633.PMC4672579.pdf
"© 2015 Surgical Neurology International | Published by Wolters Kluwer - MedknowSurgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: S. A. Enam,  MD  Aga Kahn University; Karachi,  Sindh, PakistanS637A case of metastatic brain tumor in the perfusion territory of  superficial temporal artery‑middle cerebral artery anastomosis Yutaka Fujioka1,2, Nobuhiro Hata1, Yuhei Sangatsuda1, Daisuke Inoue1,3, Sei Haga4, Shinji Nagata1 1Department of Neurosurgery, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, 3Department of Neurosurgery, Aso Iizuka  Hospital, Iizuka, 4Department of Neurosurgery, Japanese Labour Health Welfare Organization, Kyushu Rosai Hospital, Fukuoka, 2Department of Neurosurgery,  Shimonoseki Municipal Hospital, Shimonoseki, Yamaguchi, Japan E‑mail:  Yutaka Fujioka ‑ yutakafujioka19830816@yahoo.co.jp; *Nobuhiro Hata ‑ hatanobu@kyumed.jp; Yuhei Sangatsuda ‑ y.sangatsuda@gmail.com;   Daisuke Inoue ‑ dinoue@ns.med.kyushu‑u.ac.jp; Sei Haga ‑ hagasei5501@gmail.com; Shinji Nagata ‑ snagata@kyumed.jp   *Corresponding author Received: 13 July 15   Accepted: 11 September 15  Published: 25 November 15 Abstract Background:  We report a rare case of metastatic tumor in the perfusion territory  of superficial temporal artery‑middle cerebral artery (STA‑MCA) anastomosis.",Non-OADS,/arxiv_data1/oa_pdf/b0/45/SNI-6-637.PMC4672580.pdf
"http://surgicalneurologyint.com/A-case-of-metastatic-brain-tumor-in-the-perfusion- territory-of-superficial-temporal-artery-middle-cerebral-artery-anastomosis/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/b0/45/SNI-6-637.PMC4672580.pdf
"Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: S. A. Enam,  MD  Aga Kahn University; Karachi,  Sindh, Pakistan © 2015 Surgical Neurology International | Published by Wolters Kluwer - MedknowS623Abstract Background:  Clival giant cell tumors (GCTs) are extremely rare with only eight  cases reported to date, and malignant transformation is quite rare.",Non-OADS,/arxiv_data1/oa_pdf/15/f6/SNI-6-623.PMC4672581.pdf
"http://surgicalneurologyint.com/Giant-cell-tumors-of-the-clivus:-Case-report-and- literature-review/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/15/f6/SNI-6-623.PMC4672581.pdf
"[52] In the most recent database  (miRBase21 release, http://microrna.sanger.ac.uk), over 28,000 mature miRNAs were identified in over 150 species, including 2,000 miRNAs in the human genome.",OADS,/arxiv_data1/oa_pdf/36/35/EUS-4-276.PMC4672583.pdf
http://healthycanadians.gc.ca/science-research- sciences-recherches/data-donnees/ctads-ectad/index-eng.php.,OADS,/arxiv_data1/oa_pdf/54/dc/10.1177_2150131915604827.PMC4672601.pdf
E-mail  address:  torresj@iname.com  (J.R.  Torres).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2014.12.0022214-2509/ /C223 2015  Published  by  Elsevier  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/8e/46/main.PMC4672604.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8e/46/main.PMC4672604.pdf
http://dx.doi.org/10.1128/JVI.,Non-OADS,/arxiv_data1/oa_pdf/8e/46/main.PMC4672604.pdf
http://dx.doi.org/10.1016/ S0140-6736(14)60185-9 .,OADS,/arxiv_data1/oa_pdf/8e/46/main.PMC4672604.pdf
http://dx.doi.org/10.1017/S0950268808001167 .,Non-OADS,/arxiv_data1/oa_pdf/8e/46/main.PMC4672604.pdf
http://dx.doi.org/ 10.1097/CCM.0b013e318183f2d2 .,Non-OADS,/arxiv_data1/oa_pdf/8e/46/main.PMC4672604.pdf
[8]  PAHO  http://www.paho.org/hq/index.,Non-OADS,/arxiv_data1/oa_pdf/8e/46/main.PMC4672604.pdf
Venezuelan  Ministry  of  Health  http://www.mpps.,Non-OADS,/arxiv_data1/oa_pdf/8e/46/main.PMC4672604.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/98/main.PMC4672605.pdf
E-mail  address:  todd.bell@ttuhsc.edu  (T.  Bell).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2014.12.0032214-2509/ /C223 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/98/main.PMC4672605.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/fc/98/main.PMC4672605.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/8c/main.PMC4672606.pdf
:  +49  15122664466.Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2014.11.004 2214-2509/ /C223  2014  The  Authors.,OADS,/arxiv_data1/oa_pdf/6d/8c/main.PMC4672606.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 3.0/).,Non-OADS,/arxiv_data1/oa_pdf/6d/8c/main.PMC4672606.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/87/main.PMC4672607.pdf
E-mail  address:  takashi.shinha@vanderbilt.edu  (T.  Shinha).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2015.01.0012214-2509/ /C223 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/fd/87/main.PMC4672607.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/fd/87/main.PMC4672607.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/39/main.PMC4672608.pdf
E-mail  address:  sarah.collins@phe.gov.uk  (S.  Collins).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2014.11.0032214-2509/ /C223 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/39/main.PMC4672608.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/39/main.PMC4672608.pdf
https://www.gov.uk/government/ publications/tetanus-the-green-book-chapter-30 .,Non-OADS,/arxiv_data1/oa_pdf/54/39/main.PMC4672608.pdf
http://webarchive.nationa- larchives.gov.uk/20140714084352/http://www.hpa.org.uk/web/HPAweb&H- PAwebStandard/HPAweb_C/1195733816898 .,Non-OADS,/arxiv_data1/oa_pdf/54/39/main.PMC4672608.pdf
http://webarchive.nationalarchives.gov.uk/20140714084352/ http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1210060163478 .,Non-OADS,/arxiv_data1/oa_pdf/54/39/main.PMC4672608.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/36/main.PMC4672609.pdf
"E-mail  addresses:  sisaacson11@gmail.com  (S.  Working), andrew.tyser@hsc.utah.edu  (A.  Tyser),  dana.levy@hsc.utah.edu  (D.  Levy).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2015.04.0012214-2509/ /C223 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/d9/36/main.PMC4672609.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d9/36/main.PMC4672609.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/64/main.PMC4672610.pdf
E-mail  address:  sengpiseth@yahoo.fr  (P.  Seng).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2014.12.0042214-2509/ /C223 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/64/main.PMC4672610.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/64/main.PMC4672610.pdf
guideline  (http://nosobase.chu-lyon.fr/recommandations/sfhh/ 2013_gestion_preoperatoire_SF2H.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/f0/64/main.PMC4672610.pdf
"J  Pediatr  Orthop  B 2005;14,  http://journals.lww.com/jpo-b/Fulltext/2005/01000/Osteomyelitis_ of_the_rib_due_to_Streptococcus.10.aspx .",OADS,/arxiv_data1/oa_pdf/f0/64/main.PMC4672610.pdf
Clin Microbiol  Infect  2013.  http://dx.doi.org/10.1111/1469-0691.12389 .,OADS,/arxiv_data1/oa_pdf/f0/64/main.PMC4672610.pdf
J  Plast  Reconstr Aesthet  Surg  2014.  http://dx.doi.org/10.1016/j.bjps.2014.10.024 .,OADS,/arxiv_data1/oa_pdf/f0/64/main.PMC4672610.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/cf/main.PMC4672611.pdf
Lahoud).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2015.04.0022214-2509/ /C223 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/08/cf/main.PMC4672611.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/08/cf/main.PMC4672611.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/4b/main.PMC4672612.pdf
Maritato).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2015.01.0042214-2509/ /C223 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/82/4b/main.PMC4672612.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/82/4b/main.PMC4672612.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/c6/main.PMC4672614.pdf
"Berenger), linda.chui@albertahealthservices.ca  (L.  Chui),  ABorkent@shaw.ca  (A.  Borkent), Mao-Cheng.Lee@albertahealthservices.ca  (M.-C.  Lee).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2015.02.0022214-2509/ /C223 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/8d/c6/main.PMC4672614.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8d/c6/main.PMC4672614.pdf
A  624  bp  product  con- ﬁrmed  the  identity  with  99%  sequence  homology  based  on  the GenBank  database  using  the  Basic  Local  Alignment  Search  Tool algorithm  (http://blast.ncbi.nlm.nih.gov/Blast.cgi ).,OADS,/arxiv_data1/oa_pdf/8d/c6/main.PMC4672614.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/4b/main.PMC4672615.pdf
"Booth), joepeter@rm.dk  (E.  Petersen).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2015.03.0022214-2509/ /C223 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/b1/4b/main.PMC4672615.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/4b/main.PMC4672615.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/2d/main.PMC4672616.pdf
E-mail  address:  lutwick@isid.org  (L.  Lutwick).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2014.11.0022214-2509/ /C223 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/62/2d/main.PMC4672616.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 3.0/).,Non-OADS,/arxiv_data1/oa_pdf/62/2d/main.PMC4672616.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/bd/main.PMC4672617.pdf
E-mail  address:  bbran@lds.no  (B.  Brandsæter).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2015.03.0032214-2509/ /C223 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/31/bd/main.PMC4672617.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/bd/main.PMC4672617.pdf
http://www.fhi.no/artikler/?id  =  68708 ;  2014.,Non-OADS,/arxiv_data1/oa_pdf/31/bd/main.PMC4672617.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/40/main.PMC4672618.pdf
E-mail  address:  uxzhcl@ous-hf.no  (L.  Hesstvedt).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2014.11.0012214-2509/ /C223 2014  The  Authors.,OADS,/arxiv_data1/oa_pdf/0a/40/main.PMC4672618.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 3.0/).,Non-OADS,/arxiv_data1/oa_pdf/0a/40/main.PMC4672618.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/90/main.PMC4672620.pdf
E-mail  address:  takashi.shinha@vanderbilt.edu  (T.  Shinha).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2015.01.0022214-2509/ /C223 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/90/main.PMC4672620.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9c/90/main.PMC4672620.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/2d/main.PMC4672621.pdf
E-mail  address:  takashi.shinha@vanderbilt.edu  (T.  Shinha).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2015.02.0032214-2509/ /C223 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/2d/main.PMC4672621.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f4/2d/main.PMC4672621.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/27/main.PMC4672622.pdf
1All  Authors  contributed  equally  to  this  paper.Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2015.03.0012214-2509/ /C223 2015  The  Authors.,OADS,/arxiv_data1/oa_pdf/38/27/main.PMC4672622.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/27/main.PMC4672622.pdf
"Identiﬁcation  was conﬁrmed  by  sequencing  of  a  16S  rRNA  gene  900-bp  amplicon, analyzed  using  BLAST  (see  http://blast.ncbi.nlm.nih.gov/Blast.cgi ), with  a  BLAST  100%  homology  with  C.  glucuronolyticum  strain  V17 2011556  (GenBank  accession  no.",OADS,/arxiv_data1/oa_pdf/38/27/main.PMC4672622.pdf
http://dx.doi.org/10.1099/jmmcr.0.000208 .,Non-OADS,/arxiv_data1/oa_pdf/38/27/main.PMC4672622.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/5d/main.PMC4672623.pdf
"E-mail  addresses:  sanjeevan10@gmail.com  (S.  Muruganandan), stephen.guy@wh.org.au  (S.  Guy).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2015.02.0012214-2509/ /C223 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/10/5d/main.PMC4672623.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/10/5d/main.PMC4672623.pdf
http://dx.doi.org/ 10.3201/eid1903.120591 .,Non-OADS,/arxiv_data1/oa_pdf/10/5d/main.PMC4672623.pdf
"[9]  The  Global  Strategy  for  the  Diagnosis,  Management  and  Prevention  of  COPD, Global  Initiative  for  Chronic  Obstructive  Lung  Disease  (GOLD);  2013,  Available at:  http://www.goldcopd.org/ .S.",Non-OADS,/arxiv_data1/oa_pdf/10/5d/main.PMC4672623.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/dd/main.PMC4672624.pdf
Manguerra).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2014.10.0072214-2509/ /C223 2014  The  Authors.,OADS,/arxiv_data1/oa_pdf/e8/dd/main.PMC4672624.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/dd/main.PMC4672624.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/a5/main.PMC4672625.pdf
E-mail  address:  Kristine_klintebjerg@hotmail.com  (K.  Klintebjerg).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2014.12.0012214-2509/ /C223 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/a5/main.PMC4672625.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ee/a5/main.PMC4672625.pdf
"Population  statistics;  2014,  Available  at: http://www.dst.dk/pukora/epub/Nyt/2014/NR427.pdf  [accessed  August  2014].",Non-OADS,/arxiv_data1/oa_pdf/ee/a5/main.PMC4672625.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/b3/main.PMC4672627.pdf
Sonderup).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2015.01.0032214-2509/ /C223 2015  The  Authors.,OADS,/arxiv_data1/oa_pdf/95/b3/main.PMC4672627.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/b3/main.PMC4672627.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/df/main.PMC4672638.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/df/main.PMC4672638.pdf
http://dx.doi.org/10.1016/j.eucr.2015.04.001Urology Case Reports 3 (2015) 117 e119,Non-OADS,/arxiv_data1/oa_pdf/ee/df/main.PMC4672638.pdf
http://dx.doi.org/10.1001/ archsurg.1985.01390320084018 .,Non-OADS,/arxiv_data1/oa_pdf/ee/df/main.PMC4672638.pdf
http://dx.doi.org/ 10.1046/j.1464-410X.1996.07035.x .,Non-OADS,/arxiv_data1/oa_pdf/ee/df/main.PMC4672638.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6e/2a/main.PMC4672645.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6e/2a/main.PMC4672645.pdf
http://dx.doi.org/10.1016/j.eucr.2015.05.001Urology Case Reports 3 (2015) 135 e137,Non-OADS,/arxiv_data1/oa_pdf/6e/2a/main.PMC4672645.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/8a/main.PMC4672646.pdf
http://dx.doi.org/10.1016/j.eucr.2015.01.007Urology Case Reports 3 (2015) 98 e100,Non-OADS,/arxiv_data1/oa_pdf/f4/8a/main.PMC4672646.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/21/40/main.PMC4672647.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/21/40/main.PMC4672647.pdf
http://dx.doi.org/10.1016/j.eucr.2015.06.006Urology Case Reports 3 (2015) 141 e142,Non-OADS,/arxiv_data1/oa_pdf/21/40/main.PMC4672647.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/49/main.PMC4672648.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/49/main.PMC4672648.pdf
http://dx.doi.org/10.1016/j.eucr.2015.06.013Urology Case Reports 3 (2015) 173 e174,Non-OADS,/arxiv_data1/oa_pdf/d4/49/main.PMC4672648.pdf
"published online March 1, 2011. http://dx.doi.org/10.1136/bcr.10.2010.3388 .",Non-OADS,/arxiv_data1/oa_pdf/d4/49/main.PMC4672648.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/09/main.PMC4672649.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/09/main.PMC4672649.pdf
http://dx.doi.org/10.1016/j.eucr.2015.06.015Urology Case Reports 3 (2015) 149 e151,Non-OADS,/arxiv_data1/oa_pdf/41/09/main.PMC4672649.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/2d/main.PMC4672650.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/2d/main.PMC4672650.pdf
http://dx.doi.org/10.1016/j.eucr.2015.06.003Urology Case Reports 3 (2015) 138 e140,Non-OADS,/arxiv_data1/oa_pdf/74/2d/main.PMC4672650.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/5d/main.PMC4672651.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/5d/main.PMC4672651.pdf
http://dx.doi.org/10.1016/j.eucr.2015.03.006Urology Case Reports 3 (2015) 101 e102,Non-OADS,/arxiv_data1/oa_pdf/fd/5d/main.PMC4672651.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/d8/main.PMC4672652.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/d8/main.PMC4672652.pdf
http://dx.doi.org/10.1016/j.eucr.2015.03.009Urology Case Reports 3 (2015) 120 e122,Non-OADS,/arxiv_data1/oa_pdf/b3/d8/main.PMC4672652.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/e0/main.PMC4672653.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/e0/main.PMC4672653.pdf
http://dx.doi.org/10.1016/j.eucr.2015.04.002Urology Case Reports 3 (2015) 103 e105,Non-OADS,/arxiv_data1/oa_pdf/c4/e0/main.PMC4672653.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/51/main.PMC4672654.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/51/main.PMC4672654.pdf
http://dx.doi.org/10.1016/j.eucr.2015.04.005Urology Case Reports 3 (2015) 106 e108,Non-OADS,/arxiv_data1/oa_pdf/3e/51/main.PMC4672654.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC4672655.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC4672655.pdf
http://dx.doi.org/10.1016/j.eucr.2015.06.001Urology Case Reports 3 (2015) 157 e160,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC4672655.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/d8/main.PMC4672656.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/d8/main.PMC4672656.pdf
http://dx.doi.org/10.1016/j.eucr.2015.04.003Urology Case Reports 3 (2015) 123 e125,Non-OADS,/arxiv_data1/oa_pdf/ae/d8/main.PMC4672656.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/02/main.PMC4672657.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/02/main.PMC4672657.pdf
http://dx.doi.org/10.1016/j.eucr.2015.06.002Urology Case Reports 3 (2015) 161 e163,Non-OADS,/arxiv_data1/oa_pdf/9e/02/main.PMC4672657.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/11/main.PMC4672658.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/11/main.PMC4672658.pdf
http://dx.doi.org/10.1016/j.eucr.2015.03.008Urology Case Reports 3 (2015) 111 e113,Non-OADS,/arxiv_data1/oa_pdf/aa/11/main.PMC4672658.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/e3/main.PMC4672659.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/e3/main.PMC4672659.pdf
http://dx.doi.org/10.1016/j.eucr.2015.05.003Urology Case Reports 3 (2015) 152 e154,Non-OADS,/arxiv_data1/oa_pdf/6f/e3/main.PMC4672659.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/76/main.PMC4672660.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/76/main.PMC4672660.pdf
http://dx.doi.org/10.1016/j.eucr.2015.05.004Urology Case Reports 3 (2015) 155 e156,Non-OADS,/arxiv_data1/oa_pdf/e2/76/main.PMC4672660.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/4e/main.PMC4672661.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/4e/main.PMC4672661.pdf
http://dx.doi.org/10.1016/j.eucr.2015.04.006Urology Case Reports 3 (2015) 96 e97,Non-OADS,/arxiv_data1/oa_pdf/80/4e/main.PMC4672661.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/cc/main.PMC4672662.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/cc/main.PMC4672662.pdf
http://dx.doi.org/10.1016/j.eucr.2015.06.009Urology Case Reports 3 (2015) 167 e169,Non-OADS,/arxiv_data1/oa_pdf/e0/cc/main.PMC4672662.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/49/main.PMC4672663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/49/main.PMC4672663.pdf
http://dx.doi.org/10.1016/j.eucr.2015.07.001Urology Case Reports 3 (2015) 143 e145,Non-OADS,/arxiv_data1/oa_pdf/b1/49/main.PMC4672663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/96/main.PMC4672664.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/96/main.PMC4672664.pdf
http://dx.doi.org/10.1016/j.eucr.2015.04.008Urology Case Reports 3 (2015) 126 e128,Non-OADS,/arxiv_data1/oa_pdf/d6/96/main.PMC4672664.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/cf/main.PMC4672665.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/cf/main.PMC4672665.pdf
http://dx.doi.org/10.1016/j.eucr.2015.06.005Urology Case Reports 3 (2015) 132 e134,Non-OADS,/arxiv_data1/oa_pdf/ed/cf/main.PMC4672665.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/20/main.PMC4672666.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/20/main.PMC4672666.pdf
http://dx.doi.org/10.1016/j.eucr.2015.06.008Urology Case Reports 3 (2015) 170 e172,Non-OADS,/arxiv_data1/oa_pdf/b3/20/main.PMC4672666.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/36/main.PMC4672667.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/36/main.PMC4672667.pdf
http://dx.doi.org/10.1016/j.eucr.2015.04.004Urology Case Reports 3 (2015) 114 e116,Non-OADS,/arxiv_data1/oa_pdf/53/36/main.PMC4672667.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/7b/main.PMC4672668.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/7b/main.PMC4672668.pdf
http://dx.doi.org/10.1016/j.eucr.2015.03.007Urology Case Reports 3 (2015) 146 e148,Non-OADS,/arxiv_data1/oa_pdf/4b/7b/main.PMC4672668.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/2f/main.PMC4672669.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/2f/main.PMC4672669.pdf
http://dx.doi.org/10.1016/j.eucr.2015.06.010Urology Case Reports 3 (2015) 164 e166,Non-OADS,/arxiv_data1/oa_pdf/8f/2f/main.PMC4672669.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/29/main.PMC4672670.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/29/main.PMC4672670.pdf
http://dx.doi.org/10.1016/j.eucr.2015.05.002Urology Case Reports 3 (2015) 129 e131,Non-OADS,/arxiv_data1/oa_pdf/ce/29/main.PMC4672670.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/21/main.PMC4672671.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/21/main.PMC4672671.pdf
http://dx.doi.org/10.1016/j.eucr.2015.06.012Urology Case Reports 3 (2015) 175 e177,Non-OADS,/arxiv_data1/oa_pdf/17/21/main.PMC4672671.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/0f/main.PMC4672672.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/0f/main.PMC4672672.pdf
http://dx.doi.org/10.1016/j.eucr.2015.03.002Urology Case Reports 3 (2015) 93 e95,Non-OADS,/arxiv_data1/oa_pdf/e2/0f/main.PMC4672672.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/1f/main.PMC4672673.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/1f/main.PMC4672673.pdf
http://dx.doi.org/10.1016/j.eucr.2015.03.005Urology Case Reports 3 (2015) 109 e110,Non-OADS,/arxiv_data1/oa_pdf/2c/1f/main.PMC4672673.pdf
http://dx.doi.org/10.1016/j.jpedsurg.2008.04.034 .,OADS,/arxiv_data1/oa_pdf/2c/1f/main.PMC4672673.pdf
2012. http://ukgtn.nhs.uk/ ﬁleadmin/_migrated/tt_news/news_ ﬁles/UKGTN_3rd_Biennial_ Report_2012_01.pdf Accessed October 2014.,Non-OADS,/arxiv_data1/oa_pdf/69/84/pd0035-0950.PMC4672687.pdf
Available from: http://www.world2dpage.expasy.org/melanie/.,Non-OADS,/arxiv_data1/oa_pdf/e3/61/elps0036-1224.PMC4672689.pdf
Available from: http://biochemlabsolutions.com/GelQuantNET .html.,OADS,/arxiv_data1/oa_pdf/e3/61/elps0036-1224.PMC4672689.pdf
URLhttp://www.moonphases.info/full_moon_calendar_dates.html(accessed November 2014).21.,Non-OADS,/arxiv_data1/oa_pdf/3b/29/cob0005-0060.PMC4672692.pdf
Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/ﬁle/213192/9284-TSO-900701-PROMS.pdf.,Non-OADS,/arxiv_data1/oa_pdf/93/b2/ijc0137-1509.PMC4672695.pdf
"Social and economic inequalities in diet and physical activity, 2013.Available at: https://www.gov.uk/government/news/new-brieﬁng-paper-explores-inequalities-in- diet-and-physical-activity 22.",Non-OADS,/arxiv_data1/oa_pdf/93/b2/ijc0137-1509.PMC4672695.pdf
Available at: http://www.hscic.gov.uk/catalogue/PUB13648/Obes- phys-acti-diet-eng-2014-rep.pdf 23.,Non-OADS,/arxiv_data1/oa_pdf/93/b2/ijc0137-1509.PMC4672695.pdf
Data accessibility Data on plot characteristics are publicly available on the BEF-China data portalat http://china.befdata.biow.uni-leipzig.de/datasets/46 and http://china.befdata.biow.uni-leipzig.de/datasets/71.,OADS,/arxiv_data1/oa_pdf/81/26/jec0103-0563.PMC4672697.pdf
Data on herbivory and tree growth will be publicly available 12 months after publication on the BEF-China data portal at http://china.befdata.biow.uni-leipzig.de/datasets/478.,Non-OADS,/arxiv_data1/oa_pdf/81/26/jec0103-0563.PMC4672697.pdf
R package version 1.1-6. avail- able at http://CRAN.R-project.org/package=lme4.,Non-OADS,/arxiv_data1/oa_pdf/81/26/jec0103-0563.PMC4672697.pdf
Available from URL: http://www.diabetes.org/diabetes-basics/diabetes-statistics/.Accessed31October2013.,Non-OADS,/arxiv_data1/oa_pdf/79/04/dom0017-0616.PMC4672700.pdf
Available at: http://www.takeda.us/products/default.,Non-OADS,/arxiv_data1/oa_pdf/79/04/dom0017-0616.PMC4672700.pdf
"JANUVIA (sitagliptin) tablets [prescribing information].Whitehouse Station NJ: Merck&Co;2014.Availableat:http://www.merck.com/product/usa/pi_circulars/ j/januvia/januvia_pi.pdf.AccessedonOctober31,2014.",Non-OADS,/arxiv_data1/oa_pdf/79/04/dom0017-0616.PMC4672700.pdf
Available from: https://www.gov.uk/government/publi- cations/donor-selection-criteria-review 11.,Non-OADS,/arxiv_data1/oa_pdf/58/10/trf0055-2175.PMC4672705.pdf
Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm427843.htm 13.,Non-OADS,/arxiv_data1/oa_pdf/58/10/trf0055-2175.PMC4672705.pdf
Available from:http://www5.ha.org.hk/rcbts/UPFILE/BookFile/20149415268484.,Non-OADS,/arxiv_data1/oa_pdf/58/10/trf0055-2175.PMC4672705.pdf
"http://medicine.cf.ac.uk/media/ ﬁler_public/ 2012/10/23/social_worker_perspectives_on_th e_parenting_needs_of_offender_patients.pdf [10 December 2014] Benders-Hadi N, Barber M, Alexander M (2013) Motherhood in women with serious mental ill- ness.",Non-OADS,/arxiv_data1/oa_pdf/85/f7/cbm0025-0258.PMC4672706.pdf
"Mental Health Foundation (2007) http://www.mentalhealth.org.uk/help-information/mental- health-a-z/P/parents/ [16 Oct 2014] Mignon SL, Ransford P (2012) Mothers in prison: maintaining connections with children.",Non-OADS,/arxiv_data1/oa_pdf/85/f7/cbm0025-0258.PMC4672706.pdf
(Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4122816&tool=pmcentrez&rendertype=abstract.),OADS,/arxiv_data1/oa_pdf/d4/ac/tmi0020-0893.PMC4672714.pdf
Theadapter sequences and other artefacts of the pyrose-quencing procedure were trimmed using SeqClean(https://sourceforge.net/projects/seqclean/) resultingin 2.6 million reads of good quality.,OADS,/arxiv_data1/oa_pdf/77/a1/men0015-1460.PMC4672718.pdf
"Acknowledgements This work was supported by funding from the Alfred Wegener Institute (AWI) through the Research Program PACES (Polar regions and Coasts in a changing Earth System), by funding from the international ofﬁce of the Ministry of Education and Science through project 01DR12060 and by funding from the Helmholtz Association through the Helmholtz Virtual Institute ‘PolarTime’ (VH-VI-500: Biological timing in a changing marine environment –clocks and rhythms in polar pelagic organisms, http://www.polartime.org).",Non-OADS,/arxiv_data1/oa_pdf/77/a1/men0015-1460.PMC4672718.pdf
"Web links: Exome Aggregation Consortium (ExAC), Cambridge, MA (URL: http://exac.broadinstitute.org ) [accessed August, 2015].",OADS,/arxiv_data1/oa_pdf/de/e3/nihms737729.PMC4672724.pdf
"Freebayes, https://github.com/ekg/freebayes IGV, http://www.broadinstitute.org/igv/ National Heart, Lung, and Blood Institute (NHLBI) Exome Sequencing Project, http://evs.gs.washington.edu/EVS/ PEAR, http://www.exelixis-lab.org/web/software/pear Primer3, http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi/ Picard, http://picard.sourceforge.net/ Contributors G.M.M., R.G., and W.B.D designed the study.",Non-OADS,/arxiv_data1/oa_pdf/de/e3/nihms737729.PMC4672724.pdf
This is partly supported by the present case http://dx.doi.org/10.1016/j.ensci.2015.04.001 2405-6502/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/4c/main.PMC4672739.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/4c/main.PMC4672739.pdf
Contents lists available at ScienceDirect eNeurologicalSci journal homepage: http://ees.elsevier.com/ensci/,Non-OADS,/arxiv_data1/oa_pdf/46/4c/main.PMC4672739.pdf
The online-only Data Supplement is available with this article at http://hyper.ahajournals.org/lookup/suppl/doi:10.1161/HYPERTENSIONAHA.,Non-OADS,/arxiv_data1/oa_pdf/86/71/hyp-67-206.PMC4672747.pdf
"This is an open access article  under the terms of the Creative Commons Attribution Non-Commercial-NoDervis License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.Cytochrome P450 1B1 Contributes to the   Development of Atherosclerosis and Hypertension   in Apolipoprotein E–Deficient Mice Chi Young Song, Khuzema Ghafoor, Hafiz U. Ghafoor, Nayaab S. Khan,   Shyamala Thirunavukkarasu, Brett L. Jennings, Anne M. Estes, Sahar Zaidi, Dave Bridges,   Patrick Tso, Frank J. Gonzalez, Kafait U. Malik Hypertension is available at http://hyper.ahajournals.org DOI: 10.1161/HYPERTENSIONAHA.115.06427 Hypertension and Atherosclerosis",Non-OADS,/arxiv_data1/oa_pdf/86/71/hyp-67-206.PMC4672747.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/75/53/ijn-10-7275.PMC4672755.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7275–7290International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7275OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9152 9Induction of systemic and mucosal immunity  against methicillin-resistant Staphylococcus aureus   infection by a novel nanoemulsion adjuvant vaccine hongWu sun,1,* chao Wei,1,*  Baoshuai liu,1 haiMing Jing,1  Qiang Feng,2 YaNan T ong,1 Yun  Yang,1 liuYang Yang,1 QianFei  Zuo,1 Yi Zhang,1 QuanMing  Zou,1 hao Zeng1 1National engineering research center of  Immunological Products, Department of  Microbiology and Biochemical Pharmacy,   college of Pharmacy, Third Military Medical  University of chinese P la, 2Department  of Biological and chemical engineering,   chongqing University of education, chongqing,   People’s republic of china *These authors contributed equally to  this  workAbstract:  The Gram-positive bacterial pathogen methicillin-resistant  Staphylococcus aureus   (MRSA) can cause infections in the bloodstream, endocardial tissue, respiratory tract, culture- confirmed skin, or soft tissue.",Non-OADS,/arxiv_data1/oa_pdf/75/53/ijn-10-7275.PMC4672755.pdf
"The antibody immune response and protective efficacy were  clearly improved after intramuscular immunization with this antigen combined with  an aluminum adjuvant in a mouse model of MRSA systemic infection compared with  the recombination proteins alone.1correspondence: hao Zeng; QuanMing Zou National engineering research center of  Immunological Products, Department of  Microbiology and Biochemical Pharmacy, college  of Pharmacy, Third Military Medical University of  chinese Pla, 30 sha Ping Ba gaotanyan street,  chongqing 400038, People’s republic of china Tel/fax +86 23 6875 2377 email zeng1109@163.co m; qmz2007@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Sun et al Running head recto: Systemic and mucosal immunity against MRSA infection DOI: http://dx.doi.org/10.2147/IJN.S91529 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/75/53/ijn-10-7275.PMC4672755.pdf
Or use: http://youtu.be/cIlyansK_F YVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/75/53/ijn-10-7275.PMC4672755.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/75/53/ijn-10-7275.PMC4672755.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/53/ijn-10-7275.PMC4672755.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ea/79/ijn-10-7291.PMC4672756.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7291–7305International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7291OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8906 6enhanced antitumor effects by docetaxel/ll37- loaded thermosensitive hydrogel nanoparticles in  peritoneal carcinomatosis of colorectal cancer rangrang Fan1,* aiping T ong1,* Xiaoling li1 Xiang gao1 lan Mei1 liangxue Zhou1 Xiaoning Zhang2 chao Y ou1 gang guo1 1state Key laboratory of Biotherapy  and cancer center, Department of  Neurosurgery, West china hospital,   sichuan University, and collaborative  Innovation center for Biotherapy,   chengdu, People’s republic of china;   2Department of Pharmacology and  Pharmaceutical sciences, school of  Medicine, Tsinghua University, and  collaborative Innovation center for  Biotherapy, Beijing, People’s republic  of china *These authors contributed equally  to this workAbstract:  Intraperitoneal chemotherapy was explored in clinical trials as a promising strategy  to improve the therapeutic effects of chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/ea/79/ijn-10-7291.PMC4672756.pdf
"Docetaxel (Doc), a semisynthetic analog of paclitaxel, is a widely used  anticancer agent that has been used for the treatment of various human malignancies.3–5  Unlike single-agent therapy, the combination of several types of therapeutic approaches  can modulate different signaling pathways in diseased cells, maximizing the therapeutic  effect, and is considered to be a potential strategy for the effective treatment of cancers.3,6  The combination of Doc with other bioactive agents has been widely studied.7–10  correspondence: gang guo; liangxue  Zhou Department of Neurosurgery, state  Key laboratory of Biotherapy and  cancer center, West china hospital,  sichuan University, 17#, 3 Duan, renmin  Nan road, chengdu, sichuan 610041,  People’s republic of china Tel +86 28 8516 4063 Fax +86 28 8516 4060 email guogang@scu.edu.c n; liangxue_ zhou@126.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Fan et al Running head recto: Enhanced anticancer effects of Doc +LL37 NPs–hydrogel DOI: http://dx.doi.org/10.2147/IJN.S89066",Non-OADS,/arxiv_data1/oa_pdf/ea/79/ijn-10-7291.PMC4672756.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ea/79/ijn-10-7291.PMC4672756.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/79/ijn-10-7291.PMC4672756.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/11/e1500807/DC1Movie S1.,Non-OADS,/arxiv_data1/oa_pdf/03/e5/1500807.PMC4672757.pdf
"background-sub tracted Au-M a1(2.12 keV) and Ag-L a1(2.98 keV) x-ray peaks ( 47) using FIJI (open source, available at http://Fiji.sc/Fiji).",OADS,/arxiv_data1/oa_pdf/93/52/1500988.PMC4672758.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/11/e1500988/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/93/52/1500988.PMC4672758.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/11/e1501087/DC1 Fig.,Non-OADS,/arxiv_data1/oa_pdf/32/11/1501087.PMC4672760.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/11/e1501086/DC1 Materials and MethodsFig.,Non-OADS,/arxiv_data1/oa_pdf/50/f9/1501086.PMC4672761.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/11/e1500462/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/b3/67/1500462.PMC4672762.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/11/e1500615/DC1 Materials and Methods Fig.,Non-OADS,/arxiv_data1/oa_pdf/3d/d2/1500615.PMC4672763.pdf
18 http://repository.edm-forum.org/egems/vol3/iss1/18 DOI: 10.13063/2327-9214.1190,Non-OADS,/arxiv_data1/oa_pdf/93/9f/egems1190.PMC4672873.pdf
18 http://repository.edm-forum.org/egems/vol3/iss1/18 DOI: 10.13063/2327-9214.1190,Non-OADS,/arxiv_data1/oa_pdf/93/9f/egems1190.PMC4672873.pdf
18 http://repository.edm-forum.org/egems/vol3/iss1/18 DOI: 10.13063/2327-9214.1190,Non-OADS,/arxiv_data1/oa_pdf/93/9f/egems1190.PMC4672873.pdf
18 http://repository.edm-forum.org/egems/vol3/iss1/18 DOI: 10.13063/2327-9214.1190,Non-OADS,/arxiv_data1/oa_pdf/93/9f/egems1190.PMC4672873.pdf
18 http://repository.edm-forum.org/egems/vol3/iss1/18 DOI: 10.13063/2327-9214.1190,Non-OADS,/arxiv_data1/oa_pdf/93/9f/egems1190.PMC4672873.pdf
18 http://repository.edm-forum.org/egems/vol3/iss1/18 DOI: 10.13063/2327-9214.1190,Non-OADS,/arxiv_data1/oa_pdf/93/9f/egems1190.PMC4672873.pdf
18 http://repository.edm-forum.org/egems/vol3/iss1/18 DOI: 10.13063/2327-9214.1190,Non-OADS,/arxiv_data1/oa_pdf/93/9f/egems1190.PMC4672873.pdf
18 http://repository.edm-forum.org/egems/vol3/iss1/18 DOI: 10.13063/2327-9214.1190,Non-OADS,/arxiv_data1/oa_pdf/93/9f/egems1190.PMC4672873.pdf
18 http://repository.edm-forum.org/egems/vol3/iss1/18 DOI: 10.13063/2327-9214.1190,Non-OADS,/arxiv_data1/oa_pdf/93/9f/egems1190.PMC4672873.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2014 |  91  | e51785 | Page 1 of 7Video Article Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases Kathleen S. Tatem1, James L. Quinn1, Aditi Phadke1, Qing Yu1, Heather Gordish-Dressman1,2, Kanneboyina Nagaraju1,2 1Center for Genetic Medicine Research, Children's National Medical Center 2Department of Integrative Systems Biology, George Washington University School of Medicine and Health Sciences Correspondence to: Kathleen S. Tatem at KTatem@cnmc.org URL: http://www.jove.com/video/51785 DOI: doi:10.3791/51785 Keywords: Behavior, Issue 91, open field activity, functional testing, behavioral testing, skeletal muscle, congenital muscular dystrophy, muscular dystrophy Date Published: 9/29/2014 Citation: Tatem, K.S., Quinn, J.L., Phadke, A., Yu, Q., Gordish-Dressman, H., Nagaraju, K. Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases.",Non-OADS,/arxiv_data1/oa_pdf/a4/e9/jove-91-51785.PMC4672952.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51785/ Introduction Animal models have been useful for learning about disease mechanisms, but their utility in predicting treatment efficacy in clinical trials has frequently been challenged1-3.",Non-OADS,/arxiv_data1/oa_pdf/a4/e9/jove-91-51785.PMC4672952.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2014 |  91  | e51469 | Page 1 of 13Video Article Super-resolution Imaging of the Cytokinetic Z Ring in Live Bacteria Using Fast 3D-Structured Illumination Microscopy (f3D-SIM) Lynne Turnbull*1, Michael P. Strauss*1, Andrew T. F. Liew1, Leigh G. Monahan1, Cynthia B. Whitchurch1, Elizabeth J. Harry1 1The ithree Institute, University of Technology, Sydney *These authors contributed equally Correspondence to: Elizabeth J. Harry at liz.harry@uts.edu.au URL: http://www.jove.com/video/51469 DOI: doi:10.3791/51469 Keywords: Molecular Biology, Issue 91, super-resolution microscopy, fluorescence microscopy, OMX, 3D-SIM, Blaze, cell division, bacteria, Bacillus subtilis , Staphylococcus aureus , FtsZ, Z ring constriction Date Published: 9/29/2014 Citation: Turnbull, L., Strauss, M.P., Liew, A.T.F., Monahan, L.G., Whitchurch, C.B., Harry, E.J.",Non-OADS,/arxiv_data1/oa_pdf/de/69/jove-91-51469.PMC4672958.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51469/ Introduction A number of different imaging technologies have been used over the years to study bacteria including various electron and optical microscopy techniques.,Non-OADS,/arxiv_data1/oa_pdf/de/69/jove-91-51469.PMC4672958.pdf
"Hodge at James.Hodge@bristol.ac.uk URL: http://www.jove.com/video/50107 DOI: doi:10.3791/50107 Keywords: Neuroscience, Issue 90, Drosophila , Pavlovian learning, classical conditioning, learning, memory, olfactory, electric shock, associative memory Date Published: 8/7/2014 Citation: Malik, B.R., Hodge, J.J. Drosophila  Adult Olfactory Shock Learning.",Non-OADS,/arxiv_data1/oa_pdf/31/db/jove-90-50107.PMC4672959.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50107/ Introduction The method presented here is that described by Tully and Quinn with some small modifications1.,Non-OADS,/arxiv_data1/oa_pdf/31/db/jove-90-50107.PMC4672959.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2014 |  91  | e51819 | Page 1 of 12Video Article The Preparation of Electrohydrodynamic Bridges from Polar Dielectric Liquids Adam D. Wexler1, Mónica López Sáenz2, Oliver Schreer2, Jakob Woisetschläger3, Elmar C. Fuchs1 1Applied Water Physics, Wetsus - Centre of Excellence for Sustainable Water Technology 2IRCAM GmbH 3Institute for Thermal Turbomachinery and Machine Dynamics, Graz University of Technology Correspondence to: Adam D. Wexler at Adam.Wexler@wetsus.nl URL: http://www.jove.com/video/51819 DOI: doi:10.3791/51819 Keywords: Physics, Issue 91, floating water bridge, polar dielectric liquids, liquid bridge, electrohydrodynamics, thermography, dielectrophoresis, electrowetting, Sumoto effect, Armstrong effect Date Published: 9/30/2014 Citation: Wexler, A.D., López Sáenz, M., Schreer, O., Woisetschläger, J., Fuchs, E.C.",Non-OADS,/arxiv_data1/oa_pdf/f9/a0/jove-91-51819.PMC4672961.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51819/ Introduction The interaction between electric fields and liquid matter results in a number of forces evolving within the material bulk.,Non-OADS,/arxiv_data1/oa_pdf/f9/a0/jove-91-51819.PMC4672961.pdf
"Also available online from MIT OpenCourseWare at http://ocw.mit.edu (accessed 01 19, 2011) under creative commons license attribution-noncommercial share alike (1981).",Non-OADS,/arxiv_data1/oa_pdf/f9/a0/jove-91-51819.PMC4672961.pdf
"102, 194103, http://dx.doi.org/10.1063/1.4806977, (2013).",Non-OADS,/arxiv_data1/oa_pdf/f9/a0/jove-91-51819.PMC4672961.pdf
"103, 162906, http://dx.doi.org/10.1063/1.4826185, (2013).",Non-OADS,/arxiv_data1/oa_pdf/f9/a0/jove-91-51819.PMC4672961.pdf
Ground station wind and present weather data areobtained from the Met Of ﬁce Integrated Data Archive System (http://badc.nerc.ac.,OADS,/arxiv_data1/oa_pdf/59/30/jgrd0120-1536.PMC4672962.pdf
"MODIS NDVI is obtained from the Land ProcessesDistributed Active Archive Center(https://lpdaac.usgs.gov), MODIS deep-blue AOD from the Level 1 and Atmosphere Archive and DistributionSystem (http://ladsweb.nascom.nasa.gov); and SeaWiFS deep-blue AOD and TOMS AAI from the Goddard Earth Sciences Data and Information ServicesCenter (http://disc.sci.gsfc.nasa.gov/data-holdings/).",OADS,/arxiv_data1/oa_pdf/59/30/jgrd0120-1536.PMC4672962.pdf
", 33, 403 –439, doi:10.1029/95RG02097.Acknowledgments All data and codes used to produce this study can be obtained by contacting Jean-Paul Vernier (jeanpaul.vernier@nasa.gov) and will be shared through a dropboxsystem (https://www.dropbox.com/home) under the folder JGR-ATAL-2014 (https:// www.dropbox.com/sh/k3vim6ocl3tipzb/AAC25oBOkjYE_3cxedZS7mTAa?dl=0).We thank Mian Chin for the discussion on the comparison between CALIPSO and the GOCART model (not shown inthis paper).",Non-OADS,/arxiv_data1/oa_pdf/f1/9a/jgrd0120-1608.PMC4672967.pdf
We also thank Robaidek fromthe University of Wisconsin and ISRO for making available the KALPANA satellite data via the McIDAS-V system (http://www.ssec.wisc.edu/data/).,Non-OADS,/arxiv_data1/oa_pdf/f1/9a/jgrd0120-1608.PMC4672967.pdf
"The followingsatellite data used in this study are publically available at CALIPSO, https:// eosweb.larc.nasa.gov/project/calipso/calipso_table; SAGE, https://eosweb.larc.nasa.gov/project/sage2/sage2_table; MLS, http://mirador.gsfc.nasa.gov/cgibin/ mirador/homepageAlt.pl?keyword=MLS;TRMM, http://mirador.gsfc.nasa.gov/cgibin/mirador/homepageAlt.pl?",OADS,/arxiv_data1/oa_pdf/f1/9a/jgrd0120-1608.PMC4672967.pdf
keyword=TRMM; and Cosmic GPS: http://www.cosmic.ucar.edu/data.html.The COBALD balloon campaign inLhasa was supported by National Natural Science Foundation of China (grants 91337214 and 41175040).Journal of Geophysical Research: Atmospheres 10.1002/2014JD022372 VERNIER ET AL.,Non-OADS,/arxiv_data1/oa_pdf/f1/9a/jgrd0120-1608.PMC4672967.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2014 |  90  | e51419 | Page 1 of 8Video Article Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts Jan M. Knaak*1,2, Vinzent N. Spetzler*1,2, Nicolas Goldaracena1,2, Kristine S. Louis1,2, Nazia Selzner1,3, Markus Selzner1,2 1Multi Organ Transplant Program, Toronto General Hospital 2Department of Surgery, Toronto General Hospital 3Department of Medicine, Toronto General Hospital *These authors contributed equally Correspondence to: Markus Selzner at markus.selzner@uhn.ca URL: http://www.jove.com/video/51419 DOI: doi:10.3791/51419 Keywords: Medicine, Issue 90, ex vivo  liver perfusion, marginal grafts, DCD Date Published: 8/13/2014 Citation: Knaak, J.M., Spetzler, V.N., Goldaracena, N., Louis, K.S., Selzner, N., Selzner, M. Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts.",Non-OADS,/arxiv_data1/oa_pdf/87/77/jove-90-51419.PMC4672992.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51419/ Introduction Liver transplantation is the only treatment option for patients with end stage liver disease or advanced hepatocellular carcinoma.,Non-OADS,/arxiv_data1/oa_pdf/87/77/jove-90-51419.PMC4672992.pdf
"References 1.Department of Health & Human Service, Organ Procurement and Transplantation Service., http://optn.transplant.hrsa.gov (2013).",Non-OADS,/arxiv_data1/oa_pdf/87/77/jove-90-51419.PMC4672992.pdf
Keywords Tuberculosis; Molecular epidemiology; Whole genome sequencing; Beijing strains; Guatemala;  Central America This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/3d/nihms741491.PMC4672993.pdf
We visualized  variants among the Guatemalan isolates associated with the outbreak with Circular  Visualization for Microbial Genomes (URL: http://civi.cmbi.ru.nl/ ).,OADS,/arxiv_data1/oa_pdf/58/3d/nihms741491.PMC4672993.pdf
http://dx.doi.org/10.1016/j.tube.2015.02.023 .,OADS,/arxiv_data1/oa_pdf/58/3d/nihms741491.PMC4672993.pdf
http://dx.doi.org/10.1016/j.tube.2015.02.025 .,OADS,/arxiv_data1/oa_pdf/58/3d/nihms741491.PMC4672993.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.tube.,OADS,/arxiv_data1/oa_pdf/58/3d/nihms741491.PMC4672993.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/11/e1500806/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/68/18/1500806.PMC4673052.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/10/e1500947/DC1Materials and MethodsFig.,Non-OADS,/arxiv_data1/oa_pdf/4a/fc/1500947.PMC4673053.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/10/e1500854/DC1Section S1.,Non-OADS,/arxiv_data1/oa_pdf/66/8e/1500854.PMC4673054.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Diabetic Foot & Ankle 2015, 6: 29629 - http://dx.doi.org/10.3402/dfa.v6.29629 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/db/cf/DFA-6-29629.PMC4673055.pdf
"2 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2015, 6: 29629 - http://dx.doi.org/10.3402/dfa.v6.29629",Non-OADS,/arxiv_data1/oa_pdf/db/cf/DFA-6-29629.PMC4673055.pdf
"PEDIS itself stands for perfusion, extent (size), depth (tissue loss), infection, and sensation (neuropathy) (31, 34).Risk factors for amputation in patients with diabetic foot ulcer Citation: Diabetic Foot & Ankle 2015, 6: 29629 - http://dx.doi.org/10.3402/dfa.v6.29629 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/db/cf/DFA-6-29629.PMC4673055.pdf
"4 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2015, 6: 29629 - http://dx.doi.org/10.3402/dfa.v6.29629",Non-OADS,/arxiv_data1/oa_pdf/db/cf/DFA-6-29629.PMC4673055.pdf
"(30) proposed diabetic complications’ classification.Risk factors for amputation in patients with diabetic foot ulcer Citation: Diabetic Foot & Ankle 2015, 6: 29629 - http://dx.doi.org/10.3402/dfa.v6.29629 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/db/cf/DFA-6-29629.PMC4673055.pdf
"6 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2015, 6: 29629 - http://dx.doi.org/10.3402/dfa.v6.29629",Non-OADS,/arxiv_data1/oa_pdf/db/cf/DFA-6-29629.PMC4673055.pdf
"OR, odds ratio; CI, confidence interval; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; PAD, peripheral arterial disease.aBackward stepwise conditional logistic regression model was applied; *denotes statistical significance ( pB0.05) compared to non-amputation group.Risk factors for amputation in patients with diabetic foot ulcer Citation: Diabetic Foot & Ankle 2015, 6: 29629 - http://dx.doi.org/10.3402/dfa.v6.29629 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/db/cf/DFA-6-29629.PMC4673055.pdf
"8 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2015, 6: 29629 - http://dx.doi.org/10.3402/dfa.v6.29629",Non-OADS,/arxiv_data1/oa_pdf/db/cf/DFA-6-29629.PMC4673055.pdf
"If compared to mild infection (PEDIS grade 1 and grade 2) as reference categories,Risk factors for amputation in patients with diabetic foot ulcer Citation: Diabetic Foot & Ankle 2015, 6: 29629 - http://dx.doi.org/10.3402/dfa.v6.29629 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/db/cf/DFA-6-29629.PMC4673055.pdf
"10 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2015, 6: 29629 - http://dx.doi.org/10.3402/dfa.v6.29629",Non-OADS,/arxiv_data1/oa_pdf/db/cf/DFA-6-29629.PMC4673055.pdf
DiabeticFoot Ankle 2011; 2. doi: http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/db/cf/DFA-6-29629.PMC4673055.pdf
Available from: http://www.nhlbi.nih.gov/ﬁles/docs/guidelines/atg lance.pdf [cited 27 April 2015].,Non-OADS,/arxiv_data1/oa_pdf/db/cf/DFA-6-29629.PMC4673055.pdf
"Diabetes Care 2001; 24:1686/C19.Risk factors for amputation in patients with diabetic foot ulcer Citation: Diabetic Foot & Ankle 2015, 6: 29629 - http://dx.doi.org/10.3402/dfa.v6.29629 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/db/cf/DFA-6-29629.PMC4673055.pdf
Available from: http://www.podiatrytoday.com/article/257 [cited 21 October 2015].,OADS,/arxiv_data1/oa_pdf/db/cf/DFA-6-29629.PMC4673055.pdf
"12 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2015, 6: 29629 - http://dx.doi.org/10.3402/dfa.v6.29629",Non-OADS,/arxiv_data1/oa_pdf/db/cf/DFA-6-29629.PMC4673055.pdf
Sample references are available from:   http://www.nlm.nih.gov/bsd/uniform_requirements.html,Non-OADS,/arxiv_data1/oa_pdf/91/59/SaudiMedJ-36-1277.PMC4673363.pdf
Available from: http://www.anatomyatlases.org/ AnatomicVariants/MuscularSystem/Text/P/17Peroneus.shtml 17.,Non-OADS,/arxiv_data1/oa_pdf/a4/99/SaudiMedJ-36-1285.PMC4673364.pdf
Available from:  http://www.cdc.gov/dhdsp/data_statistics/fact_sheets/docs/ fs_atrial_fibrillation.pdf   2.,OADS,/arxiv_data1/oa_pdf/4f/59/SaudiMedJ-36-1290.PMC4673365.pdf
Available  from: http://www.medicines.org.uk/emc/medicine/1175/SPC/ Fosamax/ 16.,Non-OADS,/arxiv_data1/oa_pdf/aa/cb/SaudiMedJ-36-1305.PMC4673367.pdf
Available from: http://growthcalc.chip.org/   9.,Non-OADS,/arxiv_data1/oa_pdf/9c/17/SaudiMedJ-36-1312.PMC4673368.pdf
Available from: http://www.iarc.fr/en/publications/ books/wcr/     4.,Non-OADS,/arxiv_data1/oa_pdf/dd/24/SaudiMedJ-36-1319.PMC4673369.pdf
Available from:  http://www.who.int/mediacentre/news/releases/2015/older-persons-day/en/WHO News Release,Non-OADS,/arxiv_data1/oa_pdf/40/47/SaudiMedJ-36-1375.PMC4673382.pdf
Available from:  http://www.who.int/mediacentre/news/releases/2015/malaria-mdg-target/en/WHO News Release,Non-OADS,/arxiv_data1/oa_pdf/eb/b5/SaudiMedJ-36-1377.PMC4673383.pdf
"JNCI J Natl Cancer Inst  (2015) 107(12): djv273 doi:10.1093/jnci/djv273 First published online September 30, 2015 Commentary 1 of 8 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence  (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/5c/djv273.PMC4673394.pdf
"Available from http://pubs.usgs.gov/circ/2006/1298/c1298.pdf , accessed July 25, 2014.).",OADS,/arxiv_data1/oa_pdf/9c/5c/djv273.PMC4673394.pdf
"Similarly, GAVI  (http://www.gavi.org/pledging2015/ ) has worked with the World  Health Organization Expanded Program on Immunization to  prevent cervical cancer in low income countries by increasing  access to HPV and HBV vaccines.",Non-OADS,/arxiv_data1/oa_pdf/9c/5c/djv273.PMC4673394.pdf
"Another example is the IARC-coordinated Global Initiative  for Cancer Registry Development (GICR; http://gicr.iarc.fr ), which  has brought together a group of major international and national  agencies to work collaboratively to redefine the level of cancer  surveillance worldwide for cancer control action.",Non-OADS,/arxiv_data1/oa_pdf/9c/5c/djv273.PMC4673394.pdf
http://www.who.int/fctc/text_download/en/index.html .,OADS,/arxiv_data1/oa_pdf/9c/5c/djv273.PMC4673394.pdf
http://meps.ahrq.gov/mepsweb/data_ stats/tables_compendia_hh_interactive.jsp?_SERVICE=MEPSSocket0&_ PROGRAM=MEPSPGM.TC.SAS&File=HCFY2012&Table=H CFY2012_CNDXP_C&_Debug .,OADS,/arxiv_data1/oa_pdf/9c/5c/djv273.PMC4673394.pdf
"Cells 2015; 38(11): 1007-1012  http://dx.doi.org/10.14348/molcells.2015.0221                    Identification of the 187 bp EphA7 Genomic DNA  as the Dorsal Midline-Specific Enhancer of the  Diencephalon and Mesencephalon     Yujin Kim, Eunjeong Pa rk, and Soochul Park*      EphA7 is a key molecule in regulating the development of  the dien- and mesencephalon.",OADS,/arxiv_data1/oa_pdf/49/49/molce-38-11-1007.PMC4673404.pdf
Identification of the cis-acting regulatory  sequences for EphA7 is important for delineating the genetic  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/49/49/molce-38-11-1007.PMC4673404.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/49/49/molce-38-11-1007.PMC4673404.pdf
Cells http://molcells.org     pathway for the dorsoventral patterning of the dien- and me- sencephalon.,Non-OADS,/arxiv_data1/oa_pdf/49/49/molce-38-11-1007.PMC4673404.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/49/49/molce-38-11-1007.PMC4673404.pdf
Cells http://molcells.org     cassette containing an EphA7 basal promoter and a LacZ re- porter gene (Fig.,Non-OADS,/arxiv_data1/oa_pdf/49/49/molce-38-11-1007.PMC4673404.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/49/49/molce-38-11-1007.PMC4673404.pdf
Cells http://molcells.org     fates in the vertebrate central nervous system.,Non-OADS,/arxiv_data1/oa_pdf/49/49/molce-38-11-1007.PMC4673404.pdf
"Cells 2015; 38(11): 1013-1021  http://dx.doi.org/10.14348/molcells.2015.0246                    Promotion of Remyelination by Sulfasalazine in a  Transgenic Zebrafish Model of Demyelination     Suhyun Kim1,4, Yun-Il Lee2,4, Ki-Young Chang2, Dong-Won Lee1, Sung Chun Cho2, Young Wan Ha2,   Ji Eun Na3, Im Joo Rhyu3, Sang Chul Park2,*, and Hae-Chul Park1,*      Most of the axons in the vertebrate nervous system are surrounded by a lipid-rich membrane called myelin, which  promotes rapid conduction of nerve impulses and protects  the axon from being damaged.",Non-OADS,/arxiv_data1/oa_pdf/c9/88/molce-38-11-1013.PMC4673405.pdf
Sulfasalazine is an anti-inflammatory  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,Non-OADS,/arxiv_data1/oa_pdf/c9/88/molce-38-11-1013.PMC4673405.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/c9/88/molce-38-11-1013.PMC4673405.pdf
"Cells http://molcells.org     and immune-modulating drug that is mainly used in rheumatol- ogy and inflammatory bowel disease (Dale  et al., 2007; Plosker  and Croom, 2005; Zenlea and Peppercorn, 2014).",Non-OADS,/arxiv_data1/oa_pdf/c9/88/molce-38-11-1013.PMC4673405.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c9/88/molce-38-11-1013.PMC4673405.pdf
Cells http://molcells.org     of oligodendrocytes and Schwann cells.,OADS,/arxiv_data1/oa_pdf/c9/88/molce-38-11-1013.PMC4673405.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c9/88/molce-38-11-1013.PMC4673405.pdf
"Cells http://molcells.org     salazine at 24 hpf, prior to OPC specification, and subsequently  exposed the embryos to BrdU and performed immunohisto- chemistry with an anti-BrdU antibody at 36 hpf to detect prolife- ration and with an anti-Sox10 antibody at 48 hpf to detect OPCs.",Non-OADS,/arxiv_data1/oa_pdf/c9/88/molce-38-11-1013.PMC4673405.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c9/88/molce-38-11-1013.PMC4673405.pdf
"Cells http://molcells.org     reduced remyelination but macrophage depletion at later stag- es in the remyelination phase does not change remyelination, suggesting that the beneficial role of macrophages/microglia  was time-dependent (Kotter et al., 2001; 2005).",OADS,/arxiv_data1/oa_pdf/c9/88/molce-38-11-1013.PMC4673405.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c9/88/molce-38-11-1013.PMC4673405.pdf
"Cells 2015; 38(11): 925-935  http://dx.doi.org/10.14348/molcells.2015.0294                    Functions of TET Proteins in Hematopoietic   Transformation    Jae-A Han1, Jungeun An2, and Myunggon Ko1,*      DNA methylation is a well-char acterized epigenetic modifi- cation that plays central ro les in mammalian development,  genomic imprinting, X-chromosome inactivation and silenc- ing of retrotransposon elements .",OADS,/arxiv_data1/oa_pdf/50/76/molce-38-11-925.PMC4673406.pdf
"Once Fe 2+ and 2OG are incorporated into their  cognate binding motifs in the active site, dioxygen (O 2) binds to  Fe2+ and oxidizes it to ferric intermediates (Fe3+), stimulating the  oxidative decarboxylation of 2OG (to succinate and CO 2) and  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/50/76/molce-38-11-925.PMC4673406.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/50/76/molce-38-11-925.PMC4673406.pdf
Cells http://molcells.org     the oxidation of substrate molecules (Fig.,Non-OADS,/arxiv_data1/oa_pdf/50/76/molce-38-11-925.PMC4673406.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/50/76/molce-38-11-925.PMC4673406.pdf
"Cells http://molcells.org     number of cellular proteins (Ko et al., 2015; Shen et al., 2014).",OADS,/arxiv_data1/oa_pdf/50/76/molce-38-11-925.PMC4673406.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/50/76/molce-38-11-925.PMC4673406.pdf
"Cells http://molcells.org     then the resulting TET2 -mutated pre-malignant cells acquire  additional mutations in order to progress to a more malignant  phenotype (Huang and Rao, 2014; Ko et al., 2015), in line with  the ‘second hit’ hypothesis in cancer development.",Non-OADS,/arxiv_data1/oa_pdf/50/76/molce-38-11-925.PMC4673406.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/50/76/molce-38-11-925.PMC4673406.pdf
"Cells http://molcells.org     ing mutant IDH enzymes gain a novel enzymatic function to  reduce 2OG to oncometabolite 2-hydroxyglutarate (2HG)  (Dang et al., 2009; Figueroa et al., 2010; Ward et al., 2010).",OADS,/arxiv_data1/oa_pdf/50/76/molce-38-11-925.PMC4673406.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/50/76/molce-38-11-925.PMC4673406.pdf
Cells http://molcells.org     of novel families of enzymes involved in oxidative and other  complex modifications of bases in nucleic acids.,OADS,/arxiv_data1/oa_pdf/50/76/molce-38-11-925.PMC4673406.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/50/76/molce-38-11-925.PMC4673406.pdf
"Cells 2015; 38(11): 936-940  http://dx.doi.org/10.14348/molcells.2015.0233                    Synapsin Isoforms and Synaptic Vesicle  Trafficking    Sang-Ho Song1,2,  and George J. Augustine1,2,*      Synapsins were the first presynaptic proteins identified and have served as the flagship of th e presynaptic protein field.",OADS,/arxiv_data1/oa_pdf/6c/2e/molce-38-11-936.PMC4673407.pdf
"This domain is am-phipathic - containing both hydrophobic and highly charged resi- dues - and is characterised by a compact structure of roughly  elliptical shape, composed of several subdomains or ganized as  α-helices or β-sheets, as well as a disordered region at its  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/6c/2e/molce-38-11-936.PMC4673407.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/6c/2e/molce-38-11-936.PMC4673407.pdf
Synapsins and Synaptic Vesicle Trafficking  Sang-Ho Song & George J. Augustine      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/6c/2e/molce-38-11-936.PMC4673407.pdf
"Cells http://molcells.org     Release of biogenic amines   Deletion of all synapsin isoforms increases the amount of cate-cholamine released from depolarized chromaffin cells  (Villanueva et al., 2006).",OADS,/arxiv_data1/oa_pdf/6c/2e/molce-38-11-936.PMC4673407.pdf
Synapsins and Synaptic Vesicle Trafficking  Sang-Ho Song & George J. Augustine      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/6c/2e/molce-38-11-936.PMC4673407.pdf
"Cells http://molcells.org     Gitler, D., Xu, Y., Kao, H.-T., Lin, D., Lim, S., Feng, J., Greengard,  P., and Augustine, G.J.",OADS,/arxiv_data1/oa_pdf/6c/2e/molce-38-11-936.PMC4673407.pdf
"Cells 2015; 38(11): 941-949  http://dx.doi.org/10.14348/molcells.2015.2353                    Rocaglamide-A Potentiates Osteoblast   Differentiation by Inhibiting NF- κB Signaling    Aiguo Li1,*, Libin Yang1, Xiaolin Geng1, Xingmei Peng2, Tan Lu1, Yanjun Deng1, and Yuzheng Dong1      Rheumatoid arthritis is a chronic inflammatory disease  that leads to bone and cartilage erosion.",Non-OADS,/arxiv_data1/oa_pdf/5a/34/molce-38-11-941.PMC4673408.pdf
"In 2002, rocaglamide derivatives were  recognized as potent inhibitors of NF- κB activation in T cells  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/5a/34/molce-38-11-941.PMC4673408.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/5a/34/molce-38-11-941.PMC4673408.pdf
"Cells http://molcells.org     (Baumann  et al., 2002).",OADS,/arxiv_data1/oa_pdf/5a/34/molce-38-11-941.PMC4673408.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/5a/34/molce-38-11-941.PMC4673408.pdf
Cells http://molcells.org     moved and cells were washed 3 times with PBS.,OADS,/arxiv_data1/oa_pdf/5a/34/molce-38-11-941.PMC4673408.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/5a/34/molce-38-11-941.PMC4673408.pdf
Cells http://molcells.org     determine the NF- κB activation.,Non-OADS,/arxiv_data1/oa_pdf/5a/34/molce-38-11-941.PMC4673408.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/5a/34/molce-38-11-941.PMC4673408.pdf
"Cells http://molcells.org     and reduce the production of various cytokines, as well as inhibit  NF-κB activation in T cells.",Non-OADS,/arxiv_data1/oa_pdf/5a/34/molce-38-11-941.PMC4673408.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/5a/34/molce-38-11-941.PMC4673408.pdf
"Cells 2015; 38(11): 950-958  http://dx.doi.org/10.14348/molcells.2015.0121                    Gain of a New Exon by a Lineage-Specific Alu   Element-Integration Event in the BCS1L  Gene   during Primate Evolution    Sang-Je Park1,4, Young-Hyun Kim1,2,4, Sang-Rae Lee1,2,4, Se-Hee Choe1,2, Myung-Jin Kim1, Sun-Uk Kim1,   Ji-Su Kim1, Bo-Woong Sim1, Bong-Seok Song1, Kang-Jin Jeong1, Yeung-Bae Jin1, Youngjeon Lee1,  Young-Ho Park1, Young Il Park3, Jae-Won Huh1,2,*, and Kyu-Tae Chang1,2,*     BCS1L  gene encodes mitochondrial protein and is a  member of conserved AAA protein family.",OADS,/arxiv_data1/oa_pdf/07/19/molce-38-11-950.PMC4673409.pdf
Alu elements are typically     Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/07/19/molce-38-11-950.PMC4673409.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/07/19/molce-38-11-950.PMC4673409.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/07/19/molce-38-11-950.PMC4673409.pdf
Cells http://molcells.org     remove non-specific products with either of the following primer  combinations: 5 ′-RACE primer and 5 ′-specific primer (SP) or 3 ′- RACE primer and 3 ′-SP.,Non-OADS,/arxiv_data1/oa_pdf/07/19/molce-38-11-950.PMC4673409.pdf
"And also, to calculate the divergence time of AluYRa2 elements, one hundred twenty intact maca- que-specific AluYRa2 elements were selected from the Univer- sity of California Santa Cruz (UCSC) Genome Browser (http://genome.ucsc.",OADS,/arxiv_data1/oa_pdf/07/19/molce-38-11-950.PMC4673409.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/07/19/molce-38-11-950.PMC4673409.pdf
"Cells http://molcells.org     V9, and V10 transcripts had the AluYRa2-derived exon; among  them, the V1 and V9 transcripts showed the same gene struc- ture as the transcript from the rhesus monkey cDNA library, and the V8 transcript had one more exon (E3) between second and  third exon.",Non-OADS,/arxiv_data1/oa_pdf/07/19/molce-38-11-950.PMC4673409.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/07/19/molce-38-11-950.PMC4673409.pdf
Cells http://molcells.org     of these events occurred in the 5 ′ region (E1-E4) of the  BCS1L  gene (Fig.,OADS,/arxiv_data1/oa_pdf/07/19/molce-38-11-950.PMC4673409.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/07/19/molce-38-11-950.PMC4673409.pdf
"Cells http://molcells.org     Corvelo, A., and Eyras, E. (2008).",OADS,/arxiv_data1/oa_pdf/07/19/molce-38-11-950.PMC4673409.pdf
"Cells 2015; 38(11): 959-965  http://dx.doi.org/10.14348/molcells.2015.0137                    Cell Type-Specific and Inducible PTEN Gene   Silencing by a Tetracycline Transcriptional  Activator-Regulated Short Hairpin RNA     Shan Wang1,2, Ting Wang1,2, Tao Wang1, and Lintao Jia1,*      Inducible and reversible gene silencing in desired types of cells is instrumental for deciphering gene functions using  cultured cells or in vivo  models.",Non-OADS,/arxiv_data1/oa_pdf/46/9c/molce-38-11-959.PMC4673410.pdf
"Since the  irreversible deletion of this phosphatase gene from the chro- mosome causes PTEN deficiency in targeted cells (e.g., stem cells) and their offspring cells , these models may have limita- tions in dissecting the precise role of PTEN in a specific type of Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/46/9c/molce-38-11-959.PMC4673410.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/46/9c/molce-38-11-959.PMC4673410.pdf
"Cells http://molcells.org     cells during a given phase of development (Knobbe et al.,  2008).",OADS,/arxiv_data1/oa_pdf/46/9c/molce-38-11-959.PMC4673410.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/46/9c/molce-38-11-959.PMC4673410.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/46/9c/molce-38-11-959.PMC4673410.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/46/9c/molce-38-11-959.PMC4673410.pdf
"Cells http://molcells.org     DISCUSSION    Past decades have witnessed the functional denotation of nu- merous genes using conventional or conditional gene silencing model organisms (Kleinhammer et al., 2011; Kunath, 2008).",OADS,/arxiv_data1/oa_pdf/46/9c/molce-38-11-959.PMC4673410.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/46/9c/molce-38-11-959.PMC4673410.pdf
"Cells 2015; 38(11): 966-974  http://dx.doi.org/10.14348/molcells.2015.0158                    Differential Effect of MyD88 Signal in Donor T Cells  on Graft-versus-Leukemia Effect and Graft-versus-Host Disease after Experimental Allogeneic Stem Cell Transplantation    Ji-Young Lim¹, Da-Bin Ryu¹, Sung-Eun Lee¹, Gyeongsin Park2,*, Eun Young Choi3 , and Chang-Ki Min1,*      Despite the presence of toll like receptor (TLR) expression  in conventional TCR αβ T cells, the direct role of TLR sig- naling via myeloid differentiation factor 88 (MyD88) within  T lymphocytes on graft-versus-host disease (GVHD) and  graft-versus-leukemia (GVL) effect after allogeneic stem cell transplantation (allo-SCT) remains unknown.",OADS,/arxiv_data1/oa_pdf/ac/57/molce-38-11-966.PMC4673411.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/ac/57/molce-38-11-966.PMC4673411.pdf
Molecules and Cells http://molcells.org   Established in 1990,OADS,/arxiv_data1/oa_pdf/ac/57/molce-38-11-966.PMC4673411.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ac/57/molce-38-11-966.PMC4673411.pdf
Cells http://molcells.org     Cytotoxicity assays  Standard allogeneic mixed lymphocyte reaction (MLR) was  performed using naïve C57BL/6 splenic CD3+ T cells (2 × 105)  as responders and irradiated naïve BDF1 T-cell depleted mo-nonuclear cells (2 × 10 5) as stimulators.,OADS,/arxiv_data1/oa_pdf/ac/57/molce-38-11-966.PMC4673411.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ac/57/molce-38-11-966.PMC4673411.pdf
Cells http://molcells.org     cells.,OADS,/arxiv_data1/oa_pdf/ac/57/molce-38-11-966.PMC4673411.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ac/57/molce-38-11-966.PMC4673411.pdf
Cells http://molcells.org     former as compared with the latter.,Non-OADS,/arxiv_data1/oa_pdf/ac/57/molce-38-11-966.PMC4673411.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ac/57/molce-38-11-966.PMC4673411.pdf
"Cells http://molcells.org     REFERENCES    Appelbaum, F.R.",OADS,/arxiv_data1/oa_pdf/ac/57/molce-38-11-966.PMC4673411.pdf
"Cells 2015; 38(11): 975-981  http://dx.doi.org/10.14348/molcells.2015.0160                    3D Light-Sheet Fluorescence Microscopy of   Cranial Neurons and Vasculature during Zebrafish Embryogenesis    Ok Kyu Park1,6, Jina Kwak2,6, Yoo Jung Jung2, Young Ho Kim3, Hyun-Seok Hong3, Byung Joon Hwang4,5,*,  Seung-Hae Kwon1,*, and Yun Kee2,5,*      Precise 3D spatial mapping of cells and their connections within living tissues is required  to fully understand devel- opmental processes and neural activities.",OADS,/arxiv_data1/oa_pdf/5a/90/molce-38-11-975.PMC4673412.pdf
Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/5a/90/molce-38-11-975.PMC4673412.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/5a/90/molce-38-11-975.PMC4673412.pdf
"Cells http://molcells.org     Here, we used live SPIM imaging and transgenic lines to  visualize and map in 3D the blood vessels and differentiating  neurons of the entire zebrafish brain during development.",Non-OADS,/arxiv_data1/oa_pdf/5a/90/molce-38-11-975.PMC4673412.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/5a/90/molce-38-11-975.PMC4673412.pdf
Cells http://molcells.org          Fig.,Non-OADS,/arxiv_data1/oa_pdf/5a/90/molce-38-11-975.PMC4673412.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/5a/90/molce-38-11-975.PMC4673412.pdf
Cells http://molcells.org     achieve a 3D image depth of 100-200 μM (data not shown).,OADS,/arxiv_data1/oa_pdf/5a/90/molce-38-11-975.PMC4673412.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/5a/90/molce-38-11-975.PMC4673412.pdf
"Cells 2015; 38(11): 982-990  http://dx.doi.org/10.14348/molcells.2015.0169                    Photoprotective Potential of Penta-O-Galloyl- β-D- Glucose by Targeting NF- κB and MAPK Signaling  in UVB Radiation-Induced Human Dermal  Fibroblasts and Mouse Skin     Byung-Hak Kim1,2, Mi Sun Choi3, Hyun Gyu Lee4, Song-Hee Lee1, Kum Hee Noh1, Sunho Kwon1, Ae Jin  Jeong1, Haeri Lee1, Eun Hee Yi1,5, Jung Youl Park6, Jintae Lee7, Eun Young Joo3, and Sang-Kyu Ye1,2,5,8,*      Exposure of the skin to ultraviolet radiation can cause skin damage with various pathological changes including in- flammation.",Non-OADS,/arxiv_data1/oa_pdf/8f/c6/molce-38-11-982.PMC4673413.pdf
"During UV radiation, large amounts of ROS and RNS are pro- duced and trigger multiple receptor-initiated signaling pathways  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/8f/c6/molce-38-11-982.PMC4673413.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/8f/c6/molce-38-11-982.PMC4673413.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/8f/c6/molce-38-11-982.PMC4673413.pdf
"Cells http://molcells.org     Briefly, total RNA was reverse-transcribed at 42°C for 1 h and  PCR was performed 25 cycles at 94°C for 30 s, 58°C for 60 s, and 72°C for 60 s, with a final  cycle at 72°C for 5 min.",OADS,/arxiv_data1/oa_pdf/8f/c6/molce-38-11-982.PMC4673413.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/8f/c6/molce-38-11-982.PMC4673413.pdf
"Cells http://molcells.org     PGG inhibits UVB radiation-induced NF- κB signaling  Excessive ROS generation by UVB irradiation-mediated  NADPH oxidase complex modulate s Toll-like receptor (TLR)  signal transduction at multiple levels and subsequently induces  inflammatory responses and disease pathogenesis via activa- tion of signaling cascades, includi ng nuclear factor- kappaB (NF- κB) (Fan et al., 2003; Liu et al., 2009; Park et al., 2006; Siomek, 2012).",OADS,/arxiv_data1/oa_pdf/8f/c6/molce-38-11-982.PMC4673413.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/8f/c6/molce-38-11-982.PMC4673413.pdf
"Cells http://molcells.org     increased in UVB radiation-induced human dermal fibroblasts,  whereas the levels were effectively decreased in the presence  of PGG in a concentration-dependent manner in the cells (Fig.",Non-OADS,/arxiv_data1/oa_pdf/8f/c6/molce-38-11-982.PMC4673413.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/8f/c6/molce-38-11-982.PMC4673413.pdf
Cells http://molcells.org     structurally related substances and their effects on NF- κB/CRE/AP-1 signaling in murine macrophages.,Non-OADS,/arxiv_data1/oa_pdf/8f/c6/molce-38-11-982.PMC4673413.pdf
"Cells 2015; 38(11): 991-997  http://dx.doi.org/10.14348/molcells.2015.0197                    Resveratrol Induces Glioma Cell Apoptosis  through Activation of Tristetraprolin     Jinhyun Ryu1, Nal Ae Yoon1, Hyemin Seong1, Joo Yeon Jeong1, Seokmin Kang1, Nammi Park2, Jungil  Choi3, Dong Hoon Lee1, Gu Seob Roh1, Hyun Joon Kim1, Gyeong Jae Cho1, Wan Sung Choi1, Jae-Yong  Park4, Jeong Woo Park5,*, and Sang Soo Kang1,*     Tristetraprolin (TTP) is an AU-rich elements (AREs)- binding protein, which regulates the decay of AREs- containing mRNAs such as proto-oncogenes, anti-apoptotic genes and immune regulatory genes.",Non-OADS,/arxiv_data1/oa_pdf/db/14/molce-38-11-991.PMC4673414.pdf
The expression of Res-induced TTP destabilized uPA and uPAR mRNAs by binding to the ARE Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/db/14/molce-38-11-991.PMC4673414.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/db/14/molce-38-11-991.PMC4673414.pdf
Cells http://molcells.org     regions containing 3 ′ untranslated regions (3 ′ UTR) of their  mRNAs.,Non-OADS,/arxiv_data1/oa_pdf/db/14/molce-38-11-991.PMC4673414.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/db/14/molce-38-11-991.PMC4673414.pdf
Cells http://molcells.org      A      B           C  Fig.,Non-OADS,/arxiv_data1/oa_pdf/db/14/molce-38-11-991.PMC4673414.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/db/14/molce-38-11-991.PMC4673414.pdf
"Cells http://molcells.org     through the blood-brain barrier and subsequent absorption into  the brain tissue (Wang et al., 2002).",OADS,/arxiv_data1/oa_pdf/db/14/molce-38-11-991.PMC4673414.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/db/14/molce-38-11-991.PMC4673414.pdf
"Cells 2015; 38(11): 998-1006  http://dx.doi.org/10.14348/molcells.2015.0218                      Blockade of Retinol Metabolism Protects   T Cell-Induced Hepatitis by Increasing Migration  of Regulatory T Cells    Young-Sun Lee1,2, Hyon-Seung Yi1,3, Yang-Gun Suh4, Jin-Seok Byun5, Hyuk Soo Eun1, So Yeon Kim1,   Wonhyo Seo1, Jong-Min Jeong1 , Won-Mook Choi1, Myung-Ho Kim1, Ji Hoon Kim2, Keun-Gyu Park6, and  Won-Il Jeong1,*      Retinols are metabolized into retinoic acids by alcohol  dehydrogenase (ADH) and retinaldehyde dehydrogenase (Raldh).",Non-OADS,/arxiv_data1/oa_pdf/a1/fe/molce-38-11-998.PMC4673415.pdf
Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/a1/fe/molce-38-11-998.PMC4673415.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/a1/fe/molce-38-11-998.PMC4673415.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/a1/fe/molce-38-11-998.PMC4673415.pdf
"Cells http://molcells.org      RESULTS    Inhibited retinol metabolism by 4-MP attenuates   Con A-induced acute hepatitis and increases hepatic Tregs As previously reported (Dunham et al., 2013; Mucida et al.,  2007), we tested whether suppressed retinol metabolism of  HSCs by 4-MP influences the differentiation of naïve T cells into Tregs.",Non-OADS,/arxiv_data1/oa_pdf/a1/fe/molce-38-11-998.PMC4673415.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/a1/fe/molce-38-11-998.PMC4673415.pdf
"Cells http://molcells.org      retinol droplet contents compared to those of the control HSCs,  while 4-MP treatment suppressed ADH3 expression but in-creased retinol droplet contents in HSCs compared with those  of Con A-treated HSCs (Fig.",Non-OADS,/arxiv_data1/oa_pdf/a1/fe/molce-38-11-998.PMC4673415.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/a1/fe/molce-38-11-998.PMC4673415.pdf
Cells http://molcells.org      produced chimeric mice by transplantation of WT bone mar- row to WT mice (WTWT) and Raldh1-/- mice (Raldh1WT) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/a1/fe/molce-38-11-998.PMC4673415.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/a1/fe/molce-38-11-998.PMC4673415.pdf
"Cells http://molcells.org     Choi, Y .S., Lee, J., Lee, H.W., Chang, D.Y ., Sung, P.S., Jung, M.K.,  Park, J.Y ., Kim, J.K., Lee, J.I., Park, H., et al.",OADS,/arxiv_data1/oa_pdf/a1/fe/molce-38-11-998.PMC4673415.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Proﬁling of blood- monocyte-derived dendritic cells SE Autenrieth et al 8 Clinical & Translational Immunology",Non-OADS,/arxiv_data1/oa_pdf/00/61/cti201529a.PMC4673437.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by- nc-sa/4.0/ The Supplementary Information that accompanies this paper is available on t he Clinical and Translational Immuno logy website (http://www.nature.",Non-OADS,/arxiv_data1/oa_pdf/cb/27/cti201530a.PMC4673438.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by- nc-nd/4.0/ The Supplementary Information that accompanies this paper is av ailable on the Clinical and Translational Immunology website (http://www.nature.com/cti)Cell-penetrating antibodies in therapeutic IVIg AD Sali et al 11 Clinical & Translational Immunology",Non-OADS,/arxiv_data1/oa_pdf/48/5d/cti201518a.PMC4673440.pdf
Flow cytometry Detailed information on the HLDA10 mAb can be found at http://www.hcdm.org.,OADS,/arxiv_data1/oa_pdf/81/cf/cti201521a.PMC4673441.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by- nc-nd/4.0/HLDA10 analysis on human thymic dendritic cells S Gurka et al 9 Clinical & Translational Immunology",Non-OADS,/arxiv_data1/oa_pdf/81/cf/cti201521a.PMC4673441.pdf
Figure 1 Schematic representation of the human female reproductive tract mucosa surveyed by innate and adaptive immune cells and antiviral responses (generated using ePath3D: http://www.epath3d.com).,OADS,/arxiv_data1/oa_pdf/84/a2/cti201523a.PMC4673443.pdf
Available from http://www.who.int/hiv/data/epi_core_dec2014.png?ua =1.,OADS,/arxiv_data1/oa_pdf/84/a2/cti201523a.PMC4673443.pdf
Available from http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/84/a2/cti201523a.PMC4673443.pdf
Available from https://www.clinicaltrials.gov/ct2/show/NCT01386294.,Non-OADS,/arxiv_data1/oa_pdf/84/a2/cti201523a.PMC4673443.pdf
Available from https://clinicaltrials.gov/ct2/show/NCT01387022?term =tenofovir&rank =30.,Non-OADS,/arxiv_data1/oa_pdf/84/a2/cti201523a.PMC4673443.pdf
Available from https://www.clinicaltrials.gov/ct2/show/ NCT01691768.,Non-OADS,/arxiv_data1/oa_pdf/84/a2/cti201523a.PMC4673443.pdf
Availbale from https://www.clinicaltrials.gov/ct2/show/NCT01136759?term =tenofovir&rank =8.,Non-OADS,/arxiv_data1/oa_pdf/84/a2/cti201523a.PMC4673443.pdf
Available from https://www.clinicaltrials.gov/ct2/show/NCT01421368?term =tenofovir&rank =28.,Non-OADS,/arxiv_data1/oa_pdf/84/a2/cti201523a.PMC4673443.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by- nc-sa/4.0/Blocking HIV-1 transmission Plby microbicides and ARVs SG Eid et al 9 Clinical & Translational Immunology",Non-OADS,/arxiv_data1/oa_pdf/84/a2/cti201523a.PMC4673443.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/Inhibition of osteoclast formation by SAA EO h et al 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/ae/c5/emm201583a.PMC4673470.pdf
"To view a copy of this license, visit http://creativecommons.org/li censes/by-nc-sa/4.0/Prognostic value of NBS1 in EOCs Y-K Lee et al 7 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/b3/24/emm201585a.PMC4673471.pdf
"To view a copy of this license, visit http://creativecommons.org/li censes/by-nc-sa/4.0/PLD2-mediated degradation of HIF-1 α MH Park et al 7 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/2e/2c/emm201587a.PMC4673472.pdf
"To view a copy of this license, visit http://creativecommons.org/li censes/by-nc-sa/4.0/Hepatocyte differentiation from Sca1+Lin−cells KO h et al 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/6b/fd/emm201564a.PMC4673473.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/miR-139 regulates MCPIP1expression in OA chondrocytes MS Makki and TM Haqqi 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/81/17/emm201566a.PMC4673474.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)R o l e so fR a ca n dm y o s i nI Ii nK ATPchannel traf ﬁcking Y-E Han et al 12 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/6d/72/emm201572a.PMC4673475.pdf
"Speci ﬁc primers for ADRP and ALBP were designed using the IDT DNA website (http://www.idtdna.com): ALBP, 5 ′-GCCAGGAATTTGACG AAGTCAC-3 ′and 5 ′-TTCTGCACATGTACCAGGACAC-3 ′;a n d ADRP, 5 ’-GCACTCACCAAATCAGAGCTG-3 ′and 5 ′-AACTTGGC TTCTGAACCAG-3 ′.",OADS,/arxiv_data1/oa_pdf/69/bb/emm201574a.PMC4673476.pdf
"To view a copy of this license, visit http://creativecommons.org/li censes/by-nc-sa/4.0/Pycnogenol attenuates atherosclerosis HL u o et al 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/69/bb/emm201574a.PMC4673476.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/Regulation of osteoclastogenesis by caveolin-1 YD Lee et al 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/f7/f2/emm201577a.PMC4673477.pdf
Detailed informa-tion on the procedure adopted by Biobank and on the additional data collected can be found elsewhere: http://www.ukbiobank.ac.uk/.,Non-OADS,/arxiv_data1/oa_pdf/ae/bb/iija-54-599.PMC4673512.pdf
"The success of such a scheme would depend on the detection rate of at-risk pregnancies, and possible therapeutic options, that is, if only a This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial- NoDerivatives License (http://creativecommons.org/Licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distri-bution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/95/2d/iero-15-617.PMC4673513.pdf
"All three leukocyte populations (lympho-cytes, monocytes, and granulocytes) fall within a few days after exposure, reaching This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial-NoDerivatives License (http://creativecommons.org-/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the originalwork is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/c6/76/ietp-25-1085.PMC4673515.pdf
Available from: http://www.fda.gov/EmergencyPreparedness/Counterterrorism/ MedicalCountermeasures/AboutMCMi/ ucm443245.htm [Last accessed 17 April 2015] .,Non-OADS,/arxiv_data1/oa_pdf/c6/76/ietp-25-1085.PMC4673515.pdf
SUPPLEMENTAL MATERIAL Supplemental data for this a rticle can be accessed on the publisher’s Web site at http://dx.doi.org/10.1080/07448481.2015.1055567.,Non-OADS,/arxiv_data1/oa_pdf/65/61/vach-63-530.PMC4673518.pdf
Available at: http://www.acha-ncha.,Non-OADS,/arxiv_data1/oa_pdf/65/61/vach-63-530.PMC4673518.pdf
"Available at: http://monitoringthefuture.org/.Accessed August 1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/65/61/vach-63-530.PMC4673518.pdf
"Available at: http://archive.sph.harvard.edu/cas/About/index.html.Accessed August 1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/65/61/vach-63-530.PMC4673518.pdf
Available at: http://www.acha.org/ACHA/About/History/ACHA/About/History.aspx?hk ey=9937c765-d1b4-4e68-9eac- 76ed2b8f0864.,Non-OADS,/arxiv_data1/oa_pdf/65/61/vach-63-530.PMC4673518.pdf
Available at: http://nces.ed.gov/ipeds/.,OADS,/arxiv_data1/oa_pdf/65/61/vach-63-530.PMC4673518.pdf
Available at: http://www.cdc.gov/nchs/icd/icd9cm.htm.,Non-OADS,/arxiv_data1/oa_pdf/65/61/vach-63-530.PMC4673518.pdf
Available a t: http://www.cms.gov/Medi care/Medicare-Fee-for-Service -Payment/AcuteInpatientPPS/ Acute-Inpatient-File s-for-Download-Items/CMS1247844.html.,Non-OADS,/arxiv_data1/oa_pdf/65/61/vach-63-530.PMC4673518.pdf
Available at: http://www.cdc.gov/mumps/out breaks.html.,Non-OADS,/arxiv_data1/oa_pdf/65/61/vach-63-530.PMC4673518.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/62/iocc-22-355.PMC4673522.pdf
Available from: http://www.goldcopd.org/uploads/users/ files/GOLD_Report_2015.pdf [Lastaccessed 13 February 2015] ..,OADS,/arxiv_data1/oa_pdf/93/91/ieop-16-1845.PMC4673525.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT01817764 [Last accessed 5 December 2013] 64.,Non-OADS,/arxiv_data1/oa_pdf/93/91/ieop-16-1845.PMC4673525.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT01782326 [Lastaccessed 5 December 2013] 68.,Non-OADS,/arxiv_data1/oa_pdf/93/91/ieop-16-1845.PMC4673525.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT02164513 [Last accessed 4 December 2014] 69.,Non-OADS,/arxiv_data1/oa_pdf/93/91/ieop-16-1845.PMC4673525.pdf
Available from:http://www.fda.gov/ohrms/dockets/ac/02/ briefing/3830b1_02_Glaxo-ADVAIR.pdf [Last accessed 20 January 2015] 70.,Non-OADS,/arxiv_data1/oa_pdf/93/91/ieop-16-1845.PMC4673525.pdf
"Antigen-presenting This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial- NoDerivatives License (http://creativecommons.org/Licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distri- bution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/6f/13/ierz-13-1351.PMC4673539.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/7a/igas-50-1127.PMC4673540.pdf
Available from http://www.scandiatrans- plant.org.,OADS,/arxiv_data1/oa_pdf/f3/7a/igas-50-1127.PMC4673540.pdf
"9, 1512 –1522, http://dx.doi.org/10.1080/19440049.2015.1072644 © 2015 European Union.",Non-OADS,/arxiv_data1/oa_pdf/15/71/tfac-32-1512.PMC4673541.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/15/71/tfac-32-1512.PMC4673541.pdf
"http://www.iso.org/iso/cat alogue_detail.htm?csnumber=11834 Prelle A, Spadaro D, Garibaldi A, Gullino ML.",Non-OADS,/arxiv_data1/oa_pdf/15/71/tfac-32-1512.PMC4673541.pdf
"http://informahealthcare.com/dre ISSN 0963-8288 print/ISSN 1464-5165 online Disabil Rehabil, 2015; 37(24): 2282–2290 DOI: 10.3109/09638288.2015.1021021 RESEARCH PAPER Supporting children with disabilities at school: implications for the advocate role in professional practice and education Stella L. Ng1,2,3, Lorelei Lingard4,5, Kathryn Hibbert4,6, Sandra Regan7, Shanon Phelan8, Rosamund Stooke6, Christine Meston4,9, Catherine Schryer10, Madhushani Manamperi11, and Farah Friesen1 1Centre for Faculty Development, St. Michael’s Hospital, Toronto, Canada,2Centre for Ambulatory Care Education, Women’s College Hospital, Toronto, Canada,3Department of Speech-Language Pathology, University of Toronto, Toronto, Canada,4Centre for Education Research & Innovation, Schulich School of Medicine & Dentistry, Western University, London, Canada,5Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, Canada,6Faculty of Education, Western University, London, Canada,7Arthur Labatt Family School of Nursing, Faculty of Health Sciences, Western University, London, Canada,8Department of Occupational Therapy, Faculty of Rehabilitation Medicine, University of Alberta, Edmonton, Canada,9Health & Rehabilitation Sciences, Faculty of Health Sciences, Western University, London, Canada, 10Department of Professional Communication, Ryerson University, Toronto, Canada, and11Autism and Behavioural Sciences, George Brown College, Toronto, Canada Abstract Purpose : School settings are a common practice context for rehabilitation professionals; health advocacy is a common and challenging practice role for professionals in this context.",Non-OADS,/arxiv_data1/oa_pdf/07/45/idre-37-2282.PMC4673542.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution NonCommercial License (CC BY-NC) (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, andreproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/45/idre-37-2282.PMC4673542.pdf
Available from: http://www.health.gov.on.ca/en/public/ contact/ccac/docs/deloitte_shss_review_report.pdf [last accessed 4 Feb 2015].,Non-OADS,/arxiv_data1/oa_pdf/07/45/idre-37-2282.PMC4673542.pdf
"Kohen D, Uppal S, Khan S, Visentin L. Access and barriers to educational services for Canadian children with disabilities; 2010.Available from: http://www.ccl-cca.ca/pdfs/OtherReports/201009 KohenUppalKhanVisentinFullReport.pdf [last accessed 4 Feb 2015].",Non-OADS,/arxiv_data1/oa_pdf/07/45/idre-37-2282.PMC4673542.pdf
Available from: http://www.physiotherapy.ca/Practice-Resources/Practice-Management/Resources/Essential-Competencies-Profile- for-Physiotherapist?lang=en-ca [last accessed 4 Feb 2015].,Non-OADS,/arxiv_data1/oa_pdf/07/45/idre-37-2282.PMC4673542.pdf
Available from: http://www.caot.ca/default.asp?pageid=36 [last accessed 4Feb 2015].,OADS,/arxiv_data1/oa_pdf/07/45/idre-37-2282.PMC4673542.pdf
Available from: http://dconnect.acgme.org/acgmeweb/Portals/ 0/PDFs/commonguide/CompleteGuide_v2.pdf [last accessed 4 Feb 2015].,Non-OADS,/arxiv_data1/oa_pdf/07/45/idre-37-2282.PMC4673542.pdf
Available from: http://www.edu.gov.on.ca/ eng/general/elemsec/speced/guide/resource/iepresguid.pdf [lastaccessed 5 Feb 2015].,OADS,/arxiv_data1/oa_pdf/07/45/idre-37-2282.PMC4673542.pdf
"Fredericton, NB: Ministry of Education and Early Child Development; 2012 Jun, 237 p. Available from: http://www.gnb.ca/0000/publications/comm/Inclusion.pdf [last accessed 4 Feb 2015].",Non-OADS,/arxiv_data1/oa_pdf/07/45/idre-37-2282.PMC4673542.pdf
Available from:http://www.isa-sociology.org/colmemb/national-associations/en/meetings/reports/North America/Chapter 2.pdf [last accessed 4 Feb 2015].,Non-OADS,/arxiv_data1/oa_pdf/07/45/idre-37-2282.PMC4673542.pdf
Available from: http://online.wsj.com/articles/SB10000872396390444273704577633412579112188 [last accessed10 Feb 2015].,Non-OADS,/arxiv_data1/oa_pdf/07/45/idre-37-2282.PMC4673542.pdf
Available from: http://informahealthcare.com/doi/ abs/10.3109/01942638.2014.978933 [last accessed 10 Feb 2015].,Non-OADS,/arxiv_data1/oa_pdf/07/45/idre-37-2282.PMC4673542.pdf
"8, 1424 –1444, http://dx.doi.org/10.1080/02699931.2014.985635",Non-OADS,/arxiv_data1/oa_pdf/c2/e8/pcem-29-1424.PMC4673543.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License ( http://creativecommons.org/Licenses/by- nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/19/53/ghbi-28-215.PMC4673544.pdf
"1–2, 215–236, http://dx.doi.org/10.1080/08912963.2015.1027888",Non-OADS,/arxiv_data1/oa_pdf/19/53/ghbi-28-215.PMC4673544.pdf
Supplementary materials Supplementary material related to this articles is available online http://dx.doi.org/10.1080/08912963.2015.1027888 .,Non-OADS,/arxiv_data1/oa_pdf/19/53/ghbi-28-215.PMC4673544.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribu tion, and repro- duction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/35/bb/igas-50-1241.PMC4673555.pdf
"20, 2140 –2148, http://dx.doi.org/10.1080/02640414.2015.1064538 © 2015 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/ee/b3/rjsp-33-2140.PMC4673559.pdf
"The experimental light wasPhilips Hue light bulbs /C223(http://www2.meethue.com/ en-us/this-is-hue/), with 3 bulbs placed in globe-shaped frosted glass pendants in the central area of the house,i.e.",Non-OADS,/arxiv_data1/oa_pdf/ef/52/icbi-32-1049.PMC4673571.pdf
"54211, Solna, Sweden) using a side-by-side calibration method (Markvardt,2015: http://dx.doi.org/10.1080/15502724.2015.1020948).Daylight at noon-time during overcast sky condition wasused as the reference light-source.",OADS,/arxiv_data1/oa_pdf/ef/52/icbi-32-1049.PMC4673571.pdf
"11, 1914 –1926, http://dx.doi.org/10.1080/19440049.2015.1087059 © 2015 European Union.",Non-OADS,/arxiv_data1/oa_pdf/4b/1d/tfac-32-1914.PMC4673576.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by- nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/4b/1d/tfac-32-1914.PMC4673576.pdf
Available from: http://www.beesfordevelopment.,Non-OADS,/arxiv_data1/oa_pdf/4b/1d/tfac-32-1914.PMC4673576.pdf
Available from: https://ec.europa.eu/jrc/sites/default/ ﬁles/BELAC%20Annex %20to%20268-TEST.pdf?search .,Non-OADS,/arxiv_data1/oa_pdf/4b/1d/tfac-32-1914.PMC4673576.pdf
"Available from: http://tna.europarchive.o rg/20110116113217/http:// www.food.gov.uk/multimedia/pdfs/fsis8605.pdf Gómez-Ruiz J, Wenzl T. 2009.",Non-OADS,/arxiv_data1/oa_pdf/4b/1d/tfac-32-1914.PMC4673576.pdf
"Available from: http://www.iso.org/iso/home.htm Khan S, Aijun L, Zhang S, Hu Q, Zhu Y-G. 2008.",Non-OADS,/arxiv_data1/oa_pdf/4b/1d/tfac-32-1914.PMC4673576.pdf
"Available from: http://www.lidegaard.dk/Slides/ OC%20epidem/PP-VTE%2013-05-23%20Qlaira.pdfVisser M, Foidart JM, Coelingh Bennink HJ.",OADS,/arxiv_data1/oa_pdf/6b/c1/iejc-20-476.PMC4673580.pdf
"Published by Taylor & Francis This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivativesLicense ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.SAR and QSAR in Environmental Research , 2015 Vol.",Non-OADS,/arxiv_data1/oa_pdf/41/84/gsar-26-757.PMC4673582.pdf
"7 –9, 757 –782, http://dx.doi.org/10.1080/1062936X.2015.1090749",Non-OADS,/arxiv_data1/oa_pdf/41/84/gsar-26-757.PMC4673582.pdf
The sequence alignment for each individual species with thehuman aromatase template (pdb: 3EQM) [ 48] was performed using the ClustalW server (http://www.ch.embnet.org/software/ClustalW.html ).,OADS,/arxiv_data1/oa_pdf/41/84/gsar-26-757.PMC4673582.pdf
Available at http://www.birdlife.org/datazone/sowb.,Non-OADS,/arxiv_data1/oa_pdf/41/84/gsar-26-757.PMC4673582.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/81/main.PMC4673669.pdf
CSCs are small subpopulations of tumor cellsContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/pvrPapillomavirus Research http://dx.doi.org/10.1016/j.pvr.2015.08.001 2405-8521/ &2015 The Authors.,OADS,/arxiv_data1/oa_pdf/32/81/main.PMC4673669.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: HPV, Human papillomavirus; CSCs, Cancer stem cells; OSCC, Oral/ oropharyngeal squamous cell carcinomas; miRNA, MicroRNA; IL4, ALDH1, Alde- hyde dehydrogenase 1; siRNA, small interfering RNA nCorrespondence to: UCLA School of Dentistry, Center for the Health Sciences, Room 43-019, 10833 Le Conte Ave, Los Angeles, CA 90095, United States.Tel.",Non-OADS,/arxiv_data1/oa_pdf/32/81/main.PMC4673669.pdf
"(Cell Mol Gastroenterol Hepatol 2015;1:631 –645; http://dx.doi.org/ 10.1016/j.jcmgh.2015.08.004 ) Keywords: Autonomic; Chemogenetic; Enteric Nervous System; Intestine; Gut.Intestinal functions such as peristalsis require the coor- dinated activity of multiple cell types throughout the gut wall, including enteroendocrine cells, nerves, interstitial cells,and smooth muscle.",Non-OADS,/arxiv_data1/oa_pdf/14/7a/main.PMC4673674.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/7a/main.PMC4673674.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2015.08.004,OADS,/arxiv_data1/oa_pdf/14/7a/main.PMC4673674.pdf
"Details of Primary and Secondary Antibodies Antibody Source Dilution RRID Primary antibodies Goat anti-c-Kit R&D Systems, Minneapolis, MN 1:200 AB_354750Chicken anti-GFAP Abcam, Cambridge, MA 1:1000 AB_304558Rabbit anti-HA Cell Signaling Technology, Danvers, MA 1:500 AB_1549585 Invitrogen, Carlsbad, CA 1:250 AB_87935 Anti-human Hu C/D Molecular Probes, Eugene, OR 1:200 AB_1500232Rabbit anti-S100beta Abcam, Cambridge, MA 1:2000 AB_882426 Secondary antibodies Goat anti-rabbit Alexa Fluor 488 Invitrogen 1:400 AB_10562715 Donkey anti-goat Alexa Fluor 568 Invitrogen 1:400 AB_10564097Goat anti-chicken Alexa Fluor 568 Invitrogen 1:400 AB_10584483Goat anti-rabbit Alexa Fluor 568 Invitrogen 1:400 AB_10563566Streptavidin conjugated Alexa Fluor 594 Jackson ImmunoResearch, West Grove, PA 1:400 AB_2337250 RRID, Research Resource Identi ﬁers, Antibody Registry ( http://antibodyregistry.org ).632 McClain et al Cellular and Molecular Gastroenterology and Hepatology Vol.",Non-OADS,/arxiv_data1/oa_pdf/14/7a/main.PMC4673674.pdf
"Autism Res 2015, Published online, http://dx.doi.org/10.1002/aur.1467 .",Non-OADS,/arxiv_data1/oa_pdf/14/7a/main.PMC4673674.pdf
"Currently,  the  most prevalent  practice  is  to  rely  on  sequence  count  data  alone  to http://dx.doi.org/10.1016/j.bdq.2015.08.003 2214-7535/Published by  Elsevier  GmbH.",Non-OADS,/arxiv_data1/oa_pdf/15/92/main.PMC4673681.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/92/main.PMC4673681.pdf
"This  model  is  based,  in  part,  on  a  model  of  biallelic  genetic drift  provided  by  Dr.  Stephen  P.  DiFazio  that  can  easily  be  simu- lated  in  excel  <http://www.as.wvu.edu/ ∼sdifazio/popgen  12/labs/ GeneticDriftSim.pdf ,  last  accessed  06.08.15>.",Non-OADS,/arxiv_data1/oa_pdf/15/92/main.PMC4673681.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the online version,  at  http://dx.doi.org/10.1016/j.bdq.2015.08.003 .",OADS,/arxiv_data1/oa_pdf/15/92/main.PMC4673681.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6e/0f/main.PMC4673685.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2015.07.006,OADS,/arxiv_data1/oa_pdf/6e/0f/main.PMC4673685.pdf
"To determine the percentage of colocalization of two proteins,images obtained with the use of corresponding antibodieswere loaded into the ImageJ software ( http://imagej.nih.",OADS,/arxiv_data1/oa_pdf/6e/0f/main.PMC4673685.pdf
Comparison of CatB cleavage sites detected by MS versus CatB cleavage sites in mouse LAMP-1 predicted by the SitePrediction web tool ( http://www.dmbr.ugent.be/prx/bioit2 ).,OADS,/arxiv_data1/oa_pdf/6e/0f/main.PMC4673685.pdf
"Published online.http://dx.doi.org/10.1053/j.gastro.2015.05.012 25.Pandol SJ, Periskic S, Gukovsky I, et al.",OADS,/arxiv_data1/oa_pdf/6e/0f/main.PMC4673685.pdf
Available from:  http://www.fda.gov/ohrms/dockets/ac/03/briefing/3928B1_01_Merck%20.,Non-OADS,/arxiv_data1/oa_pdf/40/58/ABR-4-238.PMC4673705.pdf
: X02496) The sequence composed  of HBsAg and five epitopes was synthesized by  Biomatik Inc. (http://www.biomatik.com) and the  construct was received in pUC57 vector.,OADS,/arxiv_data1/oa_pdf/0e/e7/ABR-4-243.PMC4673707.pdf
Available from: http://research.fhcrc.org/content/ dam/stripe/hahn/methods/biochem/pet.pdf.,OADS,/arxiv_data1/oa_pdf/0e/e7/ABR-4-243.PMC4673707.pdf
Available from:  http://www.health.bih.nic.in/Docs/Guidelines/Guidelines‑NPCDCS.,Non-OADS,/arxiv_data1/oa_pdf/79/24/IJEM-19-695.PMC4673795.pdf
Available from:  http://www.moef.nic.in/sites/default/files/Final_vetted_BMW%20 Rules%202015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8b/1a/IJEM-19-698.PMC4673796.pdf
"Launched  by the then Union Health Minister, the campaign used  the slogan “one test can save two lives” and sensitized  more than a 100,000 adolescent girls regarding GDM  through school and college based interventions across  four states  (http://www.worlddiabetesfoundation.org/  projects/uttar‑pradesh‑punjab‑jharkhand‑and‑delhi‑india‑  wdf10‑500).Table 1: Definition of GDM by different criteria Criteria Method Fasting  (mg/dl)1 h  (mg/dl)2 h  (mg/dl) WHO 1999 Fasting OGTT With 75 g glucose‑ ‑ ≥140 IADPSG Fasting OGTT With 75 g glucose≥92 ≥180 ≥153 DIPSI Nonfasting OGTT With 75 g glucose‑ ‑ ≥140 GDM: Gestational diabetes mellitus, WHO: World Health Organization,  IADPSG: International Association of Diabetes and Pregnancy Study Groups,  DIPSI: Diabetes in Pregnancy Study Group in India, OGTT: Oral glucose tolerance test Table 2: Sensitivity and specificity of DIPSI criteria as  compared to WHO and IADPSG Nonfasting  2 h VBGAs compared to WHO  1999 criteria (%)As compared to  IADPSG criteria (%) Sensitivity Specificity Sensitivity Specificity ≥140 mg/dl  (DIPSI criteria)27.",Non-OADS,/arxiv_data1/oa_pdf/e7/4b/IJEM-19-701.PMC4673797.pdf
Avilable from: http://www.igovernment.in/site/diabetes‑test‑must‑pregnant‑women‑delhi‑39065.,Non-OADS,/arxiv_data1/oa_pdf/e7/4b/IJEM-19-701.PMC4673797.pdf
Available from: http://www.telegraphindia.com/1110309/jsp/ bihar/story_13684554.jsp.,Non-OADS,/arxiv_data1/oa_pdf/e7/4b/IJEM-19-701.PMC4673797.pdf
Avaliable from: https://www.idf.org/ sites/default/files/EN_6E_Atlas_Full_0.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7c/d0/IJEM-19-705.PMC4673798.pdf
Available from:  http://www.cochrane‑handbook.org.,OADS,/arxiv_data1/oa_pdf/7c/d0/IJEM-19-705.PMC4673798.pdf
Available  from: http://www.cochrane‑handbook.org.,OADS,/arxiv_data1/oa_pdf/7c/d0/IJEM-19-705.PMC4673798.pdf
Available from: https://www.dtu.,Non-OADS,/arxiv_data1/oa_pdf/7c/d0/IJEM-19-705.PMC4673798.pdf
Available from: http://www.fda.gov/Drugs/DrugSafety/ ucm446845.htm.,Non-OADS,/arxiv_data1/oa_pdf/7c/d0/IJEM-19-705.PMC4673798.pdf
Available from: http://www.fda.gov/Drugs/DrugSafety/ ucm446845.htm.,Non-OADS,/arxiv_data1/oa_pdf/d0/26/IJEM-19-722.PMC4673799.pdf
Available from: http://www.ema.europa.eu/ema/index.,Non-OADS,/arxiv_data1/oa_pdf/d0/26/IJEM-19-722.PMC4673799.pdf
Available from: http://www.typeonenation.org/groups/adults/forum/ topic/invokana‑fort1d/.,Non-OADS,/arxiv_data1/oa_pdf/d0/26/IJEM-19-722.PMC4673799.pdf
Available from: https://www.endo.confex.com/endo/2015endo/ webprogram/Paper21461.html.,Non-OADS,/arxiv_data1/oa_pdf/d0/26/IJEM-19-722.PMC4673799.pdf
Available from: http://www.endocrine‑abstracts.,Non-OADS,/arxiv_data1/oa_pdf/1a/ce/IJEM-19-731.PMC4673800.pdf
Available from: http://www.un.org/en/development/desa/population/ publications/pdf/ageing/WorldPopulationAgeing2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c1/d4/IJEM-19-744.PMC4673801.pdf
Available  from: http://www.professional.diabetes.org/admin/UserFiles/CE/PG/ Crandall%20‑%20ADA%20post%20grad%202014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c1/d4/IJEM-19-744.PMC4673801.pdf
Available from: http://www.professional.diabetes.org/Abstracts_ Display.aspx?TYP=1 and CID=54139.,Non-OADS,/arxiv_data1/oa_pdf/d5/f7/IJEM-19-764.PMC4673803.pdf
Available from:  http://www.professional.diabetes.org/Abstracts_Display.aspx?TYP=1 and CID=80992.,Non-OADS,/arxiv_data1/oa_pdf/d5/f7/IJEM-19-764.PMC4673803.pdf
Available  from: http://www.professional.diabetes.org/Abstracts_Display.,Non-OADS,/arxiv_data1/oa_pdf/d5/f7/IJEM-19-764.PMC4673803.pdf
Available  from: http://www.censusindia.gov.in.,OADS,/arxiv_data1/oa_pdf/61/1f/IJEM-19-781.PMC4673806.pdf
Available from: http://www.tnhealth.org/dph/ dphdbiod.php.,Non-OADS,/arxiv_data1/oa_pdf/61/1f/IJEM-19-781.PMC4673806.pdf
Available  from: https://www.ispad.org /resource‑ type/idfispad‑2011‑global‑ guideline‑diabetes‑childhoodand‑adolescence.,Non-OADS,/arxiv_data1/oa_pdf/30/17/IJEM-19-797.PMC4673809.pdf
Available  from: http://www.worldgastroenterology.org/assets/export/ userfiles/2012_Celiac%20Disease_long_FINAL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/30/17/IJEM-19-797.PMC4673809.pdf
Available from: http://www.who.int/ vmnis/indicators/haemoglobin.pdf.,OADS,/arxiv_data1/oa_pdf/30/17/IJEM-19-797.PMC4673809.pdf
Available from: http://c.ymcdn.com/sites/www.ispad.org/resource/ resmgr/ispad_CPCG_2009_‑ CHAPTER_18.pdf.,Non-OADS,/arxiv_data1/oa_pdf/30/17/IJEM-19-797.PMC4673809.pdf
Available from: http://www.apps.who.,Non-OADS,/arxiv_data1/oa_pdf/5a/f7/IJEM-19-850b.PMC4673820.pdf
Available from: http://www.nice.org.uk/ guidance/ng3/resources/diabetes‑ in‑pregnancy‑management‑  of‑diabetes‑and‑itscomplications‑from‑preconception‑to‑the‑  postnatal‑period‑51038446021.,Non-OADS,/arxiv_data1/oa_pdf/5a/f7/IJEM-19-850b.PMC4673820.pdf
Available from: http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ EndocrinologicandMetabolicDrugsAdvisoryCommittee/ UCM336234.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0a/f0/IJEM-19-854.PMC4673821.pdf
Available from: http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ EndocrinologicandMetabolicDrugsAdvisoryCommittee/ UCM336234.pdf.,Non-OADS,/arxiv_data1/oa_pdf/56/d6/IJEM-19-855.PMC4673822.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/b0/d4/ncomms9949.PMC4673831.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Xu, Q. et al.",Non-OADS,/arxiv_data1/oa_pdf/b0/d4/ncomms9949.PMC4673831.pdf
Available from: http://www.apho.org.uk/default.aspx?RID=40141 45.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/azph0037-0534.PMC4673870.pdf
Available from: http://healthimpactassessment.blogspot.com.au/ 46.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/azph0037-0534.PMC4673870.pdf
"More detailed data regarding reach (population size distribution, geographic coverage, duration and capacity); characteristics (role of local and state-based organisations and government, target groups, settings and strategies; quality (best practice Figure 1: The CO-OPS Map of CBI http://www.co-ops.net.au/map/index.html#/ Table 1: Focus and strategies of community based obesity prevention initiatives.",Non-OADS,/arxiv_data1/oa_pdf/58/07/azph0039-0168.PMC4673871.pdf
Available from: http://www.healthmetricsandevaluation.org/sites/default/files/country-profiles/GBD%20Country%20Report%20-%20Australia.pdf4.,Non-OADS,/arxiv_data1/oa_pdf/58/07/azph0039-0168.PMC4673871.pdf
Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/phd-prevention-np 15.,Non-OADS,/arxiv_data1/oa_pdf/58/07/azph0039-0168.PMC4673871.pdf
Available from: http://www.health.nsw.gov.au/healthyworkers/pages/default.aspx 17.,Non-OADS,/arxiv_data1/oa_pdf/58/07/azph0039-0168.PMC4673871.pdf
Available from: http://www.shapeup.gov.au/ 18.,Non-OADS,/arxiv_data1/oa_pdf/58/07/azph0039-0168.PMC4673871.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Extended Results and Discussion, Extended Experimental Procedures, three figures, and one table  and can be found with this article online at http://dx.doi.org/10.1016/j.celrep.2013.07.029 .Europe PMC Funders Group Author Manuscript Cell Rep.",Non-OADS,/arxiv_data1/oa_pdf/89/c8/emss-66289.PMC4673900.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2015, 10: 29269 - http://dx.doi.org/10.3402/ljm.v10.29269 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/78/5c/LJM-10-29269.PMC4673913.pdf
"2 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 29269 - http://dx.doi.org/10.3402/ljm.v10.29269",Non-OADS,/arxiv_data1/oa_pdf/78/5c/LJM-10-29269.PMC4673913.pdf
"**p: Statistical significance was set at a pvalueB0.05 for Kruskal /C1Wallis test.Effect of levosimendan on injury in diabetic rats Citation: Libyan J Med 2015, 10: 29269 - http://dx.doi.org/10.3402/ljm.v10.29269 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/78/5c/LJM-10-29269.PMC4673913.pdf
"4 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 29269 - http://dx.doi.org/10.3402/ljm.v10.29269",Non-OADS,/arxiv_data1/oa_pdf/78/5c/LJM-10-29269.PMC4673913.pdf
"Levosimendan facilitates weaning from cardio-pulmonary bypass in patients undergoing coronary arteryEffect of levosimendan on injury in diabetic rats Citation: Libyan J Med 2015, 10: 29269 - http://dx.doi.org/10.3402/ljm.v10.29269 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/78/5c/LJM-10-29269.PMC4673913.pdf
"6 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 29269 - http://dx.doi.org/10.3402/ljm.v10.29269",Non-OADS,/arxiv_data1/oa_pdf/78/5c/LJM-10-29269.PMC4673913.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2015, 4: 28533 - http://dx.doi.org/10.3402/jev.v4.28533 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cb/96/JEV-4-28533.PMC4673914.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 28533 - http://dx.doi.org/10.3402/jev.v4.28533",OADS,/arxiv_data1/oa_pdf/cb/96/JEV-4-28533.PMC4673914.pdf
"(a) Media from cultured cells are puriﬁed using a commercial isolation kit or differential centrifugation; (b) puriﬁed exosomes are trapped in the laser beam of a home- built microscope system, and Raman spectra are collected, yielding (c) a database of spectra of single exosomes.Single exosome study reveals subpopulations Citation: Journal of Extracellular Vesicles 2015, 4: 28533 - http://dx.doi.org/10.3402/jev.v4.28533 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cb/96/JEV-4-28533.PMC4673914.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 28533 - http://dx.doi.org/10.3402/jev.v4.28533",OADS,/arxiv_data1/oa_pdf/cb/96/JEV-4-28533.PMC4673914.pdf
"Using SDS /C1polyacrylamideSingle exosome study reveals subpopulations Citation: Journal of Extracellular Vesicles 2015, 4: 28533 - http://dx.doi.org/10.3402/jev.v4.28533 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/cb/96/JEV-4-28533.PMC4673914.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 28533 - http://dx.doi.org/10.3402/jev.v4.28533",OADS,/arxiv_data1/oa_pdf/cb/96/JEV-4-28533.PMC4673914.pdf
"3a, as expectedgiven that many cell lines have exosomes in more thanSingle exosome study reveals subpopulations Citation: Journal of Extracellular Vesicles 2015, 4: 28533 - http://dx.doi.org/10.3402/jev.v4.28533 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/cb/96/JEV-4-28533.PMC4673914.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 28533 - http://dx.doi.org/10.3402/jev.v4.28533",OADS,/arxiv_data1/oa_pdf/cb/96/JEV-4-28533.PMC4673914.pdf
"Position (cm/C281) Peak assignment Reference 700 Cholesteryl ester (45) 840 Saccharide/amines (45,46)882 Tryptophan side-chain in proteins (47)1,066 Chain C /C1C stretching in lipids (48) 1,298 CH 2deformations in lipids (49) 1,450 CH 2and CH 3deformations in proteins and lipids(49) 1,651 C /C30C stretching in lipids (50) 1,668 Amide I vibrations in proteins Cholesteryl ester(45,51)Single exosome study reveals subpopulations Citation: Journal of Extracellular Vesicles 2015, 4: 28533 - http://dx.doi.org/10.3402/jev.v4.28533 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cb/96/JEV-4-28533.PMC4673914.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 28533 - http://dx.doi.org/10.3402/jev.v4.28533",OADS,/arxiv_data1/oa_pdf/cb/96/JEV-4-28533.PMC4673914.pdf
"Spectra in (a) and (b) offset for clarity.Single exosome study reveals subpopulations Citation: Journal of Extracellular Vesicles 2015, 4: 28533 - http://dx.doi.org/10.3402/jev.v4.28533 11 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/cb/96/JEV-4-28533.PMC4673914.pdf
"12 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 28533 - http://dx.doi.org/10.3402/jev.v4.28533",OADS,/arxiv_data1/oa_pdf/cb/96/JEV-4-28533.PMC4673914.pdf
"We also acknowledge AaltoSingle exosome study reveals subpopulations Citation: Journal of Extracellular Vesicles 2015, 4: 28533 - http://dx.doi.org/10.3402/jev.v4.28533 13 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/cb/96/JEV-4-28533.PMC4673914.pdf
"2014;3:26913, doi:http://dx.doi.org/10.3402/jev.v3.26913 12.",Non-OADS,/arxiv_data1/oa_pdf/cb/96/JEV-4-28533.PMC4673914.pdf
"J Extracell Vesicles.2012;1:19179, doi: http://dx.doi.org/10.3402/jev.v1i0.19179 31.",Non-OADS,/arxiv_data1/oa_pdf/cb/96/JEV-4-28533.PMC4673914.pdf
"14 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 28533 - http://dx.doi.org/10.3402/jev.v4.28533",OADS,/arxiv_data1/oa_pdf/cb/96/JEV-4-28533.PMC4673914.pdf
"2014;3:24783, doi: http://dx.doi.org/10.3402/jev.v3.24783 39.",Non-OADS,/arxiv_data1/oa_pdf/cb/96/JEV-4-28533.PMC4673914.pdf
"2014;3:23430, doi: http://dx.doi.org/10.3402/jev.v3.23430 41.",Non-OADS,/arxiv_data1/oa_pdf/cb/96/JEV-4-28533.PMC4673914.pdf
"2013;2:19861, doi: http://dx.doi.org/10.3402/jev.v2i0.",Non-OADS,/arxiv_data1/oa_pdf/cb/96/JEV-4-28533.PMC4673914.pdf
"2011;83:5086 /C192.Single exosome study reveals subpopulations Citation: Journal of Extracellular Vesicles 2015, 4: 28533 - http://dx.doi.org/10.3402/jev.v4.28533 15 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cb/96/JEV-4-28533.PMC4673914.pdf
"Availability and implementation: The program, datasets and results are freely available to aca- demic users at http://sfb.kaust.edu.sa/Pages/Software.aspx.Contact: xin.gao@kaust.edu.sa and stefan.arold@kaust.edu.sa Supplementary information: Supplementary data are available at Bioinformatics online.",OADS,/arxiv_data1/oa_pdf/46/b4/btv477.PMC4673972.pdf
"3922 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/b4/btv477.PMC4673972.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/  Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/fb/10/mtm201546.PMC4674005.pdf
"Published by Oxford University Press.This is an Open Access article distributed under the terms of the Creative Commons Attributio n Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduc tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/19/ldv047.PMC4674007.pdf
"The full value set of the EQ-5D-5L can be accessed at http://www.phenomresearch.ca or throughthe online supplementary ﬁle (Supplemental Digital Content1, http://links.lww.com/MLR/B39).",Non-OADS,/arxiv_data1/oa_pdf/a0/f4/mlr-54-98.PMC4674140.pdf
"This battery included: the Beck Depression Inventory-II; the Wide Range Intel- ligence Test including average verbal (crystallized intel- ligence) and visual (fluid intelligence); the Wide Range Assessment of Memory and Learning, including the four domains of verbal memory, visual memory, attention/ concentration, and working memory; and the Delis– Kaplan Executive Function System (for an in-depth description of these neuropsychology tests, see Supple- mental Digital Content, http://links.lww.com/MAO/ A351) (18–28).",Non-OADS,/arxiv_data1/oa_pdf/77/1c/mao-37-70.PMC4674143.pdf
"The methods for the diagnostic studies performed can be found in the Supplemental Digital Content (http://links.lww.com/MAO/A351) (2,29–31).",Non-OADS,/arxiv_data1/oa_pdf/77/1c/mao-37-70.PMC4674143.pdf
Dizziness Handicap Inventory The methods for the Dizziness Handicap Inventory (DHI) studies performed can be found in the Supplemental Digital Content (http://links.lww.com/MAO/A351) (32).,Non-OADS,/arxiv_data1/oa_pdf/77/1c/mao-37-70.PMC4674143.pdf
"Headache Impact Test The methods for the Headache Impact Test (HIT-6) studies performed can be found in the Supplemental Digital Content (http://links.lww.com/MAO/A351) (33,34).",Non-OADS,/arxiv_data1/oa_pdf/77/1c/mao-37-70.PMC4674143.pdf
Computerized Dynamic Posturography The methods for the computerized dynamic posturography studies performed can be found in the Supplemental Digital Content (http://links.lww.com/MAO/A351) (35–37).,Non-OADS,/arxiv_data1/oa_pdf/77/1c/mao-37-70.PMC4674143.pdf
Detailed information regarding each of these neuropsychology tests can be found in the Supplemental Digital Content (http://links.lww.com/MAO/A351).,Non-OADS,/arxiv_data1/oa_pdf/77/1c/mao-37-70.PMC4674143.pdf
Additional infor- mation regarding the limitations of reporting the hearing and cVEMP outcomes can be found in the Supplemental Digital Content (http://links.lww.com/MAO/A351) (30).,Non-OADS,/arxiv_data1/oa_pdf/77/1c/mao-37-70.PMC4674143.pdf
Cognitive Functional Differences Between SCD and No-iOCD Patients Further discussion of the cognitive differences between SCD and no-iOCD patients can be found in the Supplemental Digital Content (http://links.lww.com/ MAO/A351) (50–59).,Non-OADS,/arxiv_data1/oa_pdf/77/1c/mao-37-70.PMC4674143.pdf
"Further discussion of these issues from the historical perspective can be found in the Supplemental Digital Content (http://links.lww.com/MAO/A351) (74,75).",Non-OADS,/arxiv_data1/oa_pdf/77/1c/mao-37-70.PMC4674143.pdf
Altered Spatial Orientation A discussion of the relationship between diseases producing otic capsule dehiscence syndrome and altered spatial orientation can be found in the Supplemental Digital Content (http://links.lww.com/MAO/A351) (76–79).,Non-OADS,/arxiv_data1/oa_pdf/77/1c/mao-37-70.PMC4674143.pdf
"Migraine Headache A discussion of the relationship between diseases producing otic capsule dehiscence syndrome and migraine headache can be found in the Supplemental Digital Content (http://links.lww.com/MAO/A351) (3– 7,9–12,80–82) (also see Fig.",Non-OADS,/arxiv_data1/oa_pdf/77/1c/mao-37-70.PMC4674143.pdf
Learning Effects A discussion of learning effects can be found in the Supplemental Digital Content (http://links.lww.com/ MAO/A351) (83–85).,Non-OADS,/arxiv_data1/oa_pdf/77/1c/mao-37-70.PMC4674143.pdf
https://vestibular.org/sites/default/ files/page_files/Documents/Cognitive Aspects of Vestibular Dis- orders.pdf.,Non-OADS,/arxiv_data1/oa_pdf/77/1c/mao-37-70.PMC4674143.pdf
"https://www.you- tube.com/watch?v=7azu9sszZSk Published June 8, 2015.",Non-OADS,/arxiv_data1/oa_pdf/77/1c/mao-37-70.PMC4674143.pdf
"https://www.youtube.com/ watch?v=9xVNxNGys1w Published August 2, 2015.",Non-OADS,/arxiv_data1/oa_pdf/77/1c/mao-37-70.PMC4674143.pdf
https://www.youtube.com/watch?v=Szp_kO8oVos.,Non-OADS,/arxiv_data1/oa_pdf/77/1c/mao-37-70.PMC4674143.pdf
https://www.youtube.com/watch?v=fkdFozzQ- BEc.,Non-OADS,/arxiv_data1/oa_pdf/77/1c/mao-37-70.PMC4674143.pdf
https://www.youtube.com/watch?v=2-kD 59ygKrE.,Non-OADS,/arxiv_data1/oa_pdf/77/1c/mao-37-70.PMC4674143.pdf
https://www.youtube.com/watch?v=1Nl9T6etxqM.,Non-OADS,/arxiv_data1/oa_pdf/77/1c/mao-37-70.PMC4674143.pdf
"https://www.you- tube.com/watch?v=Zy7YjCDnLYM Published April 12, 2012.",Non-OADS,/arxiv_data1/oa_pdf/77/1c/mao-37-70.PMC4674143.pdf
"In techni- cal terms, the parameters were estimated using the “drm” function in the “drc” package in R (http://cran.r-project.org/).",OADS,/arxiv_data1/oa_pdf/26/06/10.2203_dose-response.13-045.Fujii.PMC4674159.pdf
"Available at http://cvxopt.org/ Mizutani A, Okada T, Shibutani S, Sonoda E, Hochegger H, Nishigori C, Miyachi Y, Takeda S, and Yamazoe M. 2004.",OADS,/arxiv_data1/oa_pdf/26/06/10.2203_dose-response.13-045.Fujii.PMC4674159.pdf
Accessed at: http://www.cdc.gov/heartdisease/guidelines_recommendations.htm Centers for Disease Control and Prevention (CDC).,Non-OADS,/arxiv_data1/oa_pdf/83/32/10.2203_dose-response.14-021.Hart.PMC4674162.pdf
2:2. http://dx.doi.org/10.7243/2054-9911-2-2.,Non-OADS,/arxiv_data1/oa_pdf/83/32/10.2203_dose-response.14-021.Hart.PMC4674162.pdf
"2:2. http://dx.doi.org/10.7243/2054-9911-2-2 Idso CD, Idso SB, Carter RM, and Singer FS (Editors).",OADS,/arxiv_data1/oa_pdf/16/a6/10.2203_dose-response.14-024.Hart.PMC4674164.pdf
"Accessed April 19, 2014 at: http://www.nipccreport.org/reports/ccr2b/ccr2biologicalimpacts.html Jacobs DR, McGovern PG, and Blackburn H. 1992.",OADS,/arxiv_data1/oa_pdf/16/a6/10.2203_dose-response.14-024.Hart.PMC4674164.pdf
"Accessed April  20, 2014 at: http://time.com/43118/climate-change-global-warming-united-nations/",Non-OADS,/arxiv_data1/oa_pdf/16/a6/10.2203_dose-response.14-024.Hart.PMC4674164.pdf
"Health Consequences of the Chernobyl Accident9and other colleagues from Scientists for Accurate Radiation Information  (SARI), http://RadiationEffects.org.",Non-OADS,/arxiv_data1/oa_pdf/fc/97/10.2203_dose-response.14-040.Socol.PMC4674166.pdf
"Preprint IAEA-CN-48/274 http://www.osti.gov/scitech/servlets/purl/5517624 (accessed July 27, 2014) Aumann RJ.",Non-OADS,/arxiv_data1/oa_pdf/fc/97/10.2203_dose-response.14-040.Socol.PMC4674166.pdf
"The Nobel Prize, 2005 http://www.nobelprize.",Non-OADS,/arxiv_data1/oa_pdf/fc/97/10.2203_dose-response.14-040.Socol.PMC4674166.pdf
"2nd revised edition, Vienna: IAEA, 2005. http://www.iaea.org/Publications/Booklets/Chernobyl/chernobyl.pdf (accessed July 27, 2014) Fairlie I. and Sumner D. 2006.",Non-OADS,/arxiv_data1/oa_pdf/fc/97/10.2203_dose-response.14-040.Socol.PMC4674166.pdf
"http://www.ChernobylReport.org/torch.pdf (accessed July 27, 2014) Gonzalez AJ, Akashi M, Boice JD, Chino M, Homma T, Ishigure N, Kai M, Kusumi S, Lee JK, Menzel  HG, Niwa O, Sakai K, Weiss W, Yamashita S, and Yonekura Y.",Non-OADS,/arxiv_data1/oa_pdf/fc/97/10.2203_dose-response.14-040.Socol.PMC4674166.pdf
"ISBN: 0-309-53040-7 http://www.nap.edu/catalog/11340.html (accessed July 27, 2014) Popper K. 1963.",Non-OADS,/arxiv_data1/oa_pdf/fc/97/10.2203_dose-response.14-040.Socol.PMC4674166.pdf
"Volume II: Scientific Annexes C, D and E, NY: United Nations, 45-220. http://www.unscear.org/unscear/en/publications/2008_2.html (accessed July 27, 2014) United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR).",Non-OADS,/arxiv_data1/oa_pdf/fc/97/10.2203_dose-response.14-040.Socol.PMC4674166.pdf
"Fifty-ninth session (21-25 May 2012), NY: United Nations, p. 10. http://www.un.org/ga/search/view_doc.asp?symbol-=A/67/46 (accessed July 27, 2014) World Health Organization (WHO).",Non-OADS,/arxiv_data1/oa_pdf/fc/97/10.2203_dose-response.14-040.Socol.PMC4674166.pdf
"Health effects of the Chernobyl accident: an overview, April 2006.  http://www.who.int/ionizing_radiation/chernobyl/backgrounder (accessed July 27, 2014)",Non-OADS,/arxiv_data1/oa_pdf/fc/97/10.2203_dose-response.14-040.Socol.PMC4674166.pdf
"Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036393/ Feinendegen LE, Muehlensiepen H, Bond VP and Sondhaus CA.",Non-OADS,/arxiv_data1/oa_pdf/ac/60/10.2203_dose-response.15-003.Cuttler.PMC4674170.pdf
Available  at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2477707/ Sakamoto K. 2004.,Non-OADS,/arxiv_data1/oa_pdf/ac/60/10.2203_dose-response.15-003.Cuttler.PMC4674170.pdf
Available at: http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC2657505/ Simmons JA and Richards SR. 2010.,Non-OADS,/arxiv_data1/oa_pdf/ac/60/10.2203_dose-response.15-003.Cuttler.PMC4674170.pdf
http://www.efsa.europa.eu/en/topics/topic/bisphenol.,Non-OADS,/arxiv_data1/oa_pdf/02/ef/10.1177_1559325815590395.PMC4674176.pdf
(http://www.epa.gov/iris/subst/0356.htm#reforal).,OADS,/arxiv_data1/oa_pdf/02/ef/10.1177_1559325815590395.PMC4674176.pdf
(http://www.who.int/mediacentre/factsheets/fs311/en/).,Non-OADS,/arxiv_data1/oa_pdf/02/ef/10.1177_1559325815590395.PMC4674176.pdf
"2, Academie Nationale de Medecine, Institut de France—Academie des Sciences (March 30) (http://www.academiemedecine.fr/actualites/) Edition Nucleon (Paris 2005) Zeng G, Day TK, Hooker AM, Blyth BJ, Bhat M, Tilley WD, and Sykes PJ.",Non-OADS,/arxiv_data1/oa_pdf/a6/f9/10.2203_dose-response.14-025.Mitchel.PMC4674178.pdf
"Available  at http://www.aapm.org/org/policies/details.asp?id=318&type=PP&current=true Ait-Ali L, Andreassi MG, Foffa I, Spadoni I, Vano E and Picano E. 2010.",Non-OADS,/arxiv_data1/oa_pdf/4d/b4/10.2203_dose-response.14-030.Ulsh.PMC4674180.pdf
Available at http://www.arps.org.au/?q=content/low-dose-radiationBerrington de Gonzalez A and Darby S. 2004.,Non-OADS,/arxiv_data1/oa_pdf/4d/b4/10.2203_dose-response.14-030.Ulsh.PMC4674180.pdf
"Available at  http://www.fda.gov/Radiation-EmittingProducts/RadiationSafety/RadiationDoseReduction/default.htm Fletcher JG, Kofler JM, Coburn JA, Bruining DH and McCollough CH.",OADS,/arxiv_data1/oa_pdf/4d/b4/10.2203_dose-response.14-030.Ulsh.PMC4674180.pdf
"Available at  http://hps.org/documents/risk_ps010-2.pdf Hu JF, Johnson KC, Mao Y, Guo LH, Zhao XG, Jia XY, Bi DZ, Huang GR and Liu RZ.",Non-OADS,/arxiv_data1/oa_pdf/4d/b4/10.2203_dose-response.14-030.Ulsh.PMC4674180.pdf
"Funding The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by the Macao Science and Technology Development Fund (074/2013/A) and the Research Fund of the University of Macau (MYRG107(Y1-L3)-ICMS13-HCW, MRG013/HCW/2014/ICMS, MYRG2015-00081-ICMS-QRCM).Supplemental Material The supplementary figures are available at http://dos.sagepub.com/ supplemental.",Non-OADS,/arxiv_data1/oa_pdf/4c/27/10.1177_1559325815592606.PMC4674184.pdf
"EPA Final Report BISPHENOL A ALTERNATIVES IN THERMAL PAPER, January 2014. http://www.epa.gov/dfe/pubs/projects/bpa/ bpa-report-complete.pdf.",Non-OADS,/arxiv_data1/oa_pdf/7e/9a/10.1177_1559325815598304.PMC4674185.pdf
"http://ec.europa.e u/environment/endocrine/docu- ments/4_SOTA %20EDC %20Final %20Report %20V3%206% 20Feb%2012.pdf Kwak HI, Bae MO, Lee MH, Lee YS, Lee BJ, Kang KS, Chae CH, Sung HJ, Shin JS, Kim JH, Mar WC, Sheen YY, Cho MH.",Non-OADS,/arxiv_data1/oa_pdf/7e/9a/10.1177_1559325815598304.PMC4674185.pdf
"In addition, we observed the BCF estimate of 71.85 (log P¼3.32) derived by the U.S. Environmental Protection Agency’s Estimation Programs Interface (EPI) Suite software (http://www.epa.gov/opptintr/exposure/pubs/episuitedl.htm) to be much closer to laboratory-derived BCFs.",OADS,/arxiv_data1/oa_pdf/19/5e/10.1177_1559325815598308.PMC4674187.pdf
Supplemental Material The online tables are available at http://dos.sagepub.com/supplemental.,Non-OADS,/arxiv_data1/oa_pdf/19/5e/10.1177_1559325815598308.PMC4674187.pdf
"http://www.icis.com/resources/news/2008/ 10/13/9162868/chemical-profile -bisphenol-a/ (accessed January 29, 2015) Bursch W, Fu ¨rhacker M, Gemeiner M, Grillitsch B, Jungbauer A, Kreuzinger N, and Skutan S. 2004.",OADS,/arxiv_data1/oa_pdf/19/5e/10.1177_1559325815598308.PMC4674187.pdf
"http://www.cdc.gov/exposurereport/pdf/FourthRe- port_UpdatedTables_Mar2013.pdf [accessed 24 February, 2015].",OADS,/arxiv_data1/oa_pdf/19/5e/10.1177_1559325815598308.PMC4674187.pdf
"2015. https://scifinder.cas.org (accessed 9th February 2015) Seb}ok A´, Vasanits-Zsigrai A, Helenka ´r A, Za ´ray G, and Molna ´r-Perl I.",Non-OADS,/arxiv_data1/oa_pdf/19/5e/10.1177_1559325815598308.PMC4674187.pdf
"Mar Pollut Bull http://dx.doi.org/10.1016/j.marpolbul.2014.11.027 Staples C, Friederich U, Hall T, Klecka G, Mihaich E, Ortego L, Caspers N, and Hentges S. 2010.",OADS,/arxiv_data1/oa_pdf/19/5e/10.1177_1559325815598308.PMC4674187.pdf
"ISBN 973-3-540-36718-5.Available at: http://db.tt/UyrhlBpW Fliedner T.M., Graessle D., Mei neke V., Feinendegen L.E.",Non-OADS,/arxiv_data1/oa_pdf/4a/e7/10.1177_1559325815592391.PMC4674188.pdf
"Taipei, Taiwan: Ministry of Health and Welfare; 2013. http://www.nhi.gov.tw/webdata/webdata.aspx?menu¼17&menu_id ¼1023&WD_ID ¼1043&webdata_id ¼4639.",Non-OADS,/arxiv_data1/oa_pdf/d3/8e/medi-94-e1999.PMC4674191.pdf
2013; http://seer.cancer.gov/csr/1975_2010/.,Non-OADS,/arxiv_data1/oa_pdf/e9/5c/medi-94-e2063.PMC4674192.pdf
"As indicated in Table 1, specificpolymerase chain reaction (PCR) primers for amplificationof DNA fragments were designed and verified using SNPs database (dbSNP 129;http://www.ncbi.nlm.nih.gov/projects/ SNP/) and Basic Local Alignment Search Tool website(http://blast.ncbi.nlm.nih.gov/Blast.cgi).",OADS,/arxiv_data1/oa_pdf/68/86/medi-94-e2144.PMC4674197.pdf
This was in agreementwith the expected values due to NCBI website (http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?searchType ¼ adhoc_search&type ¼rs&rs ¼rs2073823).,OADS,/arxiv_data1/oa_pdf/68/86/medi-94-e2144.PMC4674197.pdf
"Characteristics of the 2 study popu-lations are shown in Appendix, http://links.lww.com/MD/ A536.",Non-OADS,/arxiv_data1/oa_pdf/75/57/medi-94-e2166.PMC4674202.pdf
"The results (Appendix, http://links.lww.com/MD/A536) indicate that PCKD patients had comparable risk of peritonitis and techniqueMedicine /C15Volume 94, Number 48, December 2015 Outcomes of Patients With PCKD on PD Copyright #2015 Wolters Kluwer Health, Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/75/57/medi-94-e2166.PMC4674202.pdf
"After adjusting forTNM stage, a nonlinear relationship between the TII valuesand the risk of recurrence was observed (see Figure S1, Supple- mental Content, http://links.lww.com/MD/A537, which illus- trates the adjusted association between TII and the risk ofNSCLC recurrence after curative resection).",Non-OADS,/arxiv_data1/oa_pdf/e2/cc/medi-94-e2174.PMC4674204.pdf
"Statistical Analysis Statistical analyses were performed with R (version 3.2.2, http://www.R-project.org).",OADS,/arxiv_data1/oa_pdf/e2/cc/medi-94-e2174.PMC4674204.pdf
"The relationship between the TII and the risk of NSCLC recurrence was explored using asmoothing plot (Figure S1, http://links.lww.com/MD/A537).Student ttest and Pearson chi-square test or Fisher exact test were used to compare differences between the groups (Table 1, TABLE 1.",OADS,/arxiv_data1/oa_pdf/e2/cc/medi-94-e2174.PMC4674204.pdf
"Table S1, http://links.lww.com/MD/A538).",Non-OADS,/arxiv_data1/oa_pdf/e2/cc/medi-94-e2174.PMC4674204.pdf
"In addition, we alsofound that patients with commodities, especially diabetes, weremore likely to have higher TII values ( P¼0.008, see Table S1, Supplemental Content, http://links.lww.com/MD/A538, which illustrates the correlation between TII and clinicopathologicalcharacteristics).",Non-OADS,/arxiv_data1/oa_pdf/e2/cc/medi-94-e2174.PMC4674204.pdf
http://www.mohw.,Non-OADS,/arxiv_data1/oa_pdf/f5/34/medi-94-e2192.PMC4674209.pdf
"Taiwan, http://nhird.nhri.org.tw/en/Background.html (cited in 2015).",Non-OADS,/arxiv_data1/oa_pdf/f5/34/medi-94-e2192.PMC4674209.pdf
"We also ascertained the association of FH categories and hypertension in the sensitivity analysis and the results were similar (Appendix Table, http://links.lww.com/MD/A548).",Non-OADS,/arxiv_data1/oa_pdf/66/ee/medi-94-e2226.PMC4674215.pdf
"Please read the full license for further details at -  http://creativecommons.org/licenses/by-nc-sa/4.0/ Correspondence: HF Zhang, hfzhang@northwestern.edu.",Non-OADS,/arxiv_data1/oa_pdf/5c/80/nihms739611.PMC4674267.pdf
Supplementary Information for this article can be found on the Light: Science & Applications ' website: ( http://www.nature.com/lsa ).,Non-OADS,/arxiv_data1/oa_pdf/5c/80/nihms739611.PMC4674267.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any228 Dermatol Ther (Heidelb) (2015) 5:217–230",Non-OADS,/arxiv_data1/oa_pdf/6c/3f/13555_2015_Article_89.PMC4674450.pdf
Dr. R. Pﬂeger GmbH 2015. http://www.fachinfo.de .,Non-OADS,/arxiv_data1/oa_pdf/6c/3f/13555_2015_Article_89.PMC4674450.pdf
Dr. R. Pﬂeger 2014. http://www.fachinfo.de .,Non-OADS,/arxiv_data1/oa_pdf/6c/3f/13555_2015_Article_89.PMC4674450.pdf
http://www.bfarm.de/SharedDocs/Bekanntmachungen/DE/Arzneimittel/klinPr/bm-KlinPr-20100707- NichtinterventePr-pdf.pdf?__blob=publicationFile& v=5.,Non-OADS,/arxiv_data1/oa_pdf/6c/3f/13555_2015_Article_89.PMC4674450.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/5d/64/13555_2015_Article_86.PMC4674451.pdf
http://www.dermpath diagnostics.com/pages/DxRefDetail?catid=25&id= 102.,OADS,/arxiv_data1/oa_pdf/5d/64/13555_2015_Article_86.PMC4674451.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit tothe original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/a5/bb/13555_2015_Article_85.PMC4674452.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/50/b8/13555_2015_Article_84.PMC4674453.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, pro- vide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/5e/c9/13555_2015_Article_87.PMC4674455.pdf
2014. http://apps.who.int/gb/ebwha/pdf_ﬁles/WHA67/A67_ R9-en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/5e/c9/13555_2015_Article_87.PMC4674455.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/72/14/13300_2015_Article_143.PMC4674462.pdf
Available from: http://www.cadth.ca/media/ pdf/341b_Long-acting-insulin_tr_e.pdf .,Non-OADS,/arxiv_data1/oa_pdf/72/14/13300_2015_Article_143.PMC4674462.pdf
Availablefrom: http://www.msssi.gob.es/profesionales/ nomenclator.do .,Non-OADS,/arxiv_data1/oa_pdf/72/14/13300_2015_Article_143.PMC4674462.pdf
Available at: https://botplusweb.portalfarma.com/ .,Non-OADS,/arxiv_data1/oa_pdf/72/14/13300_2015_Article_143.PMC4674462.pdf
Available at: http://www.oblikue.com/ bddcostes/ .,Non-OADS,/arxiv_data1/oa_pdf/72/14/13300_2015_Article_143.PMC4674462.pdf
http://www.ine.es .,Non-OADS,/arxiv_data1/oa_pdf/72/14/13300_2015_Article_143.PMC4674462.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ca/80/13300_2015_Article_137.PMC4674463.pdf
http://www.idf.org/ diabetesatlas .,Non-OADS,/arxiv_data1/oa_pdf/ca/80/13300_2015_Article_137.PMC4674463.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ab/7d/13300_2015_Article_141.PMC4674464.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any med- ium, provided appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/c7/2c/13300_2015_Article_139.PMC4674465.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/5d/10/13300_2015_Article_131.PMC4674466.pdf
2012. http://guidance.nice.org.uk/ CG147 .,Non-OADS,/arxiv_data1/oa_pdf/5d/10/13300_2015_Article_131.PMC4674466.pdf
2011. http://www.nice.org.uk/guidance/CG119 .,Non-OADS,/arxiv_data1/oa_pdf/5d/10/13300_2015_Article_131.PMC4674466.pdf
2015. http://iwgdf.org/ guidelines/guidance-on-pad-2015/ .,Non-OADS,/arxiv_data1/oa_pdf/5d/10/13300_2015_Article_131.PMC4674466.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b9/cd/13300_2015_Article_136.PMC4674467.pdf
This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.,Non-OADS,/arxiv_data1/oa_pdf/e2/db/13300_2015_Article_132.PMC4674468.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/4c/2e/13300_2015_Article_147.PMC4674469.pdf
"Brussels, Belgium: International Diabetes Federation, 2013. http://www.idf.org/ diabetesatlas/6e/diabetes .",Non-OADS,/arxiv_data1/oa_pdf/4c/2e/13300_2015_Article_147.PMC4674469.pdf
Bunkodo Co. Ltd. http://www.jds.or.jp/ modules/en/index.php?content_id=27 .,OADS,/arxiv_data1/oa_pdf/4c/2e/13300_2015_Article_147.PMC4674469.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/8f/08/13300_2015_Article_129.PMC4674470.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any544 Diabetes Ther (2015) 6:531–545",Non-OADS,/arxiv_data1/oa_pdf/ae/be/13300_2015_Article_138.PMC4674471.pdf
National Diabetes Statistics Report 2014. http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/ae/be/13300_2015_Article_138.PMC4674471.pdf
http://www.go-vgo.com/ sites/default/ﬁles/upload/instructions-for-patient- use.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ae/be/13300_2015_Article_138.PMC4674471.pdf
"This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/ 4.0/), which permits any noncommercial use, distribution, and reproduction in any med- ium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/35/6d/13300_2015_Article_130.PMC4674472.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e2/a0/13300_2015_Article_133.PMC4674473.pdf
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/516 Diabetes Ther (2015) 6:509–517,Non-OADS,/arxiv_data1/oa_pdf/0d/3a/13300_2015_Article_135.PMC4674474.pdf
12. http://www.appliedanimalbehaviour.com/article/ S0168-1591(07)00395-4/abstract .,Non-OADS,/arxiv_data1/oa_pdf/0d/3a/13300_2015_Article_135.PMC4674474.pdf
"13. http://www.behaviorworks.o rg/ﬁles/articles/What’s% 20Wrong%20with%20this%20Picture.pdf .L a s t Accessed Sep 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/0d/3a/13300_2015_Article_135.PMC4674474.pdf
15. http://www.appliedanimalbehaviour.com/article/ S0168-1591(07)00395-4/abstract .,Non-OADS,/arxiv_data1/oa_pdf/0d/3a/13300_2015_Article_135.PMC4674474.pdf
http://www.npr.org/ 2013/09/11/221017467/four-legged-impostors-give- service-dog-owners-pauseHealthCentral .A c c e s s e d 30 Sept 2015.,Non-OADS,/arxiv_data1/oa_pdf/0d/3a/13300_2015_Article_135.PMC4674474.pdf
Diabetes Alert Dogs Don’t Detect Hypoglycemic Scent (2013) http://www.healthcentral.com/ diabetes/c/110/162286/diabet es-detect-hypoglycemia .,Non-OADS,/arxiv_data1/oa_pdf/0d/3a/13300_2015_Article_135.PMC4674474.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproductionin any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/01/60/13300_2015_Article_144.PMC4674475.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit556 Diabetes Ther (2015) 6:547–558",Non-OADS,/arxiv_data1/oa_pdf/e8/3d/13300_2015_Article_140.PMC4674476.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/89/29/13300_2015_Article_145.PMC4674477.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/13/ae/13300_2015_Article_146.PMC4674478.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/bf/91/13300_2015_Article_134.PMC4674479.pdf
http://www.idf.org/diabetesatlas .,Non-OADS,/arxiv_data1/oa_pdf/bf/91/13300_2015_Article_134.PMC4674479.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/4c/e0/13300_2015_Article_142.PMC4674480.pdf
Available at: http://5026.fedimbo.,Non-OADS,/arxiv_data1/oa_pdf/4c/e0/13300_2015_Article_142.PMC4674480.pdf
685 685 DOI of original article: http://dx.doi.org/10.1016/j.neo.2015.05.003 .,OADS,/arxiv_data1/oa_pdf/1e/81/main.PMC4674481.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/81/main.PMC4674481.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2015.08.006,OADS,/arxiv_data1/oa_pdf/1e/81/main.PMC4674481.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/58/main.PMC4674482.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/58/main.PMC4674482.pdf
http://dx.doi.org/10.1016/j.shaw.2015.02.004Safety and Health at Work 6 (2015) 192 e199,Non-OADS,/arxiv_data1/oa_pdf/ae/58/main.PMC4674482.pdf
"These were carried out at the West Kowloon Rescue Training Centre of the Hong Kong Fire Services Department, whose training facilitiesincluded a simulated tunnel and maze, as well as live- ﬁre simula- tors to create ﬁre scenes of various situations (Kidde Fire Trainers, http://www.kiddeft.com ), and a simulated mountain rescue event conducted at the Pat Sin Leng Country Park in Hong Kong.",Non-OADS,/arxiv_data1/oa_pdf/ae/58/main.PMC4674482.pdf
2012 [cited 2014 Sep 28];2012:710903. http://dx.doi.org/10.1155/2012/710903 .,OADS,/arxiv_data1/oa_pdf/ae/58/main.PMC4674482.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/a8/main.PMC4674483.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2015.08.001,OADS,/arxiv_data1/oa_pdf/c8/a8/main.PMC4674483.pdf
http://dx.doi.org/10.1016/j.jss.2008.1001.1029 [Epub 2008 Mar 1013].,OADS,/arxiv_data1/oa_pdf/c8/a8/main.PMC4674483.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/7f/main.PMC4674484.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2015.08.003,OADS,/arxiv_data1/oa_pdf/b9/7f/main.PMC4674484.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/f6/main.PMC4674485.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/f6/main.PMC4674485.pdf
http://dx.doi.org/10.1016/j.shaw.2015.02.003Safety and Health at Work 6 (2015) 233 e239,Non-OADS,/arxiv_data1/oa_pdf/e2/f6/main.PMC4674485.pdf
Available from: http://cran.r-project.org/web/packages/lavaan/lavaan.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e2/f6/main.PMC4674485.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/f6/main.PMC4674486.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2015.08.004,OADS,/arxiv_data1/oa_pdf/22/f6/main.PMC4674486.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/60/main.PMC4674487.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2015.08.005,OADS,/arxiv_data1/oa_pdf/2b/60/main.PMC4674487.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/70/main.PMC4674488.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2015.08.002,OADS,/arxiv_data1/oa_pdf/a4/70/main.PMC4674488.pdf
http://dx.doi.org/ 10.1371/journal.pone.0006539 .,Non-OADS,/arxiv_data1/oa_pdf/a4/70/main.PMC4674488.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/15/main.PMC4674489.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2015.07.007,OADS,/arxiv_data1/oa_pdf/53/15/main.PMC4674489.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/cc/main.PMC4674490.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/cc/main.PMC4674490.pdf
http://dx.doi.org/10.1016/j.shaw.2015.07.007Safety and Health at Work 6 (2015) 174 e183,Non-OADS,/arxiv_data1/oa_pdf/10/cc/main.PMC4674490.pdf
Supplementary data Supplementary data related to this article can be found online at http://dx.doi.org/10.1016/j.shaw.2015.07.007 .,OADS,/arxiv_data1/oa_pdf/10/cc/main.PMC4674490.pdf
Available from: http://www.me.go.kr/mamo/web/ board/read.do;jsessionid ¼hw9piuid67CL7E8vicMooo4P79uK1DZgj1Cppq67 aqmEuoFIqMtQuBIy5lc7hp8m.meweb1vhost_servlet_engine1?pagerOffset ¼ 130&maxPageItems ¼10&maxIndexPages ¼10&searchKey ¼&searchValue ¼&Saf Health Work 2015;6:174 e183 182,Non-OADS,/arxiv_data1/oa_pdf/10/cc/main.PMC4674490.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/12/main.PMC4674494.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/12/main.PMC4674494.pdf
http://dx.doi.org/10.1016/j.shaw.2015.04.001Safety and Health at Work 6 (2015) 200 e205,Non-OADS,/arxiv_data1/oa_pdf/3f/12/main.PMC4674494.pdf
[cited 2014 Sep 27].Available from: http://www.mahashramm.gov.in/maha/acts_download/ Building&Consrtuction_Act 1996 .,Non-OADS,/arxiv_data1/oa_pdf/3f/12/main.PMC4674494.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/37/main.PMC4674495.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/37/main.PMC4674495.pdf
http://dx.doi.org/10.1016/j.shaw.2015.04.003Safety and Health at Work 6 (2015) 206 e210,Non-OADS,/arxiv_data1/oa_pdf/00/37/main.PMC4674495.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/57/main.PMC4674496.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/57/main.PMC4674496.pdf
http://dx.doi.org/10.1016/j.shaw.2015.05.004Safety and Health at Work 6 (2015) 218 e226,Non-OADS,/arxiv_data1/oa_pdf/1c/57/main.PMC4674496.pdf
Available from: http://www.ilo.org/wcmsp5/groups/public/@dgreports/@ dcomm/documents/publication/wcms_105146 .,OADS,/arxiv_data1/oa_pdf/1c/57/main.PMC4674496.pdf
Available from: http://www.dawn.com/news/1179280 .,Non-OADS,/arxiv_data1/oa_pdf/1c/57/main.PMC4674496.pdf
Available from: http://www.ilo.org/islamabad/info/public/pr/WCMS_357136/ langeen/index.htm .,Non-OADS,/arxiv_data1/oa_pdf/1c/57/main.PMC4674496.pdf
Available from: http://www.timeanddate.com/holidays/pakistan/labour-day .,Non-OADS,/arxiv_data1/oa_pdf/1c/57/main.PMC4674496.pdf
Available from:http://www.ilo.org/islamabad/info/public/pr/WCMS_338484/lang een/index.,Non-OADS,/arxiv_data1/oa_pdf/1c/57/main.PMC4674496.pdf
Available from: http://www.brecorder.com/ topstories/0/1257528/?tmpl ¼component&print ¼1&layout .Saf Health Work 2015;6:218 e226 226,Non-OADS,/arxiv_data1/oa_pdf/1c/57/main.PMC4674496.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/03/main.PMC4674498.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/03/main.PMC4674498.pdf
http://dx.doi.org/10.1016/j.shaw.2015.05.005Safety and Health at Work 6 (2015) 184 e191,Non-OADS,/arxiv_data1/oa_pdf/58/03/main.PMC4674498.pdf
"*The information is mostly obtained from searching ChemIDplus Advanced, U.S. National Library of Medicine (Rockville Pike, Bethesda, MD; http://chem.sis.nlm.nih.",OADS,/arxiv_data1/oa_pdf/58/03/main.PMC4674498.pdf
"gov/chemidplus/rn/107-05-1 ), and Material Safety Data Sheet in KOSHANET (Ulsan, Korea; http://msds.kosha.or.kr/kcic/msdsdetail.do ).",OADS,/arxiv_data1/oa_pdf/58/03/main.PMC4674498.pdf
"Searches were performed on the following sites: PubMed (http://www.ncbi.nlm.nih.gov/pubmed ), Google Scholar ( http:// scholar.google.com ), and ScienceDirect ( www.sciencedirect.com ).",OADS,/arxiv_data1/oa_pdf/58/03/main.PMC4674498.pdf
Available from: http://www.epa.gov/hpv/pubs/general/opptsrch.htm .,OADS,/arxiv_data1/oa_pdf/58/03/main.PMC4674498.pdf
Available from: http://www.cdc.gov/niosh/ipcsneng/neng0010.,OADS,/arxiv_data1/oa_pdf/58/03/main.PMC4674498.pdf
Available from: http://echa.europa.,Non-OADS,/arxiv_data1/oa_pdf/58/03/main.PMC4674498.pdf
Available from: http://www.moel.go.kr .,Non-OADS,/arxiv_data1/oa_pdf/58/03/main.PMC4674498.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/2e/main.PMC4674502.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/2e/main.PMC4674502.pdf
http://dx.doi.org/10.1016/j.shaw.2015.07.003Safety and Health at Work 6 (2015) 240 e248,Non-OADS,/arxiv_data1/oa_pdf/fb/2e/main.PMC4674502.pdf
Available from: http://www.ptil.no/get ﬁle.php/PDF/RNNP%202011/ RNNP2011_Hovedrapport.pdf [in Norwegian].,Non-OADS,/arxiv_data1/oa_pdf/fb/2e/main.PMC4674502.pdf
Available from: http://www.ptil.no/get ﬁle.php/PDF/RNNP%202011/ Frekvenstabeller/Offshore%202011_tabeller_hele%20utvalget%20%28NY%29.htm [in Norwegian].,OADS,/arxiv_data1/oa_pdf/fb/2e/main.PMC4674502.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/92/main.PMC4674504.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/92/main.PMC4674504.pdf
http://dx.doi.org/10.1016/j.shaw.2015.06.003Safety and Health at Work 6 (2015) 256 e262,Non-OADS,/arxiv_data1/oa_pdf/d7/92/main.PMC4674504.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/04/main.PMC4674506.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/04/main.PMC4674506.pdf
http://dx.doi.org/10.1016/j.shaw.2015.07.005Safety and Health at Work 6 (2015) 249 e255,Non-OADS,/arxiv_data1/oa_pdf/c5/04/main.PMC4674506.pdf
Available from: http://www.eurofound.europa.eu/ surveys/ewcs/2010/index.htm .,Non-OADS,/arxiv_data1/oa_pdf/c5/04/main.PMC4674506.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/46/main.PMC4674508.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/46/main.PMC4674508.pdf
http://dx.doi.org/10.1016/j.shaw.2015.02.006Safety and Health at Work 6 (2015) 227 e232,Non-OADS,/arxiv_data1/oa_pdf/ce/46/main.PMC4674508.pdf
10 p. Available from: http://www.hse.gov.uk/statistics/ industry/construction/index.htm .,Non-OADS,/arxiv_data1/oa_pdf/ce/46/main.PMC4674508.pdf
Available from: https://www.osha.gov/SLTC/etools/safetyhealth/mod4_ factsheets_accinvest.html .,OADS,/arxiv_data1/oa_pdf/ce/46/main.PMC4674508.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/b6/main.PMC4674510.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/b6/main.PMC4674510.pdf
http://dx.doi.org/10.1016/j.shaw.2015.05.002Safety and Health at Work 6 (2015) 211 e217,Non-OADS,/arxiv_data1/oa_pdf/5b/b6/main.PMC4674510.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/91/main.PMC4674512.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/91/main.PMC4674512.pdf
http://dx.doi.org/10.1016/j.shaw.2015.05.003Safety and Health at Work 6 (2015) 159 e173,Non-OADS,/arxiv_data1/oa_pdf/81/91/main.PMC4674512.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/cf/13/40801_2015_Article_46.PMC4674516.pdf
Available from: http://www.longtermcare.or.kr .,Non-OADS,/arxiv_data1/oa_pdf/cf/13/40801_2015_Article_46.PMC4674516.pdf
Available from: http://english.mw.go.kr .,Non-OADS,/arxiv_data1/oa_pdf/cf/13/40801_2015_Article_46.PMC4674516.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/2c/1f/40801_2015_Article_45.PMC4674517.pdf
2003; 4. http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/2c/1f/40801_2015_Article_45.PMC4674517.pdf
MIMS 2015. https://www.mims.com/home/in dex?aspxerrorpath=/Malaysia .,Non-OADS,/arxiv_data1/oa_pdf/2c/1f/40801_2015_Article_45.PMC4674517.pdf
2014. http://www.idf.org/membership/wp/malaysia .,Non-OADS,/arxiv_data1/oa_pdf/2c/1f/40801_2015_Article_45.PMC4674517.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/23/db/40801_2015_Article_43.PMC4674518.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b5/df/40801_2015_Article_51.PMC4674520.pdf
2015. http://i.walmartimages.com/i/if/hmp/fusion/customer_list.,Non-OADS,/arxiv_data1/oa_pdf/b5/df/40801_2015_Article_51.PMC4674520.pdf
2008. http://mottnpch.org/sites/default/ﬁles/ documents/021108GenericRxPrograms.pdf .,OADS,/arxiv_data1/oa_pdf/b5/df/40801_2015_Article_51.PMC4674520.pdf
2015. http://www.hcup-us.ahrq.gov/ toolssoftware/ccs/ccs.jsp .,OADS,/arxiv_data1/oa_pdf/b5/df/40801_2015_Article_51.PMC4674520.pdf
Hedis /C210and quality compass/C210.http://www.ncqa.,OADS,/arxiv_data1/oa_pdf/b5/df/40801_2015_Article_51.PMC4674520.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/78/92/40801_2015_Article_44.PMC4674521.pdf
http://www.ema.europa.eu/docs/e n_GB/document_library/EPAR_-_ Product_Information/human/001245/WC500104835.pdf .,Non-OADS,/arxiv_data1/oa_pdf/78/92/40801_2015_Article_44.PMC4674521.pdf
Guideline on good pharmacovigilance practices (GVP): ModuleXVI Risk minimisation measures: selection of tools and effec- tiveness indicators http://www.ema.europa.eu/docs/en_GB/ document_library/Scientiﬁc_guideline/2013/06/WC500144010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/78/92/40801_2015_Article_44.PMC4674521.pdf
WEUKBRE5744: Europeansurvey of patient and prescriber understanding of risks associ-ated with TROBALT TM.http://www.encepp.eu/encepp/view Resource.htm?id=9225 .,Non-OADS,/arxiv_data1/oa_pdf/78/92/40801_2015_Article_44.PMC4674521.pdf
https://clinicaltrials.gov/ct2/show/NCT01721213 .,Non-OADS,/arxiv_data1/oa_pdf/78/92/40801_2015_Article_44.PMC4674521.pdf
http://hcp.gsk.ie/content/dam/Health/ en_IE/HCP_Home/content/Product/trobalt/documents/ie-trobalt-physicians-guide.pdf .,Non-OADS,/arxiv_data1/oa_pdf/78/92/40801_2015_Article_44.PMC4674521.pdf
Risk Evaluation and Mitiga- tion Strategy (REMS) assessments: social science methodologiesto assess goals related to knowledge: public workshop in June 2012. http://www.fda.gov/Drugs/NewsEvents/ucm292337.htm .,Non-OADS,/arxiv_data1/oa_pdf/78/92/40801_2015_Article_44.PMC4674521.pdf
Guide onmethodological standard in pharmacoepidemiology June 2013. http://www.encepp.eu/standards_and_guidances .,Non-OADS,/arxiv_data1/oa_pdf/78/92/40801_2015_Article_44.PMC4674521.pdf
http://www.fda.gov/Drugs/ DrugSafety/DrugSafetyPodcasts/ucm350120.htm .,Non-OADS,/arxiv_data1/oa_pdf/78/92/40801_2015_Article_44.PMC4674521.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/40801_2015_Article_42.PMC4674522.pdf
2013. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/0223 45s006lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/40801_2015_Article_42.PMC4674522.pdf
http://www.fda.gov/downloads/Drugs/Drug Safety/PostmarketDrugSafetyInformationforPatientsandProvid ers/UCM261933.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/40801_2015_Article_42.PMC4674522.pdf
https://clinicaltrials.gov/ct2/show/NCT01938560 .,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/40801_2015_Article_42.PMC4674522.pdf
June 2012. http://www.fda.gov/Drugs/NewsEvents/ucm292337.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/40801_2015_Article_42.PMC4674522.pdf
"Strengthening Risk Evaluation and Mitigation Strategies (REMS) Through Systematic Analysis, Standardized Design, and Evi- dence-Based Assessment http://www.brookings.edu/ */media/ events/2013/9/25-engelberg-strengthening-rems/rems_summary_ﬁnal.pdf .",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/40801_2015_Article_42.PMC4674522.pdf
WEUKBRE5744: EuropeanSurvey of Patient and Prescriber Understanding of Risks Asso- ciated with TROBALT TM.http://www.encepp.eu/encepp/view Resource.htm?id=9225 .,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/40801_2015_Article_42.PMC4674522.pdf
http://www.fda.gov/Drugs/ DrugSafety/DrugSafetyPodcasts/ucm350120.htm .,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/40801_2015_Article_42.PMC4674522.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/8c/78/40801_2015_Article_49.PMC4674526.pdf
2003. http://www.whocc.no/ﬁlearchive/ publications/drug_utilization_research.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8c/78/40801_2015_Article_49.PMC4674526.pdf
Available: http://www.whocc.,Non-OADS,/arxiv_data1/oa_pdf/8c/78/40801_2015_Article_49.PMC4674526.pdf
2013. http://www.who.int/classiﬁcations/icd/en/ .,OADS,/arxiv_data1/oa_pdf/8c/78/40801_2015_Article_49.PMC4674526.pdf
2001. http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/8c/78/40801_2015_Article_49.PMC4674526.pdf
2005. http://www.rcn.org.uk/__data/assets/pdf_ ﬁle/0009/78588/002062.pdf .,OADS,/arxiv_data1/oa_pdf/8c/78/40801_2015_Article_49.PMC4674526.pdf
2005. http://www.us.,Non-OADS,/arxiv_data1/oa_pdf/8c/78/40801_2015_Article_49.PMC4674526.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/63/c2/40801_2015_Article_41.PMC4674528.pdf
2014.Available from: http://www.oecd.org/health/health-at-a-glance- europe-23056088.htm .,Non-OADS,/arxiv_data1/oa_pdf/63/c2/40801_2015_Article_41.PMC4674528.pdf
"2001. https://www.google.fr/ search?q=Auvray ?L,?Dumesnil ?S,?Le?Fur?P,?Centre ?de ?Recherche ?d%E2%80%99Etude ?et?de?Documentation ?",Non-OADS,/arxiv_data1/oa_pdf/63/c2/40801_2015_Article_41.PMC4674528.pdf
Available from: http://www.leem.org/ bilan-economique-des-entreprises-du-medicament-edition-2014 .,Non-OADS,/arxiv_data1/oa_pdf/63/c2/40801_2015_Article_41.PMC4674528.pdf
Available from: http://www.has-sante.fr/portail/upload/docs/ application/pdf/arret_des_bzd_-_argumentaire.pdf .,Non-OADS,/arxiv_data1/oa_pdf/63/c2/40801_2015_Article_41.PMC4674528.pdf
Available from: http://www.omedit-hautenormandie.fr/Files/maladie_dalzheimer__ synthese___interventions_medicamenteuses_et_non_medicamenteuses.pdf .,Non-OADS,/arxiv_data1/oa_pdf/63/c2/40801_2015_Article_41.PMC4674528.pdf
Available from: http://www.ameli.fr/l-assurance- maladie/statistiques-et-publications/points-de-repere/n-25-l-echantillon-generaliste-de-beneﬁciaires.php .,Non-OADS,/arxiv_data1/oa_pdf/63/c2/40801_2015_Article_41.PMC4674528.pdf
2012.http://www.legifrance.gouv.fr/eli/arrete/2012/1/24/ETSS1129357A/ jo/texte/fr .,Non-OADS,/arxiv_data1/oa_pdf/63/c2/40801_2015_Article_41.PMC4674528.pdf
Available from: http://www.emea.,Non-OADS,/arxiv_data1/oa_pdf/63/c2/40801_2015_Article_41.PMC4674528.pdf
Available from: http://www.has-sante.fr/portail/jcms/c_1252051/ fr/prevention-vasculaire-apres-un-infarctus-cerebral-ou-un-accident-ischemique-transitoire .,Non-OADS,/arxiv_data1/oa_pdf/63/c2/40801_2015_Article_41.PMC4674528.pdf
2002. http://www.bdsp.ehesp.fr/Base/ 260836/ .,Non-OADS,/arxiv_data1/oa_pdf/63/c2/40801_2015_Article_41.PMC4674528.pdf
1994. http://www.bdsp.ehesp.fr/Base/88339/ .,Non-OADS,/arxiv_data1/oa_pdf/63/c2/40801_2015_Article_41.PMC4674528.pdf
2012. http://www.lir.asso.fr/ .,Non-OADS,/arxiv_data1/oa_pdf/63/c2/40801_2015_Article_41.PMC4674528.pdf
2013.http://www.dartmouthatlas.org/publications/reports.aspx .,Non-OADS,/arxiv_data1/oa_pdf/63/c2/40801_2015_Article_41.PMC4674528.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/33/47/40801_2015_Article_48.PMC4674530.pdf
Available at http://www.weforum.org/reports/ global-population-ageing-peril-or-promise .,Non-OADS,/arxiv_data1/oa_pdf/33/47/40801_2015_Article_48.PMC4674530.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/48/rjv152.PMC4674533.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.References 1.",Non-OADS,/arxiv_data1/oa_pdf/32/9f/40801_2015_Article_47.PMC4674546.pdf
2005. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm150688.htm .,OADS,/arxiv_data1/oa_pdf/32/9f/40801_2015_Article_47.PMC4674546.pdf
2008. http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/32/9f/40801_2015_Article_47.PMC4674546.pdf
"Rockville, MD, USA:comparative effectiveness reviews; 2011. http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/32/9f/40801_2015_Article_47.PMC4674546.pdf
Paris: OECD; 2005. http://www.oecd.org/els/health- systems/Ensuring-quality-long-term-care-for-older-people.pdf .,Non-OADS,/arxiv_data1/oa_pdf/32/9f/40801_2015_Article_47.PMC4674546.pdf
[ http://www.whocc.no ].,Non-OADS,/arxiv_data1/oa_pdf/32/9f/40801_2015_Article_47.PMC4674546.pdf
"Ahmad Burhan, Syrian Arab Republic Altuğ Demiralp, Turkey Asli Baysal, Turkey Bo Hoon Joo, Korea Bong-Kuen Cha, Korea Bum-Soon Lim, Korea Cağrı Turkoz, Turkey Cecy Martins Silva, Brazil Cheol-Hyun Moon, Korea Chooryung Chung, Korea Chung Ju Hwang, Korea Derya Germec Cakan, Turkey Ding Bai, China Dong Hwa Chung, Korea Dong-Soon Choi, Korea Ebru Kucukyilmaz, Turkey Eduardo Espinar -Escalona, Spain Ellen BeGole, United States Enver Y etkiner, Switzerland Eung-Kwon Pae, United States Hae-Y oung Kim, Korea Hatice Gokalp, Turkey Hee-Moon Kyung, Korea Heon Jae Cho, Korea Hoi-Jeong Lim, Korea Hossein Bagheri, Iran Hyo-Sang Park, Korea Hyo-Won Ahn, Korea Hyung Seog Yu, Korea Il-Hyung Y ang, Korea Il-Sik Cho, Korea Insan Jang, Korea Jae Hyun Park, United StatesJae-Woo Park, Korea Janghoon Ahn, Korea Jianhua Hou, China Jin Hyoung Cho, Korea Jin-Hyoung Cho, Korea Jiuxiang Lin, China Ji-Y eon Lee, Korea Jong-Moon Chae, Korea Jong-Wan Kim, Korea Josep Maria Ustrell, Spain Jung Seok Lee, Korea Jung-Hoon Kim, Korea Jung-Yul Cha, Korea Junichiro Iida, Japan Kee-Joon Lee, Korea Keun Taek Oh, Korea Ki Beom Kim, United States Ki-Ho Park, Korea Kristina Peros, Croatia Kwang-Mahn Kim, Korea Kyung Hwa Kang, Korea Kyung-Ho Kim, Korea Kyu-Rhim Chung, Korea MA Papadopoulos, Greece Manish Thadani, India Manuel Lagravere, Canada Mariana Marquezan, Brazil Masaru Y amaguchi, Japan Mehmet Bayram, Turkey Mevlut Celikoglu, Turkey Min-Ho Jung, Korea Minji Kim, Korea Nam-Ki Lee, KoreaNa-young Chang, Korea Ning Zhang, China Nita Viwattanatipa, Thailand Noriaki Y oshida, Japan Omur Polat-Ozsoy, Turkey Qiang Li, China Renato Bigliazzi, Brazil Ryoon-Ki Hong, Korea Sang Jin Sung, Korea Seong Sik Kim, Korea Seung-Hak Baek, Korea Siti Adibah Othman, Malaysia Sug-Joon Ahn, Korea Sung Jin Kim, Korea Su-Jung Kim, Korea Sung-hoon Lim, Korea Sunghwan Choi, Korea Sung-Nam Gang, Korea Sung-Seo Mo, Korea Tamer Turk, Turkey Udom Thongudomporn, Thailand Visnja Katic, Croatia Won Hee Lim, Korea Wonjae Yu, Korea Woo-Sung Son, Korea Y asuhiro Shimizu, Japan Y ong-Il Kim, Korea Y ong-Keun Lee, Korea Y oon-Ah Kook, Korea Y oon-Ji Kim, Korea Y ooseok Shin, Korea Y oung Ho Kim, Korea Y oung-Guk Park, KoreapISSN 2234-7518 eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2015.45.6.341341www.e-kjo.org",Non-OADS,/arxiv_data1/oa_pdf/7c/9b/kjod-45-341.PMC4674547.pdf
Gut microbiota and glucose metabolism1–9 5:1 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0094/C2092016 The authors Published by Bioscientiﬁca Ltd.,Non-OADS,/arxiv_data1/oa_pdf/99/18/ec-05-1.PMC4674628.pdf
Gut microbiota and glucose metabolism2–9 5:2 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0094/C2092016 The authors Published by Bioscientiﬁca Ltd.,Non-OADS,/arxiv_data1/oa_pdf/99/18/ec-05-1.PMC4674628.pdf
Gut microbiota and glucose metabolism3–9 5:3 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0094/C2092016 The authors Published by Bioscientiﬁca Ltd.,Non-OADS,/arxiv_data1/oa_pdf/99/18/ec-05-1.PMC4674628.pdf
http://ngs.biodiv.tw/NGS Core/wp-content/uploads/ application%20forms/16s-m etagenomic-li brary-prep- guide-15044223-b.pdf ) using the Nextera XT Index Kit (Illumina) with a dual indexing strategy.,OADS,/arxiv_data1/oa_pdf/99/18/ec-05-1.PMC4674628.pdf
Taxonomic compo- sition of the samples was evaluated using reference-basedapproach according to the database of 16S rRNA genesequences Greengenes v. 13.5 (http://greengenes.second-genome.com/downloads/database/13_50 using RDPClassiﬁer.,OADS,/arxiv_data1/oa_pdf/99/18/ec-05-1.PMC4674628.pdf
Gut microbiota and glucose metabolism4–9 5:4 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0094/C2092016 The authors Published by Bioscientiﬁca Ltd.,Non-OADS,/arxiv_data1/oa_pdf/99/18/ec-05-1.PMC4674628.pdf
Gut microbiota and glucose metabolism5–9 5:5 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0094/C2092016 The authors Published by Bioscientiﬁca Ltd.,Non-OADS,/arxiv_data1/oa_pdf/99/18/ec-05-1.PMC4674628.pdf
Gut microbiota and glucose metabolism6–9 5:6 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0094/C2092016 The authors Published by Bioscientiﬁca Ltd.,Non-OADS,/arxiv_data1/oa_pdf/99/18/ec-05-1.PMC4674628.pdf
Gut microbiota and glucose metabolism7–9 5:7 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0094/C2092016 The authors Published by Bioscientiﬁca Ltd.,Non-OADS,/arxiv_data1/oa_pdf/99/18/ec-05-1.PMC4674628.pdf
Gut microbiota and glucose metabolism8–9 5:8 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0094/C2092016 The authors Published by Bioscientiﬁca Ltd.,Non-OADS,/arxiv_data1/oa_pdf/99/18/ec-05-1.PMC4674628.pdf
"(available from: http://www.diabetesatlas.org/ ) 6 E c k b u r gP B ,B i kE M ,B e r n s t e i nC N ,P u r d o mE ,D e t h l e f s e nL ,S a r g e n tM , Gill SR, Nelson KE & Relman DA.",Non-OADS,/arxiv_data1/oa_pdf/99/18/ec-05-1.PMC4674628.pdf
Gut microbiota and glucose metabolism9–9 5:9 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0094/C2092016 The authors Published by Bioscientiﬁca Ltd.,Non-OADS,/arxiv_data1/oa_pdf/99/18/ec-05-1.PMC4674628.pdf
Targeting HSP90 in RET-driven thyroid cancer1–10 5:10 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0098/C2092016 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/99/2c/ec-05-10.PMC4674629.pdf
Targeting HSP90 in RET-driven thyroid cancer2–10 5:11 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0098/C2092016 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/99/2c/ec-05-10.PMC4674629.pdf
Targeting HSP90 in RET-driven thyroid cancer3–10 5:12 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0098/C2092016 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/99/2c/ec-05-10.PMC4674629.pdf
Original activity was determined through online radioactive decay calculator ( http://www.radpro calculator.com/ Decay.aspx ).,OADS,/arxiv_data1/oa_pdf/99/2c/ec-05-10.PMC4674629.pdf
Targeting HSP90 in RET-driven thyroid cancer4–10 5:13 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0098/C2092016 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/99/2c/ec-05-10.PMC4674629.pdf
Targeting HSP90 in RET-driven thyroid cancer5–10 5:14 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0098/C2092016 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/99/2c/ec-05-10.PMC4674629.pdf
Targeting HSP90 in RET-driven thyroid cancer6–10 5:15 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0098/C2092016 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/99/2c/ec-05-10.PMC4674629.pdf
Targeting HSP90 in RET-driven thyroid cancer7–10 5:16 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0098/C2092016 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/99/2c/ec-05-10.PMC4674629.pdf
Targeting HSP90 in RET-driven thyroid cancer8–10 5:17 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0098/C2092016 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/99/2c/ec-05-10.PMC4674629.pdf
Targeting HSP90 in RET-driven thyroid cancer9–10 5:18 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0098/C2092016 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/99/2c/ec-05-10.PMC4674629.pdf
Targeting HSP90 in RET-driven thyroid cancer10–10 5:19 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0098/C2092016 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/99/2c/ec-05-10.PMC4674629.pdf
Open AccessA Pucci and others Anorexia and high PYY post-SG ID: 15-0020; June 2015 DOI: 10.1530/EDM-15-0020 This work is licensed under a Creative Commons Attribution 4.0International License .q2015 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd,Non-OADS,/arxiv_data1/oa_pdf/ac/04/edmcr-2015-150020.PMC4674657.pdf
A Pucci and others Anorexia and high PYY post-SG ID: 15-0020; June 2015 DOI: 10.1530/EDM-15-0020 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/ac/04/edmcr-2015-150020.PMC4674657.pdf
A Pucci and others Anorexia and high PYY post-SG ID: 15-0020; June 2015 DOI: 10.1530/EDM-15-0020 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/ac/04/edmcr-2015-150020.PMC4674657.pdf
A Pucci and others Anorexia and high PYY post-SG ID: 15-0020; June 2015 DOI: 10.1530/EDM-15-0020 http://www.edmcasereports.com 4,Non-OADS,/arxiv_data1/oa_pdf/ac/04/edmcr-2015-150020.PMC4674657.pdf
(doi:10.3109/00365513.2013.877594 ) Received in ﬁnal form 12 May 2015 Accepted 18 May 2015 A Pucci and others Anorexia and high PYY post-SG ID: 15-0020; June 2015 DOI: 10.1530/EDM-15-0020 http://www.edmcasereports.com 5,Non-OADS,/arxiv_data1/oa_pdf/ac/04/edmcr-2015-150020.PMC4674657.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/d1/b4/10.1177_2058460115617353.PMC4674689.pdf
Available at http://www.cochrane.org/ CD008576/MENSTR_metroplasty-versus-expectant-management-for-women-with-recurrent-miscarriage-and-a-septate-uterus.,Non-OADS,/arxiv_data1/oa_pdf/72/91/e2015.00085.PMC4674815.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/72/main.PMC4674832.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.10.012 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/72/main.PMC4674832.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/72/main.PMC4674832.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/,Non-OADS,/arxiv_data1/oa_pdf/38/72/main.PMC4674832.pdf
E-mail address: scj@medicine.wisc.edu http://dx.doi.org/10.1016/j.dadm.2015.09.005 2352-8729/Published by Elsevier Inc. on behalf of the Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/ce/77/main.PMC4674833.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/77/main.PMC4674833.pdf
Available at: http://www.childinfo.org/mics4.html (Accessed 9 May2006).,Non-OADS,/arxiv_data1/oa_pdf/4f/03/MCN-11-333.PMC4674961.pdf
"BMC Pediatrics 12, 151. http://www.biomedcentral.com/1471- 2431/12/151 Zongrone A., Winskell K. & Menon P .",Non-OADS,/arxiv_data1/oa_pdf/4f/03/MCN-11-333.PMC4674961.pdf
"Food and Drug Administration Advisory Committee Briefing Document:insulindegludecandinsulindegludec/insulinaspart–treatmenttoimproveglycemiccontrolinpatientswithdiabetesmellitus.November8,2012.Available from URL: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM327017.pdf.Accessed30July2014.",Non-OADS,/arxiv_data1/oa_pdf/13/8c/dom0017-0261.PMC4674964.pdf
English indices of deprivation 2010: Overall.Available from: https://www.gov .uk/government/publications/ english-indices-of-deprivation-2010[last accessed 20 August 2014].,Non-OADS,/arxiv_data1/oa_pdf/be/35/jcpp0056-0848.PMC4674965.pdf
URL http://www.worldwidewounds.com [accessed on15June 2013] 6.International consensus.,Non-OADS,/arxiv_data1/oa_pdf/d6/8b/IWJ-11-438.PMC4674970.pdf
"Thus, we are currently in a situation resembling the proverbial blind men examining different parts of an ele- phant (http://en.wikisource.org/wiki/The_Blindmen_and_the_ 1Department of Ecology, Environment and Plant Sciences, Stockholm University, Stockholm, Sweden 2Department of Ecology and Genetics, Uppsala University, Uppsala, Sweden3Department of Biology, Duke University, Durham, NC, USA *Correspondence: E-mail: wfmorris@duke.edu †Both authors contributed equally to all aspects of this work.",Non-OADS,/arxiv_data1/oa_pdf/9c/e2/ele0018-0303.PMC4674973.pdf
"2005.Available online at: https://www.guysandstthomas.nhs.uk/resources/education-training/sail/reading/crisis-mgt-pt-safety.pdf (accessed June 24, 2014).",Non-OADS,/arxiv_data1/oa_pdf/27/b8/aogs0094-0316.PMC4674974.pdf
"Available online at: http://eqs-kk.sus.no/exportkk/docs/doc_12593/index.html (accessedOctober 6, 2014).",Non-OADS,/arxiv_data1/oa_pdf/27/b8/aogs0094-0316.PMC4674974.pdf
Available at: http://www.nist.,Non-OADS,/arxiv_data1/oa_pdf/47/e0/ina0025-0610.PMC4674977.pdf
RiksSvikt is a national registry that aims to assess and improve the quality of care and provide systematic research in HF in Sweden (http://www.rikssvikt.se) 17a n di n c l u d e d5 53 13 individuals who were registered from 2000 to 20 13 at discharge from hospital or outpatientvisit.TheSwedishDementiaRegistry(SveDem)isanational registry for monitoring and improvement of the quality of dementiacare in Sweden (http://www.svedem.se).,OADS,/arxiv_data1/oa_pdf/d3/6f/ejhf0017-0612.PMC4674979.pdf
"Author contributions All authors have agreed on the ﬁnal version and meet atleast one of the following criteria [recommended by the IC- MJE (http://www.icmje.org/ethical_1author.html)]:substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; drafting the article or revising it critically for importantintellectual content.",Non-OADS,/arxiv_data1/oa_pdf/9c/b5/jan0071-1055.PMC4674980.pdf
Retrieved from http://www.nice.org.uk/nicemedia/live/13465/54202/54202.pdf on 10 February 2013.,Non-OADS,/arxiv_data1/oa_pdf/9c/b5/jan0071-1055.PMC4674980.pdf
Retrieved from http://www.nice.org.uk/guidance/cmg43/chapter/43-specify- ing-supportive-and-palliative-care-for-people-with-copd on 05October 2014.,Non-OADS,/arxiv_data1/oa_pdf/9c/b5/jan0071-1055.PMC4674980.pdf
Retrieved from https://www.nice.org.uk/guidance/cg163on 05 October 2014.,Non-OADS,/arxiv_data1/oa_pdf/9c/b5/jan0071-1055.PMC4674980.pdf
Fast and easy online submission: online submission at http://mc.manuscriptcentral.com/jan.,Non-OADS,/arxiv_data1/oa_pdf/9c/b5/jan0071-1055.PMC4674980.pdf
Data accessibility Data available from the Dryad Digital Repository: http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/9e/ea/jane0084-0723.PMC4674981.pdf
"Dryad Digital Repository , http://dx.doi.org/10.5061/dryad.3kb72.",OADS,/arxiv_data1/oa_pdf/9e/ea/jane0084-0723.PMC4674981.pdf
